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Slow and deep breathing (SDB) has long been regarded as a nonpharmacological 
method for dealing with several physiological and emotional imbalances, and widely 
used for relaxation purposes. There is, however, limited understanding of the 
putative mechanisms by which SDB acutely impacts the cardiovascular and 
autonomic systems to elicit chronic adaptations. The present thesis explored how 
the manipulation of breathing pattern and intrathoracic pressure during SDB could 
further the understanding of the regulatory mechanisms that underpin the acute 
cardiovascular response to SDB. This thesis makes an original contribution to the 
existing knowledge by reporting a previously undescribed inversion of normal within-
breath (inspiration vs. expiration) left ventricular stroke volume (LVSV) pattern for 
breathing frequencies < 8 breaths∙min-1. This finding might reflect the influence of a 
lag between enhanced right atrial filling and right ventricular stroke volume during 
inspiration, and its expression in left ventricular stroke volume; this lag results from 
the time required for blood to transit the pulmonary circulation. Furthermore, blood 
pressure variability (BPV) was reduced significantly at the lowest breathing 
frequencies, likely due to the involvement of baroreflex mediated responses. The 
pattern of responses was consistent with the buffering of respiratory-driven 
fluctuations in left ventricular cardiac output (Q̇) and arterial blood pressure (ABP) 
by within breath fluctuations in heart rate (fc), i.e., respiratory sinus arrhythmia 
(RSA) (Chapter 4). Chapter 5 demonstrated that magnifying negative intrathoracic 
pressure with inspiratory loading during SDB increased inspiratory pressure-driven 
fluctuations in LVSV and fc, and enhanced Q̇, independently of changes in VT and 
fR. The data support an important contribution to the amplification of RSA, during 
SDB, of previously underappreciated reflex, and/or ‘myogenic’, cardiac response 
mechanisms. The findings in Chapter 6 confirmed that inspiratory loading during 
SDB amplified the effects observed with un-loaded SDB (reported in chapter 5). In 
contrast, expiratory loading increased ABP and attenuated RSA, LVSV and Q̇ during 
SDB. A lower RSA for higher ABP, supports the presence of a formerly 
underappreciated contribution of sinoatrial node stretch to RSA, and throws into 
question the clinical benefits of expiratory resisted SDB, particularly in hypertensive 
populations. In conclusion, the findings of the present thesis provide novel 
information regarding the mechanisms contributing to acute cardiovascular 
response to SDB. These new insights may contribute to the development of more 
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effective SDB interventions, geared towards maximising the perturbation to the 










“You know that our breathing is the inhaling and 
exhaling of air. The organ that serves for this is the lungs 
that lie round the heart, so that the air passing through 
them thereby envelops the heart. Thus, breathing is a 
natural way to the heart. And so, having collected your 
mind within you, lead it into the channel of breathing 
through which air reaches the heart and, together with 
this inhaled air, force your mind to descend into the 
heart and to remain there.” 
 
Nikephoros the Monk  






The completion of this thesis would not have been possible without the invaluable 
support of numerous colleagues, friends and family members of which I shared this 
path with. 
 
My deepest gratitude goes to my supervisors, Professor Alison McConnell and 
Professor José Gonzalez-Alonso, for providing me with the insight, advice and 
continuous support, throughout my tenure at Brunel University. Alison, you were 
always there for me, during both good and bad moments. You were inspirational 
and words are not enough to describe how grateful I am and honoured I feel for 
having had the opportunity to work under your guidance. I have learnt so much that 
I could not have wished for better preparation for my future career. José, your 
untiring support and no-nonsense approach to research were key to the successful 
completion of this thesis. Your work and knowledge in physiology is a great 
inspiration and I am forever indebted for all your comments and advice during these 
four years.  Thank you to both for the patience and mentoring showed throughout 
my PhD studies.  
 
A word of gratitude to fellow colleagues Dr Eurico Wilhelm for the invaluable 
assistance in the collection of ultrasonographical data, and Laís Vidotto, for the help 
in the analysis of some of the data comprised in this thesis.  
 
My appreciation also goes to the friends and colleagues at the Department of Life 
Sciences, particularly my fellow research students, Dr Steve Trangmar, Dr Scott 
Chiesa, Dr Nick Tiller, Dr Andrew Simpson, Dr Adam Cocks, Giorgia D’Innocenzo, 
Patrick Fasbender, Jennifer Hall, George Pamboris, Adele Burnett, João Greca, 
Toby Ellmers and Jamie McDermott.  I feel blessed to have met such a great group 
of individuals. Our discussions about science were always insightful, and the time 
we spent together made my tenure at Brunel much more enjoyable. I wish you  the 
best for your future, and I’m thankful to have you all as friends. 
 
I am also indebted to the support of Chris Stock, Julie Bradshaw, Coral Hankins, 
and Gary Dear to the successful completion of these studies. I am further grateful 
 
v 
for the contribution of all the participants who gave their time to the research 
contained within this thesis. 
 
A special acknowledgement to Simon Wegerif, for the always fascinating scientific 
debate. Working with you over the last couple of years has been an exciting 
experience.  
 
I dedicate this thesis to my wife Filipa for all that she had to endure, for her love and 
unconditional support over the last four years. This thesis is also for my children, 
Rodrigo and Marta, who I deprived from my presence for far too long. I hope to be 
able to compensate you for my absence over the years. 
 
I am grateful to my parents for their ongoing support and for the education they gave 
me, always teaching me to try to be the best I can be. I would like to pay special 
thanks to my close friends, Nici, Will and Francesco. Your constant support, as well 
as your ability to encourage me when I was down, were fundamental. 
 
Lastly, I acknowledge Professor James Fisher, Dr Mandy Jones and Dr Richard 
Godfrey for agreeing to the thankless task of examining this thesis. 
 
 
The work contained within this thesis was funded by the Fundação para a Ciência e Tecnologia 
(Portuguese Foundation for Science and Technology), to which I am eternally grateful.  
 
vi 
TABLE OF CONTENTS 
CHAPTER 1 – GENERAL INTRODUCTION 1 
1-1 STUDY CONTEXT 2 
CHAPTER 2 – LITERATURE REVIEW 6 
2-1 INTRODUCTION 7 
2-2 AFFERENT INFLUENCES UPON ACUTE CONTROL OF BLOOD PRESSURE 7 
2-2.1 Arterial baroreceptors 7 
2-2.2 Other baroreceptors involved in the cardiovascular and 
autonomic responses 10 
2-2.3 Chemoreceptor stimulation and regulation of blood pressure 12 
2-2.4 Short term hormonal control of blood pressure 15 
2-2.5 Summary 16 
2-3 MECHANICAL EFFECTS OF BREATHING – HEART-LUNG INTERACTIONS 17 
2-3.1 Impact of breathing on right ventricular preload 19 
2-3.2 Impact of breathing on right ventricular afterload 22 
2-3.3 Impact of breathing on left ventricular preload 23 
2-3.4 Impact of breathing on left ventricular afterload 23 
2-3.5 Other factors influencing lung-heart interactions 25 
2-4 CARDIOVASCULAR OSCILLATIONS 26 
2-4.1 Historical perspective 26 
2-4.2 Oscillations in blood pressure 29 
2-4.3 Oscillations in heart rate 30 
2-4.4 Oscillations in sympathetic nervous activity 39 
2-4.5 Coherence and entrainment 41 
2-4.6 Summary 42 
2-5 ACUTE EFFECTS OF VARIATIONS IN BREATHING PATTERN AND INTRA-THORACIC 
PRESSURE UPON THE CARDIOVASCULAR SYSTEM 45 
2-5.1 Effects of breathing pattern 45 
2-5.2 Effects of intra-thoracic pressure 49 
2-6 OVERALL SUMMARY 51 
2-7 AIMS OF THE PRESENT RESEARCH AND RESEARCH HYPOTHESES 52 
 
vii 
CHAPTER 3 – GENERAL METHODS 55 
3-1 INTRODUCTION 56 
3-2 PRE-TEST PROCEDURES 56 
3-2.1 Ethical approval 56 
3-2.2 Participants 56 
3-2.3 Anthropometry 57 
3-2.4 Pulmonary function 57 
3-2.5 Randomisation procedures 58 
3-3 APPARATUS AND PROCEDURES 59 
3-3.1 Data acquisition and display 59 
3-3.2 Device guided breathing and respiratory measurements 60 
3-3.3 Rebreathing system 64 
3-3.4 Loaded breathing 66 
3-3.5 Cardiovascular measurements 67 
3-3.6 Echocardiography 70 
3-3.7 Heart rate variability 74 
3-3.8 Blood pressure variability 78 
3-3.9 ‘Peak-Valley’ methods applied to cardiovascular data 78 
3-3.10 Baroreflex sensitivity 80 
3-3.11 Phase and time shift relationships 83 
3-3.12 Statistical analysis and data presentation 84 
3-4 CONTRIBUTION 84 
CHAPTER 4 – THE INDEPENDENT INFLUENCE OF BREATHING 
FREQUENCY AND TIDAL VOLUME UPON THE ACUTE 
CARDIOVASCULAR RESPONSES TO SLOW AND DEEP 
BREATHING                                                                                      85 
4-1 ABSTRACT 86 
4-2 INTRODUCTION 88 
4-3 SPECIFIC METHODS 91 
4-3.1 Overview 91 
4-3.2 Participants 91 
4-3.3 General Design 91 
 
viii 
4-3.4 Procedure 93 
4-3.5 Statistical analysis 95 
4-4 RESULTS 95 
4-4.1 Respiratory responses elicited by each condition 95 
4-4.2 Cardiovascular response to SDB 97 
4-4.3 Heart rate and blood pressure variability responses to SDB 103 
4-4.4 Relationships between cardiovascular parameters, heart rate 
and blood pressure variabilities 108 
4-4.5 Analysis of parameters contributing to respiratory sinus 
arrhythmia 112 
4-4.6 Cardiorespiratory time shift and phase angle 112 
4-5 DISCUSSION 116 
4-5.1 Cardiovascular responses to SDB 116 
4-5.2 Insights from transfer function analysis 125 
4-5.3 Impact of stringent control of breathing pattern vs. semi-
spontaneous breathing 128 
4-5.4 Implications for future research on SDB interventions 130 
4-6 METHODOLOGICAL CONSIDERATIONS 131 
4-7 CONCLUSION 132 
CHAPTER 5 – THE INFLUENCE OF INTRATHORACIC PRESSURE 
UPON RESPIRATORY MODULATION OF CARDIOVASCULAR 
CONTROL DURING SLOW, DEEP BREATHING 133 
5-1 ABSTRACT 134 
5-2 INTRODUCTION 136 
5-3 SPECIFIC METHODS 137 
5-3.1 Participants 137 
5-3.2 Ethical approval 137 
5-3.3 Protocol 137 
5-3.4 Procedures and instrumentation of participants 139 
5-3.5 Statistical analysis 141 
5-4 RESULTS 143 
5-4.1 Cardiac function response to lower body positive pressure 143 
5-4.2 Respiratory changes with each condition 143 
 
ix 
5-4.3 Cardiovascular response to slow and deep breathing, 
inspiratory loading and lower body positive pressure 145 
5-4.4 Relationship between cardiac haemodynamics and 
respiratory sinus arrhythmia 148 
5-4.5 Heart rate and blood pressure variabilities 149 
5-4.6 Cross-spectral phase angle and time shift 153 
5-4.7 Relationship between cardiovascular, heart rate variability, 
blood pressure variability and cross-spectral time shift 
indices. 155 
5-5 DISCUSSION 158 
5-5.1 Effects of loaded breathing upon systemic haemodynamic 
response 158 
5-5.2 Potential influences upon baroreceptor stimulation 160 
5-5.3 Effects of loaded breathing upon HRV and BPV 163 
5-5.4 Effects of loaded breathing upon phase angle relationships 168 
5-5.5 Haemodynamic impact of lower body positive pressure 170 
5-5.6 Translational relevance 172 
5-6 CONCLUSIONS 173 
CHAPTER 6 – THE INFLUENCE OF DIFFERENT MODALITIES OF 
AIRWAY RESISTANCE UPON THE ACUTE CARDIOVASCULAR 
RESPONSES TO SLOW AND DEEP BREATHING 174 
6-1 ABSTRACT 175 
6-2 INTRODUCTION 176 
6-3 SPECIFIC METHODS 179 
6-3.1 Participants 179 
6-3.2 Ethical Approval 179 
6-3.3 Protocol 179 
6-3.4 Procedures and instrumentation of participants 180 
6-4 RESULTS 185 
6-4.1 Cardiovascular response 185 
6-4.2 Inspiratory vs. expiratory resistances during slow and deep 
breathing 188 
6-4.3 Strongest influences upon respiratory sinus arrhythmia during 
loaded breathing 191 
 
x 
6-4.4 Heart rate and blood pressure variability response 192 
6-4.5 Phase angle and time shift 196 
6-5 DISCUSSION 199 
6-5.1 Effects of inspiratory vs. expiratory resisted breathing 200 
6-5.2 Flow resisted breathing vs. threshold loaded breathing 205 
6-5.3 Single-nostril breathing 208 
6-6 LIMITATIONS 209 
6-7 CONCLUSIONS 209 
CHAPTER 7 – GENERAL DISCUSSION 211 
7-1 INTRODUCTION 212 
7-2 OVERVIEW OF OBJECTIVES 212 
7-3 MAIN FINDINGS 212 
7-3.1 Effects of breathing frequency, tidal volume and PaCO2 212 
7-3.2 Effects of intrathoracic pressure variation 213 
7-3.3 Effects of different methods of creating intrathoracic pressure 
variations 213 
7-4 INTERPRETATION OF FINDINGS 214 
7-4.1 Effect of breathing frequency 218 
7-4.2 Effects of tidal volume 226 
7-4.3 Effect of changes in intrathoracic pressure 227 
7-4.4 Effects of different methods of respiratory loading 229 
7-4.5 Effects of PaCO2 230 
7-4.6 Summary 231 
7-5 LIMITATIONS 233 
7-5.1 Sample size 233 
7-5.2 Measurement errors 234 
7-5.3 Day to day variability 234 
7-5.4 Breathing pattern control 235 
7-5.5 Uncoupling of heart rate and HRV 236 
7-6 DIRECTIONS FOR FUTURE RESEARCH 238 
7-6.1 Effects of breathing pattern (thoracic vs. diaphragmatic) 238 
7-6.2 Heart-lungs interactions – right vs. left ventricular function 
response to SDB 238 
7-6.3 Sensitisation and neuroplasticity in response to SDB 239 
 
xi 
7-6.4 Effect of slow and deep breathing upon cerebral blood flow 240 
7-7 NOVELTY AND UTILITY OF FINDINGS 243 
7-8 CONCLUSIONS 245 
REFERENCES 246 
APPENDICES 292 
APPENDIX I – SUMMARY 293TABLE OF RELEVANT STUDIES FOR 
THE UNDERSTANDING THE ACUTE CARDIOVASCULAR EFFECTS 
OF SDB            293 
APPENDIX II – LIST OF COMPUTED WITHIN-BREATH 
CARDIOVASCULAR VARIABLES 300 
APPENDIX III – ETHICAL APPROVAL 302 
APPENDIX IV – PARTICIPANT INFORMATION 306 
APPENDIX V – CONSENT FORM 329 




LIST OF FIGURES 
 
Figure 2-1 – Schematic representation of the neural baroreflex response to hypotensive and 
hypertensive stimuli. .............................................................................................................................. 8 
Figure 2-2 – Model of respiratory chemoreflex control of ventilation. ....................................................... 14 
Figure 2-3 – The Wigger’s diagram of the cardiac cycle ............................................................................. 18 
Figure 2-4 – Reporting changes in cardiac pressures relative to the respiratory cycle instead of the 
cardiac cycle .......................................................................................................................................... 18 
Figure 2-5 – Illustration of the mechanical effects of spontaneous respiration on cardiovascular 
function. ................................................................................................................................................. 20 
Figure 2-6 – Effects of thoracic or diaphragm breathing patterns ............................................................. 21 
Figure 2-7 – Effect of lung volume upon pulmonary vascular resistance. ................................................ 22 
Figure 2-8 – Variation in great vessel blood flow per minute as a function of respiratory phase. .......... 24 
Figure 2-9 – Scheme of the main known oscillations affecting arterial blood pressure fluctuations. .... 44 
Figure 3-1 – Example of .CSV export file from www.randomizer.com ....................................................... 59 
Figure 3-2 – Screenshot of the device guided breathing software’s interface .......................................... 61 
Figure 3-3 – Illustration of dead space volume (dark grey) and exterior configuration of the Hans 
Rudolph heated pneumotachographs. ................................................................................................ 62 
Figure 3-4 – Example of Lilly type pneumotachograph functioning. ......................................................... 62 
Figure 3-5 – Participant undergoing device guided slow and deep breathing .......................................... 65 
Figure 3-6 – Flow-dependent inspiratory resistance breathing device. ..................................................... 66 
Figure 3-7 – Example of the fitting of a photoplethysmographic finger cuff for continuous non-invasive 
arterial blood pressure measurement ................................................................................................. 68 
Figure 3-8 – Ultrasound system and probe. ................................................................................................. 72 
Figure 3-9 – Utilised Ultrasonographic views for left ventricular function assessment. ......................... 73 
Figure 3-10 – Measurements for volume calculations using the biplane method of discs (modified 
Simpson's rule) ..................................................................................................................................... 73 
Figure 3-11 – Method for determining the left ventricular volume using the Simpson’s biplane method.
 ................................................................................................................................................................ 74 
Figure 3-12 – Example of a Poincaré plot of a 5-min ECG recording. ........................................................ 77 
Figure 3-13 – Representation of the calculation of baroreflex sensitivity by the sequence method for 
one individual. ....................................................................................................................................... 81 
Figure 3-14 – Example of cross spectral analysis performed by ANSlab between heart rate period (ibi) 
and systolic blood pressure (SYS) ...................................................................................................... 82 
Figure 3-15 – Graphical representation of the relation between systolic blood pressure (SBP), heart 
rate (HR) and diastolic blood pressure (DBP) .................................................................................... 84 
Figure 4-1 – General study design. ............................................................................................................... 93 
Figure 4-2 – Cardiovascular response to SDB ............................................................................................. 99 
Figure 4-3 – Within-breath cardiovascular response to SDB ................................................................... 100 
Figure 4-4 – Time shift responses between respiration (RESP), systolic blood pressure (SBP), diastolic 
blood pressure (DBP) and heart rate (fc) to variations in breathing frequency (A-E) and tidal 
volume (F-J). ........................................................................................................................................ 114 
Figure 5-1 – Sequence of the experimental protocol. ................................................................................ 139 
Figure 5-2 – Experimental set-up ................................................................................................................ 140 
Figure 5-3 – Difference relative to slow and deep breathing at 6 breaths·min-1 and 40% of forced vital 
capacity. ............................................................................................................................................... 147 
 
xiii 
Figure 5-4 – Relationship between stroke volume (left panel), cardiac output (right panel) and 
respiratory sinus arrhythmia. ............................................................................................................. 148 
Figure 5-5 – Heart rate and blood pressure variabilities total power responses to combined slow and 
deep breathing, inspiratory loading and lower body positive pressure. ....................................... 150 
Figure 5-6 – Relationship between the within-breath variation in stroke volume and blood pressure 
variability total power. ........................................................................................................................ 151 
Figure 5-7 – Relationship between cardiovascular and cross-spectral time shift indices. .................... 156 
Figure 5-8 – Relationship between heart rate variability total power, blood pressure variability total 
power and cross-spectral time shift indices. .................................................................................... 157 
Figure 5-9 – Data from one individual breathing at 6 breaths·min-1 denoting the presence of high-
frequency harmonic components in the HRV (top) and BPV (bottom) tachograms. .................... 167 
Figure 6-1 – Example sequence of the experimental protocol ................................................................. 180 
Figure 6-2 – Left panel: expiratory (Threshold PEP) and inspiratory (Threshold IMT) threshold loading 
devices. Right panel: Bespoke threshold loading circuit ................................................................ 182 
Figure 6-3 – Placement of nasal probe for single left nostril breathing. .................................................. 183 
Figure 6-4 – Systemic haemodynamic responses to resisted slow and deep breathing. ...................... 186 
Figure 6-5 – Individual cardiovascular responses to inspiratory and expiratory resisted breathing. .. 189 
Figure 6-6 – Relationship between mean respiratory pressures (average pressure during the entire 
respiratory cycle) and the cardiovascular response to inspiratory loading, expiratory loading and 
unloaded SDB. ..................................................................................................................................... 190 
Figure 6-7 – Total heart rate variability and blood pressure variability power responses to resisted 
slow and deep breathing. ................................................................................................................... 194 
Figure 6-8 – Respiratory, heart rate and blood pressure time shift variations with resisted slow and 
deep breathing. ................................................................................................................................... 197 
Figure 6-9 – Comparison of airflow and respiratory pressures for one individual using a flow resisted 
breathing device (upper panel) and a threshold loading device (lower panel). ............................. 206 
Figure 7-1 – A schematic of an integrated mechanistic model to describe the acute cardiovascular 
responses to slow and deep breathing ............................................................................................. 217 
Figure 7-2 – Effect of pulmonary transit time upon the transmission of right to left ventricular filling 




LIST OF TABLES 
 
Table 4-1 – Descriptive characteristics of the participants. ........................................................................ 91 
Table 4-2 – Respiratory parameters for the fixed VT protocol. .................................................................... 97 
Table 4-3 – Respiratory parameters for the fixed fR protocol. ..................................................................... 97 
Table 4-4 – Cardiovascular responses to SDB at fixed VT (30% FVC). ..................................................... 101 
Table 4-5 – Cardiovascular responses to SDB at fixed individual ideal fR (4 or 6 breaths∙min-1). ......... 102 
Table 4-6 – Heart rate variability response to slow, deep breathing at fixed VT (30% FVC). .................. 105 
Table 4-7 – Heart rate variability response to slow, deep breathing at fixed individual ideal fR (4 or 6 
breaths∙min-1). ..................................................................................................................................... 105 
Table 4-8 – Blood pressure variability response to slow, deep breathing at fixed VT (30% FVC). ........ 107 
Table 4-9 – Blood pressure variability response to slow, deep breathing at fixed individual ideal fR (4 or 
6 breaths∙min-1). .................................................................................................................................. 107 
Table 4-10 – Correlations between cardiovascular parameters, HRV and BPV indices for slow, deep 
breathing at 4 to 10 breaths.min-1 with fixed VT (30% FVC). ............................................................ 110 
Table 4-11 – Correlations between cardiovascular parameters, HRV and BPV indices for slow, deep 
breathing at 20 to 40% FVC with fixed fR (4 or 6 breaths∙min-1). ..................................................... 111 
Table 4-12 – Phase angle responses to SDB at fixed VT (30% FVC). ........................................................ 115 
Table 4-13 – Phase angle responses to SDB at a fixed individual ideal fR (4 or 6 breaths∙min-1). ......... 115 
Table 5-1 – Left ventricular function in response to progressive LBPP .................................................. 143 
Table 5-2 – Experimental respiratory parameters. ..................................................................................... 144 
Table 5-3 – Systemic haemodynamic responses to slow and deep breathing with different grades of 
inspiratory loading and lower body positive pressure. ................................................................... 146 
Table 5-4 – Heart rate and blood pressure variabilities response to slow and deep breathing with 
different grades of inspiratory loading and lower body positive pressure. ................................... 152 
Table 5-5 – Phase angle response to slow and deep breathing with different grades of inspiratory 
loading and lower body positive pressure for respiration, heart rate and blood pressure. ......... 154 
Table 5-6 –Time shift responses to slow and deep breathing with different grades of inspiratory 
loading and lower body positive pressure for respiration, heart rate and blood pressure. ......... 154 
Table 6-1 – Characterisation of respiratory parameters during all loaded breathing sets. .................... 181 
Table 6-2 – Systemic haemodynamic responses....................................................................................... 187 
Table 6-3 – Heart rate and blood pressure variabilities ............................................................................. 195 
Table 6-4 – Respiratory, blood pressure and heart rate phase angle response to loaded slow and deep 





LIST OF ABBREVIATIONS 
ABP Arterial blood pressure 
Ach Acetylcholine 
ANGII Angiotensin II 
ANP Atrial natriuretic peptide 
BPV Blood pressure variability 
BPVHF Blood pressure variability high-frequency power 
BPVLF Blood pressure variability low-frequency power 
BPVTOT Blood pressure variability total power 
BRS Cardiac baroreflex sensitivity 
BRSFreq Cross-spectral cardiac baroreflex sensitivity gain 
BRSup Sequence baroreflex sensitivity positive sequence gain  
BRSdown Sequence baroreflex sensitivity negative sequence gain 
BRSSeq Average sequence baroreflex sensitivity gain 
BTPS Body temperature and pressure, saturated with water 
vapour 
CBF Cerebral blood flow 
CSF Cerebrospinal fluid 
DBP Diastolic blood pressure 
EF Expiratory flow resisted slow and deep breathing 
ET Expiratory threshold loaded breathing slow and deep 
breathing 
DF Simultaneous inspiratory and expiratory flow resisted slow 
and deep breathing 
DGB Device-guided breathing 
DT Simultaneous inspiratory and expiratory threshold loaded 
slow and deep breathing 
fc Heart rate 
fcE Heart rate during expiration 
fcI Heart rate during inspiration 
FEV1 Forced expiratory volume in one second 
FFT Fast Fourier transform 
fR Respiratory frequency 
FRC Functional residual capacity 
FVC Forced vital capacity 
 
xvi 
HF High frequency 
HRV Heart rate variability 
HRVHF Heart rate variability high frequency power 
HRVLF Heart rate variability low frequency power 
HRVTOT Heart rate variability total power 
IF Inspiratory flow resisted slow and deep breathing 
IL Inspiratory resisted slow and deep breathing 
IT Inspiratory threshold loaded slow and deep breathing 
LBNP Lower body negative pressure 
LBPP Lower body positive pressure 
LF Low frequency 
LVSV Left ventricular stroke volume 
LVSVE Left ventricular stroke volume during expiration 
LVSVI Left ventricular stroke volume during inspiration 
ΔSV Within-breath left ventricular stroke volume variation 
MAP Mean arterial pressure 
MIF Mean inspiratory flow 
MSNA Muscle sympathetic nerve activity 
PaCO2 Partial pressure of carbon dioxide in arterial blood 
PETCO2 Partial pressure of end-tidal carbon dioxide 
PaO2 Partial pressure of oxygen in arterial blood 
PE Expiratory pressure 
PEmax Maximal expiratoy pressure 
PI Inspiratory pressure 
PP Pulse pressure 
PSD Power spectral density 
PulTT Pulmonary transit time 
Q̇ Cardiac output 
Q̇I Inspiratory cardiac output 
Q̇E Expiratory cardiac output 
ΔQ̇ Within-breath cardiac output variation 
RESP Instantaneous lung volume 
RMSSD Square root of the mean squared differences of successive 
normal-to-normal RR intervals 
RSA Respiratory sinus arrhythmia 
 
xvii 
RVSV Right ventricular stroke volume 
SASRs Slowly adapting pulmonary stretch receptors 
SBP Systolic blood pressure 
SD Standard deviation 
SDB Slow and deep breathing 
SDNN Standard deviation of normal-to-normal RR intervals 
SD1 Standard deviation of the dispersion of successive RR 
intervals perpendicular to the identity line of the Poincaré 
plot 
SD2 Standard deviation of the points along the identity line of the 
Poincaré plot 
SEM Standard error of the mean 
SNA Sympathetic nerve activity 
SSfR Semi-spontaneous breathing at a fixed breathing frequency 
SSVT Semi-spontaneous breathing at a fixed tidal volume 
TE Expiratory phase duration 
TI Inspiratory phase duration 
TI/TTOT Duty cycle 
TTOT Total breath duration 
TPR Total peripheral resistance 
UL Un-resisted slow and deep breathing 
V̇A Alveolar ventilation 
V̇D Dead space ventilation 
V̇E Minute ventilation  
VLF Very low frequency 
VT Tidal volume 








1-1 Study context 
There is currently a body of evidence suggesting that the daily practice of slow and 
deep breathing (SDB), over a period of 2 months or more, may have 
antihypertensive effects in individuals with high blood pressure (Cernes and 
Zimlichman, 2015). Similarly, a very recent meta-analysis, limited to randomised 
controlled trials including a variety of SDB exercises, has shown significant 
reductions in resting heart rate (fc) and ABP, following at least 2 weeks of training, 
in patients with cardiovascular disease (Zou, Zhao, Hou et al., 2017).  
 
The use of SDB has been historically associated with meditation and yoga, and 
traditionally believed to convey a healing effect. Controlled breathing patterns have 
been a common thread in the integrative physiology and psychophysiology research 
fields for the past four decades. Early studies employed a respiratory stimulus as a 
perturbation to the cardiovascular neural control systems, in an attempt to 
understand the interaction between respiratory and cardiovascular control 
(Dornhorst, Howard and Leathart, 1952b, Angelone and Coulter, 1964, Eckberg, 
Kifle and Roberts, 1980, Eckberg, 1983). There are also early reports of SDB 
interventions using biofeedback, yoga, meditation or a combination of these 
techniques, resulting in improvement in relevant clinical outcomes, in particular 
reduced arterial blood pressure (ABP) (Patel, 1975, Patel and North, 1975, 
Blackwell, Bloomfield, Gartside et al., 1976, Surwit, Shapiro and Good, 1978, 
Messerli, Decarvalho, Christie et al., 1979, Patel, Marmot and Terry, 1981, Sundar, 
Agrawal, Singh et al., 1983). However, many of these studies were conducted in 
combination with pharmacological therapies, and/or applied more than one SDB 
technique. Furthermore, in most studies, the respiratory pattern was not controlled 
tightly. 
 
The work of an Israeli research team has been prominent in this field, using a SDB 
device that they invented (RESPeRATE, Intercure, Ltd., Lod, Israel). Their research 
has generated a series of studies that supported the antihypertensive effect of so-
called device guided breathing (DGB) (Grossman, Grossman, Schein et al., 2001, 
Rosenthal, Alter, Peleg et al., 2001, Schein, Gavish, Herz et al., 2001, Viskoper, 
Shapira, Priluck et al., 2003, Elliott, Izzo, White et al., 2004, Schein, Grossman, 
Rosenthal et al., 2005, Schein, Gavish, Baevsky et al., 2009), but the effectiveness 
of RESPeRATE is still questioned (Mahtani, Nunan and Heneghan, 2012). Whilst 
studies conducted by other research groups have reported similar outcomes (Meles, 
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Giannattasio, Failla et al., 2004, Bae, Kim, Choe et al., 2006, Anderson, McNeely 
and Windham, 2010, Bertisch, Schomer, Kelly et al., 2011, Hering, Kucharska, Kara 
et al., 2013, Howorka, Pumprla, Tamm et al., 2013, Shantsila, Adlan, Lip et al., 
2015), other studies have found no significant antihypertensive effect of DGB 
(Logtenberg, Kleefstra, Houweling et al., 2007, Altena, Kleefstra, Logtenberg et al., 
2009, Landman, Drion, van Hateren et al., 2013). A meta-analysis and systematic 
review conducted in 2012 showed no significant anti-hypertensive effects of SDB 
with RESPeRATE when only randomised controlled trials were considered and 
those trials sponsored by, or involving, the manufacturers of the device excluded 
(Mahtani et al., 2012).  
 
Notwithstanding, studies using other methods of SDB, have also resulted in 
significant positive clinical outcomes in participants other than those with 
hypertension. For example, Lehrer and coworkers demonstrated that the use of 
respiratory sinus arrhythmia (RSA) biofeedback therapy (a technique that drives 
participants to breathe at the low fR corresponding to maximum amplitude of heart 
rate oscillations) results in improvements in cardiac baroreflex sensitivity (BRS), in 
people with asthma  (Lehrer, Vaschillo, Vaschillo et al., 2003) and hypertensive 
individuals (Lin, Xiang, Fu et al., 2012). The same technique of daily training has 
been reported to increase HRV and decrease blood pressure variability (BPV) in 
women diagnosed with fibromyalgia (Hassett, Radvanski, Vaschillo et al., 2007) and 
in prehypertensive individuals (Lin et al., 2012). The use of SDB techniques 
employing a specific, fixed fR of 6 breaths·min-1, have also been suggested to lead 
to sustained reductions in ABP (Mourya, Mahajan, Singh et al., 2009, Jones, 
Sangthong and Pachirat, 2010, Sangthong, Ubolsakka-Jones, Pachirat et al., 2016), 
improvement in cardiac autonomic function (Wang, Li, Xu et al., 2010, Jones, 
Sangthong, Pachirat et al., 2015), elevation of BRS (Lin et al., 2012) and to reduce 
the exercise pressor response (Mourya et al., 2009, Jones et al., 2015), in 
hypertensive or prehypertensive  individuals. Improvement of HRV indices, cardiac 
autonomic balance and reductions in ABP were also reported in healthy individuals, 
after one month of daily deep breathing at 6 breaths·min-1 (Tharion, Samuel, 
Rajalakshmi et al., 2012). Other observations include the reduction of central 
sympathetic outflow, but with no change in BRS, arterial stiffness, cardiac function 





Overall, the reported acute physiological changes associated with SDB 
interventions have included, but are not limited to: 
• reductions in indices of muscle sympathetic nerve activity (MSNA) in both 
healthy and hypertensive individuals with a single session of DGB (Oneda, 
Ortega, Gusmao et al., 2010, Hering et al., 2013, Shantsila, Adlan, Lip et 
al., 2014a, Shantsila, Adlan, Lip et al., 2014b). A similar effect had been 
observed previously in chronic obstructive pulmonary disease (COPD) 
patients (Raupach, Bahr, Herrmann et al., 2008); 
• reduction of chemoreflex sensitivity with breathing at 6 breaths·min-1 in 
healthy controls performing yoga or paced breathing (Spicuzza, Gabutti, 
Porta et al., 2000, Bernardi, Gabutti, Porta et al., 2001);  
• increase of BRS in hypertensive (Joseph, Porta, Casucci et al., 2005), 
pulmonary (Raupach et al., 2008) and cardiac heart failure patients 
(Bernardi, Porta, Spicuzza et al., 2002), as well as healthy individuals 
(Lehrer et al., 2003, Radaelli, Raco, Perfetti et al., 2004);  
• augmented HRV and/or improved cardiac autonomic balance (Lehrer, 
Sasaki and Saito, 1999, Anderson, McNeely and Windham, 2009, Chang, 
Liu and Shen, 2013, Chang, Liu, Li et al., 2015);  
• increased tolerance to orthostatic  stress (Lucas, Lewis, Sikken et al., 2013);  
• reduced end tidal CO2 (PETCO2; Anderson et al., 2009).  
 
Based on some of these results, several presumed mechanisms have been 
advanced to explain a potential anti-hypertensive and cardioprotective effect of SDB 
interventions. These include changes in central chemosensitivity accompanied by 
alterations in acid-base regulation and renal regulation of sodium (Gilbert, 2003, 
Anderson et al., 2009); re-conditioning of cardiac baroreflex control of ABP 
(Vaschillo, Lehrer, Rishe et al., 2002, Lehrer et al., 2003); increased blood flow to 
internal organs (Fonoberova, Mezic, Buckman et al., 2014), and alteration of 
sympathetic baroreflex regulation (Fonoberova et al., 2014). Nonetheless, these 
potential links between the acute and chronic response to SDB lack experimental 
proof and are mostly founded on mathematical models of the cardiovascular system 
or based on a series of compound indices that are thought to provide information 
about autonomic and reflex cardiovascular regulation. Furthermore, the direct 
impact of SDB upon the most traditional measures of cardiovascular function still 
lacks detailed characterisation, as a large number of assumptions are based upon 




Collectively, there is currently compelling and intriguing evidence suggesting the 
existence of relevant acute responses, and chronic adaptations, to SDB 
interventions. However, the mechanisms connecting the reported acute effects and 
the longer-term responses to the regular practice of SDB remain controversial and 
require further examination. Furthermore, the acute modulatory effect of SDB upon 
key haemodynamic variables, such as left ventricular stroke volume (LVSV), cardiac 
output (Q̇) and ABP, remain insufficiently understood, and should be regarded as 
an essential stepping stone in the process of identifying the putative acute 
mechanisms that might underpin chronic health benefits of the regular practice of 
SDB. Thus, studying the characteristics of the respiratory stimulus by manipulating 
rate and depth during SDB may provide new insights into the acute cardiac and 
systemic response, and presumed regulatory mechanisms stimulated by SDB. 
Additionally, the integration of small respiratory resistances to conventional SDB will 
lead to a better understanding of the contribution of a key feature of SDB, viz., 
intrathoracic pressure changes. These mechanistic insights may lead to 
improvement in the effectiveness of SDB interventions by facilitating manipulation 
of these factors to optimise the acute stimulus provided by SDB.  
 
To this end, this thesis seeks to understand the acute effects of SDB upon a range 
of cardiovascular variables that might underpin the stimulus to the chronic lowering 
of ABP. 
 
Specific aims of this thesis were:  
1.  To understand the independent effects of breathing frequency (fR) and tidal 
volume (VT) on the cardiovascular and autonomic response to SDB (Chapter 
4). 
2. To explore the increasingly negative intrathoracic pressure to the magnitude 
of cardiovascular respiratory modulation elicited by SDB (Chapter 5). 
3. To provide insight into the cardiac and systemic haemodynamics in response 
to SDB combined with different modalities of resisted breathing (Chapter 6).  
 
These three integrative intervention studies were performed at the Department of 
Life Sciences – College of Health and Life Sciences, Brunel University London, from 
October 2013 to October 2015. 
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2-1 Introduction  
This chapter will provide a synopsis of the relevant literature concerning the 
interactions between the respiratory and cardiovascular systems in the context of 
the acute response to slow and deep breathing (SDB). Section 2-2 describes the 
mechanisms behind the acute regulation arterial blood pressure (ABP) as these are 
likely involved in the direct haemodynamic modulatory effects of SDB. Section 2-3 
provides a summary of the known mechanical interactions between the lungs and 
the heart. Section 2-4 focuses on the description of the known cardiovascular 
rhythms that are present in both ABP and fc, as well as in sympathetic nerve activity, 
and culminates with a description of how synchrony of such rhythmicities can 
potentiate the effects of SDB. This leads into section 2-5, where a summary of the 
current understanding of the acute effects of SDB is provided.  Finally, this chapter 
of the thesis is summarised in section 2-6 and closes with the study aims and 
hypotheses section 2-7. 
 
 
2-2 Afferent influences upon acute control of blood 
pressure 
2-2.1 Arterial baroreceptors 
The principal arterial baroreceptors located in the carotid arteries and the aortic 
walls play a focal role in the reflex response to acute cardiovascular perturbations. 
Both sets of mechanoreceptors consist of unencapsulated nerve endings situated 
in the medial-adventitial arterial border of the aortic arch and carotid sinus (Mancia 
and Mark, 1983, Milnor, 1990) and operate as the sensors of a negative feedback 
control system (Sagawa, 1983, Milnor, 1990). Variations in arterial blood pressure 
(ABP) result in deformation of the baroreceptors thereby modulating afferent 
neuronal traffic. These afferent impulses are relayed centrally within the nucleus 
tractus solitarius, in the medulla oblongata (Milnor, 1990). A decrease in ABP results 
in reduced afferent firing leading to a decrease in parasympathetic nerve activity 
and enhanced sympathetic nerve activity (SNA). The converse occurs when ABP is 
elevated, with the stretch of the baroreceptors augmenting afferent traffic, thus 
triggering a reflex-mediated increase in parasympathetic nerve activity and 
reduction of SNA, as depicted in Figure 2-1 (Fadel, 2008). Therefore, acute 
regulation of blood pressure in mammals is mainly accomplished through 
modulation of sympathetic and parasympathetic nerve activity to the heart and 
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sympathetic outflow to the peripheral vasculature (Thames and Kontos, 1970, 
Eckberg, Fletcher and Braunwald, 1972, Eckberg, 1977, Abboud, Eckberg, 
Johannsen et al., 1979). Accordingly, the combined influences of cardiac output (Q̇; 
as the product of heart rate and left ventricular stroke volume) and vasomotor tone 
determine ABP at any given moment. Despite the constant adjustment of these 
variables it has been shown that arterial baroreceptor stimulation has minimal 
impact  upon LVSV at rest (Ogoh, Fadel, Monteiro et al., 2002, Ogoh, Fadel, Nissen 
et al., 2003, Kim, Deo, Vianna et al., 2011) making heart rate (fc) the main factor 
controlling Q̇. Furthermore, the changes in vascular resistance (determined by 
vasomotor tone) account for the majority of the baroreflex-mediated ABP response 
in resting human males (Ogoh et al., 2002, Keller, Wasmund, Wray et al., 2003, 
Ogoh et al., 2003), while women show a dominant contribution of Q̇ (via fc), 
particularly to hypertensive stimulus (Kim et al., 2011). 
 
 
Figure 2-1 – Schematic representation of the neural baroreflex response to hypotensive and 
hypertensive stimuli.The alteration of arterial blood pressure (ABP) is sensed by carotid and aortic 
baroreceptors leading to changes in afferent baroreceptor nerve firing. Stimulation with hypertensive 
stimulus leads to increased neural input to the brainstem, resulting in increased parasympathetic 
efferent activity to the heart and decreased sympathetic outflow to the vasculature and heart. 
Conversely, a sudden drop in ABP (hypotensive stimulus) results in decreased parasympathetic 
nerve activity and increased sympathetic efferent discharge. HR – heart rate; SV – stroke volume; 
TVC – total vascular conductance. From Fadel (2008). 
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Differences between carotid and aortic arterial baroreceptor response 
The diffuse network of sensing structures localised in the arterial walls has been the 
object of extensive research, particularly during the 1960s and 1970s. The review 
by Kirchheim (1976) considers in detail all aspects of baroreceptor reflexes, 
including the receptors themselves. Notwithstanding, structurally and functionally 
the two most important systemic arterial baroreceptors are those located in the 
aortic arch and carotid sinus (Milnor, 1990). Whilst the presence of different 
sensorial sites might appear redundant as ABP is similar in both regions, under 
certain conditions that might not necessarily be the case. 
 
Important for the context of this thesis, the aortic arch baroreceptors are susceptible 
to variations in aortic transmural pressure caused by respiratory changes in 
intrathoracic pressure, while the carotid sinus baroreceptors, due to its extra-
thoracic location, are only affected by systemic arterial pressure (Angell James, 
1971). Furthermore, each set of receptors seems to possess a specific operating 
range, suggesting that for the same variation in ABP a change in afferent discharge 
might only arise from one sensorial region. In brief, animal studies have 
demonstrated that carotid baroreceptors operate over a wider range, above and 
below normal ABP levels, while aortic baroreceptors operate only at higher 
pressures (Hainsworth, Ledsome and Carswell, 1970, Pelletier, Clement and 
Shepherd, 1972). However, when these receptors were stimulated at normal 
pulsatile pressures, both no differences (Angell James and de Burgh Daly, 1970) or 
increased carotid reflex-mediated vascular response relative to that of aortic arch 
receptors (Dampney, Taylor and McLachlan, 1971), were reported. Nonetheless, 
Angell James and de Burgh Daly (1970) also demonstrated that the vasodilatory 
response produced by a rise in mean carotid sinus pressure was significantly 
greater than that secondary to a similar rise in aortic arch pressure. 
 
Collectively, this might suggest that aortic baroreceptors are functionally more 
important in providing buffering to ABP rises than falls, while suggestion that the 
isolated carotid sinus baroreflex response might be better tailored to buffer 
reductions in ABP (Mancia and Mark, 1983). Nevertheless, the isolated stimulation 
of aortic and carotid baroreflexes is only achieved in non-physiological, experimental 
conditions; in ‘real life’, a combined stimulation is integrated centrally leading to a 
summated response (Kendrick, Matson and Lalley, 1979, Sagawa, 1983). 
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2-2.2 Other baroreceptors involved in the cardiovascular and autonomic 
responses  
Atrial stretch receptors 
The atria also contain a series of unencapsulated nerve endings, mostly 
concentrated in the atria-venous junctions. These are responsive to the stretch of 
the atria, caval and pulmonary veins (Coleridge, Hemingway, Holmes et al., 1957), 
triggering a reflex tachycardia (Ledsome and Linden, 1964, Goetz, 1965, Ledsome 
and Linden, 1967), but no appreciable inotropic (Furnival, Linden and Snow, 1971) 
or vasomotor effects (Carswell, Hainsworth and Ledsome, 1970). Notwithstanding, 
atrial stimulation inhibits renal nerve activity and the secretion of vasopressin, renin 
and cortisol, thus promoting diuresis (Carswell et al., 1970, Drinkhill, Hicks, Mary et 
al., 1988, Drinkhill and Mary, 1989). This response pattern was first described in 
1915 when Francis Bainbridge reported a cardiac acceleration in response to rapid 
increases in venous return, induced by rapid intravenous infusions (Bainbridge, 
1915). Since then, the response to atrial stretch is commonly referred to as 
Bainbridge reflex.  
 
In human beings, this response pattern was only fully confirmed in the 1950s, when 
it was established that central venous pressure could be increased with no 
concurrent rise in ABP, by passively elevating the legs of supine human volunteers, 
thus isolating the atrial stretch response from that of the arterial baroreflex (Roddie 
and Shepherd, 1956, Roddie, Shepherd and Whelan, 1957). Despite the original 
ascription to a vagal autonomic reflex, more recent research has supported the 
existence of an intracardiac myogenic mechanism, capable of inducing a positive 
chronotropic response to atrial stretch, beyond that associated with a reflex 
response (Quinn and Kohl, 2012). Even though most evidence supporting this 
theory arises from isolated hearts or cardiac tissue, isolated sino-atrial nodes, fibres 
or even single cells, at least two studies involving denervated individuals (animal 
and human) provide strong support for the existence of an intracardiac myogenic 
mechanism mediating chronotrpoic changes (Cooper and Kohl, 2003, Quinn and 
Kohl, 2012). Specifically, data from denervated, anaesthetised, open-chested dogs 
showed an instantaneous increase in fc, even in the presence of cholinergic and 
adrenergic blockade, when exposed to graded stretch of the sino-atrial node 
(Brooks, Lu, Lange et al., 1966). Furthermore, in heart transplanted human beings 
(i.e. denervated hearts) a small degree of RSA is still present, which might be 
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explained by sino-atrial node stretch induced by respiratory-driven fluctuations in 
venous return (Bernardi, Keller, Sanders et al., 1989, Taha, Simon, Dempsey et al., 
1995). 
 
Other cardiac baroreceptors 
Over the last century, extensive research has examined the anatomical, 
physiological and functional characteristics of a series of reflexogenic areas in the 
heart and large vessels. A detailed description of these baro- and chemoreceptors 
is beyond the scope of this thesis. Nonetheless, it is pertinent to highlight the 
existence of both ventricular and coronary artery receptors. The first seem to not be 
readily activated by changes in ventricular filling, being more responsive to chemical 
stimuli, suggesting a minor role in normal cardiovascular control. The latter, 
correspond to nerve endings in the proximal regions of the coronary arteries and  
are stimulated by changes in coronary pressure. When stimulated, these receptors 
trigger a vasomotor response analogous to that of the arterial baroreceptors. 
However, the coronary baroreceptors seem to operate at much lower pressures and 
have a more prolonged effect upon sympathetic efferent activity than the carotid 
arterial baroreceptors, leading to the assumption that they might be relevant in the 
cardiovascular response to hypotension and ‘longer’ term control of blood pressure. 
A detailed description of these (and other) cardiovascular mechano-reflexes can be 
found in a comprehensive review and a recent symposium report produced by 
Roger Hainsworth (1991, 2014). 
 
Pulmonary artery receptors 
Distension of the pulmonary trunk and its bifurcation with the right and left pulmonary 
arteries, stimulates myelinated vagal nerve afferents (Coleridge and Kidd, 1960, 
Coleridge, Kidd and Sharp, 1961) triggering reflex vasoconstriction, augmented 
respiratory drive and increased renal sympathetic nerve activity (McMahon, 
Drinkhill, Myers et al., 2000, Moore, Hainsworth and Drinkhill, 2011). The first 
studies conducted in open chested dogs suggested that these baroreceptors were 
only stimulated at unphysiologically high distension pressures (Coleridge and Kidd, 
1960, Coleridge, Coleridge, Dangel et al., 1973, McMahon et al., 2000). However, 
more recent work from Moore and colleagues demonstrates that closing the chest, 
delivering phasic negative intrathoracic pressures and applying pulsatile pressures 
to distend the pulmonary artery, all prompt a reflex response at pressures perfectly 
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within the physiological range (Moore, Hainsworth and Drinkhill, 2004b, a, Moore et 
al., 2011). 
 
Overall, the reflex response observed during stimulation of pulmonary artery 
receptors opposes that of the systemic baroreceptors. Evidence that these two 
reflexes interact strongly, with the stimulation of low-pressure pulmonary artery 
receptors altering the operating range of carotid baroreceptors and vice-versa, 
suggests a significant role of the pulmonary artery baroreflex in the control of the 
cardiovascular system (Moore et al., 2011). This effect is thought to be more 
physiologically relevant during dynamic exercise, hypotensive states and hypoxic 
stress (Moore et al., 2011, Fadel and Raven, 2012, Hainsworth, 2014). Importantly, 
for the context of this thesis, it is believed that these receptors are sensitive to 
changes in transmural pulmonary artery pressure, as demonstrated by increased 
vagal afferent activity during inspiration (Moore et al., 2004b, a). This suggests that 
respiratory interventions altering intrathoracic pressure, and thus affecting 
transmural pressure, possibly trigger a physiological response from these afferents.  
 
 
2-2.3 Chemoreceptor stimulation and regulation of blood pressure 
The chemoreflexes exert remarkable influences upon breathing regulation (Clark 
and von Euler, 1972, Duffin, 1990), as well as on cardiovascular control (de Burgh 
Daly and Scott, 1958, Heistad, Abboud, Mark et al., 1975b, Karim, Hainsworth, 
Sofola et al., 1980, O'Regan and Majcherczyk, 1982, Honig, 1989, Marshall, 1994, 
Gates, Bartels, Downey et al., 2009). Chemoreflex physiology is extremely complex, 
and for the ease of its understanding, these reflex responses are usually classified 
as either peripheral or central, based on the location of the primarily stimulated 
chemoreceptive structures. 
 
Peripheral chemoreceptors are mostly located in the aortic and carotid bodies 
(Marshall, 1994). The peripheral chemoreceptors are mainly responsive to hypoxic 
stimulation, but might also be modulated by hypercapnia (Duffin, 1990). Central 
chemoreceptor location and structure is still not fully established but is believed to 
lie in the ventral surface of the medulla oblongata (Mitchell, Loeschcke, Massion et 
al., 1963, Loeschcke, 1973, Bruce and Cherniack, 1987). Central chemoreceptors 
respond indirectly to elevations in PaCO2 in the brain circulation, as its diffusion from 
 
13 
the cerebral capillaries into the cerebrospinal fluid (CSF) liberates H+ ions, which 
reduce CSF pH (Mitchell et al., 1963, Leusen, 1972, Loeschcke, 1982). Figure 2-2 
depicts a model of the chemoreflex control of ventilation.  
 
In healthy adults undergoing SDB the stimulation of the peripheral chemoreceptors 
by alteration of PaO2 is likely negligible, particularly if minute ventilation (V̇E) is 
unchanged.  Decreased chemoreflex responsiveness to hypoxia (and hypercapnia) 
has been observed with SDB, which is possibly due to improvement of the 
ventilation/perfusion ratio, leading to improved O2 saturation of arterial blood 
(Bernardi, Spadacini, Bellwon et al., 1998, Spicuzza et al., 2000, Bernardi et al., 
2001, Nepal, Pokharel, Khanal et al., 2013). Furthermore, PaCO2 impacts the 
responsiveness to hypoxic stimuli (and vice-versa), in such a way that at a PaCO2 
of 35-40 mmHg, the ventilatory response to hypoxia is absent above a PaO2 of 50 
mmHg (Mohan and Duffin, 1997, Duffin, 2005). Nonetheless, reductions in V̇E with 
SDB might increase PaCO2 and trigger a chemoreflex response consisting primarily 
of a stimulus to increase ventilation (increased fR or VT). 
 
While the dominant chemoreflex response to hypercapnia is to induce hyperpnoea, 
there is a clearly defined cardiovascular impact that translates into an increase in 
SNA (Somers, Mark, Zavala et al., 1989a, Oikawa, Hirakawa, Kusakabe et al., 2005, 
Gates et al., 2009), leading to a rise in ABP. Nonetheless, the negative feedback 
loop between breathing and cardiovascular control promotes an attenuation of the 
chemoreflex-driven cardiovascular response, in such a way that the increased 
activation of pulmonary stretch afferents inhibits the sympathetic response triggered 
by chemoreflex stimulation (Somers et al., 1989a, Somers, Mark, Zavala et al., 
1989b). Furthermore, the interaction between chemoreflex and cardiovascular 
baroreflex control has been established, with baroreflex stimulation by raised blood 
pressure blunting the chemoreflex response (Heistad, Abboud, Mark et al., 1974, 
Heistad, Abboud, Mark et al., 1975a, Somers, Mark and Abboud, 1991). An effect 
of both peripheral and central chemoreflex activation upon baroreflex cardiovascular 
regulation has also been demonstrated recently in human beings (Cooper, Bowker, 
Pearson et al., 2004, Cooper, Pearson, Bowker et al., 2005). Notwithstanding, later 
evidence points to the absence of any meaningful impact of mild hypercapnia (5 
mmHg above eucapnia) upon baroreflex regulation of fc and ABP (Simmons, 




In the context of SDB, a reduced chemoreflex influence is expected if resting levels 
of PaCO2 and PaO2 are unaltered due to the maintenance of V̇E. Moreover, as 
mentioned previously, increased lung inflation with SDB is expected to limit 
chemoreflex response. Nonetheless, some studies have reported acute decreases 
in end tidal CO2 (PETCO2) during and after SDB (Anderson et al., 2009), while others 
have reported that SDB is associated with a reduction chemoreflex sensitivity to 
both hypercapnia and hypoxia (Spicuzza et al., 2000, Bernardi et al., 2001). 
 
From a methodological point of view, changes in PaCO2 alter HRV, independent of 
fR and VT (Al-Ani, Forkins, Townend et al., 1996, Sasano, Vesely, Hayano et al., 
2002, Poyhonen, Syvaoja, Hartikainen et al., 2004) and might possibly impact the 
cardiac response to SDB. It is therefore important to clarify the extent to which acute 




Figure 2-2 – Model of respiratory chemoreflex control of ventilation. Pulmonary ventilation 
controls PaCO2 and PaO2, the forward part of the loop. The concentration of hydrogen ions ([H+]) and 
PaO2 control ventilation via the respiratory chemoreflexes in the feedback part of the loop. Ventilation 




2-2.4 Short term hormonal control of blood pressure 
The acute change of ABP prompts variations in the concentration of certain 
hormones over the course of minutes to hours; these changes act principally via 
alteration of vasomotor activity, i.e. by altering peripheral resistance, but they also 
affect Q̇. Overall, adrenal medulla catecholamines, atrial natriuretic peptide (ANP) 
and angiotensin II (ANGII) can contribute to the immediate reflex response to 
baroreceptor stimulation. Accodingly, SDB might influence one or all of these 
hormonal pathways. 
 
Adrenal medulla catecholamines 
Throughout periods of increased sympathetic activity, the adrenal glands release 
catecholamines (adrenaline and noradrenaline) and enhance the adrenergic 
response as observed in the fight-or-flight response. However, evidence regarding 
an association between acute baroreflex stimulation and plasma catecholamine 
levels suggests that the latter are not changed significantly during moderate 
baroreflex-driven sympathetic responses (Mancia, Leonetti, Picotti et al., 1979, 
Mancia, Ferrari, Gregorini et al., 1983). Instead, the engagement of low pressure 
cardiopulmonary receptors, as observed in orthostatic challenges and submaximal 
aerobic exercise, seems necessary for significant rises in circulatory levels of these 
hormones (Mancia et al., 1979, Mancia et al., 1983, Grassi, Gavazzi, Cesura et al., 
1985, Floras, Vann Jones, Hassan et al., 1986). In the context of acute responses 
to SDB, there has been at least one report of reduced plasma noradrenaline, 
following 15 min of SDB, in healthy human volunteers (Wehrwein, Johnson, 
Charkoudian et al., 2012). 
 
Atrial natriuretic peptide (ANP) 
The stretch of the atrial walls promotes the release of ANP, triggering an ABP 
decrease by inducing peripheral vasodilatation, promoting diuresis and natriuresis, 
while also inhibiting renin and aldosterone secretion (de Bold, 1985). However, the 
short half-life of this hormone, together with the slow rate of its release by increased 
atrial distention, suggests that significantly higher ANP plasma concentrations might 
only be achieved after sustained elevation of venous return lasting several minutes, 
while saturation of plasma levels might only occur after 1 hour (Anderson, Donckier, 
Payne et al., 1987, Anderson, Maxwell, Payne et al., 1989, Tanaka, Sagawa, Miki 
et al., 1991). It is not clear if the practice of SDB leads to acute increases in 
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circulating ANP, but the addition of a small inspiratory resistance can potentially 
facilitate its release (Anderson et al., 1989). 
 
Renin-angiotensin axis 
The biosynthesis of the vasoconstrictor hormone ANGII results from the elevation 
of the plasma levels of the hormone renin. Renin is released from the kidneys’ 
juxtaglomerular apparatus and acts as an enzyme in the synthesis of ANGII. Since 
the rate of renin release is the limiting factor in the production of ANGII, the 
concentration of plasma renin determines the presence of ANGII in the circulation 
(Reid, 1992). Numerous factors can affect renin release into the circulation (Laragh 
and Sealey, 1992). Importantly, the plasma concentration of renin is augmented in 
situations of heightened sympathetic nerve efferent activity and increased levels of 
circulating catecholamines (Reid, Morris and Ganong, 1978, Laragh and Sealey, 
1992), and inhibited by atrial stimulation (Annat, Grandjean, Vincent et al., 1976, 
Anderson et al., 1987, Anderson et al., 1989). 
 
The ANGII promotes a potent vasoconstrictor effect, leading to a rapid rise in ABP 
and reduction of fc, with a concurrent decrease in Q̇ (Debono, Leegde, Mottram et 
al., 1963, Laragh and Sealey, 1992). Apart from the direct vasomotor effect, the 
ANGII acts centrally upon the baroreflex control of fc, allowing ABP to increase 
without a simultaneous bradycardic response. At the same time, ANGII enhances 
sympathetic activity, presumably easing neurally-mediated catecholamine release 
(Ferrario, 1983, Reid, 1992). In the context of acute responses to SDB, the potential 
change in plasma levels of renin and/or ANGII has not yet been established. 
However, due to the inhibitory effect of ANP, the depressing effect of SDB upon 
SNA during inspiration and the aforementioned reduction in plasma catecholamines 
with SDB, it is plausible to expect an acute reduction in the activity of the renin-
angiotensin axis during, or immediately following, SDB interventions.  
 
2-2.5 Summary 
This section of the literature review briefly summarises the known afferent and 
efferent signals thought to be involved in the acute regulation of ABP during SDB 
interventions. Furthermore, it provides a brief summary of the most important 
hormonal mechanisms involved in the regulation of ABP, which in theory can also 
be implicated in the chronic response to SDB. Nonetheless, a substantial portion of 
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this extant literature arises from studies that employed reductionist models, using 
isolated stimuli, in quadrupeds.  
 
The integrated human response is highly complex, as the integration of the 
information arising from these receptors occurs within a series of structures located 
in the brainstem. The nucleus tractus solitarius seems to play a fundamental 
integrative role, relaying vagal sensory information from cardiorespiratory afferents 
and organs of the gastrointestinal tract (Andresen and Kunze, 1994, Lawrence and 
Jarrott, 1996, Travagli, 2007, Dergacheva, Griffioen, Neff et al., 2010). Co-
localisation of respiratory and cardiovascular neurones can also be found in other 
structures, such as the rostral ventrolateral medulla, nucleus ambiguous and ventral 
respiratory group (Spyer, 1994, Dergacheva et al., 2010).  
 
However, this thesis does not seek to explore the neural control mechanisms, or the 
neural structures, involved in determining the acute cardiac and vascular response 
to SDB. Instead, it aims to characterise the response itself, attempting to further 




2-3 Mechanical effects of breathing – heart-lung interactions 
The existence of a respiratory-driven cardiovascular response to SDB is inherently 
determined by the direct mechanical effects of the varying intrathoracic pressure 
upon preload, afterload and SV of the right and left sides of the heart. The following 
section will describe the mechanics underpinning these interrelationships. Crucial 
to the understanding of this section is to note that the changes in cardiac pressures 
herein described, are always relative to respiration and not relative to the cardiac 
cycle. While the latter takes place in every single heart beat and are inherent to the 






Figure 2-3 – The Wigger’s diagram of the cardiac cycle demonstrating the normal relationships 
between heart chamber pressures, volumes and sounds, relative to the ECG events, for the left side 
of the heart. a - atrial contraction, c - small increase in atrial pressure from the mitral valve bulging 
into the atrium after closure, v - passive atrial filling. In the electrocardiogram: P wave -  atrial 
depolarisation, QRS complex -  ventricular depolarisation, and T wave - ventricular repolarization. 
From Hagen-Ansert (2017). 
 
 
Figure 2-4 – Reporting changes in cardiac pressures relative to the respiratory cycle instead 
of the cardiac cycle implies that these may take place over the course of several heart beats. For 
example, for an individual breathing at 6 breaths·min-1 (10s cycle) and heart rate of 60 beats∙min-1 
each respiratory phase (inspiration/expiration) will contain, on average, 5 cardiac cycles. Adapted 
from Thompson and McVeigh (2006).   
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2-3.1 Impact of breathing on right ventricular preload 
The location of the right atrium within the thorax leads to decreased right atrial 
pressure throughout inspiration, relative to atmospheric pressure (Permutt and 
Wise, 1986). As indicated by Guyton’s work, the atrial pressure is, in effect, the back 
pressure to systemic venous return (Guyton and Adkins, 1954, Guyton, 1955, 
Guyton, Lindsey and Kaufmann, 1955, Guyton, Lindsey, Abernathy et al., 1957). 
Inspiration thus results in an augmentation of the pressure gradient between mean 
systemic pressure and right atrial pressure, thus accelerating blood flow towards the 
right atrium (Shabetai, Fowler, Fenton et al., 1965). Both right atrial pressure and 
venous pressure (systemic pressure in the peripheral veins) are minimal, with right 
atrial pressure oscillating between slightly above or below a mean value of 0 mmHg 
and venous pressure only being a few mmHg higher, in the supine position. Thus, 
the pressure gradient is small in absolute terms (<10 mmHg), which implies that 
small, respiratory-induced changes in either right atrial pressure or venous pressure 
can result in large relative changes to this pressure gradient, and thus significant 
alteration of venous return to the right atrium (Klabunde, 2011). According to the 
Frank-Startling Law, under normal conditions, increased right ventricular preload 
leads to an inspiratory increase in right ventricular stroke volume (RVSV) and 
pulmonary arterial flow (Figure 2-5) (Brecher and Hubay, 1955, Shabetai et al., 
1965, Robotham, Rabson, Permutt et al., 1979). 
 
Notwithstanding, venous return might be limited by the collapse of the venae cavae, 
if the right atrial pressure decreases substantially below atmospheric pressures 
(Guyton and Adkins, 1954). In other words, collapse occurs if extravascular 
pressure exceeds intravascular pressure, which tends to occur with deep inspiratory 
movements, particularly in the region where the venae cavae enters the thoracic 
cavity (Amoore and Santamore, 1994). Furthermore, the breathing pattern (thoracic 
vs. diaphragmatic) might impact venous return not only by altering vessel transmural 
pressure, but also by increasing the intra-abdominal pressure due to the descent of 
the diaphragm into the abdominal cavity (dominant in diaphragmatic breathing), 
leading to inferior vena cava compression (Willeput, Rondeux and De Troyer, 1984, 
Miller, Pegelow, Jacques et al., 2005b, Kimura, Dalugdugan, Gilcrease et al., 2011). 
As a consequence, diaphragmatic breathing has been demonstrated to lead to an 
inversion of the phase relation for venous return, relative to breathing, compared to 
thoracic breathing (Miller, Pegelow, et al., 2005b). In other words, for comparable 
lung excursions, venous return is augmented throughout inspiration with thoracic 
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breathing, while with diaphragmatic breathing, the venous return is larger throughout 
expiration.  
 
In summary, respiratory induced fluctuations in intrathoracic pressure alter the 
pressure gradient for venous return to the heart, thus leading to respiratory phase-
dependent changes in right ventricular filling, as illustrated in Figure 2-5. The 
magnitude of the variation of venous return can be limited by collapse of the venae 
cavae, and/or compression, determined by the respiratory depth and the pattern of 
breathing (thoracic vs. diaphragmatic), which can promote an opposite respiratory 




Figure 2-5 – Illustration of the mechanical effects of spontaneous respiration on 
cardiovascular function. Notice how venous return and right ventricular stroke volume increase 
with a more negative pleural pressure associated with inspiration (I; shaded) and concurrent fall 
throughout expiration (E; white). Ppl – Pleural pressure; VR – venous return; SVr – right ventricular 








Figure 2-6 – Effects of thoracic or diaphragm breathing patterns on femoral arterial inflow, mean 
arterial pressure (MAP), femoral venous outflow, intrathoracic pressure (Peso), intra-abdominal 
pressure (Pgastric) and tidal volume. Despite no discernible effect of breathing pattern on arterial inflow, 
femoral venous return (an indicator of overall venous return) is facilitated during a thoracic (RIB) 
inspiration and impeded during a diaphragmatic inspiration, with these modulatory effects being 
reversed during the ensuing expiratory phase of the breath. Grey circles - thoracic breathing; black 
circles - diaphragm breathing; †, P < 0.01 and *, P < 0.05 for comparisons of ribcage vs. diaphragm. 




2-3.2 Impact of breathing on right ventricular afterload 
The relationship between lung vessel resistance and lung volume is extremely 
complex. The existence of both intra-alveolar and extra-alveolar vessels produces 
a coalesced effect of lung expansion stemming from the dissimilar response of each 
of these types of vessels to lung inflation. The overall relationship between lung 
volume and pulmonary vascular resistance is best described by a ‘U’ shaped 
relationship with a nadir at functional residual capacity (Figure 2-7; [West and Luks, 
2016]). Increases in lung volume compress the lumen of intra-alveolar vessels, while 
also promoting the widening of the extra-alveolar vessels by increasing the radial 
interstitial forces (‘parenchymal pull’). In healthy individuals, the net result is a small 
increase in pulmonary vascular resistance with increasing tidal breathing. This 
increase is more marked with larger inspiratory excursions, as the stretch across 
the diameter of the intra-alveolar vessels contributes to significant reduction of 
vessel calibre, and thus increased resistance (Permutt and Wise, 1986, Hamzaoui, 





Figure 2-7 – Effect of lung volume upon pulmonary vascular resistance. Low lung volumes 
result in increased resistance as extra-alveolar vessels become narrow. Inflation beyond tidal 
breathing promotes stretching of the intra-alveolar capillaries with reduction of their calibre, 
contributing to increased resistance. Therefore, resistance is lowest at normal, tidal breathing 




2-3.3 Impact of breathing on left ventricular preload 
Evidence of a significant buffering of respiratory related fluctuations in systemic 
venous return occurring at the right ventricle and lungs has been reported previously 
in dogs and in computer based simulations of the human cardiovascular system 
(Hoffman, Guz, Charlier et al., 1965, Santamore and Amoore, 1994). These 
accounts are suggestive of a reduced respiratory influence upon left ventricular 
preload. However, data from healthy human beings suggests there is no significant 
difference between the within-breath amplitude of RVSV and LVSV. These data 
indicate that increased systemic venous return to the right side of the heart with 
inspiration is translated into similar-sized variation in blood flow to the left ventricle 
(Elstad, 2012). According to Elstad and colleagues, in spontaneously breathing 
individuals, RVSV and LVSV are 180º out of phase relative to the respiratory cycle, 
i.e. increased RVSV during inspiration only impacts preload to the left ventricle 
during the ensuing expiration (as illustrated in Figure 2-5). Overall, this suggests 
there is a decreased left ventricular preload during inspiration and increased left 
ventricular output during expiration, although it is not clear how SDB might influence 
this phase relationship. 
 
 
2-3.4 Impact of breathing on left ventricular afterload 
The inspiratory decrease in intrathoracic pressure also impacts left ventricular 
afterload, as the pressure surrounding the extra-thoracic compartment remains 
constant, or increases. Thus, during inhalation, a higher ejection pressure needs to 
be generated by the left ventricle to overcome the relatively higher afterload 
(Robotham, Lixfeld, Holland et al., 1978, Robotham et al., 1979, Scharf, Brown, 
Saunders et al., 1979). Moreover, during spontaneous breathing, intra-abdominal 
pressure increases due to the descent of the diaphragm, increasing the intraluminal 
pressure of major arterial vessels, particularly the abdominal aorta and 
consequently the impedance to left ventricular output (Karam, Wise, Natarajan et 
al., 1984, Robotham, Wise and Bromberger-Barnea, 1985). However, studies in 
both animals and healthy human beings seem to indicate that, when breathing 
spontaneously, LVSV is dominated by the respiratory effects upon preload, rather 
than afterload (Robotham, Stuart, Doherty et al., 1988, Scharf, 1995). Finally, a 
compressive effect of lung expansion (at high lung volumes) upon the heart has 
been hypothesised to impact left ventricular afterload (Robotham, Badke, Kindred 
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et al., 1983), although its role during spontaneous breathing in healthy individuals 
has been questioned (Scharf, Brown, Warner et al., 1989). 
 
In summary, respiration induces cyclic changes in cardiac and great vessel 
transmural pressure, thus producing respiratory phase-related oscillations in blood 




Figure 2-8 – Variation in great vessel blood flow per minute as a function of respiratory phase. 







2-3.5 Other factors influencing lung-heart interactions 
Interventricular dependence phenomenon 
The right and left ventricles are intimately interconnected by the presence of a 
shared pericardial casing, as well as a common septum, and myocardial fibres, 
which convey an obligatory interdependence between the two cardiac chambers. 
The shared anatomy implies that the mechanical events of one ventricle influence 
the behaviour of the other ventricle, as demonstrated by Janicki and Weber  (Janicki 
and Weber, 1980, Weber, Janicki, Shroff et al., 1981). Previously, Dornhorst and 
colleagues had hypothesised about the impact of cardiac interdependence upon 
lung-heart interaction but suggested it to be of minor importance in healthy 
individuals, despite its relevance in certain conditions like cardiac tamponade 
(Dornhorst, Howard and Leathart, 1952a). Later studies explored the 
interdependence phenomenon and highlighted that an increase in right ventricular 
volume augmented both diastolic and systolic elastance (tendency to recoil) in the 
left ventricle, effectively impeding left ventricular filling, as well as reducing end 
diastolic volume. 
 
In other words, increased inspiratory right ventricular filling pushes the septum 
towards the left ventricle increasing transmural pressure for a given left ventricular 
volume, thereby inhibiting left ventricular filling and LVSV (Bove and Santamore, 
1981, Olsen, Tyson, Maier et al., 1985, Slinker and Glantz, 1986, Amoore and 
Santamore, 1989). However, this is contested by studies demonstrating similar 
values of RVSV and LVSV (Santamore and Amoore, 1994, Elstad, 2012). Although 
the interdependence phenomenon is most frequently examined from the 
perspective of how right ventricular filling affects left ventricular function, the 
phenomenon is bi-directional. Furthermore, experimental evidence has shown that 
between 20 and 40% of RVSV results from left ventricular contraction (Santamore, 
Lynch, Meier et al., 1976, Janicki and Weber, 1980, Slinker and Glantz, 1986, 
Santamore and Dell'Italia, 1998). 
 
Pulmonary transit time 
Another example of interdependence between the right and left side of the heart is 
the delay between the increase in right ventricular ejection and a consequent 
increase in LVSV, i.e. the pulmonary transit time. Before arriving at the left atrium, 
blood pumped from the right ventricle must transit the pulmonary circulation. 
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Pulmonary transit time is in the order of several seconds at rest, between 5 and 17 
s (Blumgart and Weiss, 1927a, Zavorsky, Walley and Russell, 2003), which 
interposes a delay between changes in RVSV and LVSV (Dornhorst et al., 1952b, 
Amoore and Santamore, 1989). This delay might dictate that, at certain respiratory 
frequencies (fR), both ventricles might be completely in phase or completely out of 
phase with respect to their stroke volume, which could either amplify or limit the 
influence of any septal interdependence (Hamzaoui et al., 2013). The combination 
of these two forms of interventricular dependence likely underpins the reported 
180º-phase relationship between RVSV and LVSV, in spontaneously breathing 
healthy human beings (Elstad, 2012). However, it is not clear how, or if, this 
relationship is affected by SDB. 
 
 
2-4 Cardiovascular oscillations 
2-4.1 Historical perspective  
Blood pressure oscillations 
The existence of respiratory fluctuations in ABP has long been identified with the 
first records tracing back to Stephen Hales in 1733. Later, in 1760 Albrect von Haller 
was the first to note rhythmic fluctuations also occurring in heart rate (fc). However, 
neither Hales nor Haller made assumptions regarding a link between respiratory 
activity and cardiovascular fluctuations (Leake, 1962). The first accounts of 
respiratory-related oscillations in ABP came in the mid-1800s with Traube (and later 
Hering) observing slow oscillations at around seven cycles per minute when artificial 
respiration was interrupted in vagotomised dogs and cats. These oscillations ceased 
after two or three minutes of respiratory arrest, which led both Traube and Hering to 
postulate that they were linked to a strong respiratory centre discharge modulating 
the rhythmic activity of a vasomotor centre (Killip, 1962). Just a few years later, in 
1876, Mayer described ABP oscillations in spontaneously breathing rabbits that 
were slower than breathing frequency (fR), but that matched those described 
previously by Traube and Hering. In 1882, Fredericq reviewed the work of Mayer, 
Hering and Traube and concluded that the oscillations described by Traube and 
Hering occurred at respiratory frequency, while Mayer’s waves were slower than the 




The respiratory variations in ABP were explored in further detail in a seminal paper 
by Dornhorst, Howard and Leathart (1952b). In a series of small experiments in 
human volunteers, published in a single article, Dornhorst and colleagues 
demonstrated that the amplitude of ABP oscillations increased with decreasing fR, 
while the phase relation between respiration and ABP was also altered by a change 
in fR. Furthermore, the respiratory-driven variation in ABP seemed to be enhanced 
in the upright posture (compared to supine), while apnoea elicited regular ABP 
waves at a rate of around six cycles per minute, confirming the previous accounts 
of Mayer. Another important observation by Dornhorst and colleagues was that the 
respiratory modulation of LVSV was induced by respiratory driven fluctuations in 
intrathoracic pressure, which influenced right atrial filling, and that passive inflation 
of the lungs resulted in an 180° phase inversion between respiration and LVSV. 
Moreover, the relationship between respiration and LVSV also seemed to show a 
frequency dependent phase pattern, which the authors attributed to pulmonary 
transit time, i.e. the time required for blood to transit between the right and left sides 
of the heart. Nonetheless, the most significant finding was perhaps the identification 
of a synchronisation between respiratory driven variations in LVSV and those 
observed in peripheral resistance, when breathing at around 6 breaths·min-1 (0.1 
Hz). It was suggested that at this fR, the oscillations of LVSV and peripheral 
resistance were timed in such a way that they reinforced each other, thus creating 
a resonant effect (see also paragraphs dedicated to coherence and entrainment in 
section 2-4.5). 
 
Earlier, in 1951, two different studies by Arthur Guyton reported vasomotor 
oscillations in anaesthetised, hypovolemic dogs that underwent progressive 
denervation; they concluded that so-called Mayer waves were sympathetically 
mediated (Guyton, Batson, Smith et al., 1951, Guyton and Harris, 1951). These 
findings were expanded by Preiss and Polosa (1974), who identified a synchrony 
between sympathetic preganglionic nerve activity patterns and the occurrence of 
the Mayer waves, in anaesthetised or otherwise decerebrated cats. One subsequent 
study from the same group supported the existence of temporal associations 
between respiratory rhythm, sympathetic outflow and ABP oscillations (Preiss, 
Kirchner and Polosa, 1975).   
 
The body of evidence that rose from these (and other) studies in animals gave 
support to the theory that fluctuations occurring at the respiratory frequency must 
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involve the presence of a central mechanism modulating sympathetic 
cardiovascular activity, and synchronised with breathing. The slower Mayer waves 
were suggested to stem directly from sympathetically mediated vascular resistance 
oscillations (Cohen and Taylor, 2002).  
 
Heart rate oscillations 
The study of heart rate (fc) and heart rate variability (HRV) received less attention 
initially than that of ABP. However, a series of relevant accounts regarding the 
existence of oscillation in fc and the driving mechanisms were made throughout the 
19th century. Around 1845, Ernst and Eduard Weber showed that fc was depressed 
by vagus nerve activity, while Albert Bezold demonstrated in 1867 that other nerves 
(sympathetic efferents) innervating the heart had cardio-acceleratory properties 
(Hurst, Fye and Zimmer, 2005). Herman Stannius (1852) established that heart 
rhythmicity and automaticity originated in the sino-atrial node, while Czermak’s 
(1866) report of cardiac deceleration is response to increased pressure applied to 
the carotid sinus preceded Heinrich Hering’s 1924 description of the cardiac 
baroreceptor reflex (Leake, 1962, Fleming, 1997, Fye, 2000, Larsen et al., 2010). 
 
As is the case with ABP, two distinct rhythms have been identified in fc. The first 
has a cycle duration of approximately 10 s (0.1 Hz), i.e. like the previously described 
Mayer waves in ABP. This rhythm has been attributed to various mechanisms, but 
most recently has been assumed to reflect an integrated response to baroreflex-
mediated fluctuations in sympathetic outflow to the vasculature and in 
parasympathetic and sympathetic cardiac activity (De Boer, Karemaker and 
Strackee, 1987, Di Rienzo, Parati, Radaelli et al., 2009).  
 
A second oscillation of fc occurs at the respiratory frequency (fR) and is thought to 
represent both mechanically-driven central blood volume changes, and autonomic 
neural fluctuations that are synchronised with breathing (Cohen and Taylor, 2002). 
These respiratory-synchronous swings in fc are termed respiratory sinus arrhythmia 
(RSA) and though they have received considerable research interest over the last 
decades, the exact mechanisms underpinning the origin(s) and amplitude of RSA 
remain elusive (see section 2-4.3 for a description of current theories relating to the 




In 1936, Anrep, Pascual and Rössler, conducted a series of elegant experiments in 
dogs, seeking to clarify the mechanism underlying RSA (Anrep, Pascual and 
Rossler, 1936a, b). This was the first serious attempt to systematically test the 
existing theories of the time. There were, and remain, three ‘schools of thought’ in 
relation to the origin(s) of RSA: 
1. lung-originated reflex mechanism, (initially proposed by Edwald and Heinrich 
Hering); 
2. central interaction between cardiac and respiratory control centres (defended 
by Traube, Fredericq and Heymans); 
3. based on Francis Bainbridge’s work, changes in atrial filling and ABP 
occurring with changes in intrathoracic pressure. 
Anrep et al.’s (1936a, b) experiments provided a unifying perspective, suggesting 
that RSA was due to a combination of factors, namely: 1) a direct inhibitory influence 
of central respiratory neurones upon cardiac vagal activity; and, 2) a reflex cardiac 
response to mechanical inflation of the lung. 
 
The mechanisms responsible for RSA in human beings were explored in detail in a 
later series of studies conducted by Freyschuss and Melcher (1976a, b, c), who 
attributed RSA to 1) a reflex response from cardiopulmonary receptors to variations 
in venous return with breathing, and; 2) pulmonary stretch reflexes. Studies over the 
40 years since the work of Freyschuss and Melcher have elucidated many of the 
factors that influence the magnitude of RSA (see section 2-4.3). 
 
2-4.2 Oscillations in blood pressure 
Oscillations occurring at 0.1Hz – Mayer waves 
The current, prevalent theory suggests that Mayer waves are the result of 
resonances in the baroreflex control loop, occurring at 0.1 Hz in human beings 
(Julien, 2006). Within this conceptual framework, it has been argued that the 
existence of fixed time delays in the vascular baroreflex control loop lead to the 
production of resonant, self-sustained oscillations in ABP. The amplitude of Mayer 
waves is thus determined both by the sensitivity of the sympathetic branch of the 
baroreceptor reflex, and the strength of the triggering perturbations (De Boer et al., 




Finally, some researchers have proposed an additive role of reflex (neurogenic) and 
myogenic processes. According to the proposers of the ‘myogenic’ theory, rhythmic 
oscillations in blood vessels are generated by pacemaker cells in the vascular 
smooth muscle contracting in response to variations in intravascular pressure, 
thereby contributing to the generation and amplitude of Mayer waves (Johnson, 
1991, Stefanovska and Bracic, 1999a, b, Stefanovska, Bracic and Kvernmo, 1999). 
 
Oscillations occurring at the respiratory frequency – Traube-Hering waves 
Mechanical effects of respiration partly explain the respiration-coupled blood 
pressure oscillations, while the vagally induced RSA might also contribute (Eckberg 
and Sleight, 1992, Karemaker, 1999). Recent evidence also supports the notion that 
the respiratory fluctuations in ABP are, at least partly, the consequence of 
respiratory mediated changes in sympathetic outflow to the periphery; thereby 
suggesting central respiratory-sympathetic coupling as a putative mechanism for 
the Traube-Hering waves (Simms, Paton, Pickering et al., 2009, Towie, Hart and 
Pickering, 2012, Shantsila, McIntyre, Lip et al., 2015). 
 
2-4.3 Oscillations in heart rate 
Oscillations occurring at the Mayer wave frequency 
One increasingly popular theory states that these 0.1Hz frequency oscillations 
reflect a resonant behaviour of the baroreflex control loop, determined by inherent, 
fixed delays in the sympathetic control loop (De Boer et al., 1987). This would 
suggest that 0.1Hz oscillations in fc are the direct consequence of the ABP 
fluctuations at the same frequency. However, this only seems to be observed 
consistently in situations where the sympathetic vascular outflow is high (e.g. head-
up tilt, or standing). Typically, under other conditions, low-frequency ABP and fc 
oscillations show wide inconsistencies in coherence (i.e. spectral correlation) 
(Taylor and Eckberg, 1996, Hamner, Morin, Rudolph et al., 2001, Cohen and Taylor, 
2002). 
 
Respiratory sinus arrhythmia 
The physiology underlying the interrelationship of breathing and heart rate variability 
(HRV) has been known for many years. Its best-known manifestation is the 
phenomenon of respiratory sinus arrhythmia (RSA), which is the broadly accepted 
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term describing the oscillations of the RR interval of the ECG occurring at a 
frequency similar to respiration. This phenomenon has been suggested to have an 
important teleological function, either by, 1) improving the efficiency of gas 
exchange by matching the alveolar ventilation with pulmonary perfusion throughout 
the respiratory cycle (Yasuma & Hayano, 2004), 2) reducing workload of the heart 
while maintaining normal levels of blood gases (Ben-Tal et al., 2012), 3) 
counteracting respiratory variations in LVSV, Q̇ and ABP (Toska and Eriksen 1993; 
Elstad et al. 2001; Elstad, 2012; Elstad et al. 2015). Notwithstanding the existence 
of these theories, the precise underlying mechanisms and function of RSA, if any, 
remain unclear. 
 
Currently, there are four mechanisms proposed as potential generators of RSA: 
1) Reflex inhibition of the cardioinhibitory centre by the slowly adapting 
stretch receptors (SASR) in the lungs; 
2) Central irradiation of inhibitory impulses from the respiratory centres to 
the cardioinhibitory centre;  
3) Increased filling of the right atrium during inspiration, which activates 
mechanoreceptors at the junction of the great veins with the right atrium, 
increasing sympathetic activity to the sinus node (Bainbridge reflex); and 
4) a change in sensitivity of the arterial baroreflex occurring in phase with 
the respiration. 
 
The following section describes the evidence supporting each of the four theories: 
 
RSA as a manifestation of vagal afferent input from lung mechanoreceptors 
The first hypothesis arises from some of the first studies conducted on RSA, in the 
late 1930s. Anrep and colleagues (Anrep et al., 1936a, b) concluded that the 
mechanisms responsible for RSA included a reflex inhibition arising from the 
activation of mechanoreceptors in the lungs. 
 
More than two decades later, de Burgh Daly and Scott (1958) described the 
cardiovascular responses to stimulation of the carotid arterial chemoreceptors in 
 
32 
anaesthetized dogs and showed that the primary bradycardic response was not 
seen when breathing increased in response to the chemostimulation, but ocurred 
when ventilation was controlled. They attributed the overriding of this primary reflex 
response to the activation of the lungs’ mechanoreceptors, more particularly 
SASRs. The SASRs are vagal afferents believed to lie in the airway smooth muscle 
(Schelegle and Green, 2001, West and Luks, 2016). According to Adrian’s classic 
paper (Adrian, 1933), the SASRs are primarily responsive to changes in lung 
volume, are inhibited by deflation and tend to adapt slowly to sustained inflation 
(hence the nomenclature). The stimulation of these receptors triggers cardio-
acceleration; the so-called Hering-Breuer reflex. Importantly, the stimulation of 
SARs promotes slowing of breathing frequency (fR) by extending expiratory time. 
However, unlike other mammals, which show a reflex response at resting lung 
volumes (Widdicombe, 1961b), respiratory pattern in human beings is not altered 
unless VT exceeds 1 L (Iber, Simon, Skatrud et al., 1995). However, more recent 
evidence shows that afferent vagal feedback from SASR does modulate breathing 
in healthy adults, particularly when the perception of chest wall movements is 
suppressed  (BuSha, Judd, Manning et al., 2001, BuSha, Stella, Manning et al., 
2002). 
 
The involvement of SASRs in RSA was supported by the research of Haymet and 
McCloskey (1975), reporting inhibition of both baroreceptor and chemoreceptor 
effects on fc during inspiration. Furthermore, Gandevia and colleagues (Gandevia, 
McCloskey and Potter, 1978) indicated that, in dogs,  this inhibition is abolished by 
denervation of the lungs. These authors also reported that the level of inhibition was 
dependent upon the rate of lung inflation and that this inhibition only occurred during 
the inspiratory phase of breathing. 
 
Relevant to the context of this thesis, the reflex increase in fc with lung expansion 
has direct implications for the acute chronotropic response to SDB, as studies in 
both lung denervated dogs and human beings showed almost complete abolition of 
RSA in the absence of afferent feedback from the lungs, thereby lending support to 
an obligatory contribution from lung vagal feedback to the generation of RSA (Anrep 
et al., 1936a, Taha et al., 1995). Furthermore, both the rate of change of lung volume 
(Davis, Fowler and Lambert, 1956) and increasingly negative intrapleural pressures 
(Widdicombe, 1961a, Davenport, Frazier and Zechman, 1981) are known to 
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increase the afferent discharge from the SASRs. Collectively, these data supported 
the hypothesis that excitation of lung SASRs underpinned RSA. 
 
RSA resulting from a central generator 
The findings of some of the aforementioned studies also provided support for the 
hypothesis of a central inhibitory impulse underpinning the generation of RSA (point 
2 above). Studies conducted in dogs demonstrated the existence of an inhibitory 
effect of inspiration upon baro- and chemo-receptor reflex effects upon fc, leading 
to a bradycardia during the expiratory phase of breathing (Davidson, Goldner and 
McCloskey, 1976). Said bradycardia occurred even when ventilation was 
temporarily stopped and the baro- and chemo-receptor stimuli were delivered during 
the inspiratory phase of the neural respiratory cycle (Gandevia et al., 1978). Studies 
in human beings confirmed the modulation of vagal responsiveness to arterial 
baroreceptor stimulation (Eckberg and Orshan, 1977, Eckberg et al., 1980). The 
observation of the maintained fc rhythms within the typical respiratory band, even 
during apnoea and concomitant absence of respiratory movements, has provided 
yet more evidence to support a role for central irradiation of inhibitory impulses from 
the respiratory center in the generation of RSA (Hirsch and Bishop, 1981, Kollai and 
Mizsei, 1990).  
 
The influence of the respiratory control centre is not limited to its effect upon cardio-
vagal motoneurones; it also modulates the activity of sympathetic motoneurones. It 
appears that vagal cardio-motoneurones are inhibited during the inspiratory phase, 
but are mildly activated during expiration (Gilbey, Jordan, Richter et al., 1984, 
Richter and Spyer, 1990). On the other hand, sympathetic neurones exhibit high 
inter-species variability in their pattern of discharge, which may account the variety 
of confounding findings across the literature (Eckberg, Nerhed and Wallin, 1985, 
Richter and Spyer, 1990). That said, sympathetic outflow demonstrates a systematic 
pattern of respiratory modulation, in that excitation in one phase of respiration, is 
accompanied by inhibition in the opposite respiratory phase (Richter and Spyer, 
1990). In human beings, inhibition of the sympathetic motoneuron discharge seems 
to occur mostly during inspiration, whilst increased sympathetic activity is observed 
particularly in late-expiration (Eckberg et al., 1985, Seals, Suwarno, Joyner et al., 




These, and other observations gave way to the well-known ‘respiratory gate’ theory 
proposed by Dwain Eckberg (Eckberg, 2003), which expanded on the ‘respiratory 
gating’ concept introduced by Lopes and Palmer, almost 30 years earlier (Lopes 
and Palmer, 1976). The technological breakthroughs occurring during the three 
decades between Lopes and Palmer’s provocative work and Eckberg’s review 
allowed a deeper comprehension of the interrelation between autonomic 
cardiovascular and respiratory control. According to Eckberg, these shed light on 
the ‘respiratory gate’ concept. Eckberg’s theory postulates that the respiratory 
modulation of fc can be best described as a ‘gate’ consisting of inspiratory 
interneurones (probably located within the nucleus tractus solitarius; a brainstem 
structure that receives and relays vagal afferent feedback from the cardiovascular 
system and other structures in central nervous system), which control the passage 
of impulses into the nucleus ambiguous1 (Lopes and Palmer, 1976, Eckberg, 2003).  
 
The first of Eckberg’s new concepts was that evidence of respiratory activity could 
be found imprinted upon human autonomic signals. It is known that as breathing 
rate decreases the RR intervals fluctuations (RSA) increase, as does the total 
spectral power (Hirsch and Bishop, 1981, Eckberg, 1983, Saul, Berger, Chen et al., 
1989, Song and Lehrer, 2003). Simultaneously, important but smaller fluctuations 
have also been detected in ABP and SNA (Badra, Cooke, Hoag et al., 2001). 
Together with previously reported evidence regarding the responsiveness of vagal 
motoneurones to baroreceptor stimulation (Eckberg and Orshan, 1977, Eckberg et 
al., 1980), these findings led Eckberg to define the ‘respiratory gate’ as a 
sinusoidally varying, permanently open gate (Eckberg, 2003) that regulates both 
vagal and sympathetic motoneurone responsiveness to external inputs, particularly 
of baroreflex origin (Eckberg et al., 1985, Eckberg, 2003, Rothlisberger, Badra, 
Hoag et al., 2003). 
 
According to Eckberg and colleagues (Eckberg, 2003, Rothlisberger et al., 2003), 
not only does respiration gate muscle sympathetic nerve activity, but it also 
determines the timing of spontaneous baroreflex sequences through a cascade of 
events: 
1) the respiratory gate opens, and sympathetic bursts appear;  
                                            
1 Structure in the brainstem that is responsible for vagal efferent traffic to the heart. 
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2) the sympathetic bursts increase ABP, triggering baroreflex RR interval 
prolongations; 
3) the increase of ABP silences sympathetic motoneurones, ABP falls, leading 
to RR interval shortening. 
Importantly, the Rothlisberger et al. (2003) study suggested that respiration does 
not affect the cardiac baroreflex sensitivity (BRS), as BRS was similar during 
spontaneous breathing and apnoea.   
 
The magnitude of respiratory gating of neural outflow depends critically on the level 
of stimulation. This is supported by evidence showing abolition of respiratory 
modulation of vagal motoneurone response with intense baroreceptor stimulation 
(Eckberg and Orshan, 1977), or pharmacologically elevated ABP, leading to 
diminished RSA (Goldberger, Ahmed, Parker et al., 1994). Similar findings arose 
from experiments exploring graded passive upright tilt and its effects on SNA; they 
observed that significant inspiratory-expiratory differences of sympathetic outflow in 
the supine position and lower tilt angles disappear when moving to an upright 
posture (Cooke, Hoag, Crossman et al., 1999). 
 
Despite not ruling out the contribution of other sources of variability, the persistence 
of RR interval fluctuations at the respiratory frequency in the absence of 
intrathoracic pressure variations (apnoea), in both human (Hirsch and Bishop, 1981, 
Kollai and Mizsei, 1990) and animal (Shykoff, Naqvi, Menon et al., 1991) models, 
favours the argument around the contribution of a central mechanism towards the 
timing and amplitude of respiratory related variations in fc. Furthermore, 
conventional mechanical ventilation (with phasic tidal lung inflation) reduces 
respiratory RR fluctuations, much like what is observed for high-frequency jet 
ventilation (continuous lung inflation with minute VTs), strengthening the case for a 
central generator of RSA (Koh, Brown, Beightol et al., 1998).      
 
RSA resulting from atrial stimulation 
A third putative mechanism for the generation of RSA suggests it is underpinned by 
the stimulation of mechanoreceptors located mainly at the junctions of the great 
veins with the right atrium. A more in-depth characterisation of these atrial 
baroreceptors has been previously provided in section 2-2.2. The first evidence of 
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the existence of such afferents came from the studies of Francis Bainbridge, who 
demonstrated that the infusion of saline or blood into the jugular vein of the 
anesthetised dog produced tachycardia (Bainbridge, 1915). Similar cardiac 
acceleration was secondary to increased venous return accompanying inspiration, 
in anesthetised cats and dogs (Bainbridge, 1920); this phenomenon was later to 
become known as the Bainbridge reflex. 
 
The Bainbridge reflex was studied throughout the 20th century, with subsequent 
researchers confirming its existence and clarifying its anatomical and physiological 
features, mostly in dogs (Coleridge et al., 1957, Ledsome and Linden, 1964, 1967, 
Horwitz and Bishop, 1972, Vatner, Boettcher, Heyndrickx et al., 1975). Later studies 
demonstrated a species-dependency of the Bainbridge reflex, suggesting a much-
attenuated magnitude of response in human beings than had been previously 
observed in dogs (Boettcher, Zimpfer and Vatner, 1982). A more dominant arterial 
baroreceptor mechanism and lower baseline vagal tone in human beings, thus 
precluding substantial vagal-withdrawal-mediated increases in fc, are the likely 
factors behind the less potent response observed in humans (Boettcher et al., 
1982). Interestingly, in supine, conscious individuals, undergoing graded increases 
in central blood volume (within physiological range), the baroreflex vagal-mediated 
decrease in fc was dominant during the initial increases in blood volume but was 
suppressed when central blood volume increased further. This was consistent with 
the existence of a mild Bainbridge reflex in human beings and suggested a potential 
role in controlling short-term fluctuations of fc, and thus RSA (Barbieri, Triedman 
and Saul, 2002). 
 
Despite the supporting evidence of the existence of cardiac modulation in response 
to changes in central blood volume, and potentially by respiratory-driven changes in 
venous return, it is still unclear if the dominant mechanism underpinning change in 
fc is of reflex origin (Bainbridge reflex) or, mainly myogenic. Studies in heart 
transplanted individuals (with no vagal innervation of the heart) demonstrated the 
existence of respiratory modulation of fc (RSA), likely linked to a direct mechanical 
stretch of atrial walls, induced by respiratory variations in venous return (Bernardi et 




RSA resulting from baroreflex mechanisms 
The fourth and final mechanism proposed to underlie the generation of RSA is 
related to the arterial baroreflex. The deformation of mechanosensitive 
baroreceptors provides afferent neural information to the medullary centres, via the 
vagus nerve, resulting in increases or decreases in the outflow of efferent 
sympathetic nerve traffic to the peripheral vasculature and heart, as well as efferent 
vagal traffic to the heart. A more detailed description of the mechanisms of action 
has been provided previously in section 2-2.1. 
 
The idea that RSA could be mainly determined by respiratory driven alterations in 
ABP, transiently affecting fc by stimulation of the aortic arch and carotid 
baroreceptors, was first suggested by Schwheitzer in 1937, and later supported by 
a 1961 paper from Koepchen and colleagues (cit by de Burgh Daly, 1986). These 
early studies, performed in isolated and perfused carotid sinuses, garnered little 
support, primarily because they failed to explain why during slow breathing, 
tachycardia could occur in the presence of an increase in ABP (de Burgh Daly, 
1986). However, the discovery of a within-breath variation in the responsiveness of 
cardiac vagal motoneurones to incoming baroreceptor afferent traffic (Haymet and 
McCloskey, 1975, Eckberg and Orshan, 1977, Eckberg et al., 1980) shed new light 
on the matter, and re-ignited interest in the role of the baroreflex in the generation 
and amplitude of RSA.  
 
Significant advances resulted from the mathematical modelling work of De Boer et 
al. (1987), and later TenVoorde, Faes, Janssen et al. (1995), in which they 
advocated that ABP was altered mechanically by the act of breathing, with an 
immediate response from fc (within the same heart beat), determined by a fast-
acting cardiac vagal baroreflex loop.  
 
This hypothesis gained support from studies using neck suction to stimulate the 
carotid baroreceptors in conjunction with paced breathing (Piepoli, Sleight, Leuzzi 
et al., 1997, Keyl, Dambacher, Schneider et al., 2000). Piepoli and colleagues 
reported that RSA could be either mimicked or suppressed through the stimulation 
of arterial baroreceptors with neck suction. When delivering continuous sinusoidal 
neck suction at the frequency of respiration during apnoea, they managed to 
reproduce oscillations in ABP, thus supporting the idea of a mechanical origin of 
respiratory oscillations in ABP. In the same study, similar stimulation of a non-
 
38 
baroreflex area (thigh) had no measurable effect on RSA, confirming the carotid 
baroreceptors as the source of the resulting RSA. The contribution of a baroreflex 
mechanism to the generation and amplitude of RSA was also demonstrated by the 
attenuation of RSA when carotid stimulation was delivered at a phase of the 
respiratory cycle that would counteract the normal phase relation between 
respiration and ABP (Piepoli et al., 1997). This was further supported by Keyl et al.’s 
data (2000), demonstrating that neck suction at 0.2Hz produced a similar time lag 
between systolic blood pressure (SBP) change and RR interval alteration to that 
observed with paced breathing at 0.25Hz.  
 
What does determine respiratory sinus arrhythmia? 
All things considered, the existence of a single, unifying mechanism controlling the 
generation and magnitude of RSA seems unlikely. In a highly interesting 
point/counterpoint paper in the Journal of Applied Physiology, both Dwain Eckberg 
and John Karemaker (with some valuable input to the discussion being provided 
from other expert members of the scientific community) defended their differing 
views regarding the main determinant(s) of RSA (Eckberg, 2009a, b, Julien, Parkes, 
Tzeng et al., 2009, Karemaker, 2009a, b, c). Eckberg strongly advocated that central 
gating was sufficient to explain respiratory frequency RR interval fluctuations and 
that the latency between ABP changes and parallel RR interval changes, as defined 
by cross-spectral phase, was too short for meaningful baroreflex responses to be 
mounted. Contrarily, Karemaker championed the important role of the baroreflex in 
the generation and the magnitude of RSA and argued that if all RSA is due to central 
modulation alone, similar-sized oscillations would be expected in both systolic (SBP) 
and diastolic blood pressures (DBP). Karemaker went on to argue that while a large 
respiratory variability in SBP exists, DBP varies very little, thus arguing for an 
extremely quick cardiovagal-baroreceptor loop, in line what he and others had 
previously demonstrated with mathematical models (De Boer et al., 1987). In the 
end, both acknowledged the existence of an undefined blend of baroreflex 
mechanism and central gating in the generation of respiratory frequency RR interval 
fluctuations, with Karemaker also pointing out the importance of other reflex input 
mechanisms. These included those resulting from the effects of respiration on 
venous return and the resulting pressure changes inside the heart chambers, which 
are known to have a modulating effect upon autonomic outflow (Karemaker, 2009c). 
Nonetheless, apart from the intricacy of the underlying physiology here discussed, 
and some concessions with regards to the existence of multiple mechanisms 
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underpinning RSA, the fact remains that no one has yet managed to provide 
unequivocal evidence in support of a unifying model, if in fact, one exists, 
underpinning respiratory-related fluctuations in RR interval. 
 
2-4.4 Oscillations in sympathetic nervous activity 
Historically, ever since it has been possible to obtain direct recordings of 
sympathetic nerve activity (SNA), evidence of respiratory modulation has been 
reported (Okada and Fox, 1967, Hagbarth and Vallbo, 1968, Preiss et al., 1975, 
Gerber and Polosa, 1978, Eckberg et al., 1985). Despite the evidence that 
sympathetic outflow is not uniform across the different vascular beds, it is accepted 
that cardiac, splanchnic, renal and muscle sympathetic nerve activities (MSNA) are 
strongly influenced by baroreceptor and chemoreceptor stimulation (Hart, Head, 
Carter et al., 2017). Thus, the measurement of MSNA provides a convenient 
indicator of sympathetic vasoconstrictor outflow to these vascular beds (Wallin, 
Esler, Dorward et al., 1992, Wallin, Thompson, Jennings et al., 1996). Also, relevant 
for the foregoing discussion, MSNA shows high inter-individual variability, but very 
low intra-individual variability (Fagius and Wallin, 1993). 
 
Respiratory modulation of MSNA 
In healthy individuals, vagally mediated lung stretch reflex is the primary mechanism 
through which MSNA is modulated by respiration (Seals, Suwarno and Dempsey, 
1990, Seals et al., 1993), with the degree of lung inflation affecting the magnitude 
of the respiratory modulation. However, the latter is not observed in lung denervated 
individuals, which despite showing modulation of MSNA at the respiratory 
frequency, did not demonstrate a potentiation of this effect at elevated tidal volumes 
(Seals et al., 1993) 
 
A contribution of baroreceptor afferent stimulation by respiratory induced changes 
in ABP has also been advocated as a contributor to the fluctuations in MSNA, within 
the respiratory frequency band (St. Croix et al., 1999). During spontaneous 
breathing, MSNA usually reaches a nadir in late inspiration and peaks during 
expiration (Dempsey, Sheel, St Croix et al., 2002). However, the modulatory 
influence of respiration upon MSNA seems to be attenuated in some disease 
conditions, including hypertension (Fisher, Reynolds, Farquhar et al., 2010, Fisher, 
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McIntyre, Farquhar et al., 2011), and to a lesser extent in chronic heart failure (Goso, 
Asanoi, Ishise et al., 2001). Furthermore, while older people tend to have higher 
MSNA than their younger counterparts, the pattern of respiratory inhibition of MSNA 
does not show substantial age-related modifications (Shantsila, McIntyre, et al., 
2015). As mentioned earlier in section 2-4.2, the respiratory modulation of MSNA 
likely represents a causative relationship, with the presence and amplitude of ABP 
fluctuations occurring in parallel with respiration. 
 
Fluctuations in MSNA occurring at 0.1Hz 
Reported oscillations in SNA at a frequency close to that of the so-called Mayer 
waves in ABP has led to the assumption that MSNA oscillations driven by a central 
oscillator could be responsible for the ABP Mayer waves (Julien, 2006). Studies in 
animal models have demonstrated that fluctuations in SNA persist even when ABP 
oscillations are abolished, and are thus independent of baroreflex control (Preiss 
and Polosa, 1974, Grasso, Rizzi, Schena et al., 1995). Further evidence of a 
possible link between a central modulator of SNA and Mayer waves was shown in 
vagotomised, baroreflex-denervated, anesthetised cats, where oscillations in both 
medullary neurones and cardiac SNA were detected at the Mayer wave frequency 
(Montano, Gnecchi-Ruscone, Porta et al., 1996, Montano, Cogliati, da Silva et al., 
2000). 
 
There is some support for a centrally originated rhythm in SNA that is independent 
of baroreflex afferent signals but only under strict experimental conditions. Data from 
human beings where, under physiological conditions, the arterial baroreflex is the 
dominant ABP regulatory mechanism, shows a necessary modulation of ABP Mayer 
waves by reflex mechanisms (Julien, 2006). This can be demonstrated clearly by 
sino-aortic deafferentation, where the complete removal of baroreflex afferent input 
abolishes Mayer waves despite the presence of oscillations in vasomotor outflow 
(Di Rienzo, Parati, Castiglioni et al., 1991, Julien, Zhang, Cerutti et al., 1995, 
Mancia, Parati, Castiglioni et al., 1999).  Thus, sinusoidal baroreflex stimulation 
occurring at 0.1Hz, as a consequence of resonances in the baroreflex control loop 
triggering an ABP rhythm, could be the main driver of 0.1Hz fluctuations in SNA 




Importantly, the magnitude of SNA outflow to each vascular bed will be determined 
by said organ’s baroreceptor sensitivity and will be delivered with a fixed time delay 
in relation to the previous ABP perturbation. The combination of the delays from the 
different vascular beds, including the skeletal muscle vasculature, kidney, gut and 
lungs, implies that the vascular resistance response following the change in ABP 
can amplify said oscillations, instead of buffering them, thereby contributing to the 
0.1 Hz fluctuations in ABP by a mechanism other than a central oscillator (Malpas 
et al., 2001). 
 
2-4.5 Coherence and entrainment 
The previous points in this section have highlighted the presence of rhythmicity in 
cardiovascular signals occurring at the respiratory frequency (fR), but also at lower 
frequencies, which in humans, tend to occur with a periodicity circa 10s (0.1 Hz).  
The alignment of the different rhythms when breathing at a frequency close to 0.1Hz 
(6 breaths.min-1) is thought to produce synchronisation, entrainment (of respiration, 
ABP and fc) and resonance (likely from the baroreflex control of ABP and fc, leading 
to amplification of the oscillations in these physiological variables). This 
phenomenon is sometimes referred to as ‘coherent breathing’ (McCraty and 
Tomasino, 2004, Elliot and Edmonson, 2006). ‘Coherent breathing’ normally results 
in smooth, sinusoid patterns in vascular and cardiac rhythms, which translates into 
a very high-amplitude peak in the low frequency (LF; 0.04-0.15 Hz) band of the HRV 
and BPV power spectrum (McCraty and Tomasino, 2004). 
 
The mechanism behind this amplification of the cardiovascular rhythmicity is 
believed to be linked to the resonance characteristics of the vascular baroreflex 
control loop. Resonances are typical of some physical systems, more specifically 
those that comprise fixed delays (Grodins, 1963, cited by Lehrer, 2013). These 
result in very high amplitude oscillations at a specific frequency (resonant frequency) 
when a stimulus is applied with the same or similar frequency. Furthermore, existing 
oscillations at other frequencies are completely suppressed in the presence of 
resonant fluctuations (Lehrer, 2013). 
 
While ABP and fc oscillations are irregular and small during spontaneous breathing, 
these become much larger and regular when breathing at the resonant frequency, 
or close to it.  Although the mechanism proposed by Lehrer, Vaschillo and others to 
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explain the effects of breathing at resonant frequencies is likely an over-
simplification (Lehrer, Vaschillo and Vaschillo, 2000, Vaschillo et al., 2002), the 
existence of a slow breathing frequency, which amplifies cardiovascular oscillations, 
is undeniable, and might be of clinical relevance. According to Vaschillo and 
colleagues (2002), resonant breathing is characterised by: 
1) Respiration and fc with a 0º phase relation (completely in phase); 
2) ABP and fc with an 180º phase relation (completely in antiphase). 
 
The authors associated the aforementioned phase relations to a ~5 s delay within 
the cardiac baroreflex loop. They also argued that this interpretation was 
strengthened further by evidence that the ABP resonant frequency lays at even 
lower frequencies, corresponding to the time delay of the vascular baroreflex loop 
(Vaschillo et al., 2002). Furthermore, Vaschillo reasoned that the mechanical effect 
of breathing triggers a decrease in fc that reduces blood flow and therefore ABP, 
thus promoting a stimulus for fc to increase. Despite being physiologically plausible, 
it has been previously demonstrated that RSA only significantly contributes to the 
amplitude of ABP variations when sympathetic tone is suppressed (Saul, Berger, 
Albrecht et al., 1991). 
 
Postural changes impact autonomic activity and can, therefore, change the 
contribution of RSA to ABP fluctuations, particularly when considering variations in 
systolic blood pressure (SBP) in the supine position (Elstad, Toska, Chon et al., 
2001). Therefore, any causality between RSA and ABP must be interpreted with 
care. Moreover, others have reported a quicker time course of the action (2 s of time 
delay followed by 2s of time constant for the maximal response to be attained) of 
the sympathetic baroreflex control of the vasculature (TenVoorde et al., 1995, van 
de Vooren, Gademan, Swenne et al., 2007) than the 5 s delay proposed by 
Vaschillo. Thus, it is likely that Vaschillo’s explanation is deficient by being unable 
to explain how and if other mechanisms producing rhythmic oscillations in fc, ABP 
and SNA (described earlier in this section) contribute to, or buffer, the amplitude of 
the observed resonant behaviour.  
 
2-4.6 Summary 
The advent of new mathematical methods has permitted the study of cardiac, 
respiratory and vascular fluctuations in the frequency domain and to better 
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understand the phase relationships between the different rhythms. Also, the 
widespread use of methods like the neck pressure/suction chamber and the 
application of lower body positive/negative pressure or tilt techniques have 
permitted selective manipulation of inputs to cardiovascular receptors and to 
gradually change autonomic tone, in human beings. Furthermore, the development 
of minimally invasive ways of assessing MSNA, and the reliable noninvasive 
measurement of beat-to-beat ABP, LVSV and Q̇, has permitted in vivo studies in 
human beings, which were only previously possible in animal models. Taken 
together, the research using these techniques has furthered the understanding of 
cardiovascular rhythms and their interaction with breathing, but overall, the exact 
underlying mechanisms remain somewhat elusive. Figure 2-9 represents one of the 
many attempts in the literature to provide an integrated picture of the existing 





Figure 2-9 – Scheme of the main known oscillations affecting arterial blood pressure 
fluctuations. Circles reflect local oscillators in the central nervous system or smooth muscle system 
(myogenic mechanisms) Arrows represent feedback systems that oscillate under certain conditions. 
ARAS – Ascending reticular activating system (series of nuclei in the brainstem of which the reticular 
formation is the most relevant); III – Baroreceptor circuit; IV – Chemoreceptor circuit; V – Brain 
ischemic circuit. From Koepchen (1991).  
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2-5 Acute effects of variations in breathing pattern and intra-
thoracic pressure upon the cardiovascular system 
2-5.1 Effects of breathing pattern 
The promise of potential clinical applications of SDB interventions stems mostly from 
the outcome of studies where SDB was administered daily for several weeks. Some 
of the relevant findings from such studies were summarised in the introductory 
section of this thesis (Chapter 1 – General Introduction). However, little is known 
about the link between the acute cardiovascular responses taking place during SDB 
and the long-term adaptations it might stimulate. Furthermore, a significant portion 
of the existing body of literature has focused specifically on measures of RSA, 
cardiac baroreflex sensitivity (BRS), heart rate variability (HRV) and blood pressure 
variability (BPV), as well as MSNA. Much less attention has been devoted to the 
actual within-breath modulation of LVSV, Q̇ and ABP, and how changing the 
characteristics of the SDB stimulus might impact the respiratory modulation of 
cardiovascular parameters, and therefore alter the stimuli to some of the afferent 
signals described above; particularly to the arterial baroreceptors. Nonetheless, 
there is a significant body of research that provides a better understanding of what 
is currently known regarding the acute cardiovascular impact of SDB, which is 
summarised in the following sections. This summary is not intended to be 
comprehensive, but is a focused account of what is considered to be the most 
pertinent evidence. A more detailed description of each study can be found in table 
format in Appendix I.  
 
The seminal paper of Dornhorst and colleagues (1952b), was one of the first to show 
the existence of a phase relation between respiration and ABP that was altered by 
the reduction of fR. A similar finding was made a few years later for the relationship 
between respiration and fc, or more precisely, RSA (Angelone and Coulter, 1964). 
In their study, Angelone and Coulter reported maximal values of RSA at 
approximately 6 breaths·min-1. Many others have reported a similar behaviour of 
RSA (or HRV), with a tendency for maximisation close to 6 breaths·min-1 (Hirsch 
and Bishop, 1981, TenVoorde et al., 1995, Song and Lehrer, 2003, Vaschillo, 
Vaschillo and Lehrer, 2006). The response of RSA, and other quantifiers of HRV, to 
the alteration of fR, is characterised by individualised curves (Hirsch and Bishop, 
1981, Vaschillo et al., 2006), which have been claimed to represent individual 
variations in resonant frequency location (Lehrer, 2007). These individual variations 
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are independently related to height and gender, thus possibly reflecting inter-
individual differences in the volume of the vasculature (Vaschillo et al., 2002, Lehrer, 
Vaschillo, Lu et al., 2006). However, the influence of fR has not been studied in a 
systematic way, i.e. such that potential confounders as the simultaneous changes 
in VT (see also below) and PaCO2 are controlled; neither have the cardiac 
haemodynamic and blood pressure responses to changes in fR been studied 
systematically, i.e. studied simultaneously and over a comprehensive range of slow 
fRs. 
 
An important gap in the literature is how changes in tidal volume (VT) can 
simultaneously, and independently, influence the acute cardiovascular response to 
SDB. Most of the studies cited above failed to control for the increase in VT that 
accompanies the decrease in fR, which arises automatically to maintain minute 
ventilation (V̇E) and arterial CO2 levels (PaCO2). While it has been argued that the 
impact of the VT upon some variables, particularly RSA, is reduced (believed to only 
account for a small percentage of the overall variation of RSA during SDB, against 
a much larger contribution arising from the change in fR (Hirsch and Bishop, 1981, 
Brown, Beightol, Koh et al., 1993, Pinna, Maestri, La Rovere et al., 2006)) the 
differentiation of the independent effects of both fR and VT is fundamental to a better 
understanding of the acute cardiovascular effects of SDB.  
 
Currently, a direct positive relationship has been established between VT and, 1) 
RSA magnitude (Hirsch and Bishop, 1981, Eckberg, 1983, Cooke, Cox, Diedrich et 
al., 1998); and 2) the amplitude of within-breath changes in MSNA (Seals et al., 
1990, Seals et al., 1993). Importantly, it seems that the depth of breathing impacts 
the cardiac responsiveness to baroreflex stimulation; as demonstrated by increased 
inspiratory inhibition of efferent cardiac vagal activity at higher VTs, leading to 
diminished cardiac baroreflex responses to changes in ABP during inspiration  
(Eckberg and Orshan, 1977). The impact of VT upon RSA and MSNA is thought to 
relate to either the stimulation of SASRs (Freyschuss and Melcher, 1976c, Seals et 
al., 1990), or to a direct mechanical effect of the change of intrathoracic pressure 
upon venous return during inspiration, leading to fluctuations in ABP (Dornhorst et 
al., 1952b, Freyschuss and Melcher, 1976a, b). 
 
Lowering fR has also been shown to increase the amplitude of ABP oscillations, i.e. 
blood pressure variability (BPV) (TenVoorde et al., 1995, Cooke et al., 1998, 
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Vaschillo et al., 2002). However, at least one account has shown a reduction in the 
amplitude of within-breath fluctuations of SBP when fR is lowered (Sin, Galletly and 
Tzeng, 2010). These changes in the within-breath amplitude of fc and ABP 
oscillations seem to occur without significant alteration of the mean values of said 
variables, thus suggesting the absence of acute autonomic adjustments. This 
construct is reinforced by unaltered mean MSNA during SDB, despite significant 
within-breath modulation of MSNA (Seals et al., 1990, Limberg, Morgan, Schrage 
et al., 2013). 
 
Perhaps surprisingly, there appear to be no relevant studies exploring the influence 
of VT upon ABP or BPV, either during spontaneous breathing or during SDB. 
Furthermore, where studies have reported measures of BPV in response to SDB 
(TenVoorde et al., 1995, Cooke et al., 1998, Vaschillo et al., 2002, Sin et al., 2010) 
they failed to control for the potential effect of increased VT upon both preload 
(increasing venous-return) and afterload (altering aortic transmural pressure), that 
would be associated with a decrease in fR. It is accepted that increasing VT impacts 
both preload and afterload, which would be predicted to increase the amplitude of 
oscillations in LVSV and ABP (Dornhorst et al., 1952b, Freyschuss and Melcher, 
1976a, b). Thus, the independent influence of VT upon the simultaneous behaviour 
of some cardiovascular parameters remains uncharacterised. 
 
For example, little is known about the effects of SDB upon cardiac function, 
specifically LVSV and Q̇; in particular, their within-breath behaviour in response to 
changes in fR and/or VT. Most of the current evidence regarding the respiratory 
modulation of cardiac function results from studies conducted in animal models 
(Brecher, 1952, Brecher and Hubay, 1955, Hoffman et al., 1965, Robotham et al., 
1978, Robotham and Mintzner, 1979, Robotham et al., 1979, Scharf et al., 1979, 
Olsen et al., 1985, Robotham et al., 1988), or human cardiac patients (Ruskin, 
Bache, Rembert et al., 1973, Guz, Innes and Murphy, 1987). The other studies have 
been performed during quiet breathing (Karam et al., 1984, Guz et al., 1987, Innes, 
De Cort, Kox et al., 1993, Toska and Eriksen, 1993, Peirce, Panerai and Potter, 
2001, Elstad, 2012, Claessen, Claus, Delcroix et al., 2014), or during exercise 
(Claessen et al., 2014), which also lack relevance to the contributions of fR and/or 
VT to cardiac function during SDB. The two studies that have explored paced 
breathing have done so at frequencies that were above 10 breaths·min-1 (Boutellier 
and Farhi, 1986, Peirce et al., 2001) and therefore also cannot be considered as 
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representative of the cardiac haemodynamic response during SDB. This gap in the 
literature is likely determined by the invasiveness of some of the interventions, as 
well as by the respiratory-imposed limitations inherent in more recent, non-invasive 
methods, such as Doppler ultrasound imaging (Armstrong and Ryan, 2012). 
However, the development of valid and reliable, non-invasive 
photoplethysmographic methods (Sugawara, Tanabe, Miyachi et al., 2003, van 
Lieshout, Toska, van Lieshout et al., 2003, Bogert and van Lieshout, 2005) currently 
allows for an easy and continuous evaluation of the cardiac response to respiratory 
challenges; albeit indirect. Despite not being in the context of SDB, one example is 
the study of Elstad (2012), which characterised the simultaneous variations in 
pulmonary and systemic blood flow in healthy human beings by combining Doppler 
ultrasound assessment of the right ventricular function and Modelflow, a 
mathematical model used to estimate LVSV and Q̇, from the ABP waveform 
obtained by photoplethysmography. The understanding of volume and/or 
frequency-dependent left ventricular function responses is fundamental to the 
understanding of the acute response to SDB, and thus to the understanding of the 
mechanisms that might lead to any longer-term impact upon ABP. 
 
Similarly, to better comprehend the relationships that are established between the 
different biological rhythms during SDB, it is important to clarify its impact upon the 
phase relationships between respiration, fc and ABP, as these are known to be 
altered by fR. Using frequency domain techniques, Angelone and Coulter (1964) 
reported that at approximately 10 breaths·min-1, respiration and fc tend to show an 
180º phase relationship (opposite phase), which changed progressively with a 
reduction of fR to 0º phase ≤ 4 breaths·min-1. Others have suggested that respiration 
and fc are in phase (0º phase relation) at frequencies closer to 6 breaths·min-1 
(Vaschillo et al., 2002). The same authors have argued that at 6 breaths·min-1, the 
phase relation between respiration and ABP (in this case SBP) is 180º. This is 
consistent with a phase relationship between SBP and fc close to 180º at the 
frequencies close to 6 breaths·min-1. However, experimental data from healthy 
individuals seems to contradict this idea, by showing a relatively unchanged SBP to 
fc phase relationship at around 90º, even for fR below 6 breaths·min-1 (TenVoorde 
et al., 1995). Recent developments in time-domain analysis techniques have 
confirmed fR-dependent alterations in the relationship between respiration, fc and 
SBP (Sin et al., 2010) that could not be extracted from classical frequency domain 
spectral methods. This new approach highlighted the presence of nonlinearities in 
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the respiratory-cardiovascular interactions in human beings (Sin et al., 2010). Thus, 
the influence of changes in fR upon these phase relationships remains poorly 
understood. Furthermore, to the best of the author’s knowledge no study has yet 
investigated whether the phase relationships between respiration, fc and SBP are 
in any way affected, or confounded, by variations in VT. 
 
Another suggested acute effect of SDB is to increase cardiac baroreflex sensitivity 
(BRS) (Bernardi et al., 2001, Lehrer et al., 2003). The determination and 
interpretation of BRS are known to be affected by posture (TenVoorde et al., 1995, 
O'Leary, Kimmerly, Cechetto et al., 2003), experimental protocol (Bowers and 
Murray, 2004a) and quantification method (Tzeng, Sin, Lucas et al., 2009). This 
probably explains why some studies have noted no relevant change in cardiac BRS 
with SDB (Shantsila et al., 2014a, Shantsila et al., 2014b), resulting in a lack of 
clarity in relation to the BRS response to SDB. Nonetheless, apart from TenVoorde’s 
study, I am not aware of any study that has attempted to characterise cardiac BRS 
over a range of frequencies and volumes that are consistent with SDB. 
 
To the author, the lack of consistent and comprehensive data that clearly 
characterises the independent acute cardiovascular impact of fR and VT justifies 
further research. Such understanding seems necessary to fully comprehend and 
identify the acute mechanisms behind the perturbing stimulus delivered to 
cardiovascular control system during SDB.  
 
2-5.2 Effects of intra-thoracic pressure 
Two recent studies have observed more profound and sustained effects of SDB 
training over the course of weeks, when used in combination with inspiratory 
resistances (Jones et al., 2010, Sangthong et al., 2016). These findings suggest 
that the acute and chronic influence of SDB might be enhanced by the addition of 
small respiratory resistances. Whilst I am not aware of any research that has 
examined specifically the acute cardiovascular response to resisted SDB, several 
studies have tested the effects of small inspiratory resistances; these data suggest 
that magnifying intra-thoracic pressure oscillations might modify the acute 




In healthy supine human beings, the use of a small inspiratory resistance reportedly 
results in increased ABP, with no change in cardiac BRS (Convertino, Ratliff, Ryan, 
Cooke et al., 2004), as well as increases in LVSV and Q̇ (Convertino, Ratliff, Ryan, 
Doerr et al., 2004). In common with SDB (Lucas et al., 2013), application of small 
inspiratory resistances increases cerebral blood flow (CBF) and improves tolerance 
to orthostatic challenges and hypovolemia (Cooke, Lurie, Rohrer et al., 2006, 
Rickards, Ryan, Cooke et al., 2007, Rickards, Cohen, Bergeron et al., 2008, 
Rickards, Ryan, Cooke et al., 2011). One study in particular, explored the 
independent cardiovascular effect of various magnitudes of respiratory resistance 
(simultaneously during inspiratory and expiratory phases) during paced breathing at 
12 breaths·min-1 with fixed VT. The study demonstrated an unaltered phase 
relationship between surrogate measures of LVSV, as well as ABP and fc. The use 
of a range of respiratory resistances supported the existence of an important 
functional mechanical link between respiratory-related intra-thoracic pressure 
oscillations and changes in LVSV, ABP, and RSA. Collectively, these data suggest 
that studying of the combined influences of SDB and inspiratory loading may aid 
understanding of the contribution from intrathoracic pressure to changes in venous 
return and the associated cardiac haemodynamic responses. Furthermore, the 
characterisation of the acute effect of the combined use of the two interventions may 
contribute to identification of the factors underpinning a potential long-term benefit 
of inspiratory resisted SDB.  
 
Finally, in line with the dearth of information relating to combining SDB with 
inspiratory resistances, no studies appear to have explored the cardiovascular 
impact of spontaneous breathing against small expiratory resistances, either in 
isolation or in conjunction with SDB. Similarly, little is known regarding the 
cardiovascular effects of the simultaneous use of inspiratory and expiratory 
resistances.  
 
While this might seem to the reader to be a departure from the study of the 
cardiovascular responses to SDB, the use of inspiratory, expiratory and dual 
resistive breathing in conjunction with SDB is an integral part of yogic breathing 
techniques. These techniques require practitioners to breathe through a single-
nostril, thus increasing the resistance to airflow and magnifying respiratory-induced 
intra-thoracic pressure oscillations. Indeed, single-nostril breathing has been 
suggested to have distinct beneficial effects upon ABP (Raghuraj and Telles, 2008, 
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Pal, Agarwal, Karthik et al., 2014), HRV (Pal et al., 2014) and autonomic activity 
(Telles, Nagarathna and Nagendra, 1994), with effects claimed to differ between 
right and left-nostril breathing. The confirmation of said differences between airway 
route (mouth, nostrils), and the understanding of the respiratory-phase dependent, 
within-breath cardiovascular responses to expiratory or dually resisted SDB, might 
contribute to a better understanding of the mechanisms underlying the acute 
response to SDB, as well as to enhancing the long-term efficacy of SDB 
interventions. 
 
2-6 Overall summary  
Respiration induces fluctuations in fc, ABP and MSNA that occur with a periodicity 
similar to the respiratory frequency. These oscillations are the result of the cyclic 
stimulation of mechanoreceptors in the lungs, heart and main vessels by increased 
inflation, and variations in blood volume. Similarly, cardiovascular rhythmicity has 
also been identified with a cadence of approximately six cycles per minute (0.1 Hz), 
in human beings.  
 
Slowing breathing down to approximately 6 breaths·min-1 entrains the respiratory 
and cardiovascular rhythms and potentiates within-breath oscillations in fc (RSA) 
and ABP (BPV). This amplification phenomenon is thought to reflect resonance 
phenomena present in the baroreflex control mechanism of ABP. It could be that 
such a resonant effect creates a state of heightened systemic and autonomic 
stimulation that underpins the claimed positive, prospective clinical benefits of SDB.  
 
However, no study has yet investigated the independent cardiovascular perturbation 
that might be delivered by independently manipulating fR (within the range of slow 
breathing) and VT, Similarly, no study to date has looked into whether different 
systemic haemodynamic variables tend to respond similarly, or differently to such 
manipulations, i.e. if there is a generalised tendency that favours breathing at an 
individualised resonant frequency.  
 
Furthermore, secondary to deeper breathing, increased venous return is expected 
because of larger and more sustained (longer respiratory cycle duration) negative 
intrathoracic pressures throughout inspiration; this may also contribute to the 
amplitude of fc and ABP fluctuations during SDB. These respiratory-driven 
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oscillations in venous return and ABP can be amplified by breathing against small 
respiratory resistances, which might provide an adjunctive stimulus to the 
cardiovascular control mechanisms. Manipulation of this factor may also help to 
further the understanding of the mechanisms involved in the acute response to SDB, 




2-7 Aims of the present research and research hypotheses 
The general aim of this thesis is to increase understanding of the acute responses 
to SDB, with an emphasis on the mechanical factors contributing to cardiovascular-
respiratory interactions. In doing so, it is intended to facilitate the identification of a 
putative mechanistic link(s) between the acute response to SDB and its claimed 
chronic antihypertensive effects, with the purpose of optimising the factors involved.  
 
The preceding review has summarised the existing literature regarding the 
interaction between respiration and cardiovascular regulation, as well as the known 
acute cardiovascular responses to SDB. Apart from the lack of understanding of the 
factors that translate the repeated practice of SDB into positive health benefits, the 
characterisation of within-breath acute impact of SDB upon key cardiac and 
haemodynamic variables is still poorly described. Furthermore, the independent 
effects of fR, VT, PaCO2 and intrathoracic pressure, and how these can be 
manipulated to deliver a more potent antihypertensive stimulus from SDB deserve 
deeper, systematic exploration. 
 
To achieve the general aim, a series of systematic steps were taken; a summary of 
these follows and precedes a definition of the principal aims of this thesis, which 
guided the ensuing experimental chapters. The therapeutic SDB techniques 
currently in use might not be the most efficient in maximising acute cardiovascular 
perturbations, or promoting a maximal cardiovascular adaptive response; in 
particular: 
 
1) Several existing techniques fail to recognise the existence of an 




2) The independent effect of VT upon HRV and heart-lung interactions is not 
thoroughly understood and normally not accounted for; 
3) Most studies examining the acute cardiovascular impact of SDB have failed 
to investigate it over a comprehensive range of fRs and VTs; 
4) There is a general lack of data regarding the acute effects of SDB upon 
venous return, and hence cardiac haemodynamic responses to SDB.  
 
Thus, there is the need for a systematic and comprehensive re-examination of the 
acute cardiovascular impact of SDB, which addresses the gaps in the literature 
articulated above. 
 





1) To elucidate the independent effect of fR and VT upon the magnitude of RSA 
and other cardiovascular fluctuations occurring with SDB; 
2) To determine whether there is an optimal, individual breathing pattern that 
generates maximal acute cardiovascular responses; 
3) To assess the contribution of respiratory synchronous fluctuations in LVSV, 
Q̇ and ABP to the cardiac chronotropic response (RSA) to SDB. 
 
Research hypotheses: 
1) Reducing fR will amplify RSA and ABP oscillations independently of VT, with 
the maximum amplitude of fluctuations being attained at different, 
individualised, frequencies; 
2) Increasing the magnitude of the change in lung volume (VT) will increase the 
within-breath amplitude of LVSV and Q̇, leading to increased ABP oscillations 







1) To determine if the simultaneous use of inspiratory resistance amplifies the 
acute cardiovascular responses to SDB; 




1) The addition of an inspiratory resistance will magnify the cardiovascular 
responses induced by SDB at similar fR and VT; 
2) The cardiovascular response to resisted SDB will be coupled closely to the 
magnified within-breath fluctuations in intrathoracic pressure; 
3) Reducing lower limb blood volume (by compression of the legs) will attenuate 
any potentiating effects of inspiratory resisted SDB; 
 
 
Chapter 6  
Aims: 
1) To identify if the phase of breathing during which respiratory resistance is 
applied impacts the cardiovascular response to SDB. 
2) To compare the influences of different respiratory loading modalities upon 
the cardiovascular response to SDB. 
 
Research hypotheses: 
1) Inspiratory, expiratory and dual resisted SDB will result in distinct 
cardiovascular responses to SDB; 
2) Dual resisted SDB will amplify the cardiovascular response to SDB to a larger 
extent than the isolated application of inspiratory or expiratory resistances; 
3) The scale of the cardiovascular response to resisted SDB will be determined 
by the magnitude of the load, and not by the type of load, or airway (mouth 
vs. nostril);  
4) The extent of the cardiovascular response to single nostril SDB will not differ 
between left nostril vs. right nostrils. 
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A detailed explanation of the general methods applied to the studies that form this 
thesis is outlined in this chapter. Specific methods that are unique to individual 
studies are described in the chapters relating to those studies. In some instances, 
due to their complexity, some specific procedures that are not common to all studies 
are outlined in the present chapter; in those cases, a clear rationale is provided. 
 
3-2 Pre-test procedures 
The ensuing section describes procedures carried out prior to experimental testing. 
 
3-2.1 Ethical approval 
Before commencing each of the studies, ethics committee approval was obtained 
from the Brunel University London - Department of Life Sciences Research Ethics 
Committee (Appendix III). All studies were performed in compliance with the latest 
version of the Declaration of Helsinki (World Medical Association, 2013). 
 
3-2.2 Participants 
Recreationally active, healthy, male participants between 18 and 35 years of age, 
were recruited for each study. The sample selection was based on the 
understanding that some variables of interest, particularly those related to heart rate 
variability (HRV), are affected by gender, age and health status. For example, total 
HRV power is known to decrease steadily with age (Zhang, 2007), whilst healthy 
young women appear to exhibit menstrual cycle fluctuations in HRV (Sato, Miyake, 
Akatsu et al., 1995, Yildirir, Kabakci, Akgul et al., 2001, Sato and Miyake, 2004).   
 
Each participant received a detailed participant information sheet that described the 
testing procedures (Appendix IV). Written informed consent (Appendix V) and 
completion of a health screening questionnaire (Appendix VI) were required prior to 
testing. Participants who reported any contra-indicated health issues were excluded 
from the study. All participants were familiarised thoroughly with the testing 
procedures, on a separate occasion, before any data collection took place.  
 
Participants were instructed to avoid drinking alcohol the day before the test and to 
refrain from caffeinated beverages during the 12 h prior to testing. Participants were 
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also advised to limit food ingestion in the 2 h leading up to testing. Acute alcohol 
ingestion has been showed to reduce HRV (Gonzalez Gonzalez, Mendez Llorens, 
Mendez Novoa et al., 1992, Bau, Moraes, Bau et al., 2011, Shi, Chen, Guo et al., 
2014) and TPR (Kupari, 1983) while increasing fc, Q̇, SBP and circulating 
catecholamines (Kupari, 1983, Ireland, Vandongen, Davidson et al., 1984). 
Similarly, substantial evidence supports the existence caffeine-induced acute 
cardiovascular effects, including effects on blood pressure, plasma catecholamine 
levels and arterial stiffness (Smits, Thien and Van 't Laar, 1985, Mahmud and Feely, 
2001). The consumption of food and ensuing digestive process have been shown 
to increase both blood flow to the splanchnic organs (Moneta, Taylor, Helton et al., 
1988, Waaler, Eriksen and Janbu, 1990, Sidery, Macdonald, Cowley et al., 1991) 
and Q̇ (Kelbaek, Munck, Christensen et al., 1989), and to alter post-prandial HRV 
spectral indices (Lu, Zou, Orr et al., 1999, Chang, Ko, Lien et al., 2010), with these 
effects lasting up to 2 h (Waaler, Eriksen and Toska, 1991). Furthermore, the 
aforementioned pre-test dietary restrictions are aligned with the current 




Participant’s date of birth was recorded and then converted to decimal age. Standing 
stature was measured to the nearest 1 cm using a stadiometer (SECA 798, 
Germany). Participants stood barefoot and straight, with their back, buttocks and 
both heels touching the stadiometer. Participants were instructed to orientate their 
head in the Frankfort horizontal plane (i.e. the inferior margin of the orbit and upper 
margins of the ear opening, aligned in a horizontal line) and to inspire fully; stature 
was recorded as the maximum distance from the floor to the vertex of the head 
(Stewart, Marfell-Jones and International Society for Advancement of, 2011). Body 
mass in minimal clothing was recorded to the nearest 0.1 kg using calibrated 
electronic scales (SECA 798, Germany). 
 
3-2.4 Pulmonary function 
Measurements of pulmonary function were carried out according to standardised 
procedures (Miller, Hankinson, Brusasco et al., 2005). Maximal flow-volume 
manoeuvres were performed using a hand-held spirometer (Micro Loop Mk8, 
MicroMedical, UK). The spirometer incorporated a digital turbine flow transducer, 
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which is claimed to exhibit excellent stability of measurement, even with changes in 
ambient temperature, altitude and humidity (Dirksen, Madsen, Pedersen et al., 
1996). 
 
All measurements were performed with participants in a seated upright position. 
Throughout the respiratory manoeuvres, all participants wore a nose clip and 
breathed through a disposable inline filter connected to the spirometer. For the 
forced vital capacity (FVC) manoeuvres, the participants were instructed to inhale 
rapidly and fully from functional residual capacity (FRC, i.e. starting from the end of 
a passive expiration) and to begin a forced exhalation with minimal pause or 
hesitation (<1 s) from total lung capacity (TLC) (Miller, Hankinson, et al., 2005). The 
participants were instructed not to “blow” the air, but to “blast” the air from their lungs 
until the end of the forced exhalation. The FVC, forced expiratory volume in the first 
second (FEV1), as well as the ratio of FEV1 to FVC, were derived from the flow-
volume profiles. 
 
In agreement with the American Thoracic Society/European Respiratory Society 
task force guidelines (Miller, Hankinson, et al., 2005) all FVC manoeuvres were 
performed to specific criteria, which included: 
1) at least three reproducible measurements were made (i.e. the difference 
between the largest and the next largest FVC is ≤ 0.150 L, and the difference 
between the largest and next largest FEV1 is ≤ 0.150 L); 
2) an expiratory duration in the maximal expiratory effort of at least 6 s or, the 
existence of a plateau in the volume-time curve (i.e. volume kept unchanged 
over the last 2 s of exhalation);  
3) extrapolated volume was < 5% of FVC or 0.150 L (criteria for the acceptable 
start of expiration).  
 
The largest FVC and FEV1 were recorded after examination of data from all usable 
curves, even when not derived from the same curve. 
 
3-2.5 Randomisation procedures 
The conditions tested in all studies were randomised. Randomisation procedures 
involved the use of a freely available random number generator 
(www.randomizer.org). This software is best described as a ‘pseudo-random 
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number generator’ as the numbers are generated by way of a complex algorithm 
that uses the computer’s clock to generate quasi-random series of numbers. 
 
For the first two studies (Chapters 4 and 5 respectively) the sets involving the 
smallest minute ventilation (V̇E) were always performed first, immediately following 
baseline measurements. This approach permitted identification of the PETCO2 
associated with the lowest V̇E, allowing for clamping of PETCO2 at equivalent levels 
in succeeding, randomised sets. In Chapter 6, as all sets were performed at the 
same V̇E, full randomization of the intervention was undertaken (Figure 3-1). 
 
 
Figure 3-1 – Example of .CSV export file from www.randomizer.com with randomised 
intervention order for study 3 (Chapter 6). 
 
 
3-3 Apparatus and procedures 
The following sections describe the different apparatus and procedures used in the 
studies. Information regarding other specialised apparatus or techniques used in 
individual studies is contained within the appropriate chapters. 
 
3-3.1 Data acquisition and display 
All respiratory and cardiovascular data were sampled at 250Hz via an analogue to 
digital converter (NI USB-6212 BNC, National Instruments Inc.) and analysed by a 
bespoke analysis system built using Labview acquisition and analysis software 
(LabView 13.0, National Instruments Inc.). The software was written by Professor 
Alison McConnell (primary supervisor). Respiratory airflow, instantaneous lung 
volume, respiratory pressure, arterial blood pressure (ABP), ECG, LVSV and end-
tidal CO2 (PETCO2) signals were processed using both built-in and bespoke coded 
sub-routines that computed, mean, peak, nadir and amplitude of variations in 
relevant cardiovascular variables. Respiratory phase-dependent changes 
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(inhalation vs. exhalation) in the aforementioned and other variables were also 
calculated. In situations where a given cardiac cycle overlapped both respiratory 
phases, a criterion was established to include it in either inspiration or expiration 
based on the location of the R wave peak.  
 
After each trial, a raw data file containing all analogue signals was created 
immediately, as well as a summary data file containing breath-by-breath values for 
all respiratory and the majority of cardiovascular variables of interest. 
 
 
3-3.2 Device guided breathing and respiratory measurements 
As well as recording data, a bespoke device guided breathing (DGB) system was 
incorporated within the Labview data acquisition software. The DGB displayed both 
visual guidance of the desired breathing pattern, as well as real time biofeedback of 
the person’s actual respiratory pattern. 
 
Device guided breathing  
The front panel of the system displayed two similar bars (see figure 3-2, below). The 
right-hand side bar represented the desired instantaneous lung volume, while the 
left bar depicted the subject’s measured volume, allowing the participants to match 
closely the two. The height of the bars represented the VT for every breath while the 
rate of change of the height of the bar corresponded to respired flow rate. In so 
doing, it was possible to control both rate and volume simultaneously and 
independently. 
 
The DGB system delivered three different breathing modes: 
1) Semi-spontaneous breathing mode where only fR was controlled. In this mode 
participants could breathe freely at any VT and duty cycle, with the only 
restriction being the timing of each new breathing cycle, which was signalled by 
illumination of a green light on the screen (“Pacer” on the front panel in figure 3-
6); 
2) Semi-spontaneous breathing mode where only VT was controlled, and all other 
dimensions of the breathing pattern were spontaneous. For this mode, the 




3) Fully controlled mode, where the target bar was set to deliver a specified 
respiratory duty cycle of 0.5 (inspiratory time = expiratory time), VT (the height 
of the target bar) and flow rate corresponding to the desired fR (the speed of the 





Respired flow rate (V’) was measured continuously using a linear, Lilly type, bi-
directional, heated pneumotachograph (Figure 3-3; Chapter 4 - Hans Rudolph 3813, 
Hans Rudolph Inc.; Chapters 5 and 6 - Hans Rudolph 3700, Hans Rudolph Inc.), 
controlled by a flow measurement system (Hans Rudolph RSS 100HR, Hans 
Rudolph Inc., Shawnee, KS, USA). The pneumotachographs interfaced with the 
participants through a mask that covered both mouth and nose. For the study in 
Chapter 4 we employed an Oro Nasal 7450 V2 Mask (Hans Rudolph Inc., Shawnee, 
KS, USA), while for the experiments in Chapters 5 and 6 an Intersurgical Quadralite 
Mask (Intersurgical Ltd., Wokingham Berkshire, UK) was utilised. According to the 
manufacturer, the pneumotachographs used in the studies comprised in this thesis 
tend to achieve laminar flow over an airflow range between 0 and 13.3 l·s-1 (for the 
Hans Rudolph 3813) and between 0 and 2.7 l·s-1 (for the Hans Rudolph 3700), both 
covered the airflow rates generated throughout the studies.  
Figure 3-2 – Screenshot of the device guided breathing software’s interface for a participant 
breathing at 6 breaths·min-1 and with prescribed tidal volume of 2 l. Dark blue bar accurately 
represents the actual breathing pattern of the participant, while the light blue bar provides indication 




Figure 3-3 – Illustration of dead space volume (dark grey) and exterior configuration of the 
Hans Rudolph heated pneumotachographs. (Reproduced from Hans Rudolph 
pneumotachographs user’s manual). 
 
 
With the Lilly type pneumotachographs, airflow is derived from the pressure 
differential over a fine metal mesh. The pressure changes (P1-P2) across the mesh 
are proportional to V’ when this is laminar, i.e. at relatively low flows. Respired 
volume is then computed by integrating V’ over time (Figure 3-4), which in turn 
allows calculation of VT as well as the inspiratory (TI), expiratory (TE) and total (TTOT) 






Figure 3-4 – Example of Lilly type pneumotachograph functioning.  The pressure difference 
across the screen (mesh) is equal to the known resistance of the screen multiplied by airflow (V’). 
The integral of airflow over time allows to calculate air volume (V) going through the 
pneumotachograph. Reproduced from  http://www.spirxpert.com/technical3.htm. 
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Before starting each study, a large servo motor driven piston pump (Hans Rudolph 
1120 Flow/Volume simulator, Hans Rudolph Inc., Shawnee, KS, USA) was 
connected in series with the pneumotachographs and followed a built-in linearisation 
and calibration routine over which a predetermined range of continuous flow rates 
was delivered. 
 
Prior to each laboratory test, the pneumotachograph was calibrated for volume. A 
calibration routine incorporated in the flow measurement system (Hans Rudolph 
RSS 100HR, Hans Rudolph Inc., Shawnee, KS, USA) consisted of repeatedly 
passing a known volume of gas (3 l) through the pneumotachograph. The necessary 
volume of air was delivered by way of a calibration syringe (Hans Rudolph 5530 
Hans Rudolph Inc., Shawnee, KS, USA), which was stroked at a frequency that 
allowed to generate air-flow rates that were roughly half of the sensor’s flow range. 
For a 160 L pneumotachograph sensor like the Hans Rudolph 3700, this equated to 
stroking the 3 L syringe in or out for 2.25 s.  The calibration process was repeated 
by continuously stroking the syringe until the values for inspiratory and expiratory 
volumes recorded by the sensor differed < 5 mL from the volume of the calibration 
syringe. The flow measurement system automatically compared the measured gas 
volume with the syringe volume and calculated inspiratory and expiratory calibration 
factors, which were stored in the built-in non-volatile memory of the flow measuring 
system.  
 
Respired gases were sampled continuously at the mouth via a fine catheter, and 
analysed for carbon dioxide (CO2) concentrations using an analyser with laser diode 
absorption and infrared technologies, respectively (GA-200 gas analyser, iWorx 
Systems Inc., NH). End-tidal partial pressures of CO2 (PETCO2) were calculated from 
the analogue signals by the Labview software. Before each test, the gas analyser 
was switched on at least 30 min prior to testing to eliminate electrical drift. Pre-test 
procedures also included calibration across the normal physiological range using a 





3-3.3 Rebreathing system 
Both reductions (hypocapnia) and increases (hypercapnia) in PaCO2 beyond 
physiological values, are known to impact cardiovascular regulation (Price, 1960, 
Marshall, 1994, Henry, Lu, Beightol et al., 1998, Laffey and Kavanagh, 2002, Kara, 
Narkiewicz and Somers, 2003, Steinback, Salzer, Medeiros et al., 2009). To avoid 
the confounding effect of altered PaCO2 upon the cardiovascular and autonomic 
response to SDB, we clamped PaCO2 at a fixed, predetermined individual value. A 
variable volume re-breathing system was created to maintain a comparable PaCO2 
across the range of fully controlled breathing patterns, which consisted of a series 
of different volume dead spaces. This system was based on the principle that PaCO2 
levels could be kept constant even in situations of increased V̇E by artificially 
increasing physiological dead space (therefore increasing V̇D). The following 
principles were applied in order to determine the appropriate volume for V̇D. 
 
The minute ventilation (V̇E) represents the total volume of expired air in each minute, 
resulting from the product of tidal volume (VT) and respiratory frequency (fR): 
V̇E = VT x fR 
 
Nonetheless, not all the mobilised air reaches the alveoli, where the gas exchange 
occurs (alveolar ventilation – V̇A). Part of the air remains in the conducting airways, 
therefore not entering in the so called respiratory zone (dead space ventilation – 
V̇D). The anatomical dead space is difficult to measure, but in healthy individuals it 
equates to roughly 150 mL per breath. This value tends to increase with large 
inspiratory efforts, as the bronchi are expanded due to the traction exerted by the 
adjacent lung parenchyma (West and Luks, 2016). For the sake of simplicity, 
throughout this thesis we considered anatomical dead space to be exactly 150 mL 
for every participant, and included instrument dead space (tubes, connectors, mask 
and pneumotachograph) for each study to provide the total dead space.   
 
The V̇E is the sum of V̇A and V̇D: 
V̇E = V̇A + V̇D 
 
 
As anatomical and instrument dead space were constant, altering the volume of 
each inspiration (changing VT) changes only V̇A. This is of fundamental importance 
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when considering the relation between V̇A and CO2 elimination. The alveolar 
ventilation equation depicts this relationship: 
V̇A = (VCO2 / PETCO2) x K 
 
Where VCO2 is carbon dioxide production, and K is a constant representing the 
difference between barometric pressure and water-vapour pressure. As all volumes 
measured by the heated pneumotachograph were at body temperature, pressure 
saturated with water vapour (designated BTPS), K related solely to the barometric 
pressure. Also, in normal, healthy, individuals at rest, PETCO2 and the arterial partial 
pressure of CO2 (PaCO2) are virtually identical (West and Luks, 2016) and therefore 
used interchangeably in this thesis. Throughout the studies there was no physical 
exertion and no alteration in metabolic activity. Thus VCO2 remained unchanged. 
Therefore, any changes in VA were inversely proportional to variations in PaCO2. 
 
The added dead spaces consisted of adjustable pieces of tubing attached to one 
end of the respiratory circuit (see Figure 3-5). The target PaCO2, and thus the length 
of the tube (manipulation of V̇D), was estimated for each participant using the 
alveolar air equation. The target PaCO2 was defined by that observed during the 
condition with the lowest V̇E, which was always performed first. Throughout the 
subsequent breathing sets, PETCO2 was inspected visually, and the length of tubing 




Figure 3-5 – Participant undergoing device guided slow and deep breathing exhibiting a piece 
of tubing attached to the pneumotachograph, in order to maintain a pre-determined arterial partial 
pressure of CO2. 
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3-3.4 Loaded breathing 
In this thesis, the imposition of respiratory loads was achieved through a bespoke 
flow resistive breathing circuit (Figure 3-6), and using proprietary pressure threshold 
loading devices (Philips Threshold IMT and Philips Threshold PEP; Philips 
Respironics, Murrysville, PA, USA). Loaded breathing was used in two studies to 
investigate the effects of changes in intrathoracic pressure upon the cardiovascular 
and autonomic response to SDB. The pressure threshold loading devices were only 
used in one of the studies comprised in this thesis (Chapter 6) and are described in 
detail in section 6-3. 
 
The flow resistor inside the circuit comprised a number of nylon washers that 




Figure 3-6 – Flow-dependent inspiratory resistance breathing device. Red arrows indicate the 




According to Poiseuille’s Law, if the flow is laminar, the resistance to airflow varies 
as a function of the airway diameter. In fluid dynamics, flow is considered to be 
laminar when the fluid flows in parallel, with no apparent disruption between the 
different layers (Batchelor, 2000), which tends to happen at slow fluid speeds or flow 
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rates. Poiseuille’s Law is defined by the following equation, where R is the 
resistance to flow within the airways, ƞ is the viscosity of the fluid flowing within the 
airways, l is the length of the airway and r represents the radius of the airways:  
𝑅 = 8𝜂𝑙 ∕ 𝜋𝑟4 
 
As the radius is raised to the power of four, a reduction of r to half means a 16-fold 
increase in the resistance that is generated for the same tube (airway) length 
(Hasan, 2010). The resistive load in centimetres of water produced by an airway of 
any given radius and length is also dependent upon the airflow rate and can be 
estimated by multiplying R by the mean inspiratory flow (MIF). 
𝑅𝑒𝑠𝑝𝑖𝑟𝑎𝑡𝑜𝑟𝑦 𝑙𝑜𝑎𝑑 = 𝑅 × 𝑀𝐼𝐹 
 
In the context of the present research, both the viscosity and MIF were assumed to 
be constant; the latter was achieved by maintaining the same fR and VT throughout 
all breathing sets that included resisted breathing, via the previously mentioned 
biofeedback system. 
 
Alterations in the magnitude of inspiratory resistances were accomplished by 
changing the number of washers, thereby extending or reducing the length of the 
breathing resistor. Washers with different diameters were also used to guarantee 
that the desired load was administered. While it is unlikely that the conditions for 
laminar flow were met by the breathing circuit due to the interference of the 
unidirectional valves and the y-shaped connectors, it was guaranteed that the 
pressure generated by a given respiratory airflow was the intended by empirically 
adjusting the number of washers being used. Simultaneously, the y-shape of the 
breathing resistance circuit, and the inclusion of unidirectional inspiratory and 
expiratory valves ensured that the resistance could be applied selectively to a 
specific phase of the respiratory cycle, while also allowing the rebreathing of the 
exhaled air for the control of PaCO2 (see section 3-3.3). 
 
 
3-3.5 Cardiovascular measurements 
Beat-by-beat arterial blood pressure measurements 
Arterial blood pressure (ABP) was estimated noninvasively using a Finometer 
(Finometer® Pro, Finapress Medical Systems, The Netherlands). This non-invasive 
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finger ABP measuring system is used widely in a multitude of settings and is 
considered to be within the Association for the Advancement of Medical 
Instrumentation (AAMI) the validation criteria (Guelen, Westerhof, van der Sar et al., 
2008). 
 
The Finometer ® Pro utilises the ‘volume-clamp’ method (Penaz, 1973, Boehmer, 
1987, Imholz, van Montfrans, Settels et al., 1988), which involves the use of an 
inflatable finger cuff with inbuilt photo-electric plethysmography to detect finger 
pulse pressure waveforms (Figure 3-7). This technique, pioneered by Jan Penaz 
(1973), relies on the equalisation of the external (inflatable cuff) pressure with 
intraluminal pressure and subsequent clamping of said null transmural pressure at 
a constant level by continuous automatic adjustments. This zero transmural 
pressure condition also allows the measurement of the artery diameter by an 
infrared sensing technique. Any variations in intraluminal pressure associated with 
systole or diastole are proportional to a change in arterial diameter and detected by 
sensors within the cuff, which is rapidly inflated or deflated to maintain the zero 
transmural pressure ‘set-point’. The external pressure adjustments delivered by the 
cuff to maintain vessel diameter are analogous to that being generated within the 
finger arteries themselves, and as such, allow continuous, accurate noninvasive 




Figure 3-7 – Example of the fitting of a photoplethysmographic finger cuff for continuous non-





The ABP readings at the finger are inherently different to those at the brachial artery 
due to changes in pressure gradients and wave distortion along the artery. To 
counter such effect, the Finometer ® Pro incorporates a series of corrections, 
allowing the collection of valid and reliable estimates of brachial artery pulse 
pressure and derived variables. A good agreement between ABP values obtained 
by this method and direct recordings from the radial artery under an array of 
experimental conditions has been previously demonstrated (Imholz et al., 1988, 
Parati, Casadei, Groppelli et al., 1989, Imholz, Dambrink, Karemaker et al., 1990, 
Imholz, Settels, van der Meiracker et al., 1990). 
 
The Finometer ® Pro also corrects for the hydrostatic height of the finger with 
respect to the heart by means of a height sensor. The system also corrects for the 
distortion of the pressure waveform along the arm, by measuring the brachial 
pressure in a traditional way (using an arm cuff). The latter, known as ‘return-to-flow’ 
correction (RTF), involves a protocol of stepwise arm cuff occlusion to supra-systolic 
levels, followed by gradual deflation. The first pulsation measured at the finger 
during cuff deflation is then compared to the arm cuff pressure, allowing for the RTF 
correction, and thus a reconstructed brachial artery pressure pulse wave to be 
constructed. The system uses a continuous built-in calibration, consisting of 
repeated zeroing of the finger pulse measurements at fixed intervals ranging from 
10 to 60 s. For the purposes of the present studies, the RTF calibration was 
performed before the start of data collection and repeated throughout the testing 
session at roughly 30 min intervals. The auto-calibration function was turned off after 
the initial calibration, and re-started during each of the rest periods, allowing for 
uninterrupted sets of data, while maintaining proper calibration. Beat-to-beat 
reconstructed ABP waveforms, and LVSV were recorded by the bespoke data 
acquisition system (LabView, National Instruments Inc.) and averaged for each 
breath. A raw data file was also produced for offline analysis. 
 
 
Heart rate, stroke volume and cardiac output measurements 
The fc was monitored continuously using a 3-lead ECG (PysioControl VSM® 3, 
PhysioControl Inc., Redmond, WA, USA). An estimate of LVSV was calculated by 
the Finometer ® Pro software using the ‘Modelflow method’ by reconstructing raw 
brachial artery pressure waveforms. This approach utilises Wesseling’s three-
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element model (Wesseling et al., 1993), which calculates aortic flow using three 
known haemodynamic properties of the arterial system: 
1) nonlinear pressure dependent aortic compliance (how effective the aorta and 
arterial system can store the elastic energy derived from the left ventricle upon 
contraction); 
2) the characteristic impedance of the aorta ( the extent to which the aorta impedes 
pulsatile flow); 
3) time-dependent systemic vascular resistance (sum of the total resistance of all 
vascular beds). 
 
By assuming these qualities, the Modelflow method calculates aortic flow over time 
(thus estimating LVSV). The LVSV measurements obtained through this approach 
have been shown to agree strongly with LVSV measured by Doppler ultrasound 
(van Lieshout et al., 2003). Cardiac output (Q̇) was estimated by Labview by 
multiplying fc (ECG) by LVSV (Finometer).  
 
3-3.6 Echocardiography 
Echocardiography (or cardiac ultrasonography) was employed to determine 
changes in left ventricular volumes in response to specific interventions, more 
particularly, to different levels of lower body positive pressure (see Study 2, Chapter 
5). Currently, echocardiography is the single most used tool to assess cardiac 
function in both the clinical and research settings; virtue of its easy and safe 
application, allied with its relatively low cost (Lang, Bierig, Devereux et al., 2005). 
 
Principles of echocardiography  
Echocardiography uses ultrasound to determine the structure and function of the 
heart. When these waves are discharged by a transducer, propagating through the 
body, the particles in the bodily tissues oscillate in parallel to the line of propagation, 
creating longitudinal waves (Armstrong and Ryan, 2012). The reflected ultrasound 
waves from the tissues interact with the piezoelectric crystals in the transducer and 
produce an electric signal that is converted into a digital grey-scale image 
(Armstrong and Ryan, 2012). The resolution of the created ultrasound imageis the 
result of interaction between the transmitted waves and the tissue properties. As 
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sound waves encounter materials with a different density (acoustical impedance), 
part of these waves is echoed back to the probe. The greater the difference between 
acoustic impedance, the larger the echo is, therefore translating into different 
shades of grey in the digital image, allowing the sonographer to differentiate different 
layers of tissue. 
 
Procedures for image acquisition  
In this thesis, echocardiography was used to assess systolic and diastolic left 
ventricular (LV) function as part of one experimental study examining the impact of 
progressive lower body positive pressure (LBPP) upon the cardiovascular response 
to deep and slow breathing (Chapter 5). Echocardiographic image acquisition and 
analysis were performed by an experienced sonographer (Dr Eurico Wilhelm) 
according to current guidelines for cardiac chamber assessment (Lang et al., 2005). 
Several published studies have investigated intra-observer reproducibility in either 
clinical populations or healthy cohorts. These have mostly reported low intra-
observer variability in the evaluation of left ventricular function (Himelman, Cassidy, 
Landzberg et al., 1988, Pearlman, Triulzi, King et al., 1988, Nidorf, Picard, Triulzi et 
al., 1992, Gottdiener, Livengood, Meyer et al., 1995, Otterstad, Froeland, St John 
Sutton et al., 1997, Gottdiener, Bednarz, Devereux et al., 2004, Frikha, Girerd, 
Huttin et al., 2015). 
 
Two-dimensional ultrasound imaging was recorded on a Vivid 7 (GE Medical, 
Horton, Norway) ultrasound machine, using an M4S 2–5 MHz probe (Figure 3-8) 
with the frequency set at 1.7 MHz on transmit and 3.6 MHz on receive. A built-in 3-
lead electrocardiogram (ECG) recorded fC with each image. Off-line analysis of LV 
function (including calculation of LV systolic and diastolic dimensions and ejection 
fraction) was performed and averaged on 2-3 consecutive cardiac cycles, using 








Figure 3-8 – Ultrasound system and probe. Images show (left panel) Vivid 7 ultrasound and (right 
panel) 2-D phased-array M4S transducer (both GE Medical, Horton, Norway) used in study 2 
(Chapter 5). 
 
Left ventricular volumes and ejection fraction 
Two-dimensional images were recorded using the four-chamber and two-chamber 
apical views (Figure 3-9). Measurements for LV internal dimensions were taking by 
tracking the interior of the LV, between the endocardial border of the septum and 
the endocardial border of the posterior wall, both in systole and diastole (Figure 3-
10). Manufacturer specific software (EchoPAC, GE Medical, Horton, Norway, 
Version 7.0.0) then calculated left ventricular end-diastolic volumes (EDV), end-
systolic volumes (ESV), stroke volume (LVSV) and ejection fraction (EF) according 
to the modified Simpson’s biplane rule (Figures 3-10 and 3-11), currently regarded 
by the American Society of Echocardiography as the most common and preferable 
method for volume measurements (Lang et al., 2005). With the Simpson’s biplane 
method, total left ventricular volume is calculated from the summation of a stack of 
elliptical disks, with each disk representing a fraction of the left ventricle’s long axis 
taken from the 2- and 4-chamber apical views (Lang et al., 2005, Evangelista, 
Flachskampf, Lancellotti et al., 2008).  Linear echocardiographic measurements 
from 2D images have proven to be reproducible with low intra-observer and inter-
observer variability (Ihlen, Endresen, Myreng et al., 1987, Pearlman et al., 1988, 




Figure 3-9 – Utilised Ultrasonographic views for left ventricular function assessment. Left: 
apical four chamber view. In this view the left (LV) and right ventricles (RV) as well as the left (LA) 
and right atria (RA) are visible. Right: apical two chamber view exhibiting left ventricle (LV) and left 






Figure 3-10 – Measurements for volume calculations using the biplane method of discs 
(modified Simpson's rule), in the apical four-chamber (A4C) and apical two-chamber (A2C) views 
at end diastole (EDV) and end-systole (ESV). In all panels, the tracking of the internal wall of the left 
ventricle is evident and shows a clear difference between end-systole and end-diastole. Reproduced 






Figure 3-11 – Method for determining the left ventricular volume using the Simpson’s biplane 
method. Top: The left ventricular cavity is arbitrarily divided into ‘n’ segments of equal height (d1, 
d2, d3… dn). The height of each cylinder corresponds to the overall length divided by the number of 
disks (h = L/n). Individual disk volume is calculated as noted, with the ventricular volume being the 
sum of the individual disk volumes. Bottom: Example of calculation of the left ventricular volume 
using an apical two-chamber view. Reproduced from Armstrong and Ryan (2012). 
 
 
3-3.7 Heart rate variability 
In this thesis, heart rate variability (HRV) analysis was performed on the raw ECG 
time series with the goal of obtaining indirect insight into the influence and control 
of the cardiovascular system by the autonomic nervous system. Throughout the 
thesis, two different tools were used to process and analyse HRV data. For the first 
experimental chapter (Chapter 4) the proprietary software Kubios 2.1 (University of 
Eastern Finland, Kuopio, Finland) was utilised, while for studies 2 and 3 (Chapters 
5 and 6) all HRV analysis were performed using the MATLAB (MathWorks, Inc., 
Natick, MA, USA) based software suite ‘Autonomic Nervous System Laboratory’ 




The last 3 min of each 5 min data collection period was used for HRV analysis. The 
ECG data were initially converted into RR times series. This is typically 
accomplished by evaluating the time difference between R-spikes from the QRS 
complexes. The preprocessing of the QRS usually involves bandpass filtering to 
reduce several sources of noise followed by a decision rule (Tarvainen and 
Niskanen, 2006). With Kubios this decision rule was included in the built-in QRS 
detection algorithm and comprised adaptively adjusted amplitude thresholds and 
expected times between adjacent R-waves (Tarvainen, Niskanen, Lipponen et al., 
2014). Furthermore, to improve the time resolution, R-waves were interpolated at 
2000 Hz, prior to R-wave extraction (Tarvainen et al., 2014).  
 
When ANSLAB was utilised, RR time series were initially created by R-spike 
detection (within each individual QRS complex) using default decision criteria of 
minimum 375 ms length for inter-beat intervals and a minimal rise time to 0.53 mV 
of 38 ms for valid R-wave detection (Blechert, Peyk, Liedlgruber et al., 2016). Visual 
inspection of the detected R-peaks before the generation of the RR time series 
allowed for manual detection and correction of artefacts. Finally, with both software 
packages, cubic spline interpolation at a default interpolation sampling rate of 4 Hz 
was used to convert the RR time series into an equidistantly sampled series. 
 
Artefact screening is fundamental in HRV computation as a single error within a 
relatively small RR time series is sufficient to impart substantial added variance in 
all frequency bands (Berntson and Stowell, 1998). With the Kubios software, visual 
inspection of the RR time series was performed initially and when the last 3 min of 
the data collection periods present artefacts, the closest artefact free section was 
selected. When that was not possible, the software’s built in artefact removal option 
was utilised to make the necessary adjustments by way of cubic spline interpolation 
(Tarvainen et al., 2014). 
 
Time domain analysis 
The standard deviation of NN interval (SDNN) and the square root of the mean 
squared differences of successive NN intervals (RMSSD) were used. Both variables 
are calculated using the intervals between adjacent QRS complexes resulting from 
sinus node depolarizations, i.e. the normal-to-normal (NN) RR intervals (Task Force, 
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1996). The SDNN is the square root of the total variance. Since variance is 
mathematically equivalent to the total PSD, SDNN represents the entirety of cyclic 
variations in fc within the analysed recording period, therefore reflecting the overall 
HRV (Task Force, 1996). The RMSSD, on the other hand, is considered to be an 
estimate of the short-term, high-frequency RR interval fluctuations (Ewing, Neilson 
and Travis, 1984, Kleiger, Stein, Bosner et al., 1992, Task Force, 1996, Malik, 
1997). The RMSSD is thought to correlate well with respiratory related high-
frequency HRV fluctuations and has been demonstrated to be sensitive to cardiac 
vagal control, as suggested by pharmacological vagal blockade (Penttilä, Helminen, 
Jartti et al., 2001). Notwithstanding, at least one study has demonstrated that 
RMSSD also encompasses low-frequency fluctuations, suggesting that RMSSD can 
also reflect sympathetic influences, despite the high association between RMSSD 
and high-frequency spectral variability (Berntson, Lozano and Chen, 2005). 
 
Frequency domain analysis 
Analysis frequency bands were set according to the recommendations of the Task 
Force of the European Society of Cardiology and the North American Society of 
Pacing and Electrophysiology (Task Force, 1996) - high frequency (HF) band: 0.15-
0.4 Hz; low frequency (LF) band: 0.04-0.15 Hz and, very low frequency (VLF) band: 
0-0.04 Hz.  
 
Using Kubios, spectral analysis was performed through a Fast Fourier Transform 
(FFT) based Welch’s periodogram. In this method, the RR time series is divided into 
overlapping segments using default window and window overlap of 265 s (240 s 
with ANSLAB) and 50%, respectively, which decreases the leakage effect 
(Tarvainen et al., 2014). The spectrum estimate was then obtained by averaging 
FFT spectra of the analysed segments. Before spectral analysis with ANSLAB a low 
pass filter set at 0.5 Hz was used for detrending, while the Kubios software applied 
no detrending method.  
 
In this thesis, spectral results for the VLF band are not reported because the 
analysed segments were of very short duration (< 5 min). According to the Task 
Force of the European Society of Cardiology the North American Society of Pacing 
Electrophysiology, VLF assessed from short-term recordings should be avoided in 
the interpretation of power spectral density (PSD) of ECGs, as it seems to be deeply 
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affected by algorithms of baseline or trend removal (Task Force, 1996). The 
analysed variables were, therefore, the PSD for the HF (HRVHF) and LF (HRVLF) 
spectral bands, as well as the combined PSD (HRVTOT), measured in milliseconds 
squared (ms2). 
 
Nonlinear analysis: Poincaré plot 
The Poincaré plot of the RR time series was analysed as part of the built-in analysis 
options provided by both Kubios and ANSLAB software. The Poincaré plot is a 
graphical presentation of the correlation between consecutive RR intervals, i.e. a 
plot of RRi+1 as a function of RRi (Figure 3-12). The basic descriptors of the Poincaré 
plot are:  
• SD1 – the standard deviation of the dispersion of successive RR intervals 
perpendicular to the identity line of the plot (line where RRn equals RRn+1);  
• SD2 – the standard deviation of the points along the line of identity (Brennan, 
Palaniswami and Kamen, 2001) and,   
• SD2/SD1 – the ratio of SD2 to SD1, which is thought to reflect the balance 
between long- and short-term HRV (Guzik, Piskorski, Krauze et al., 2007). 
While SD1 is considered to describe short-term variability and relates strongly with 
time-domain RMSSD (Guzik et al., 2007), SD2 is commonly associated with 




Figure 3-12 – Example of a Poincaré plot of a 5-min ECG recording. SD1 measures the 
dispersion of points across the identity line, and SD2 measures the dispersion of points along the 
identity line of the Poincaré plot. Both SD1 and SD2 are axes of an imaginary ellipse whose shape 
is visible in the diagram. Reproduced from Guzik et al. (2007). 
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3-3.8 Blood pressure variability 
The last 3 min of each 5-min data collection period was considered for blood 
pressure variability (BPV) analysis. The analysis was performed using ANSLAB 
software and included an initial preprocessing of the raw ABP signal, which entailed 
visual inspection and manual removal of outliers. A built-in analysis routine then 
allowed for the determination of systolic (SBP) and diastolic blood pressure (DBP) 
time series. 
 
For spectral analysis of ABP, only the SBP time series was considered. Analysis 
frequency bands were the same as those used for HRV - high frequency (HF) band: 
0.15-0.4 Hz; low frequency (LF) band: 0.04-0.15 Hz and, very low frequency (VLF) 
band: 0-0.04 Hz. As for HRV, the VLF band results are not reported due to the short 
length of the epochs. 
 
Detrending was performed ahead of the spectral analysis by using a low-pass filter 
set at 0.5 Hz. The same spectral analysis procedures used for HRV with ANSLAB 
were applied to the SBP time series, i.e. FFT based Welch’s periodogram with a 
window size of 240 s and 50% window overlap. Results were presented in square 
millimetres of mercury (mmHg2).  
 
3-3.9 ‘Peak-Valley’ methods applied to cardiovascular data 
One commonly used method to quantify the amplitude of oscillating fc rhythms is 
the ‘peak-valley’ method (Katona and Jih, 1975, Hirsch and Bishop, 1981, Fouad, 
Tarazi, Ferrario et al., 1984, Grossman and Svebak, 1987, Schechtman, Kluge and 
Harper, 1988, Grossman, van Beek and Wientjes, 1990, Grossman and Kollai, 
1993). This method has been traditionally used to quantify respiratory sinus 
arrhythmia (RSA), either by measuring the difference between the maximum and 
minimum instantaneous fc or RR interval associated with a specific respiratory 
phase or simply by determining the difference between the absolute peak and 
through, irrespective of the breathing phase in which it occurred. In the experimental 
chapters of this thesis both versions of RSA are calculated; a ‘phase locked’ version 
of RSA, which considered the minimum RR interval during inspiration and the 
longest interval accompanying expiration (Katona and Jih, 1975, Grossman et al., 
1990), and one that considered the absolute minimum RR interval and ensuing 
maximum after the onset of inspiration (Hirsch and Bishop, 1981). 
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In the thesis, the difference between the absolute peak and through, irrespective of 
the breathing cycle was also calculated for other cardiovascular parameters to 
provide a time domain index of their variation, e.g. LVSV, SBP, DBP and PP. 
Despite limited evidence validating the use of this approach to cardiovascular 
indices other than RSA, we consider that this method might prove helpful in 
characterising the phasic cardiovascular variations induced by slow and deep 
breathing (SDB) interventions. 
 
Regardless of the potential benefit of using this quantitative approach to 
characterise the cardiovascular response to SDB, this method is not without issues. 
These have been highlighted previously in the particular case of the utilisation of 
‘peak-valley’ methods for the quantification of RSA (Porges and Byrne, 1992, Byrne 
and Porges, 1993). These involve the existence of complex trends and other 
periodic oscillations in cardiovascular parameters that are not perfect sine waves 
(e.g. baroreceptor influence upon fc), resulting in an underlying non-stationarity that 
may compress or stretch the amplitude of the analysed waveform. Simultaneously, 
the existence of non-sinusoidal slow periodic processes results in different durations 
in which the ‘peak-valley’ calculation will be increased or reduced. Thus, these 
trends can, in theory, lead to a variability in the ‘peak-valley’ estimates, even in the 
absence of changes to the respiratory pattern. 
 
Finally, some ‘peak-valley’ techniques assume that any peak to trough difference 
must occur within a clearly defined respiratory cycle. This implies that phase 
relationships between breathing and the analysed cardiovascular signals remain 
constant, therefore disregarding the well-known impact that breath holding or 
respiratory manoeuvres (Valsalva and Mueller) have upon the phase relationships 
between respiration, fc and LVSV (Condos, Latham, Hoadley et al., 1987, Bernardi 
et al., 1989, Looga, 2001, 2002, 2005).  
 
Accordingly, it has been suggested that ‘peak-valley’ methods can be used as a 
good approximation of instantaneous, breath-by-breath, phase relationships. When 
applied correctly, the ‘peak-valley’ methods can be advantageous, particularly if the 
vulnerabilities herein described result in a minor impact of the underlying trends, 
compared to the peak to through amplitude contribution that stems from a given 
intervention. In the particular case of RSA, ‘peak-valley’ estimates have been shown 
to correlate strongly with other signal processing methods in short-duration epochs 
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of 5 min (Grossman et al., 1990).The usefulness of ‘peak-valley’ methods is 
therefore dependent on the consideration of its inherent limitations, proper pre-
processing of the data and removal of trends and careful interpretation of the 
findings, based on the characteristics of the applied “stress” mechanism. A summary 
of respiratory phase-related and ‘peak-valley’ variables used in this thesis can be 
found in Appendix II. 
 
3-3.10  Baroreflex sensitivity 
Baroreflex sensitivity (BRS) was calculated both by the sequence method (Bertinieri, 
di Rienzo, Cavallazzi et al., 1985, Parati, Di Rienzo, Bertinieri et al., 1988) and from 
the cross-spectral transfer function gain (BRSFreq) (Robbe, Mulder, Ruddel et al., 
1987). The sequence method is a time-domain technique that relies on the 
identification of a beat-to-beat series of SBP in which a monotonic change (either 
decrease or increase) of SBP is followed by a directionally opposite series of heart 
beats (sequence). 
 
In this thesis, sequence BRS values were calculated via a built-in Labview 
subroutine (LabView 13.0, National Instruments Inc.). For a sequence to be 
considered valid a reference delay between the changes in SBP and the subsequent 
fc response of one beat, and a threshold change of 1 mmHg and 4 ms had to be 
met, for a minimum of three consecutive beats. The linear correlation between RR 
and SBP was computed for each sequence; if r >0.8, the software calculated the 
slope of the regression line, which is considered to be an estimate of BRS and is 
expressed in ms·mmHg-1. Overall BRS (BRSSeq) was calculated as the average 
between the sequences where the increases in SBP are paralleled by increases in 
RR interval (BRSup) and the sequences representing decreases in SBP 



















The frequency domain methods used in the calculation of the BRSFreq represent an 
entirely distinct approach to the calculation of BRS. These methods assume that 
spontaneous SBP fluctuations and fc are linked due to the influence of a closed-
loop baroreflex cardiovascular control (Robbe et al., 1987, Pagani, Somers, Furlan 
et al., 1988).  
 
While there are several distinct spectral methods to quantify BRS, including the 
alpha method, the transfer function method and the trigonometric method (Parati, 
Saul and Castiglioni, 2004), only the transfer function method is explored and 
utilised in this thesis. This approach to BRS quantification was first proposed by 
Robbe and colleagues (1987) and is based on the premise that the SBP-RR interval 
relation is described by a linear system in which SBP is the input and the heart 
period is the noisy output. 
 
Figure 3-13 – Representation of the calculation of baroreflex sensitivity by the sequence 
method for one individual. The mean slope of all valid sequences is utilised as a measure of ‘up’ 
and ‘down’ baroreflex sensitivity. Overall baroreflex sensitivity is given by the average of the values 
(in this particular case,11.97 ms). 
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The BRS estimates are computed by dividing the modulus of the SBP to RR interval 
cross-spectrum by the SBP spectrum (Figure 3-14). The transfer function is usually 
evaluated separately in both the LF and HF frequency bands. However, in this 
thesis, I only considered the transfer function calculation at the respiratory 
frequency, which means that in some instances (baseline epochs or sets at fRs > 8 
breaths·min.1) the HF transfer function was utilised as an estimate of BRSFreq, 
instead of the LF transfer function value. Power spectrum density calculations and 
the transfer function between signals was performed by the ANSLAB software using 




Figure 3-14 - Example of cross spectral analysis performed by ANSlab between heart rate 
period (ibi) and systolic blood pressure (SYS) for one individual at 6 breaths∙min-1. The analysis 
is performed at the frequency that shows highest cross spectral density within the spectral band of 
interest (left). Transfer function estimate (cross-spectral baroreflex gain), phase angle and coherence 




3-3.11  Phase and time shift relationships 
The use of the cross-spectral analysis also provided information on the phase 
relationship between respiratory and cardiovascular waveforms at the peak 
respiratory frequency. As high linear association between the two analysed 
waveforms is one of the premises of significant cross-spectral relationships, a 
squared coherence cut-off at 0.5 was deemed necessary for the phase values to be 
considered valid (Baselli, Cerutti, Civardi et al., 1986). Elstad and colleagues (2001) 
have previously suggested calculating average phase angles of cross-spectral data 
by weighing the phase angles with their squared coherence. Notwithstanding, as I 
encountered squared coherence values > 0.95 for the vast majority of individuals 
and SDB conditions, I opted to calculate the un-weighted circular mean (?̅?) for phase 
angles for all relationships of interest, as suggested by Mardia and Jupp (2009). 
After converting the angles into their Cartesian coordinates, the following equation 
was used to calculate ?̅? : 
?̅? = 𝑎𝑟𝑐𝑡𝑎𝑛 (∑ cos 𝛼𝑗
𝑛
𝑗=1





Circular standard deviation (𝑣) was calculated by: 
𝑣 = √−2 ln(?̅?), 
 
while the circular standard error (?̂?)was given by: 
?̂? = 1 ∕ √𝑛?̅??̂? 
, where ?̂? represents the concentration parameter (Fisher, 1995). 
 
The blood pressure waveforms (both SBP and DBP) phase data relative to the 
instantaneous lung volume (RESP) were advanced by 180 degrees so that the 
physiological phase and time differences between the increases in RESP and 
concurrent decreases in ABP could be more easily observed. Similarly, RR interval 
phase relationships were converted to fc by adding 180 degrees (Figure 3-15). The 
time delay (shift) between any two signals was calculated by dividing the cross-
spectral phase angle by the peak respiratory period (i.e. 10 s for an fR of 0.1 Hz or 




Figure 3-15 - Graphical representation of the relation between systolic blood pressure (SBP), 
heart rate (HR) and diastolic blood pressure (DBP) at 6 breaths∙min-1 for one individual. Values 
are presented as phase shift and time delay between events. The diagram suggests that at 6 
breaths∙min-1 that SBP lags behind the respiratory fluctuations by approximately 1.41 s. 
 
 
3-3.12  Statistical analysis and data presentation 
Detailed descriptions of statistical methods can be found in each experimental 
chapter. All graphs were created using a commercially available graphing software 
(Prism 7, GraphPad Software, La Jolla, CA, USA). Circular data were analysed 
using a commercial statistical software package (Oriana 4, Kovach Computing 
Services, Pentraeth, Isle of Anglesey, UK), while all remaining data was processed 
using IBM® SPSS version 21.0 statistical software (IBM Corp., Armonk, NY, USA). 
All data are expressed as mean ± SEM and significance is set at a level of P < 0.05, 
unless stated otherwise. 
 
3-4 Contribution 
Within this thesis, I contributed to the definition of study design and establishment 
of the research hypothesis for each study. I undertook identification and recruitment 
of participants, their screening, consent, examination and data acquisition (except 
for cardiac ultrasonography, which was performed by an experienced sonographer 
– Dr Eurico Wilhelm). Additionally, I performed all data analysis, data interpretation 
and wrote all chapters of the thesis. 
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CHAPTER 4 – THE INDEPENDENT INFLUENCE OF 
BREATHING FREQUENCY AND TIDAL VOLUME 
UPON THE ACUTE CARDIOVASCULAR 





[Note: parts of this chapter were presented and accepted for publication in 
Proceedings of the 9th Annual Physiological Society Meeting – Physiology 2014; 
and in the Proceedings of the 2015 International Society for the Advancement of 






Introduction and objective: Controlled, slower than normal, breathing frequencies 
have substantial effects on the cardiovascular and autonomic nervous systems 
(ANS). The exact mechanisms underlying the observed impact of slow and deep 
breathing (SDB) upon cardiac sympathovagal balance and other cardiovascular 
regulatory mechanisms are still not fully understood. Similarly, the independent 
influences of alterations in tidal volume (VT), breathing frequency (fR), and arterial 
partial pressure of carbon dioxide (PaCO2), during SDB remain unclear. 
Furthermore, the influence of SDB upon cardiac haemodynamics has not been 
explored systematically; in particular, there has been little investigation of the within 
breath changes (inhalation vs. exhalation). The purpose of this study was to clarify 
these issues; specifically, to explore how the well-established within-breath changes 
in heart rate (respiratory sinus arrhythmia; RSA) relate to other cardiovascular 
changes during SDB.  
Materials and methods: Fourteen healthy males (28±3 y; 179±6 cm; 76.9±9.6 kg) 
undertook SDB in a seated upright position. In part 1 of the study the independent 
effect of fR was assessed, whilst maintaining a constant VT of 30% of forced vital 
capacity (FVC), and individual fR optima identified (i.e. the individual fR that 
generated the highest RSA amplitude). In part 2, the optimal fR identified in part 1, 
was implemented across a range of VTs. Parts 1 and 2 included a semi-spontaneous 
condition in which only VT or fR were controlled (SSVT and SSfR, respectively). 
Conditions were randomised and a fixed magnitude of mild hypercapnia was 
maintained under all conditions, except for SSVT and SSfR. 
Results and conclusion: Decrease in fR and increase in VT were both 
independently associated with higher amplitudes of RSA, as well as within-breath 
fluctuations of left ventricle stroke volume (ΔSV) and cardiac output (ΔQ̇), but no 
significant changes in MAP, Q̇ and TPR (P<0.003). The RSA amplitude also 
increased linearly with both the decrease of fR and increase VT, but plateaued at 4 
and 6 breaths·min-1. Semi-spontaneous breathing resulted in no significant 
differences when compared to breathing with clamped fR, VT and PaCO2. Blood 
pressure variability (BPVTOT) was smallest at the lowest fRs (≤ 6 breaths·min-1), while 
heart rate variability (HRVTOT) maximised at those same frequencies. Collectively, 
the data are consistent with the involvement of baroreflex-mediated mechanisms in 
minimising BPV and maximising RSA during SDB. The data also suggest the 
presence of respiratory induced modulation of right atrial filling, perhaps mediated 
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There is a growing body of evidence that slow and deep breathing (SDB) may exert 
chronic antihypertensive effects when practiced daily, by people with hypertension, 
for several weeks (Grossman, Wilhelm, Kawachi et al., 2001, Schein et al., 2001, 
Viskoper et al., 2003, Elliott et al., 2004, Meles et al., 2004, Mourya et al., 2009, 
Singh, Gaurav and Parkash, 2011, Lin et al., 2012). In the acute context, SDB 
influences: i) RSA (Lehrer, Generelli and Hochron, 1997, Lehrer et al., 1999, Cysarz 
and Bussing, 2005), ii) baroreflex sensitivity (BRS) (Bernardi et al., 2001, Bernardi 
et al., 2002, Radaelli et al., 2004, Joseph et al., 2005), iii) spectral heart rate 
variability (HRV) indices (Cysarz and Bussing, 2005, Tharion et al., 2012), and iv) 
muscle sympathetic nerve activity (Raupach et al., 2008, Hering et al., 2013, Mozer, 
Fadel, Johnson et al., 2014). 
 
The precise mechanisms underlying any antihypertensive effect of SDB remain 
unknown. A number of putative pathways have been suggested, including, 
‘strengthening’ of baroreceptor homeostasis via neuroplasticity of the baroreflex 
(Vaschillo et al., 2002, Lehrer et al., 2003, Vaschillo et al., 2006) and changes in 
acid-base balance and renal sodium regulation induced by changes in PaCO2 
(Anderson et al., 2009). However, the key to understanding the mechanism(s) 
underlying any chronic adaptation to physiological perturbation(s) is first to 
comprehend the mechanisms underpinning the acute adjustments. The exact 
mechanisms underlying the acute changes induced by SDB also remain unclear; in 
particular, whether the input variables (VT and fR) exert independent effects upon 
the cardiovascular system.  
 
One of the most robust responses to SDB is its magnifying effect upon within breath 
fluctuations in heart rate, i.e. respiratory sinus arrhythmia (RSA).  The functional 
significance of RSA has been the object of ample debate over the last century, and 
while some advances towards understanding its physiological purpose and 
underlying mechanisms have been made, disagreement still abounds (Eckberg, 
2009b, Julien et al., 2009, Karemaker, 2009c, a). Fundamentally, however, RSA is 
a manifestation of the differing conditions that are experienced by the cardiovascular 
system during inhalation and exhalation. The RSA amplitude is known to maximise 
at fRs around 0.1Hz (Angelone and Coulter, 1964, Hirsch and Bishop, 1981, Song 
and Lehrer, 2003) and to increase with progressively higher VTs (Freyschuss and 
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Melcher, 1976c, Hirsch and Bishop, 1981). The reasons for this were explored in 
detail in section 2-4.3 of this thesis. In short, these include: i) the involvement of 
central mechanisms gating the responsiveness of cardiac vagal motoneurone 
throughout the respiratory cycle (a comprehensive review of this topic can be found 
in Eckberg [2003]); ii) the presence of baroreflex-mediated mechanisms (De Boer 
et al., 1987, TenVoorde et al., 1995, Karemaker, 2009a, c); iii) the mechano-electric 
and/or reflex response to atrial stretch, brought about by increased venous return to 
the right atria during inspiration (Bainbridge, 1915, Donald and Shepherd, 1978, 
Bolter and Wilson, 1999, Wilson and Bolter, 2002, Quinn and Kohl, 2012); iv) the 
contribution of lung stretch receptors (Anrep et al., 1936a, Seals et al., 1990).  
 
Most of the mechanisms above either result from or contribute to, the generation of 
important within-breath cardiovascular changes induced by breathing. To further the 
understanding of the impact of SDB upon RSA and cardiovascular regulation, it is 
necessary to characterise the within-breath cardiovascular responses within the 
range of fRs and VTs typically implemented in SDB interventions. While this has been 
accomplished to some extent for RSA and other indices of HRV (Angelone and 
Coulter, 1964, Freyschuss and Melcher, 1976c, Hirsch and Bishop, 1981, Berger, 
Saul and Cohen, 1989a, Cooke et al., 1998), the characterisation of frequency and 
volume dependencies has yet to be extended to the within-breath haemodynamic 
and cardiac responses to SDB.  
 
There is a general assumption that for fRs and VTs consistent with spontaneous 
breathing, LVSV during inhalation (LVSVI) decreases at a time when heart rate (fc) 
increases (Dornhorst et al., 1952b, Robotham and Mintzner, 1979, Saul et al., 
1989), leaving cardiac output (Q̇) relatively unaffected by breathing (Elstad, 2012), 
minimising fluctuations in arterial blood pressure (ABP) induced by breathing 
(Elstad, Walløe, Holme et al., 2015). However, some of the handful of studies that 
have sought to characterise the frequency dependent respiratory modulation of 
ABP, and thus blood pressure variability (BPV), hint at an increased modulatory 
influence of breathing upon BPV at lower fRs (TenVoorde et al., 1995, Radaelli et 
al., 2004, Chang et al., 2013), supporting the argument that some of the within-
breath cardiovascular responses observed during spontaneous breathing might be 




The present study intends to shed light on how changes in fR and VT independently 
influence the within-breath cardiovascular response to SDB. It is hoped that the 
description of these response patterns can contribute to a better understanding of 
the mechanisms underpinning the generation and amplification of RSA by SDB, and 
reveal potential contributors to the reported antihypertensive effects of SDB 
programs 
 
Thus, the specific objectives of this study are, 1) to elucidate the independent effect 
of fR and VT upon the within-breath cardiovascular response to SDB; 2) to identify 
whether there is an optimal breathing pattern (fR and VT) that maximises within-
breath cardiovascular fluctuations; 3) to assess the contribution of respiratory-
synchronous fluctuations of LVSV, Q̇ and ABP, to the generation of RSA; and 4) to 
characterise the interrelationship of breathing, fc and ABP across a range fRs and 




4-3 Specific Methods 
4-3.1 Overview 
The study consisted of two experimental protocols, in which the independent 
influences of fR (Protocol 1) and VT (Protocol 2) upon the cardiovascular and 
autonomic response to SDB were assessed, with ‘clamped’ PETCO2. 
 
4-3.2 Participants 
The study sample comprised fourteen healthy, recreationally-active men (28 ± 3 y). 
All participants were nonsmokers with no previous history of cardiovascular or 
respiratory disease, and self-reported to be free from medication usage. Descriptive 
characteristics of the participants are provided in Table 4-1. 
 
 
Table 4-1 Descriptive characteristics of the participants. 
 Mean ± SD %Predicted 
Anthropometry    
Age (y) 28 ± 2.5 - 
Stature (cm) 179 ± 6 - 
Body mass (kg) 76.9 ± 9.6 - 
SBP(mmHg) 133 ± 11 - 
DBP (mmHg) 74 ± 10 - 
Resting pulmonary function   
FEV1 (L) 4.7 ± 0.5 110 ± 10 
FVC (L) 6.2 ± 0.8 121 ± 13 
FEV1/FVC  76.8 ± 5.5 93 ± 7 
Values are mean ± SD for n = 14. Systolic blood pressure (SBP); diastolic blood pressure (DBP); 
forced expiratory in 1s (FEV1); forced vital capacity (FVC). Predicted values for lung function were 
determined from the equations derived from Stanojevic, Wade, Stocks et al. (2008). 
 
 
4-3.3 General Design 
A within-subject design was utilised whereby participants underwent two 
experimental trials to access the independent effects of fR and VT upon 
cardiovascular and autonomic response. All participants undertook one 
familiarisation session and the two experimental trials (Protocols 1 and 2).  
 
 During their first visit, participants performed a baseline pulmonary function 
assessment. Those participants with a forced vital capacity (FVC) under 4.5 litres 
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(L), as well as individuals showing signs of asthma or other lung disease were 
excluded from the study. The exclusion of participants with FVCs below 4.5 L was 
deemed necessary after pilot testing demonstrated that these individuals would be 
unable to maintain stable and tolerable PaCO2 levels at the lowest breathing 
frequencies due to inadequate alveolar volume. The severe hypercapnia that would 
result from this situation would have led to unphysiological levels of PaCO2, leading 
to the activation of chemoreflex feedback mechanisms, precluding some 
participants from completing the experimental procedures, and compromising the 
study design. Also, a familiarisation test was undertaken using a bespoke device 
guided breathing (DGB) biofeedback system to assess participants’ ability to follow 
an imposed breathing pattern accurately (Labview, National Instruments Inc.; 
please refer to Chapter 3, for a detailed description of pulmonary function 
assessment and familiarisation session protocols). Participants who were unable to 
follow the required pattern were excluded (only one participant out of 15 individuals 
tested did not meet the necessary inclusion criteria). Figure 4-1 depicts the study 
design. 
 
During the second and third visits, participants undertook the two experimental 
protocols of DGB. Protocol 1 manipulated fR and began with 5 min of quiet baseline 
breathing, followed by four 5 min sets at 4, 6, 8 and 10 breaths∙min-1 and at a 
constant VT corresponding to 30% of each participant’s FVC. A condition where 
participants were allowed to breathe freely at the previously fixed VT of 30% FVC 
was also included, henceforth referred to as ‘semi-spontaneous breathing 
frequency’ (SSfR). Five minute rest periods separated each set. To enable the 
‘clamped’ target level of PETCO2 to be identified, the 4 breaths∙min-1 condition was 
always performed first, with full randomisation of all remaining sets (a detailed 
description of the randomisation procedures is presented in section 3-2.5). Protocol 
2 manipulated VT. Following an initial quiet breathing baseline 5 min set, participants 
performed 5 guided breathing sets at 20, 25, 30, 35 and 40% FVC at a constant fR 
corresponding to the individual fR that elicited the highest amplitude of peak-to-valley 
RSA (RSA for each participant). The RSA was defined as the difference between 
the maximum RR interval during expiration minus the minimum RR interval during 
inspiration, in ms (Grossman et al., 1990). The RSA was chosen as the variable on 
which to select the fR for the evaluation of VT manipulations because of its known 
association with cardiovascular system resonance and BRS (Vaschillo et al., 2002). 
A condition where participants were asked to breathe freely at the previously 
 
93 
designated fR was also included; henceforth referred to as ‘semi-spontaneous tidal 
volume’ (SSVT). Similar to the first experimental visit, sets were performed in fully 
randomised order, with the exception of the condition that would deliver the smallest 
V̇E and consequently the highest PETCO2 levels. 
 
 
Figure 4-1 General study design. Tidal volume (VT), forced vital capacity (FVC), breathing 






Written informed consent was obtained from all participants prior to the start of the 
study. The study was approved by a local sub-panel of the Brunel University London 
Research Ethics Committee and conducted in accordance with the Declaration of 





Participants were asked to refrain from alcohol, caffeine and strenuous physical 
activity for at least 12 h before testing and to avoid consuming food during the two 
hours leading up to testing. All sessions were conducted at the same time of the day 
and were separated by at least 48 h but no more than one week. Throughout all 
sessions, participants assumed an upright-reclined position by sitting on a reclining 
lounge chair, set at an approximate angle of 60o. They also breathed through a mask 
that allowed for normal mouth and/or nasal breathing (Oro Nasal 7450 V2, Hans 
Rudolph Inc., Shawnee, KS, USA). Room temperature was 22-25oC and barometric 
pressure was recorded for each of the trial sessions. A detailed description of 
participant preparation guidelines as well exclusion criteria can be encountered in 
Chapter 3 (section 3-2.3). 
 
Device guided breathing  
Specified respiratory flow rates and a respiratory duty cycle of 0.5 (inspiratory 
duration = expiratory duration) were delivered using the aforementioned bespoke 
guided breathing biofeedback system (Labview, National Instruments Inc.) and 
measured using a heated pneumotachograph (Hans Rudolph 3813, Hans Rudolph 
Inc.). The PETCO2 (GA-200 gas analyser, iWorx Systems Inc.)  was maintained at a 
slightly hypercapnic level (defined by the lowest fR and VT conditions; see above) 
under all fully controlled conditions via a re-breathing system consisting of added 




Heart rate was monitored continuously using a 3-lead ECG (PhysioControl VSM® 3, 
PhysioControl Inc.). Non-invasive beat-to-beat arterial blood pressure was obtained 
using finger photoplethysmography (Finometer® PRO, Finapres Medical Systems, 
Amsterdam, The Netherlands). Total peripheral resistance (TPR) was calculated by 
dividing Q̇ by the mean arterial pressure (MAP). Baroreflex sensitivity (BRS) was 
calculated by the sequence method (Bertinieri et al., 1985, Parati et al., 1988), as 
well as from the cross-spectral transfer function gain (Robbe et al., 1987). Phase 
angles and coherence between respiratory and cardiovascular (fc, SBP and DBP) 
waveforms were obtained from the cross-spectra at the peak respiratory frequency. 
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A more detailed description of these outcome variables can be found in the Chapter 
3 (section 3-3).  
 
4-3.5 Statistical analysis 
Values are expressed as means ± standard error of the mean (SEM), unless stated 
otherwise. Repeated measures ANOVA with post hoc pairwise comparisons using 
Bonferroni correction were used to test differences between conditions after 
normality was confirmed via the Shapiro-Wilk test. Circular data (phase 
relationships) were analysed using multi-sample Watson-Williams F-test following 
confirmation of a Von Mises circular distribution (Fisher, 1995, Mardia and Jupp, 
2009). Bonferroni corrections were applied to circular data for post hoc pairwise 
comparisons. A justification regarding the use of these statistical tests in instances 
where the requirements for the use of parametric statistics were not met can be 
found in Chapter 3 (section 3-3.12). Finally, the associations amongst fR, VT, and 
cardiovascular indices were accessed using linear correlation coefficients 
(Pearson’s r) and respective coefficients of determination (R2). For all analyses, P 




4-4.1 Respiratory responses elicited by each condition 
A summary of the respiratory data associated with each experimental condition can 
be found in Tables 4-2 and 4-3. As intended, duty cycle (~0.5) remained constant 
throughout all conditions, while PETCO2 was stable for all fully clamped conditions, 
in both the fixed VT (40-41 mmHg) and fixed fR protocols (41-42 mmHg).  Both VT 
(~30% FVC) and fR (~5.4 breaths·min-1) remained constant throughout Protocol 1 
and 2, respectively (Tables 4-2 and 4-3). The semi-spontaneous conditions showed 
significantly lower PETCO2 than the fully clamped conditions (SSVT: ~36 mmHg vs. 







Table 4-2 Respiratory parameters for the fixed VT protocol. 
Data represent mean ± SEM for 14 subjects. Breathing frequency (fR) in breaths·min-1, tidal volume (VT) in % of forced vital capacity, duty cycle (Ti/TTOT), partial pressure of 
end tidal carbon dioxide (PETCO2) in mmHg. * different from baseline; † different from semi-spontaneous; § different from 4 breaths∙min-1; ¥ different from 8 breaths∙min-1; ǂ 
different from 10 breaths∙min-1. Signalled differences between conditions are significant at P < 0.003. 
 
Table 4-3 Respiratory parameters for the fixed fR protocol. 
Data represent mean ± SEM for 11 subjects. Breathing frequency (fR) in breaths·min-1, tidal volume (VT) in % of forced vital capacity, duty cycle (Ti/TTOT), partial pressure of 
end tidal carbon dioxide (PETCO2) in mmHg. * different from baseline; § different from 20% FVC; ¥ different from 25% FVC; ǂ different from 30% FVC; # different from 35% 
FVC; † different from semi-spontaneous. Signalled differences between conditions are significant at P < 0.002. 
 










fR  12.2±0.8 4.1±0.1*† 6.1±0.1*§¥ǂ 8.1±0.1*§ǂ† 10.1±0.1*§† 5.2±0.4* 
VT  12.3±0.7 29.9±0.4* 29.7±0.3* 29.7±0.4* 29.6±0.3* 29.9±0.4* 
TI/TToT  0.53±0.02 0.51±0.01 0.52±0.01 0.51±0.01 0.51±0.01 0.52±0.01 
PETCO2  38.2±1.4 41.3±0.8† 41.0±0.7† 40.9±0.7† 40.6±0.7† 35.5±1.3 
 Baseline 20%FVC 25%FVC 30%FVC 35%FVC 40%FVC 
Semi-Spontaneous 
(SSfR) 
fR 11.5±0.5 5.4±0.3* 5.5±0.3* 5.3±0.3* 5.4±0.3* 5.3±0.3* 5.3±0.3* 
VT 11.6±0.5 19.8±0.4*† 25.5±0.3*§† 30.2±0.5*§¥ 34.9±0.6*§¥ǂ 40.2±0.5*§¥ǂ#† 31.4±2.5 
TI/TToT 0.54±0.01 0.51±0.02 0.52±0.01 0.52±0.01 0.52±0.01 0.52±0.01 0.52±0.03 
PETCO2 39.9±1† 42.1±1.6† 42.0±1.6† 42.1±1.6† 41.8±1.6† 41.7±1.7† 34.7±1.4 
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4-4.2 Cardiovascular response to SDB 
Respiratory sinus arrhythmia and heart rate 
The amplitude of RSA increased progressively with both the decrease of fR and the 
increase of VT, but exhibited a plateau for breathing frequencies ≤ 6 breaths·min-1 
(P<0.001; Table 4-4; Figure 4-2A). The average gain of the change in RSA relative 
to the change in fR was circa -20 ms∙breath-1∙min-1. The increased amplitude of the 
RSA fluctuations resulted from significant frequency dependent changes in fc during 
both inspiration (fcI) and expiration (fcE) (Table 4-4). Despite the tendency for fcI to 
increase (R2=0.89) and fcE to decrease (R2=0.70) with a reduction in fR, the 
regression coefficient b was not significantly different from zero (P>0.05 for both; 
Figure 4-2A), indicating a small effect size of fR upon fcI and fcE. Mean fc was only 
slightly, but significantly, affected by the changes in fR (Table 4-4). The increments 
in VT during the fixed fR protocol (Protocol 2) also resulted in a linear increase in 
RSA (R2=0.96, P=0.003, average gain: ~103 ms·L-1; Figure 4-2E) accompanied by 
a linear decay in fcE (R2=0.90, P=0.015, Table 4-5; Figure 4-3D). 
 
Stroke volume and cardiac output 
The decrease in fR resulted in increments in LVSV during expiration (LVSVE, Table 
4-4; Figure 4-3B). Despite the existence of a significant main effect of fR upon LVSVI, 
post-hoc analysis revealed no statistically significant differences between different 
fRs. Lower fRs were associated with an inversion of the within-breath pattern of LVSV 
(ΔSV), i.e. LVSVE was higher than LVSVI for frequencies close to, or below, 6 
breaths∙min-1, whilst the reverse was true for the higher fRs (Table 4-4, Figures 4-
2B and 4-3B). Breathing at progressively higher VTs did not alter either LVSVI or 
LVSVE, but a significant main effect of VT was identified for ΔSV (Table 4-5). The 
post-hoc analysis only revealed significant differences relative to baseline, and not 
between the different VTs (Table 4-5).  
 
No significant main effect of either fR or VT was detected for Q̇ or the breath phase-
specific variables (Q̇I and Q̇E) (Tables 4-4 and 4-5). Nonetheless, while fR changes 
did not significantly impact ΔQ̇ (Table 4-4, Figure 4-2C), increasing VT at a fixed fR 
resulted in a linear increase in ΔQ̇ (Figure 4-2G) resulting from a trend for Q̇E to 




Arterial blood pressure 
Mean arterial pressure (MAP), pulse pressure (PP), SBP and DBP all increased 
across the range from 6 and 10 breaths∙min-1, with a significant main effect of fR 
(P<0.001, Table 4-4). At 4 breaths∙min-1, MAP, PP, SBP and DBP returned to near 
baseline values. Breathing at a fixed individual optimal frequency (4 or 6 
breaths∙min-1) resulted in no significant main effects of VT upon MAP, PP, SBP or 
DBP (Table 4-5). Nevertheless, at its maximum (30% FVC), the difference in SBP 




A main effect of fR was observed for all BRS indices, but post-hoc analysis only 
revealed significant differences between 6 and 10 breaths∙min-1 for BRSdown, and 
between 6 breaths∙min-1 and baseline using the cross-spectral index of BRS 
(BRSFreq; Table 4-4). No significant main effect of VT was observed for any of the 
analysed BRS variables (Table 4-5). 
 
Semi-spontaneous breathing 
Breathing with fixed VT, but without clamped fR or PETCO2 (SSVT) resulted in no 
significant differences from breathing under fully controlled conditions with similar 
fRs (i.e. 4 and 6 breaths∙min-1), for any of the analysed cardiovascular variables, 
except for SBP, DBP and MAP. For these variables, SSVT exhibited slightly smaller, 
but significantly different values than those observed for fRs ≥ 6 breaths∙min-1. In 
contrast, breathing with fixed fR, but without controlled VT or PETCO2 (SSfR), did not 
result in any significant difference from any of the fully controlled conditions for any 




Figure 4-2 Cardiovascular response to SDB at different breathing frequencies (A, B, C, D) and 
tidal volumes (E, F, G, H). Respiratory sinus arrhythmia (A, E), amplitude of inspiratory to expiratory 
(∆) stroke volume variation (B, F), amplitude of inspiratory to expiratory (∆) cardiac output variation 
(C, G) and mean arterial pressure (D, H) Values are means ± SEM for fully fixed (○ black), semi-
spontaneous (△red) and baseline (■ blue) breathing pattern. Presented R2 represent Pearson’s 
coefficient of determination. P < 0.05 indicate regression coefficients (b) that are significantly 




Figure 4-3 Within-breath cardiovascular response to SDB at different breathing frequencies (A, 
B, C) and tidal volumes (D, E, F). Inspiratory (solid shapes) and expiratory (open shapes) mean 
values are presented for heart rate (A, D), stroke volume (B, E) and cardiac output (C, F), Values are 
means ± SEM for fully fixed (○, ●, black), semi-spontaneous (△,▲, red) and baseline (□,■, blue) 
breathing patterns. Presented R2 represent Pearson’s coefficient of determination. P < 0.05 indicate 








Table 4-4 Cardiovascular responses to SDB at fixed VT (30% FVC). 
Values are Mean ± SEM for n=14. Respiratory sinus arrhythmia (RSA), heart rate (fC), heart rate during inspiration (fcI), heart rate during expiration (fcE), left ventricle stroke 
volume (LVSV), stroke volume during inspiration (LVSVI), stroke volume during expiration (LVSVE), within-breath variation in stroke volume (ΔSV), cardiac output (Q̇), cardiac 
output during inspiration (Q̇I), cardiac output during expiration (Q̇E), within-breath variation in cardiac output (ΔQ̇), systolic blood pressure (SBP), diastolic blood pressure 
(DBP), mean arterial pressure (MAP), pulse pressure (PP), total peripheral resistance (TPR), sequence baroreflex sensitivity positive sequence gain (BRSup), sequence 
baroreflex sensitivity negative sequence gain (BRSdown), sequence baroreflex sensitivity average gain (BRSSeq); cross-spectral baroreflex sensitivity gain (BRSFreq). * Different 
from baseline; † different from semi-spontaneous; § different from 4 breaths∙min-1; ¥ different from 8 breaths∙min-1; ǂ different from 10 breaths∙min-1. Signalled differences 
between conditions are significant at P < 0.003. Note: a a non-physiological outlier affecting the LVSV values was detected for one of the participants at 10 bpm, and was 













RSA (ms) 111±13 265±27*ǂ 274±35*ǂ¥ 205±28*ǂ 166±31 259±31*ǂ 
fC (beats∙min-1) 65±2 64±2 62±2ǂ 65±2 65±2 63±2 
fcI (beats∙min-1 68±2 72±3* 71±2 71±2 69±2 70±2 
fcE (beats∙min-1) 60±2 55±2*ǂ 54±2*ǂ¥ 58±2 59±3 54±2*ǂ¥ 
LVSV (mL∙beat-1) 99±2 103±3 105±3 104±3 104±3 102±3 
LVSVI (mL∙beat-1) 99±3 98±3 103±3 106±3 107±5 98±3 
LVSVE (mL∙beat-1) 96±2 105±3* 105±4*ǂ 100±4 98±6 102±3 
ΔSV (mL∙beat-1) 4±1 -7±1*ǂ¥ -3±1ǂ¥ 6±2 9±2 -4±2*ǂ¥ 
Q̇ (L∙min-1) 6.4±0.2 6.5±0.2 6.6±0.3 6.7±0.3 6.7±0.3 6.4±0.3 
Q̇I (L∙min-1) 6.7±0.3 7.0±0.2 7.3±0.3 7.5±0.3 7.5±0.3 6.9±0.3 
Q̇E (L∙min-1) 5.8±0.2 5.8±0.3 5.7±0.3 5.8±0.3 5.8±0.4 5.6±0.3 
ΔQ̇ (L∙min-1) 1.0±0.1 1.2±0.1* 1.5±0.2* 1.7±0.2* 1.7±0.2* 1.3±0.2* 
SBP (mmHg) 133±3 135±4 144±4*† 143±4† 145±4*† 132±4 
DBP (mmHg) 74±3 75±3 79±3*† 79±3 79±3 72±3 
MAP (mmHg) 94±2 95±4 101±3*† 100±3† 101±3*† 92±3 
PP (mmHg) 58±3 60±3 65±3* 65±3* 65±3* 60±3 
TPR (mmHg∙min∙L-1) 15±1 15±1 16±1 16±1 16±1 15±1 
BRSup (ms∙mmHg-1) 13±2 19±3 20±2 18±3 14±3 22±3 
BRSdown (ms∙mmHg-1) 11±1 14±1 14±1¥ 11±1 11±2 14±2¥ 
BRSSeq (ms∙mmHg-1) 12±2 17±2 17±2 15±2 13±2 18±2¥ 







Table 4-5 Cardiovascular responses to SDB at fixed individual ideal fR (4 or 6 breaths∙min-1). 
Values are Mean ± SEM for n=11. Respiratory sinus arrhythmia (RSA), heart rate (fC), heart rate during inspiration (fcI), heart rate during expiration (fcE), left ventricular stroke 
volume (LVSV), left ventricular stroke volume during inspiration (LVSVI),left ventricular stroke volume during expiration (LVSVE), within-breath variation in left ventricular 
stroke volume (ΔSV), cardiac output (Q̇), cardiac output during inspiration (Q̇I), cardiac output during expiration (Q̇E), within-breath variation in cardiac output (ΔQ̇), systolic 
blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), pulse pressure (PP), total peripheral resistance (TPR), sequence baroreflex sensitivity 
positive sequence gain (BRSup), sequence baroreflex sensitivity negative sequence gain (BRSdown), sequence baroreflex sensitivity average gain (BRSSeq); cross-spectral 
baroreflex sensitivity gain (BRSFreq). * different from baseline; ǂ different from 25% FVC; †different from semi-spontaneous. Signalled differences between conditions are 
















RSA (ms) 155±27 253±30* 280±33* 287±38* 322±39*† 360±41*†ǂ 298±35* 
fC (beats∙min-1) 63±3 63±2 62±3 62±2 63±2 61±2 62±3 
fcI (beats∙min-1) 68±3 71±2 70±3 70±2 72±2 73±2 71±2 
fcE (beats∙min-1) 58±2 55±3 53±3 53±3* 53±3* 51±3*†ǂ 53±2* 
LVSV (mL∙beat-1) 95±4 96±3 95±3 96±4 91±3 97±3 97±3 
LVSVI (mL∙beat-1) 99±4 95±3 93±3 94±4 87±4 94±4 96±4 
LVSVE (mL∙beat-1) 93±4 98±3 98±4 99±4 94±4 100±3 98±3 
ΔSV (mL∙beat-1) 6±1 -3±2 -5±3 -6±2* -6±2* -5±3 -3±3 
Q̇ (L∙min-1) 6.1±0.5 6.0±0.3 5.8±0.2 6.0±0.3 5.7±0.4 5.9±0.3 6.0±0.3 
Q̇I (L∙min-1) 6.7±0.5 6.7±0.3 6.5±0.3 6.5±0.4 6.3±0.4 6.8±0.3 6.8±0.2 
Q̇E (L∙min-1) 5.4±0.4 5.4±0.3 5.2±0.2 5.2±0.3 5.0±0.4 5.0±0.3 5.2±0.3 
ΔQ̇ (L∙min-1) 1.3±0.1 1.3±0.2 1.3±0.3 1.3±0.3 1.4±0.3 1.8±0.3 1.5±0.3 
SBP (mmHg) 127±3 133±4* 135±3* 137±4* 133±5 132±4 136±5 
DBP (mmHg) 75±2 78±2 79±2 81±3 81±4 77±3 79±3 
MAP (mmHg) 93±2 96±3 98±3 100±3 99±4 96±3 98±3 
PP (mmHg) 52±2 54±2 56±2 56±3 52±3 55±2 57±3 
TPR (mmHg∙min∙L-1) 16±1 17±1 17±1 18±1 18±1 17±1 17±1 
BRSup (ms∙mmHg-1) 19±4 21±4 20±3 28±5 23±4 27±5 25±5 
BRSdown (ms∙mmHg-1) 17±2 15±1 18±2 15±2 14±1 16±2 16±2 
BRSSeq (ms∙mmHg-1) 18±3 18±2 19±3 21±3 18±3 21±3 21±3 
BRSFreq (ms∙mmHg-1) 18±3 18±2 20±3 20±2 21±4 21±2 20±3 
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4-4.3 Heart rate and blood pressure variability responses to SDB 
Heart rate variability 
In common with RSA, other heart rate variability (HRV) parameters showed 
significant frequency-dependent responses with SDB (Table 4-6). The time domain 
variables SDNN and RMSSD, exhibited a significant main effect of fR, increasing 
steadily from baseline and reaching maximal average values at 6 breaths∙min-1 
(Table 4-6). When breathing at a fixed, optimal fR there was a significant main effect 
of VT for SDNN, but not for RMSSD, with the peak SDNN values attained at the 
highest VT (40%FVC, Table 4-7).  
 
In the frequency domain, HRVLF and HRVTOT followed a similar trend, increasing 
with the reduction in fR and maximising at 6 breaths∙min-1 (Table 4-6), where a 6-
fold increase in HRVLF and 3-fold increase in HRVTOT were observed. In contrast, 
HRVHF peaked at 10 breaths∙min-1, with lower fRs resulting in significantly lower 
values (Table 4-6), as fR moved into the low-frequency spectral band (<0.15 Hz).  
 
The analysis of the two components of the nonlinear Poincaré plot method (SD1 
and SD2) showed close similarities to the patterns observed in RMSSD and SDNN, 
respectively (Table 4-6).  Both SD1 and SD2 increased with a reduction in fR, 
peaking at 6 breaths∙min-1, with SD1 exhibiting a further marked decrease at 4 
breaths∙min-1 (P<0.001). The ratio between SD1 and SD2 reached a nadir at 4 
breaths∙min-1 (P<0.001; Table 4-6). 
 
All frequency domain variables were also affected significantly by changes in VT with 
both HRVLF and HRVTOT peaking at 40%FVC (P<0.001; Table 4-7) For HRVHF post-
hoc analysis revealed no statistically significant changes between the different VTs 
(P>0.05). Importantly, the fRs used in Protocol 2 were outside of the high-frequency 
spectral band, leading to HRVHF values during the SDB sets that were always 
roughly one fifth of those recorded at baseline (e.g. 40%FVC = 538±545 vs. 
2324±2300 ms2 at baseline, Table 4-7). 
 
No significant differences for SD1 and SD2 (P>0.05) were encountered when 
breathing at progressively higher VTs and fixed fR, despite SD2 tracking the 
increments in VT (Table 4-7). SD1/SD2 ratio showed a strong main effect of VT 
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(P<0.001) but post-hoc analysis failed to demonstrate significant differences 
between conditions linear association with the changes in VT (P>0.002; Table 4-7). 
 
Breathing semi-spontaneously at a fixed VT (SSVT) did not result in any significant 
difference from breathing at 6 breaths∙min-1 (P>0.05), nor from any of the different 
VTs (SSfR). However, it was noticeable that the SSfR condition elicited slightly higher 
(but not significantly different) average values across all analysed HRV indices, than 
those recorded at similar VTs, more precisely, the 30 and 35% FVC conditions 
(Table 4-7). Overall, SDNN, HRVLF and HRVTOT demonstrated a response pattern 









Table 4-6 Heart rate variability response to slow, deep breathing at fixed VT (30% FVC). 
 
Baseline 4 breaths∙min-1 6 breaths∙min-1 8 breaths∙min-1 10 breaths∙min-1 Semi-Spontaneous 
(SSVT) 
SDNN (ms) 61±7 86±7* 98±9*ǂ 78±7* 68±8 94±8*ǂ 
RMSSD (ms) 45±6 41±4 60±6*§ 56±7§ 54±8 53±5§ 
HRVLF (ms2) 1308±222 6901±952*ǂ¥ 8099±1192*ǂ¥ 4912±889*ǂ 1015±307 7517±973*ǂ 
HRVHF (ms2) 1388±328 271±120*ǂ 493±103ǂ 331±68*ǂ 2951±749 561±142 
HRVTOT (ms2) 2695±489 7172±991*ǂ 8592±1255*ǂ¥ 5242±952* 3966±848 8078±1062*ǂ 
SD1 (ms) 32±4 29±3 42±4*§ 40±5§ 38±5 37±4§ 
SD2 (ms) 79±9 118±9*ǂ 131±12*ǂ¥ 102±9 88±10 127±10*ǂ 
SD1/SD2 0.41±0.02 0.24±0.01* 0.33±0.01*§ǂ 0.38±0.02§ 0.43±0.03§ 0.29±0.01*ǂ¥ 
Values are Mean ± SEM for n=14. Standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD), low-frequency power 
(HRVLF), high-frequency power (HRVHF), total power (HRVTOT), poincaré plot SD1 (SD1), poincaré plot SD2 (SD2). * different from baseline; † different from semi-
spontaneous; § different from 4 breaths∙min-1; ¥ different from 8 breaths∙min-1; ǂ different from 10 breaths∙min-1. P < 0.003. 
 
 
Table 4-7 Heart rate variability response to slow, deep breathing at fixed individual ideal fR (4 or 6 breaths∙min-1). 




SDNN (ms) 71±8 91±9 96±10* 99±9* 104±8* 113±10* 117±11* 
RMSSD (ms) 58±10 54±7 56±8 57±7 60±7 65±8 70±8 
HRVLF (ms2) 1612±423 7675±1270* 8029±1643* 8637±1406* 9150±1103* 12126±1877* 10863±2153* 
HRVHF (ms2) 2324±693 476±105 471±119 513±103 557±161 538±164 689±171 
HRVTOT (ms2) 3936±986 8152±1348* 8499±1743 9150±1483* 9706±1185* 12664±1997* 11552±2168 
SD1 (ms) 41±7 38±5 40±6 41±5 42±5 46±6 50±5 
SD2 (ms) 90±9 124±11 129±13 133±12 141±11 153±13 158±14 
SD1/SD2 0.43±0.04 0.3±0.02 0.3±0.02 0.3±0.02 0.29±0.02 0.29±0.02 0.32±0.02 
Values are Mean ± SEM for n=11. Standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD), low-frequency power 
(HRVLF), high-frequency power (HRVHF), total power (HRVTOT), Poincaré plot SD1 (SD1), Poincaré plot SD2 (SD2). * different from baseline. P < 0.002.
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Blood pressure variability 
The blood pressure variability (BPV) also exhibited significant main effects of fR for 
all indices analysed. The BPVLF exhibited a pattern similar to that described 
previously for LVSVE, demonstrating higher values at the highest fRs and peaking at 
8 breaths∙min-1, followed by a steep decrease, with the lowest values at 4 
breaths∙min-1 (42.19 ± 28.46 vs. 580.94 ± 300.42 mmHg2 at 4 breaths∙min-1 and 8 
breaths∙min-1, respectively). Similarly, both BPVHF and BPVTOT peaked at 10 
breaths∙min-1 and reached their lowest values at 4 breaths∙min-1 (Table 4-8).  
 
There was a significant main effect of VT upon BPVLF and BPVHF (but not for 
BPVTOT). However, post-hoc Bonferroni correction for multiple comparisons did not 
reveal any significant differences between conditions for BPVLF (P>0.002, Table 4-








Table 4-8 Blood pressure variability response to slow, deep breathing at fixed VT (30% FVC). 
Values are Mean ± SEM for n=14. Low-frequency power (BPVLF), high-frequency power (BPVHF), total power (BPVTOT). * different from baseline; † different from semi-
spontaneous; § different from 4 breaths∙min-1; ¥ different from 8 breaths∙min-1; ǂ different from 10 breaths∙min-1. P < 0.003. 
 
 
Table 4-9 Blood pressure variability response to slow, deep breathing at fixed individual ideal fR (4 or 6 breaths∙min-1). 
Values are Mean ± SEM for n=11. Low-frequency power (BPVLF), high-frequency power (BPVHF), total power (BPVTOT). * different from baseline. P < 0.002. 
 
Baseline 4 breaths∙min-1 6 breaths∙min-1 8 breaths∙min-1 10 breaths∙min-1 Semi-Spontaneous 
(SSVT) 
BPVLF (mmHg2)  94.66±22.19 42.19±7.61 175.1±21.17§ǂ¥ 580.94±80.29*†§ 287.64±43.99*§ 127.278±32.98 
BPVHF (mmHg2) 96.56±24.03 8.34±3.04* 18.73±3.23ǂ 24.53±11.43 454.34±71.22*†§¥ 11.63±3.18 
BPVTOT (mmHg2) 191.23 ±39.13 50.53±7.88* 193.84±22.66§ǂ¥ 605.57±77.33*†§ 742.04±115.19*†§ 138.92±33.24 




BPVLF (mmHg2)  68.19±16.40 92.33±17.16 104.87±23.86 119.87±27.22 153.33±40.20 159.67±36.66 128.58±22.70 
BPVHF (mmHg2) 81.58±13.80 10.48±3.29* 17.02±5.98* 16.75±4.18* 25.52±6.24 21.76±6.65* 41.75±21.65 
BPVTOT (mmHg2) 149.78±19.59 102.82±18.98 121.89±27.75 136.63±29.32 178.85±40.80 181.44±39.23 170.34±36.23 
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4-4.4 Relationships between cardiovascular parameters, heart rate and blood 
pressure variabilities 
An analysis of the relationships between cardiovascular parameters, HRV and BPV 
is depicted in Tables 4-10 and 4-11. As expected, this confirmed the existence of a 
strong and significant correlation between RSA and HRVTOT (r = 0.98 and r = 0.95 
in the fixed VT (Protocol 1) and fixed fR (Protocol 2) protocols, respectively; Tables 
4-10 and 4-11, both P < 0.01). Similarly, mean fc also correlated positively with 
HRVTOT (r = 0.95, P < 0.01, for the fixed VT protocol; and r = 0.77, P < 0.05 for the 
fixed fR protocol), and negatively with RSA (r = -0.88 and r = -0.79, respectively; P < 
0.05, Tables 4-10 and 4-11). Interestingly, fc correlated negatively with BRSSeq in 
both protocols (r = -0.92, P < 0.01), while both RSA and HRVTOT showed significant 
correlations with the cross-spectral baroreflex sensitivity (BRSFreq), also in both 
protocols (RSA: r = 0.97, P < 0.01, and r = 0.88, P < 0.05; HRVTOT: r = 0.92 and 
0.72, P < 0.05, for fixed VT and fixed fR, respectively; Tables 4-10 and 4-11). In 
contrast, only in the fixed VT protocol were RSA and HRVTOT correlated with BRSSeq 
(RSA: r = 0.95; HRVTOT: r = 0.98, P < 0.01; Table 4-10). 
 
The within-breath variations in left ventricular stroke volume (∆SV) where 
moderately/strongly inversely correlated with RSA and HRVTOT, despite only being 
significant for Protocol 2 (r = - 0.71 and r = -0.77, P > 0.05, in Protocol 1 and; r = - 
0.88 and r = -0.76, P < 0.05, in Protocol 2 for RSA and BPVTOT, respectively). In 
contrast, only in the Protocol 1 was there a strong correlation between ∆SV and 
BPVTOT (r = 0.90, P < 0.05). The ∆SV also related strongly and negatively with SBP, 
MAP and TPR in response to changes in VT at a fixed, optimal fR, but did not 
translate into similarly significant correlations when breathing at different fRs. An 
opposite pattern was encountered for the within-breath amplitude of cardiac output 
fluctuations (∆Q̇), which correlated strongly with SBP (r = 0.89, P < 0.05), MAP (r = 
0.89, P < 0.05) and PP (r = 0.95, P < 0.05) during Protocol 1, but not with Protocol 
2. The mean Q̇ also correlated positively and strongly with SBP (r = 0.87, P < 0.05), 
MAP (r = 0.87, P < 0.05) and PP (r = 0.86, P < 0.05), as well as BPVTOT (r = 0.88, P 
< 0.05) in the fixed VT protocol (Protocol 1), but showed no significant correlation 
with the same variables in the second part of the study (Protocol 2 - fixed fR 
conditions). Perhaps surprisingly, HRVTOT and BPVTOT were not significantly 
correlated in any of the protocols (r = -0.50 and -0.48, P > 0.05). Finally, while both 
baroreflex sensitivity indices (BRSSeq and BRSFreq) exhibited a significant correlation 
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during Protocol 1 (r = 0.88, P < 0.05), the same did not occur during Protocol 2 (r = 
0.69, P > 0.05), raising questions regarding the interchangeability of these methods 







Table 4-10 Correlations between cardiovascular parameters, HRV and BPV indices for slow, deep breathing at 4 to 10 breaths.min-1 with fixed 
VT (30% FVC). 
 RSA fc LVSV ΔSV Q̇ ΔQ̇ SBP MAP PP TPR HRVTOT BPVTOT BRSSeq BRSFreq 
RSA – -0.88* 0.70 -0.71 -0.04 0.37 0.11 0.04 0.26 0.20 0.98** -0.41 0.95** 0.97** 
fc  – -0.51 0.70 0.32 -0.18 -0.01 0.06 -0.13 -0.26 0.95** 0.55 -0.92* -0.75 
LVSV   – -0.04 0.64 -0.89* 0.77 0.72 0.86* 0.73 0.61 0.32 0.50 0.74 
ΔSV    – 0.64 0.38 0.54 0.57 0.45 0.40 -0.75 0.90* -0.78 -0.65 
Q̇     – 0.84* 0.87* 0.87* 0.85* 0.62 -0.19 0.88* -0.28 0.11 
ΔQ̇      – 0.89* 0.84* 0.95** 0.79 0.27 0.67 0.19 0.42 
SBP       – 0.99** 0.98** 0.92** 0.19 0.71 -0.12 0.16 
MAP        – 0.96** 0.91* -0.06 0.72 -0.21 0.08 
PP         – 0.92* 0.17 0.67 0.04 0.29 
TPR          – 0.17 0.50 0.02 0.15 
HRVTOT           – -0.50 0.98** 0.92* 
BPVTOT            – -0.55 0.28 
BRSSeq             – 0.88* 
BRSFreq              – 
The values represent r for mean group values for n=14. Respiratory sinus arrhythmia (RSA), heart rate (fc), left ventricular stroke volume (LVSV), within-breath variation of 
left ventricular stroke volume (ΔSV), cardiac output (Q̇), within-breath variation of cardiac output (ΔQ̇), systolic blood pressure (SBP), mean arterial pressure (MAP), pulse 
pressure (PP), total peripheral resistance (TPR), heart rate variability total power (HRVTOT), blood pressure variability total power (BPVTOT), sequence baroreflex sensitivity 








Table 4-11 Correlations between cardiovascular parameters, HRV and BPV indices for slow, deep breathing at 20 to 40% FVC with fixed fR (4 
or 6 breaths∙min-1). 
 RSA fc LVSV ΔSV Q̇ ΔQ̇ SBP MAP PP TPR HRVTOT BPVTOT BRSSeq BRSFreq 
RSA – -0.79* -0.05 -0.88* -0.62 0.66 0.61 0.60 0.44 0.67 0.95** 0.46 0.62 0.88** 
fc  – -0.36 0.68 0.30 -0.58 -0.62 -0.48 -0.68 -0.43 0.77* -0.30 -0.92** -0.70 
LVSV   – 0.19 0.77* 0.32 0.15 -0.17 0.67 -0.57 0.19 -0.16 0.55 -0.31 
ΔSV    – 0.71 -0.25 -0.79* -0.83* -0.47 -0.81* -0.76* -0.07 -0.46 -0.72 
Q̇     – -0.07 -0.32 -0.53 0.16 -0.87* -0.37 -0.31 -0.03 -0.77* 
ΔQ̇      – 0.00 -0.13 0.23 -0.01 0.77* 0.71 0.58 0.60 
SBP       – 0.94** 0.79* 0.65 0.61 -0.10 0.61 0.41 
MAP        – 0.54 0.83* 0.51 -0.05 0.43 0.49 
PP         – 0.11 0.58 -0.16 0.75 0.15 
TPR          – 0.47 0.29 0.30 0.77 
HRVTOT           – 0.48 0.69 0.76* 
BPVTOT            – 0.39 0.71 
BRSSeq             – 0.56 
BRSFreq              – 
The values represent r for mean group values for n=11. Respiratory sinus arrhythmia (RSA), heart rate (fc), left ventricular stroke volume (LVSV), within-breath variation of 
left ventricular stroke volume (ΔSV), cardiac output (Q̇), within-breath variation of cardiac output (ΔQ̇), systolic blood pressure (SBP), mean arterial pressure (MAP), pulse 
pressure (PP), total peripheral resistance (TPR), heart rate variability total power (HRVTOT), blood pressure variability total power (BPVTOT), sequence baroreflex sensitivity 
(BRSSeq) and cross-spectral baroreflex sensitivity (BRSFreq). *P < 0.05, **P < 0.01.
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4-4.5 Analysis of parameters contributing to respiratory sinus arrhythmia 
A three-predictor model that included ∆Q̇, fc and ∆SV provided a significant 
regression equation (F (3, 69) =121.675, P < 0.001), with an R2 = 0.834. 
 
Predicted RSA = 594 + 1.62 (∆Q̇) – 8.976 (fc) – 12.766 (∆SV) 
 
Where ∆Q̇ is measured in L·min-1, fc in beats∙min-1 and ∆SV in mL·beat-1.  
 
Thus, RSA varied by around 1.62 ms for each L∙min-1 of within-breath variation of Q̇ 
(∆Q̇), varied by 8.97 ms for each beat.min-1 if fc and varied by 12.76 ms for each 
mL·beat-1 change in within-breath LVSV (∆SV). All three variables were significantly 
correlated with RSA. 
 
 
4-4.6 Cardiorespiratory time shift and phase angle 
The cross-spectral analysis of the relevant cardiovascular and respiratory signals 
revealed high squared coherence (> 0.5) at the respiratory frequency for all different 
combinations of fR and VT, including for the baseline conditions. Tables 4-12 and 4-
13 show mean values ± SEM of the results of cross-spectral analysis for phase 
angle (in degrees) between the respiratory airflow (RESP) and SBP, DBP and fc. 
Phase angle differences between SBP and DBP and fc are also presented. Figure 
4-4 depicts the time shifts graphically (in seconds) corresponding to the 
abovementioned phase angle differences between signals. 
 
Phase varied significantly between all variables except between SBP and DBP; in 
this case, the angular relation between the SBP and DBP waveforms remained 
relatively stable across different fRs (Table 4-12). Notwithstanding, the increase in 
breath duration resulting from the reduction in fR accounted for noticeable increases 
in time delay at the lower fRs (~2.6 s at 4 breaths·min-1 vs. ~1 s at the remaining 
analysed fRs; Figure 4-4E). 
 
Heart rate, SBP and DBP all lagged behind RESP, with both the phase angle and 
time delay increasing with a decrease in fR, consistent with frequency dependent 
behaviour. On the other hand, fc tended to lag SBP, but both phase angle and the 
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temporal difference between the two variables were shortened by the decrease in 
fR, tending to be completely in phase at 4 breaths∙min-1 (Table 4-12, Figure 4-4D).  
 
Significant main effects of VT upon phase angle were observed for all analysed 
relations, except between SBP and DBP. However, post-hoc statistical tests 
revealed no significant differences in phase angle (P>0.002) between different VTs 
at the same fixed fR for any analysed relationships. Time shift values were largely 
unaffected by the changes in VT. Notwithstanding, the temporal lag between DBP 
and RESP exhibited a significant linear relationship with an increase in VT (R2=0.93, 
P=0.008; Figure 4-4H). 
 
Finally, none of the semi-spontaneous conditions (SSVT and SSfR) differed from the 
previously described frequency and volume-dependent relationships. Phase angle 
and time shift values for SSVT were situated between those observed for 4 and 6 
breaths∙min-1 as illustrated by Figure 4-4 (panels A through E) and Table 4-12.  
Breathing at a fixed fR but without regulating VT or PETCO2 levels (SSfR) resulted in 
no significant differences in either phase angle or time shift when comparing to fully 




Figure 4-4 Time shift responses between respiration (RESP), systolic blood pressure (SBP), 
diastolic blood pressure (DBP) and heart rate (fc) to variations in breathing frequency (A-E) 
and tidal volume (F-J). Values are means ± SEM for fully fixed (○ black), semi-spontaneous (△red) 








Table 4-12 Phase angle responses to SDB at fixed VT (30% FVC). 
For the determination of phase angle, the initiation of the respiratory cycle and fc and/or SBP fluctuations were considered. Values are presented as mean ± SEM.   Signalled 
significant differences are of post-hoc Bonferroni corrected multiple comparisons after the application Watson-Williams F-Test. * different from baseline; † different from semi-
spontaneous; § different from 6 breaths∙min-1; ¥ different from 8 breaths∙min-1; ǂ different from 10 breaths∙min-1. Signalled differences between conditions are significant at 
P < 0.003. 
 
Table 4-13 Phase angle responses to SDB at a fixed individual ideal fR (4 or 6 breaths∙min-1). 
For the determination of phase angle, the initiation of the respiratory cycle and fc and/or ABP fluctuations were considered. Values are presented as mean ± SEM. Signalled 
significant differences are of post-hoc Bonferroni corrected multiple comparisons after the application Watson-Williams F-Test. * different from baseline. Signalled differences 
between conditions are significant at P < 0.002.  
 
Baseline 4 breaths∙min-1 6 breaths∙min-1 8 breaths∙min-1 10 breaths∙min-1 Semi-Spontaneous 
(SSVT) 
RESP – fc 22±6 109±5*†§¥ǂ 70±8*¥ǂ 42±7*† 38±6† 81±9* 
RESP – SBP 111±168 106±6†§¥ǂ 18±7*¥ǂ -45±4*† -81±5*† 47±13 
RESP – DBP -156±38 177±7†§¥ǂ 73±14*¥ǂ 4±12*† -4±13*† 118±16 
SBP – fc -113±163 2±7§¥ǂ 51±6*¥ǂ 87±7*†ǂ 119±7*† 33±8* 
SBP – DBP 117±20 65±8* 57±12* 46±12* 66±14* 65±8 
 Baseline 20%FVC 25%FVC 30%FVC 35%FVC 40%FVC Semi-Spontaneous 
(SSfR) 
RESP – fc 16±7 89±12* 96±14* 98±11* 93±12* 94±13* 79±14* 
RESP – SBP -133±11 34±17* 42±18* 44±20* 31±18* 38±18* 22±19* 
RESP – DBP -42±16 99±21* 104±27* 108±80* 122±37* 138±24* 101±27* 
SBP – fc 141±7 47±9* 47±9* 45±11* 49±13* 40±11* 22±10* 




The objectives of this study were to systematically characterise the cardiovascular 
response to SDB, across a range of fRs and VTs, with particular emphasis on the 
respiratory-synchronous fluctuations in LVSV, Q̇, fc and ABP. Simultaneously, we 
sought to clarify any contribution of haemodynamic mechanisms to the generation 
and frequency modulation of RSA. The data from the current study showed no 
change in MAP, Q̇ and TPR when increasing FVC from 20% to 40% or altering fR 
from 4-10 breaths·min-1. However, significant within-breath responses were 
observed for LVSV (∆SV), Q̇ (∆Q̇) and fc (RSA). The data suggest that across the 
range of fRs and VTs studied, fR exerts a more potent within-breath influence upon 
the cardiovascular system than VT, whilst RSA appears to attenuate respiratory-
related fluctuations, thereby stabilising Q̇ and ∆Q̇. A simple, three component 
mathematical model including ∆Q̇, ∆SV and fc seems able to account for most of 
the variability of the RSA response to SDB. The total variability of the systolic blood 
pressure (BPVTOT) was highest between 8 and 10 breaths·min-1, but fluctuations 
appeared to be dampened at frequencies ≤ 6 breaths·min-1. In contrast, heart rate 
variability (HRVTOT) maximised at the lowest fRs, but surprisingly, HRVTOT and 
BPVTOT were not correlated. Altering VT while breathing at a fixed fR did not seem to 
influence BPV, while HRV changes paralleled those in VT. Furthermore, changing 
fR contributes to important alterations of the phase and time relationships between 
breathing, fc and SBP, whilst altering VT has seemingly no influence. Breathing 
semi-spontaneously at either a controlled low fR or high VT did not result in any 
significant cardiovascular differences, compared to breathing with a fully controlled 
breathing pattern. Overall, while not providing conclusive evidence regarding which 
mechanisms are involved in the regulation of the acute cardiovascular response to 
SDB, data from this study hint at a relevant contribution from the enhancement of 
within-breath fluctuations in fc and LVSV with SDB. They also suggest that the 
cardiac baroreflex is insufficient to explain the pattern of responses observed, and 
that other putative mechanisms are a work during SDB. 
 
4-5.1 Cardiovascular responses to SDB 
Impact upon fc and RSA 
The frequency and respiratory volume dependency of RSA has been thoroughly 
described over the past decades (Angelone and Coulter, 1964, Freyschuss and 
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Melcher, 1976c, Hirsch and Bishop, 1981, Song and Lehrer, 2003) and was 
confirmed by the present study, which showed a twofold increase in RSA from 
baseline when breathing at 6 breaths∙min-1 at a fixed VT of 30% FVC. The RSA 
increased linearly with increments in VT, with maximal values occurring at the 
highest VT (40% FVC); this effect was entirely independent of fR, which was fixed. 
Lower fRs produced no further increases in average RSA values, despite 
approximately half of the participants showing maximal RSA at 4 breaths∙min-1. 
While it is accepted that RSA tends to maximise at frequencies between 6 and 5.5 
breaths∙min-1 (Hirsch and Bishop, 1981, Vaschillo et al., 2002), several reports have 
shown the existence of higher magnitude respiratory-driven fluctuations of fc at even 
lower fRs (Song and Lehrer, 2003). Previous studies have also shown gender and 
height dependency (Lehrer, 2007), suggesting an individualised fR at which RSA 
can be maximised.  
 
In the present study, the changes in RSA, in the presence of a largely constant mean 
fc, except for a small (~3 beats∙min-1), but significant reduction in fc at 6 breaths∙min-
1. Nonetheless, the 2-3 beats∙min-1 average reduction from baseline is unlikely to be 
physiologically relevant. These findings confirm those of others (Hayano, Mukai, 
Sakakibara et al., 1994, Cooke et al., 1998, Pitzalis, Mastropasqua, Massari et al., 
1998, Song and Lehrer, 2003), who found no significant changes in mean fc during 
SDB interventions. The increase in RSA with VT had been demonstrated previously 
and is associated with both an increased fcI and decreased fcE (Freyschuss and 
Melcher, 1976c). Both fcI and fcE responded linearly to the changes in fR and VT; 
increases in fcI followed reductions in fR and/or increases in VT, while fcE exhibited 
the opposite pattern (Figure 4-3[A, D]). However, the variation in fcE was slightly 
more pronounced than that observed for fcI, confirming early observations (Eckberg, 
1983, Song and Lehrer, 2003). These authors hypothesised that sino-atrial node 
activity is inhibited during expiration due to the effects of the bolus of acetylcholine 
(ACh) released throughout expiration (Eckberg, 2003) A longer expiration at lower 
fRs would allow for a larger bolus of ACh to be released therefore contributing to a 
greater decrease in fcE. A longer respiratory interval also allows for a more complete 
hydrolisation of ACh by acetylcholinesterase, thus resulting in a more pronounced 
increase in fcI. Importantly, these respiration-related fluctuations of cholinergic 
inhibition are asymmetrical, such that expiratory inhibition of the sinoatrial node is 
more abrupt than its decay throughout inspiration (Eckberg, 1983, 2003). Potential 
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contributions from haemodynamic respiratory-related changes to RSA are 
discussed below. 
 
Impact upon stroke volume and cardiac output 
The observation of a lower left ventricular expiratory stroke volume (LVSVE) during 
spontaneous breathing contradicts previous reports (Kim, Ishida, Tsuneoka et al., 
1987, Elstad, 2012), and was also present for other fRs above 6 breaths.min-1 (Figure 
4-3B). A novel finding of the present study was the observation that for fRs close to 
(or below) 6 breaths.min-1, LVSVE exceeded LVSVI (Figure 4-3C). These findings 
suggest the existence of a complex, breathing frequency-dependent response. 
Respiratory-induced fluctuations in LVSV are thought to be related to a complex 
interplay of several different mechanisms, which include according to Hamzaoui et 
al. (2013): 1) the passive transmission of the decreased intrathoracic pressure to 
the cardiac structures; 2) the effects of the variations of intra-abdominal pressure 
upon cardiac preload and afterload; 3) the mechanical effects of lung expansion 
upon the surrounding structures; 4) the existence of interventricular dependence 
phenomena; and 5) the existence of a delay between RVSV and LVSV interposed 
by the pulmonary circulation (pulmonary transit time - PulTT). This is the first time 
that such a pattern of LVSV response has been demonstrated during SDB, and we 
believe that it might be underpinned by the capacitance of the pulmonary circulation, 
i.e. to the effect of PulTT. However, the confounding effect of postural and breathing 
pattern dissimilarities (not only with regards to lung excursion but also diaphragmatic 
vs. thoracic breathing) between studies should not be overlooked. 
 
The theory underpinning the influence of transit time upon LVSV has previously 
been proposed (Dornhorst et al., 1952b, Hamzaoui et al., 2013), but to the best of 
the author’s knowledge, never demonstrated experimentally. The PulTT introduces 
a phase lag between RVSV and LVSV, such that during breathing at any given 
frequency, inspiratory-induced increases in venous return (Brecher and Hubay, 
1955) and RVSV are delayed, and not translated immediately to LVSV. Inter-
individual variation in pulmonary transit time ranges from 5 to 10 s (Zavorsky et al., 
2003), and when combined with different fRs, induces different effects upon LVSV. 
The complexity of these interrelationships is further exacerbated by the fact that 
PulTT is influenced by Q̇ (Lund, Flø, Rasmussen et al., 1997, Zavorsky et al., 2003), 
which not only differs between fRs, but also between inspiration and expiration 
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(Tables 4-4 and 4-5; Figure 4-3[C,F]). Lower fRs allow more time for an increased 
RVSV to transit the pulmonary circulation within the same respiratory cycle; thus, as 
illustrated by this chapter’s data, allowing an inspiratory-generated increase in LVSV 
to occur during the immediately ensuing expiration, rather than during the inspiration 
of the subsequent breath. This supposition is supported by the fact that there was 
no statistically significant difference in mean LVSV between fRs, suggesting that the 
mechanism responsible modulates, but does not impair or enhance, mean LVSV 
during SDB. 
 
Recently, it was demonstrated that the amplitude of the respiratory-related, LVSV 
variations is similar to that in the right ventricle (Elstad, 2012).  Assuming the 
respiratory-driven variations in venous return are not buffered by the right side of 
the heart and pulmonary circulation, enhanced venous return during inspiration is 
the most likely cause of the observed increase in LVSVE at 4 and 6 breaths.min-1.  
Increments in VT are known to affect both preload and afterload, mainly by impacting 
right-atrial filling pressure and aortic transmural pressure (Freyschuss and Melcher, 
1976a, Scharf et al., 1979, Karam et al., 1984). This is due to the increase in 
intraabdominal pressure stemming from the descent of the diaphragm during 
inspiration and concurrent decrease in intrathoracic pressure with the increase in 
lung volume, as well as the gradient that is established between the two (Scharf et 
al., 1979, Takata, Wise and Robotham, 1990, Takata and Robotham, 1992, Scharf, 
1995). This gradient can be affected by breathing mechanics, i.e. abdominal vs. 
thoracic breathing (Kimura et al., 2011, Osada, Nagata, Murase et al., 2011). The 
clamping of VT throughout Protocol 1 allows to exclude the potential influence of 
changes in VT at lower fRs upon the frequency dependent pattern of within-breath 
variations in LVSV (Figure 4-3B). However, while we cannot completely discard the 
existence of slight changes in breathing pattern, from abdominal to thoracic 
breathing pattern (or vice-versa) between sets, it is reasonable to assume that 
diaphragmatic excursion and the amplitude of variations of intrathoracic and 
abdominal pressures were significantly altered throughout Protocol 1.  
 
If one accepts the premise that SDB influences venous return to the right atrium 
during inspiration, it would be expected that larger amplitude swings in intrathoracic 
pressure would result in larger LVSV and SBP oscillations (Dornhorst et al., 1952b, 
Freyschuss and Melcher, 1976a). Accordingly, increasing VT might, therefore, be 
predicted to magnify the LVSV-related changes induced by SDB. However, a 
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relatively modest influence of VT upon LVSV was observed, with no significant 
alteration of mean Q̇ (Table 4-5). Mean LVSV, LVSVI and LVSVE exhibited no 
significant response to changes in VT, with the important changes in ΔQ̇ (Figure 4-
3G) being attributable mainly to the fluctuations in fc, particularly during expiration. 
Previous findings that suggest increases in mean Q̇ following an increase of VT at 
fixed breathing rates (Boutellier and Farhi, 1986) were not confirmed in the present 
study. This is most likely explained by the fact that the fRs utilised by Boutellier and 
Farhi ranged between 20 and 40 breaths∙min-1. These data also tend to lend support 
to the aforementioned modulatory role for pulmonary transit time, rather than the 
amplitude of intra-thoracic pressure swing per se, in the intra-breath haemodynamic 
fluctuations that were observed in the present study. Another way in which 
enhanced inspiratory venous return might influence Q̇ is via a cardio-acceleratory 
atrial stretch mechanism, whereby the mechanical distention of the atrial sinus by 
expansion of the right atria with increased venous return produces a chronotropic 
response. This cardio-acceleration has been suggested to have either a reflex origin 
(Bainbridge, 1915, 1920, Pawelczyk and Levine, 1995), or to arise from mechanical 
factors, i.e. a stretch-responsive intracardiac ‘myogenic’ mechanism (Cooper and 
Kohl, 2003, Quinn and Kohl, 2012), and might therefore contribute either to the 
amplification (if LVSVI also increases) or maintenance (if LVSVI decreases) of Q̇I. 
The role of intrathoracic pressure and venous return will be explored in more detail 
in subsequent studies of this thesis. 
 
Impact upon blood pressure and blood pressure variability 
Blood pressure related variables (SBP, DBP, MAP and PP) were higher at fRs 
between 6 and 10 breaths·min-1 when compared to baseline and semi-spontaneous 
breathing (SSVT). This increase in ABP (~11 mmHg for SBP, ~5 mmHg for DBP and 
~7 mmHg for both MAP and PP) is not consistent with previous studies in healthy 
people during SDB, which have reported reduced (Radaelli et al., 2004, Pramanik, 
Sharma, Mishra et al., 2009, Pramanik, Pudasaini and Prajapati, 2010, Mason, 
Vandoni, Debarbieri et al., 2013, Zhang, Wang, Wu et al., 2016) or unchanged ABP 
when breathing at 6 breaths·min-1 (Bernardi et al., 2002, Limberg et al., 2013, 
Paprika, Gingl, Rudas et al., 2014). Similarly, a relatively large number of studies in 
hypertensive individuals have observed significant, acute reductions in ABP during 
SDB (Joseph et al., 2005, Kaushik, Kaushik, Mahajan et al., 2006, Oneda et al., 
2010, Chang et al., 2015). The increases in ABP in the present study at fRs between 
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6 and 10 breaths·min-1 were not present at 4 breaths·min-1, nor during semi-
spontaneous breathing at the same fixed VT. While in the latter the lower PaCO2 
(PETCO2: 6 breaths·min-1 = 41±1 mmHg vs. SSVT = 36±1 mmHg) could support an 
argument for the potential contribution of a chemoreflex driven reduction in ABP, the 
reported values are within the normal physiological range. Furthermore, this is 
backed by the lack of any significant differences between conditions with regards to 
TPR. Instead, the higher ABP during SDB observed in the present study are 
interpreted to be indicative of strong contribution from small changes in Q̇ and ∆Q̇. 
The lowest values for both Q̇ and ∆Q̇ were observed during the baseline, SSVT and 
4 breaths·min-1 conditions, and ∆Q̇ explained 79-90% of the total variation in the 
aforementioned ABP variables; this made ∆Q̇ the variable that best described the 
general behaviour in ABP in response to changes in fR2. Similarly, Q̇ accounted for 
~74% of the variation of SBP, MAP and PP. 
 
Only SBP showed significant differences with baseline values for VTs of 20, 25 and 
30%, where it reached its maximal values (baseline: 127±3 mmHg vs. 30%FVC: 
137±3 mmHg, P < 0.002). All analysed ABP variables exhibited a pattern of initial 
increase between 20 and 30% FVC (with SBP and MAP increasing ~4 mmHg 
between 20 and 30% FVC, while DBP mean values increased by ~3 mmHg) 
followed by a fall at higher percentages of FVC. This pattern was likely associated 
to changes in the LVSV within-breath amplitude as suggested by the strong, 
negative correlations between ∆SV and SBP (r = -0.79, P < 0.05) and MAP (r = -
0.83, P < 0.05). Despite showing no change with the increase in VT, TPR was also 
significantly correlated with MAP (r = 0.83, P < 0.05), which questions its relative 
contribution to the observed ABP behaviour. 
 
As no changes in mean TPR in response to variations in fR or VT were observed in 
the present study, the significant increase in all MAP related variables (SBP, DBP 
and PP) between 6 and 10 breaths∙min-1 likely reflect a slight, non-significant, 
respiratory-induced increase in mean Q̇. Unfortunately, the within-breath responses 
for TPR and SBP were not calculated in the present study, precluding the impact of 
SDB upon afterload to be judged, as well as the influence of the increased 
                                            
2 As TPR was calculated based on MAP and Q̇ values according to the formula TPR ≈ MAP ÷ Q̇ instead of a 
direct output by the finometer I did not want to include it in the discussion of the ABP data, despite an indication 
that TPR could explain ~84% of the total variability found in SBP, MAP and PP (Table 4-10). Such approach is 
supported by a recent study showing that estimations of TPR from MAP and Q̇ underestimates the TPR results 
calculated by the Finometer’s ModelFlow method (Hill et al., 2013). 
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modulation of LVSV upon SBP fluctuations. However, this is addressed in later 
studies within this thesis. 
 
The response of BPV did not show the anticipated fR-dependent pattern of an 
increase in BPVTOT and BPVLF at the lowest fRs (Radaelli et al., 2004, Chang et al., 
2013), due to increased respiratory modulation of SBP (TenVoorde et al., 1995). 
Previously, it has been proposed that the teleological role of RSA is limiting the 
impact of increased BPV by effectively counteracting unwanted excessive BPV with 
HRV (De Boer et al., 1987, Karemaker and Wesseling, 2008). Data from the fixed 
VT protocol supports this concept, with a marked reduction of BPV at the lowest fRs, 
where the recorded HRVTOT was highest. In addition, the fixed fR protocol highlighted 
that at those same low frequencies, BPV is only slightly affected (Table 4-9) by 
changes in VT (slight non-significance trend to increase with the progressively higher 
VTs), while HRVTOT tended to linearly follow the increase in VT. The small number of 
studies exploring the frequency-dependency of BPV have neglected to consider the 
effect of the fR-related changes in VT induced by SDB (TenVoorde et al., 1995, 
Radaelli et al., 2004, Chang et al., 2013), which necessarily raises a question in 
relation to the interpretation of the resulting data.  
 
The HRV and BPV data of the present study is interpreted as a possible indication 
of the effectiveness of the baroreflex control of blood pressure at frequencies around 
0.1Hz. This observation seems to be aligned with the previous reports in sino-atrial 
denervated cats, suggesting that baroreflex regulation of ABP (and BPV) is 
ineffective at high breathing frequencies (Mancia et al., 1999). Studies employing 
mathematical models also suggest that the effectiveness of baroreflex regulation for 
frequencies close to or below 0.1Hz implies that most BPV is controlled and 
minimised (Wesseling and Settels, 1993). At the same time, the moderate 
correlation coefficients between HRVTOT and BPVTOT (r = -0.50 and r = 0.48 between 
HRVTOT and BPVTOT, for Protocols 1 and 2, respectively) argue against the idea of 
a uniquely (or predominantly) baroreflex-determined contribution to the magnitude 
of HRV (and RSA), suggesting that mechanisms such as direct stretch-driven 
stimulation of the sinoatrial node by venous-return may be more important than 
previously thought (Bernardi et al., 1989, Saul et al., 1991).  
 
The present data highlight the complexity of the phenomena being studied. 
Nonetheless a common feature seems to lie within the modulatory effect that 
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breathing exerts upon LVSV, ABP and fc. These appear to be inherently linked to 
the way breathing impacts venous return to the heart, and therefore a more careful 
evaluation of the effects of changing venous return and intrathoracic pressure may 
help to further the understanding of the mechanisms involved in the cardiovascular 
and autonomic response to SDB. Future studies within this thesis will explore these 
themes.  
 
Impact on baroreflex sensitivity 
We analysed cardiac BRS using both the sequence-method and the cross-spectral 
transfer function between SBP and fc (at a frequency corresponding to fR). Protocol 
1 showed that the highest BRS values for both methods (BRSFreq and BRSSeq) were 
encountered at the lowest fRs and in the SSVT condition (Table 4-4). Nonetheless, 
statistical significance was only obtained for a small number of conditions, which 
highlights not only the strictness of the post-hoc analysis criterion (number of 
analysed comparisons) but also the variability within the BRS data. No indication of 
any significant alteration of BRS was found in Protocol 2, suggesting that changing 
VT at a pre-determined fixed fR fails to influence the sensitivity of the cardiac-vagal 
baroreflex (Table 4-5). Furthermore, while the results obtained in Protocol 2 show a 
strong and significant correlation between the BRS estimated using the two methods 
(r = 0.88, P < 0.05; Table 4-10), the data arising from the fixed VT intervention 
(Protocol 1) shows only a moderate association between methods (r = 0.56, Table 
4-11). 
 
We believe these data are indicative of the limitations of these methods of assessing 
spontaneous baroreflex-mediated control of ABP during SDB interventions, and the 
interpretation and use of BRS should be object of carefull consideration. This 
interpretation stems from a number of factors, which include: 
• baroreflex control is not limited to a single cardiac vagal efferent limb but 
relies instead on distinct vagal and sympathetic pathways to the heart, and 
sympathetic pathways to the peripheral vasculature. In fact, several studies 
suggest that the blood pressure buffering capacity of the arterial baroreflex is 
mainly determined by the sympathetic vascular baroreflex (van de Vooren et 
al., 2007, Di Rienzo et al., 2009), while BRS, as traditionally measured, 
translates almost exclusively the vagal efferent gain to the sino-atrial node 
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(Pomeranz, Macaulay, Caudill et al., 1985, Abrahamsson, Ahlund, 
Nordlander et al., 2003, van de Vooren et al., 2007); 
• baroreflex buffering seems only to be effective at frequencies below the ABP 
resonant frequency, i.e. <0.1Hz (Di Rienzo et al., 2009); 
• the presence of a resonant effect on the ABP and fc behaviour at 0.1Hz, 
which might preclude a correct BRS evaluation during SDB; 
• the existence of other sources of variability in RR interval and ABP that are 
unrelated to the cardiac baroreflex pathway, including: 
• feedforward mechanisms by which ABP variations are produced/limited by 
Starling and Windkessel effects driven by fc changes (Porta, Baselli, Rimoldi 
et al., 2000); 
• the presence of reflex driven changes in fc resultant from stimulation of 
pulmonary (McMahon et al., 2000, Moore et al., 2004a, b, 2011) or low-
pressure atrial baroreceptors (Bainbridge, 1915, 1920, Pawelczyk and 
Levine, 1995); 
• the presence of respiratory modulation of the responsiveness of vagal–
cardiac motoneurones influencing fc phasically (Eckberg, 2003). 
 
In summary, the usefulness of both time- and frequency-domain mathematical 
based techniques for the evaluation of spontaneous cardiac baroreflex responses 
to respiratory challenges is, in my view, questionable. Some limitations of these 
techniques have been emphasised previously by others and involve the criteria used 
to determine valid baroreflex sequences, the number of sequences used in the 
calculations, the poor agreement with modified Oxford method (gold standard 
method to access arterial baroreflex function), and the inability to distinguish 
between baroreflex and non-baroreflex respiratory-synchronous fluctuations in fc 
(Di Rienzo, Castiglioni, Mancia et al., 2001, Di Rienzo, Parati, Castiglioni et al., 
2001, Rothlisberger et al., 2003, Laude, Elghozi, Girard et al., 2004, Reyes del 
Paso, Cea, Gonzalez-Pinto et al., 2006, Reyes del Paso, Hernandez and Gonzalez, 
2006, Tzeng et al., 2009, Hart, Joyner, Wallin et al., 2010), particularly at fRs close 
to, or multiples, of 0.1 Hz (Bothova, Honzikova, Fiser et al., 2010). Furthermore, 
ABP buffering and BRS are unrelated unless the contribution of all baroreflex limbs 




4-5.2 Insights from transfer function analysis 
Some valuable insights regarding the interplay between respiratory and 
cardiovascular changes can be garnered from transfer function analysis. In the 
present study, variations in VT resulted in no apparent phase or temporal changes 
between RESP, SBP and fc, except for a non-significant increase of the phase angle 
between RESP and DBP (Figure 4-4H); increases in VT resulted in an average 
difference of 400 (1.2 s) between the lowest and highest analysed VT conditions. 
This might be attributable to an increase in diastolic ‘run-off’ period, following the 
decrease in fc during exhalation, i.e. as fc decreases the length of the diastolic 
relaxation period increases (while left ventricular ejection period remains unaltered) 
leading to a greater delay of DBP change relative to RESP. Simultaneously, the 
greater diastolic ‘run-off’ can promote a DBP decay due to the Windkessel 
properties of the aorta (De Boer, Karemaker and Wieling, 1985, De Boer, 
Karemaker and Strackee, 1985b). In contrast, the influence of changes in fR upon 
phase angle and time delays was more pronounced, with both phase angle and the 
time shift increasing with decreases in fR for RESP-fc, RESP-SBP and RESP-DBP. 
In contrast, a reduction in both phase and time shift was observed for SBP-fc, and 
no significant changes were detected for the SBP-DBP phase relation. 
 
These findings contradict previous studies, using both cross-spectral (De Boer, 
Karemaker, et al., 1985b, De Boer, Karemaker and Van Montfrans, 1986, Pitzalis et 
al., 1998, Sin et al., 2010) and time-domain techniques (Sin et al., 2010), which 
found an increase in both phase and time shift between SBP and the ensuing RR 
interval changes, with the decrease in fR. Notably, seemingly contradictory results 
between different studies regarding the SBP to fc phase relation have been widely 
reported in the literature. In common with the present study, some authors have 
found that SBP changes lead fc fluctuations (De Boer et al., 1986, De Boer et al., 
1987, Pagani et al., 1988, Saul et al., 1991, Pitzalis et al., 1998), while others have 
argued that the RR fluctuations lead, rather than follow, the beat-to-beat SBP 
changes (Weise, London, Guerin et al., 1995, Zhao, Yamamoto, Munakata et al., 
1999).  
 
The reasons for these inconsistencies include (but may not be limited to): 
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• Individual differences in resonant frequency3 in the low-frequency band 
(Vaschillo et al., 2002); 
• Postural differences leading to a baroreflex-driven or sympathetically 
mediated phase shift at the respiratory frequency (Berger, Saul and 
Cohen, 1989b, Berger et al., 1989a, Saul et al., 1989, TenVoorde et al., 
1995, Taylor and Eckberg, 1996, Cooke et al., 1999, Gilad, Swenne, 
Davrath et al., 2005); 
• Differences in breathing patterns, particularly duty cycle (Mason et al., 
2013) et al., 2013), but also PaCO2 levels (Tzeng, Larsen and Galletly, 
2007), and the presence/absence of VT control (Laude, Goldman, 
Escourrou et al., 1993); 
• Differing methods used to calculate phase/time relations and distinct 
methods/strategies to define the peaks and troughs for both ABP and fc 
fluctuations (Bowers and Murray, 2004b). This issue is particularly 
relevant to the present study, as the SBP and DBP signals were inverted 
by 1800 to better reflect the expected physiological response to 
respiratory fluctuations; by doing so, the phase angle values reflect the 
known reduction in ABP that occurs during inhalation. Thus, the transfer 
function analysis quantified the relationship between the onset of 
inhalation (a positive change) and the start of a reduction in ABP (a 
negative change). Importantly, it was confirmed that duty cycle (TI/TTOT) 
was 0.5 and that the SBP and DBP waveforms closely resembled 
sinusoid waveforms. More details regarding this approach can be found 
in General Methods section (Chapter 3). 
 
While it has been suggested that at a particular ‘resonant’ frequency, usually close 
to 0.1 Hz (Vaschillo et al., 2002), the SBP-fc function is ~00 in-phase and RESP-
SBP function is ~1800 out of phase, the present study only observed such 
relationships for SBP-fc at even lower fRs (4 breaths∙min-1). Simultaneously, RESP-
SBP was ~1800 out of phase at 6 breaths∙min-1 (0.1 Hz). The former may reflect 
lower resonant frequencies in our participants. Importantly, the time shift between 
SBP and fc observed at 6 breaths∙min-1 was consistent with the known delays in the 
cardiac baroreflex reflex arc (Baskerville, Eckberg and Thompson, 1979).  
                                            
3 Resonance refers to the physical phenomenon in which an oscillatory system oscillates with increased 
amplitude at a specific natural (resonant) frequency, by action of a small periodic stimulus of similar frequency 
as the resonant frequency of the system. In the particular case of SDB this is accomplished, by breathing at an 




Unlike Vaschillo and colleagues, data from the present study showed phase 
increases in RESP-fc at the lowest fRs, with values of 109±5o at the lowest breathing 
frequencies, compared with 38±6o at the highest (Table 4-12). In situations of strong 
cardio-ventilatory coupling, like the one we expect to encounter at a common 
resonant frequency, the shortest RR intervals tend to occur during late inspiration, 
while maximal RR intervals typically appear just before inspiratory onset (Galletly 
and Larsen, 1998). If this construct is applied to the present findings (with equal 
inspiratory and expiratory durations), the smallest RR interval is expected to occur 
a quarter of a respiratory cycle after the start of inhalation or approximately 90o. This 
pattern, which is consistent with the present data and those of others (Bowers and 
Murray, 2004c), supports the presence of strong cardio-ventilatory coupling at 
frequencies between 4 and 6 breaths∙min-1. 
 
Importantly, the consistent increase in the RESP-SBP phase and time relation with 
the decrease in fR might be interpreted as evidence of the presence of a relatively 
constant lag in the respiratory increase in systemic venous return during SDB, and 
the translation of this lag into variations in SBP. As mentioned earlier, such a lag is 
generated mainly by the long PulTT (5 to 10 sec). At fRs above 6 breaths∙min-1, the 
SBP increases take place mainly during exhalation as can be inferred by the 
negative time lag (SBP precedes RESP). However, at 6 breaths∙min-1 this lag 
becomes positive (SBP lags RESP) and both time and phase shifts continue to 
increase when fR is reduced further to 4 breaths∙min-1. Therefore the zero-crossing 
(x-axis) of the RESP-SBP transfer function (Figure 4-4B) likely reflects the average 
cardiopulmonary transit time and closely matches the likely fR at which LVSVE 
equals LVSVI (Figure 4-3B). 
 
Collectively these findings highlight the presence of nonlinearities that cannot be 
explained simply by the presence of the baroreflex mechanisms. An argument can 
be made regarding the contribution of non-reflex mechanisms, particularly those 
directly related to the respiratory modification of LVSV during SDB, which underpin 
alterations of the relationship between ABP and fc. Overall, the cross-spectral 
transfer function analysis showed a substantial impact of fR upon the phase relations 
between respiration, fc and ABP, possibly reflecting alterations in the relative 
contribution of central, reflex and mechanical factors; in line with the other findings 
from this study. This tends to support a pivotal role for respiratory driven-fluctuations 
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in LVSV in the cardiovascular response to SDB, particularly by affecting the timing 
of the respiratory modulation of ABP. 
 
4-5.3 Impact of stringent control of breathing pattern vs. semi-spontaneous 
breathing 
When SDB is implemented in trials of its anti-hypertensive effects, only fR is 
controlled, leading to the question of whether any effects are due to fR per se, the 
increase in VT per se or the combined influence of both fR and VT. The present study 
sought to evaluate these possibilities in two ways; firstly, by assessing the 
independent effects of fR and VT, and secondly, by including a semi-spontaneous 
condition in which only fR was controlled. For completeness, we also included a 
semi-spontaneous condition in which only VT was controlled. Neither of the semi-
spontaneous conditions resulted in any changes to minute ventilation (V̇E). Thus, 
any differences between the semi-spontaneous and the fully clamped conditions, 
were most likely due to the only other factor that differed, which was PaCO2 (Tables 
4-2 and 4-3).  
 
A small number of studies have compared the effects of different fRs and VTs upon 
RSA (Angelone and Coulter, 1964, Freyschuss and Melcher, 1976a, c, Hirsch and 
Bishop, 1981, Berger et al., 1989a, Cooke et al., 1998), but none has done so in a 
way that has standardised PaCO2, or maintained CO2 at physiological levels. 
Instead, participants typically breathed freely, varying their VT in order to maintain a 
prescribed fR or V̇E (Hayano et al., 1994, Patwardhan, Evans, Bruce et al., 1995, 
Bernardi, Wdowczyk-Szulc, Valenti et al., 2000, Stark, Schienle, Walter et al., 2000, 
Wilhelm, Grossman and Coyle, 2004). Breathing at a fixed fR and VT potentially 
generates a V̇E that falls above or below that required to clear metabolic CO2 
production, eventually leading to either hypocapnia or hypercapnia. The PaCO2 has 
a powerful influence on both the cardiovascular and autonomic systems (Marshall, 
1994, Sasano et al., 2002, Cooper et al., 2005, Simmons et al., 2007, Tzeng et al., 
2007); acute hypercapnia can lead to a sympathetically mediated pressor response 
(Shepard, 1990, Serebrovskaya, 1992), while hypocapnia has the opposite effect 
(Rothe, Flanagan and Maass-Moreno, 1990).  Thus, failure to control this influence 
creates uncertainties in relation to differentiation between frequency- and volume-
driven responses to SDB. Although we clamped PETCO2 at slightly hypercapnic 
levels (circa. 41 mmHg), this exceeded the PETCO2 during spontaneous breathing 
 
129 
by only around 2 mmHg. A significant pressor effect would require PETCO2 levels 
far beyond those encountered in the present study (Serebrovskaya, 1992). 
Accordingly, we are confident that the clamping of PETCO2 did not influence any of 
the findings. 
 
The stringent control of the breathing pattern with ‘clamped’ PETCO2, in both 
protocols, resulted in no discernible differences in RSA compared to semi-
spontaneous breathing at either fixed fR or VT, despite significantly different PETCO2 
levels, but similar V̇E. My results are contrary to those of others (Yasuma and 
Hayano, 2001, Sasano et al., 2002, Tzeng et al., 2007) who found a dose-response 
effect of PaCO2 upon RSA. Such dissimilarities between studies are likely 
attributable to important methodological differences, which include species 
differences, the use of different methods to quantify RSA, the application of fRs that 
are not consistent with SDB, or the establishment of hypercapnia at consistently 
higher PETCO2 values than those in the present study, which leads me to believe 
that in my study the degree of hypercapnia was insufficient to stimulate a 
chemoreflex response. 
 
The increased blood pressure response that was seen in the ‘fully clamped’ 
conditions at fRs ≥ 6 breaths.min-1, during Protocol 1, is consistent with the findings 
of others (Cooper et al., 2005). In contrast, during Protocol 2, there were no 
significant differences between ‘semi-spontaneous’ breathing and any of the ‘fully 
clamped’ breathing patterns for any variables. At the same time, the absence of 
changes, in TPR argues against the potential role of sympathetic involvement in the 
changes in ABP. In our study, MAP was significantly lower for SSVT, compared to 
other tested fRs. Notwithstanding, the MAP was similar during both SSVT and the 
‘fully-clamped’ 4 breaths∙min-1, suggesting that any potential pressor effect was 
unlikely to be related to hypercapnia per se. Inspection of the LVSV and Q̇ 
responses indicate that these exhibit a similar pattern to that of MAP (despite not 
achieving significance) suggesting that any observed differences in MAP are likely 
attributable to the same mechanisms that determine the LVSV response to SDB. 
Overall, the present study did not reveal any advantage of simultaneously clamping 
fR, VT and PaCO2, over controlling just fR or VT. A significant pressor response was 
observed during Protocol 1 in the fully clamped breathing conditions, which was 




4-5.4 Implications for future research on SDB interventions 
The use of RSA as a control variable for numerous SDB interventions, particularly 
those using HRV biofeedback, relies on the amplification of fc fluctuations (Lehrer, 
2013, Lehrer and Gevirtz, 2014). While HRV exhibits a somewhat ‘chaotic’ structure 
involving various superimposed oscillatory rhythms, related nonlinearly to each 
other (Ivanov, Amaral, Goldberger et al., 1999), the exact mechanisms by which 
SDB increases RSA and HRV are not entirely understood. A proposed theory 
involves the confluence of a series of reflex processes, operating as negative 
feedback loops, leading to increased amplitude of fc oscillations (Lehrer, 2013, 
Lehrer and Eddie, 2013). These include, but might not be limited to: 
1) phase relationships between heart rate oscillations and breathing at specific 
frequencies; 
2)  phase relationships between heart rate and blood pressure oscillations at 
specific frequencies; 
3) the activity of the baroreflex; 
4) resonance characteristics of the cardiovascular system (Lehrer and Gevirtz, 
2014).  
 
The present study demonstrated no significant differences for the RESP-fc and 
SBP-fc phase relationships with the changes in fR, thus counteracting points 1 and 
2. Instead, the data suggest that these fc fluctuations are, to some extent, secondary 
to variations in RVSV brought about by increased venous return during SDB. While 
the findings do not eliminate a contribution from the baroreflex modulation of fc and 
the amplification of LVSV and ABP fluctuations by way of resonances in the 
cardiovascular system, they support a contribution from a mechanical stretch of the 
sinoatrial node. The data suggest that the contribution of this mechanism to the 
amplitude of acute respiratory-driven ABP and fc swings during SDB, may be larger 
than previously suggested (Saul et al., 1991). Studies using inspiratory resisted 
breathing have showed increased fc fluctuations (RSA) secondary to mechanically 
driven swings in LVSV and ABP (Freyschuss and Melcher, 1976c, Blaber and 
Hughson, 1996). Breathing against modest inspiratory resistances (< 10 cmH2O) 
results in increased LVSV, Q̇ and SBP, secondary to respiratory-driven increased 
venous return (Convertino, Ratliff, Ryan, Doerr, et al., 2004, Ryan, Cooke, Rickards 
et al., 2008, Convertino, Ryan, Rickards et al., 2011). Therefore, future research on 
the effectiveness of SDB should focus on understanding the effect of interventions 
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that maximise venous return and LVSV, as well as how these factors affect both 
haemodynamic and autonomic responses to SDB. These issues will be explored 
further in subsequent studies of this thesis. 
 
4-6 Methodological considerations  
Several methodological aspects should be taken into account when interpreting the 
results of the present study. Firstly, Protocol 2 was performed at the theoretical 
optimal individual fR for RSA based on the results of Protocol 1. By taking this 
approach, it was recognised that some of the participants would be unable to 
complete Protocol 2 (due to hypercapnia), leading to the exclusion of 3 participants 
for the second part of the study. These participants all exhibited maximal RSA at 4 
breaths∙min-1, which combined with a VT of only 20% FVC resulted in insufficient V̇E 
to prevent progressive hypercapnia. Overall, the reduction of n for Protocol 2 
contributed to a decrease in statistical power, which may have been reflected on the 
borderline non-significant results seen in some of the study’s outcome variables. 
Secondly, by asking participants to breathe at a specific fR (4 or 6 breaths∙min-1) 
throughout Protocol 2, the full expression of volume-dependent cardiovascular 
responses to paced breathing might have been limited. These ‘optimised’ fRs had a 
strong impact on the cardiovascular response, independently of VT during Protocol 
1, which may have attenuated the effects resulting from the manipulation of VT 
during Protocol 2. Thirdly, in the semi-spontaneous breathing conditions, the re-
breathing method for controlling PETCO2 prevented the maintenance of PETCO2 at 
the same levels present in the fully controlled sets. While this might limit the ability 
to interpret differences between the semi-spontaneous conditions and the other 
conditions, it did allow comparison of the effectiveness of a natural semi-
spontaneous breathing versus a more rigorously controlled breathing pattern. 
Fourthly, the use of cross-spectral methods assumes that respiratory and 
cardiovascular fluctuations occur in parallel, and are bounded by fixed phase 
relations (Sin et al., 2010), i.e. that the signals are stable and truly sinusoidal. By 
making some adjustments to the pre-processing of the cardiovascular signals (see 
footnote 2), advancing one of the signals by half a cycle will have changed the 
reference point for calculation of phase differences, which considering the 
underlying waveform deviations from a true sinus shape, might have contributed to 
either increased or decreased error in the phase and time shift estimates. Fifthly, 
the fRs used during the first part of the study were primarily aimed at providing a 
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general overview of the behaviour of the different dependent variables that were 
tested, over a broad range of slow frequencies. Thus, any assumptions on the 
effectiveness of the different frequencies must be seen at the light of this limitation. 
The use of smaller intervals between different fRs (one or half a breath∙min-1) would 
have allowed for further detail, but would have increased the length of the testing 
sessions dramatically, imposing unreasonable demands upon the participants. 
Finally, the existence of a possible ‘hangover’ effect of undertaking a large number 
of SDB interventions in a single session, with only a short break between each 
condition, cannot be ignored. Pilot-testing conducted prior to the trials demonstrated 
that 5 min rest periods appeared to be sufficient to restore mean cardiovascular 
(LVSV, Q̇ and SBP) and respiratory (PETCO2) variables to baseline levels, following 
each 5 min SDB intervention. A recent study has shown that the recovery kinetics 
for HRV following SDB might not follow a similar pattern (Dick, Mims, Hsieh et al., 
2014). Notwithstanding, Dick’s study involved a much longer (20 min) SDB epoch 
than the ones employed in the present study, and the randomisation of the SDB 
conditions certainly limited any potential impact of a systematic ‘hangover’ order 
effect, upon the study’s results. 
 
4-7 Conclusion 
In summary, the independent effects of fR and VT upon the cardiovascular response 
to SDB have been assessed, and the findings confirmed the established frequency 
and volume-dependent response of RSA, which is maximised at breathing 
frequencies between 4 and 6 breaths·min-1. Also, the data support existing evidence 
that RSA contributes to the attenuation of the respiratory modulatory effect of SDB 
upon LVSV and ABP, and that ABP fluctuations are mostly determined by within-
breath variations of LVSV. Furthermore, the data provided new evidence that the 
impact of SDB on the cardiovascular response is mainly determined by the changes 
in fR. At 4 and 6 breaths·min-1, a previously undescribed influence upon LVSV was 
observed, whereby LVSVE exceeded LVSVI, and the fR at which this occurs is likely 
related to the individual length of pulmonary transit time. Finally, while being 
consistent with stimulation and involvement of baroreflex regulation during SDB, the 
presented data hint at a relevant involvement of other sources of heart rate 
variability during SDB, likely arising from respiratory induced modulation of right 
atrial filling.   
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CHAPTER 5 – THE INFLUENCE OF 
INTRATHORACIC PRESSURE UPON 
RESPIRATORY MODULATION OF 






Introduction and objective: Slow and deep breathing (SDB)has substantial effects 
on the cardiovascular and autonomic nervous systems. The use of inspiratory 
resistances has been shown to increase left ventricular stroke volume (LVSV) in 
normo- and hypovolemic individuals. Loading also magnifies the respiratory sinus 
arrhythmia (RSA) during paced, high frequency, breathing. The present study tested 
the hypothesis that magnifying inspiratory pressure (PI) swings via inspiratory 
loading amplifies the cardiovascular response to SDB and that the effect is mediated 
primarily by mechanical mechanisms that modulate systemic venous return.  
Materials and methods: Eleven healthy males (25±4 years; 179±5 cm; 76.5±10.5 
kg) were tested in a seated upright-reclined position. The protocol consisted of eight 
5 min bouts of SDB at a breathing frequency (fR) of 6 breaths·min-1 and tidal volumes 
(VT) of 25% and 40% of forced vital capacity (FVC). The SDB was combined 
systematically with two different inspiratory loads of -9.2±0.8 (IL1) and -22.9±1.1 
(IL2) cmH2O and two different lower body positive pressures of 10 (LBPP1) and 20 
(LBPP2) mmHg. All interventions were randomised and interleaved with 5 min of 
unrestricted, spontaneous breathing. 
Results: The response to SDB was proportional to IL magnitude for respiratory 
sinus arrhythmia (RSA) (40%FVC = 347±33; IL1 = 432±44; IL2 = 459±41 ms, P < 
0.002), cardiac output (Q̇) (6.2±0.3, 6.5±0.3, 6.8±0.4 L·min-1, P < 0.002), within-
breath stroke volume (ΔSV) (2±2, -6±2, -11±2 mL·beat-1, P < 0.002), heart rate 
variability (HRV) (HRVTOT: 16396±2733, 23282±4042, 26621±4138 ms2·Hz-1, P < 
0.002) and blood pressure variability (BPV) (BPVTOT: 149±24, 452±57, 722±117 
mmHg2·Hz-1, P < 0.002). Both within-breath cardiac output (∆Q̇) and ΔSV were 
moderately correlated with RSA (R2 = 0.75 and 0.52, respectively, P < 0.001), while 
time-shifts between instantaneous lung volume, systolic blood pressure and heart 
rate waveforms correlated strongly with RSA, ΔSV, HRV and BPV (P < 0.05). 
Isolated LBPP did not alter left ventricular function as revealed by Doppler 
ultrasound. However, when combined with IL, a significant main effect of LBPP was 
detected for Q̇, with LBPP counteracting the effects of IL upon Q̇ (P < 0.05). 
Conclusion We conclude that the imposition of an IL during to SDB amplifies the 
effects of SDB alone. The data support the notion that respiratory-related 
intrathoracic pressure swings are the predominant breathing-related stimulus 
underlying the acute cardiovascular response to SDB. While the exact contribution 
of baroreflex mediated mechanisms to the amplification of RSA, HRV and BPV by 
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IL is unclear. The data suggest that amplification of these variables necessarily 





Study 1 (Chapter 4) identified an important acute impact of specific fRs upon within-
breath fluctuations of LVSV and Q̇. Other variables, commonly associated with 
heightened parasympathetic activity (Berntson, Bigger, Eckberg et al., 1997), such 
as RSA, were also greatly affected by fR. These results hinted that acute and chronic 
responses to SDB might be mediated via stimulation of cardiac, aortic and/or carotid 
baroreceptors. Such stimulation is most likely underpinned by respiratory-driven 
fluctuations in venous return, maximising at fRs around 6 breaths.min-1. 
 
Breathing against an inspiratory load (IL) exaggerates cardiovascular responses to 
spontaneous breathing (Dornhorst et al., 1952b, Kilburn and Sieker, 1960, Wise, 
Robotham and Summer, 1981, Coast, Jensen, Cassidy et al., 1988, Convertino, 
Ratliff, Ryan, Doerr, et al., 2004), and potentially also that to SDB. The underlying 
stimulus from IL is most likely a more negative pleural pressure during inspiration, 
which increases transmural pressure across the heart chambers and intrathoracic 
vessels, impacting both preload and afterload (Alian and Shelley, 2012). Recently, 
a study with healthy people reported increases in LVSV, Q̇ and MAP during SDB 
(Lucas et al., 2013). This pattern is similar to that observed with small inspiratory 
loads (Convertino, Ratliff, Ryan, Cooke, et al., 2004, Convertino, Ratliff, Ryan, 
Doerr, et al., 2004), suggesting the involvement of similar underlying mechanisms. 
Data from this thesis (Chapter 4) also indicates that SDB modulates the within 
breath oscillations in LVSV and Q̇.  The use of respiratory loading under constant fR 
and VT conditions has also been used previously to test the link between 
mechanically coupled variations in LVSV and the activation of baroreflex mediated 
fc responses (Blaber and Hughson, 1996). This study revealed no differences in 
SBP and LVSV, while RSA and the transfer function magnitude between SBP and 
RR interval both increased, with the increasing respiratory (inspiratory and 
expiratory) load magnitude, supporting the hypothesis that mechanisms other than 
the arterial baroreflex are involved in the RSA response to SDB with respiratory 
loads. However, it is unclear if the same response occurs when only the inspiratory 
phase of breathing is loaded.  
 
Importantly, the application of IL is believed to contribute to a marked reduction in 
right atrial pressure, which in turn contributes to augmentation of the pressure 
gradient for central venous return, driving an increased quantity of blood to the right 
atrium during inspiration (Robotham et al., 1978, Convertino, Cooke and Lurie, 
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2005). Increases in venous return can also be accomplished by altering body 
position or by compression of the extremities by a positive pressure. The 
compression at the lower limbs with lower body positive pressure (LBPP) produces 
a displacement of blood into the abdominal and thoracic compartments, effectively 
increasing central blood volume; increasing central venous return has been shown 
to promote rises in LVSV and ABP (Shi, Crandall and Raven, 1993). We reasoned 
that if inspiratory ‘suction’ during inhalation increased venous return and LVSV, that 
effect could be attenuated by squeezing blood from the lower legs into the 
abdominal compartment. Such a shift would make it easier for breathing to enhance 
venous return, thereby lessening the benefit of magnifying the ‘suction’ effect using 
an IL. 
 
For this study it was hypothesised that 1) the addition of an IL would magnify the 
cardiovascular and autonomic responses induced by SDB at similar fR and VT; 2) 
this response would be closely coupled to heightened within-breath fluctuations in 
intrathoracic pressure, and 3) the addition of LBPP would attenuate the combined 
effects of SDB and IL.  
 
 
5-3 Specific Methods 
5-3.1 Participants  
Eleven healthy, recreationally-active men participated (mean ± SD; age 25±4 years; 
179±5 cm; 76.5±10.5 kg). All participants were nonsmokers with no previous history 
of cardiovascular or respiratory disease and reported not taking any medication. 
  
5-3.2 Ethical approval  
Fully informed, written consent was obtained from the participants prior to the study. 
All procedures were approved by the Brunel University Research Ethics Committee 
(RE17-14) and conformed to the guidelines of the Declaration of Helsinki (World 
Medical Association, 2013). 
 
5-3.3 Protocol 
Participants visited the laboratory on two different occasions. On the first session, 
the participants were introduced to the experimental set-up and familiarised with the 
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methodology. A baseline pulmonary function assessment was performed with those 
participants showing signs of asthma or other lung disease being excluded from the 
study. Additionally, a familiarisation trial using a bespoke device guided breathing 
biofeedback system was performed (Labview, National Instruments Inc.) (please 
refer to the General Methods section – Chapter 3 - for a detailed description of the 
pulmonary function assessment and familiarisation session protocols). Finally, 
participants also underwent an ultrasonography cardiac function analysis to 
evaluate their individualised response to graded LBPP (at compression levels 
corresponding to 0, 10, 20 and 30 mmHg; see General Methods – Chapter 3 - for 
details of LBPP). Cardiac ultrasound measurements (echocardiography) were 
performed by a trained researcher to estimate the change in left ventricular blood 
volume at different levels of LBPP. Procedures followed the recommendations of 
the American Society of Echocardiography (Lang et al., 2005). Participants were 
tested in an upright-reclined position at an angle similar to that used during the 
second visit. Four consecutive beats were taken in both the apical two and four-
chamber views and used to estimate end-diastolic and end-systolic left ventricular 
volumes, as well as LVSV and Q̇ through the Simpson-biplane method (Lang et al., 
2005). 
 
During the second visit, participants undertook device guided SDB. The trial session 
began with 5 min of quiet baseline spontaneous breathing, followed by eight 5 min 
sets of device guided SDB. All interventions were performed at an fR of 6 
breaths∙min-1. Two sets included SDB at a constant VT corresponding to 25% and 
40% of each participants’ FVC, respectively. The remaining conditions were all 
performed at a fixed VT of 40% FVC and included a combination of SDB against two 
different inspiratory resistances (IL) and with two different levels of LBPP. Five 
minute rest periods separated each condition (Figure 5-1). The 6 breaths∙min-1 at 
25% FVC condition was always performed first as this condition delivered the 
smallest VE and consequently highest PETCO2 levels. All remaining conditions were 
conducted in a fully randomised order (a detailed description of the randomisation 




Figure 5-1 - Sequence of the experimental protocol. Participants were exposed to 5 min of 
spontaneous baseline (B) breathing followed by device guided slow and deep breathing at 6 
breaths·min-1 and 25% FVC (dotted light grey bar). Subsequent, randomly assigned, device guided 
slow and deep breathing sets included unloaded slow and deep breathing (light grey), inspiratory 
loaded slow and deep breathing (dark grey) and combined inspiratory loaded slow and deep 
breathing conditions with lower body positive pressure (dark). Interventions lasted for 5 min and were 
interleaved by 5 min of spontaneous, unrestricted breathing (R).  
 
5-3.4 Procedures and instrumentation of participants 
Participants were asked to refrain from alcohol, caffeine and strenuous physical 
activity for at least 12 h before testing and to avoid consuming food during the 2 h 
leading up to testing. All sessions were conducted at the same time of the day, 
generally in consecutive days, but no more than one week apart. Throughout the 
entirety of the trials, participants assumed an upright-reclined position by sitting on 
a reclining lounge chair, set at an approximate 60o angle, and breathed through a 
mask that allowed for normal mouth and/or nasal breathing (Intersurgical Quadralite 
Mask; Intersurgical Ltd., Wokingham Berkshire, UK). Room temperature remained 
at a comfortable 22-25oC and barometric pressure was recorded for each of the trial 
sessions. 
 
Specified respiratory flow rates and a respiratory duty cycle of 0.5 (inspiratory time 
= expiratory time) were delivered using the bespoke guided breathing biofeedback 
system described in the General Methods section (Labview, National Instruments 
Inc.) and measured using a heated pneumotachograph (Hans Rudolph 3700, Hans 
Rudolph Inc.). PETCO2 was maintained at a slightly hypercapnic level (GA-200 gas 
analyser, iWorx Systems Inc.) under all conditions via a re-breathing system 
consisting of added dead spaces. A summary of the experimental respiratory 
parameters can be found in the Results section of this chapter (Table 5-2). 
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The inspiratory loads were imposed by a bespoke breathing circuit containing a flow 
resistor that comprised a number of nylon washers that reduced the internal 
diameter of the airway, thus creating resistance to flow and generating a precisely 
calibrated inspiratory load. As flow was kept constant throughout each step, via the 
aforementioned DGB system, the addition and removal of washers allowed the 
length of the breathing resistor to be adjusted, thereby altering resistance to flow 
according to the Hagen–Poiseuille equation. The y-shape and separate inspiratory 
and expiratory valves ensured that the load only acted upon the inspiratory portion 
of the respiratory cycle, whilst the joining of the inspiratory and expiratory limbs 
allowed for the aforementioned rebreathing of exhaled air to maintain isocapnia. A 
detailed description of this flow resistive breathing circuit can be encountered in 
Chapter 3 – General Methods (section 3-3.4). 
 
The increase in central blood volume was attempted through application of LBPP 
(Figure 5-2), delivered by an anti-G suit (Royal Air Force MK2A Anti-G trousers) 
inflated at two different pressures of 10 and 20 mmHg and permanently controlled 
through a pressure meter (Comark C9553, Comark Instruments, Norwich, Norfolk, 
UK).  
 
Figure 5-2 - Experimental set-up showing participant sitting in a semi-reclined chair while breathing 
against an inspiratory resistance and legs being compressed with anti-G trousers. The abdominal 




Non-invasive beat-to-beat arterial blood pressure was obtained using finger 
photoplethysmography (Finometer® PRO, Finapres Medical Systems, Amsterdam, 
The Netherlands), whilst heart rate was monitored using a 3-lead ECG 
(PysioControl VSM® 3, PhysioControl Inc.). Total peripheral resistance (TPR) was 
calculated by dividing Q̇ by the mean arterial pressure (MAP). Baroreflex sensitivity 
(BRS) was calculated by the sequence method (Bertinieri et al., 1985, Bertinieri, Di 
Rienzo, Cavallazzi et al., 1988, Parati et al., 1988) as well as from the cross-spectral 
transfer function gain (Robbe et al., 1987). Phase angles and coherence between 
respiration and cardiovascular (heart rate, SBP and DBP) waveforms were obtained 
from the cross-spectra transfer function at the peak respiratory frequency. Average 
phase angles were calculated as the un-weighted circular mean (?̅?) for phase angles 
for all relationships of interest (Mardia and Jupp (2009). A more detailed description 
of the BRS and cross-spectral calculations can be encountered in Chapter 3 (section 
3-3).  
 
5-3.5 Statistical analysis 
Data were analysed using IBM® SPSS version 21.0 statistical software (IBM Corp.). 
Values are expressed as means ± SEM unless otherwise stated. Repeated 
measures ANOVA with post hoc pairwise comparisons using Bonferroni correction 
were used initially to test differences between conditions after normality was 
confirmed via the Shapiro-Wilk test. Two-way repeated measures ANOVA with 
similar post-hoc testing was conducted to test the independent effect of IL and 
LBPP,on selected variables. Circular (cross-spectral) data were analysed using 
multi-sample Watson-Williams F-test following confirmation of the existence of a 
Von Mises circular distribution (Fisher, 1995, Mardia and Jupp, 2009). Bonferroni 
corrections were applied for post-hoc paired sample comparisons. 
 
Despite some violations of requirements for the multisample ANOVA and Watson-
Williams F-test, involving deviations from the required distributions that could not be 
corrected using data transformation, a decision was made to use the parametric 
options rather than the nonparametric alternatives. The use of continuous data, the 
robustness of the repeated measures ANOVA against moderate deviations in 
normality (Glass, Peckham and Sanders, 1972), and the similarity of  results 
encountered when analysed the data using the nonparametric alternatives 
(Friedman and Mardia-Watson-Wheeler tests), provide assurance that the findings 
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drawn from the data were not affected by false positives deriving from the author’s 
approach. Finally, for the analysis of the relationship between cardiovascular, HRV 
and BPV indices, multiple regression for within-subject repeated measures was 
applied (Bland and Altman, 1995), while simple, linear regression analysis was used 
to evaluate the relationship between cross-spectral time-shift and the 





5-4.1 Cardiac function response to lower body positive pressure  
The ultrasonographic analysis of the impact of progressive increases in LBPP upon 
left ventricular cardiac function revealed no changes in average steady-state values 
for end diastolic (EDV), end systolic (ESV) volumes, LVSV, fc, Q̇ or MAP (Table 5-
1). 
 
Table 5-1 – Left ventricular function in response to progressive LBPP 
Data represent mean ± SEM for 11 subjects. End diastolic volume (EDV) in mL, end systolic volume 
(ESV) in mL, left ventricular stroke volume (LVSV) in mL, heart rate (fc) in beats∙min-1, cardiac output 
(Q̇) in L∙min-1 and mean arterial pressure (MAP) in mmHg. All variables were acquired by Doppler 




5-4.2 Respiratory changes with each condition 
A summary of the respiratory data each experimental condition can be found in 
Table 2. As intended, duty cycle (~0.5), PETCO2 (41-43 mmHg) and fR (~6 
breaths·min-1) remained constant throughout all interventions (Table 2). Mean PI 
was ~10 cmH2O for the IL1 conditions, while for the IL2 it was set at ~23 cmH2O 
(Table 2). The VT in the IL2 conditions was slightly, but non-significantly, higher than 














EDV (mL) 137±3 136±3 137±4 137±3 
ESV (mL) 40±3 38±2 38±3 38±3 
LVSV (mL) 97±2 99±1 98±1 99±2 
fc (beats∙min-1) 58±2 57±2 56±2 57±2 
Q̇ (L∙min-1) 5.6±0.2 5.6±0.2 5.6±0.2 5.6±0.2 







Table 5-2 - Experimental respiratory parameters. 
Data represent mean ± SEM for 11 subjects. Breathing frequency (fR) in breaths·min-1, tidal volume (VT) in % of forced vital capacity, duty cycle (Ti/TTOT), partial pressure of 












 Baseline 25%FVC 40%FVC IL 1 IL1/LBPP1 IL1/LBPP2 IL 2 IL2/LBPP1 IL2/LBPP2 
fR (breaths∙min-1) 13.4±1.1 6.3±0.1* 6.1±0.1* 6.1±0.1* 6.0±0.1* 6.0±0.1* 6.1±0.1* 6.0±0.1* 6.1±0.1* 
VT (L∙breath-1) 0.64±0.05 1.49±0.11* 2.30±0.12*† 2.39±0.12*† 2.34±0.13*† 2.32±0.12*† 2.48±0.14*† 2.49±0.12*† 2.45±0.12*† 
TI/TToT 0.55±0.02 0.50±0.02 0.51±0.01 0.49±0.01 0.49±0.02 0.50±0.01 0.48±0.01 0.48±0.02 0.48±0.02 
PETCO2 (mmHg) 40.9±2.8 41.9±1.4 41.3±1.4 41.0±1.4 42.1±1.4 42.5±1.5 42.1±1.3 42.9±1.1 42.7±1.6 
PI (cmH2O) -0.5±0.1 -0.5±0.1 -0.5±0.1 -9.2±0.8* -10.0±1.5* -10.0±1.4* -22.9±1.1*ǂ -23.8±1.0*ǂ -23.7±0.8*ǂ 
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5-4.3 Cardiovascular response to slow and deep breathing, inspiratory 
loading and lower body positive pressure 
The use of inspiratory loads (IL1 and IL2) resulted in significant increases in RSA 
when compared to unloaded SDB at the same VT. This was accompanied by 
unaltered fc and fcE. The fcI followed a pattern similar to RSA, with the effect being 
more noticeable during IL2 and IL2/LBPP1. The use of IL2 also increased LVSVE, 
ΔSV, Q̇, Q̇I and ΔQ̇ significantly, particularly when compared to baseline and the 
unloaded SDB conditions (Table 5-3). 
 
When compared to unloaded breathing at 40% FVC a significant main effect of 
inspiratory loading was detected for LVSVE, ΔSV, Q̇, Q̇I and Q̇E, while a significant 
main effect of LBPP was only present for Q̇ (Figure 5-3, P < 0.05). 
 
The MAP, SBP, PP and TPR responses to both unloaded and inspiratory loaded 
breathing did not reach statistical significance, while DBP exhibited significantly 
higher values in the IL1/LBPP2 condition when compared to baseline (Table 5-3). 
 
The response of the different BRS indices revealed that both the sequence method 
and BRSFreq were largely unaffected by the interventions; however, BRSup was 












Table 5-3 – Systemic haemodynamic responses to slow and deep breathing with different grades of inspiratory loading and lower body positive 
pressure.  
Data represent mean ± SEM for 11 subjects. Respiratory sinus arrhythmia (RSA), heart rate (fC), heart rate during inspiration (fcI), heart rate during expiration (fcE), left 
ventricle stroke volume (LVSV), stroke volume during inspiration (LVSVI), stroke volume during expiration (LVSVE), within-breath variation in stroke volume (ΔSV), cardiac 
output (Q̇), cardiac output during inspiration (Q̇I), cardiac output during expiration (Q̇E), within-breath variation in cardiac output (ΔQ̇), systolic blood pressure (SBP), diastolic 
blood pressure (DBP), mean arterial pressure (MAP), pulse pressure (PP), total peripheral resistance (TPR), sequence baroreflex sensitivity positive sequence gain (BRSup), 
sequence baroreflex sensitivity negative sequence gain (BRSdown), sequence baroreflex sensitivity average gain (BRSSeq); cross-spectral baroreflex sensitivity gain (BRSFreq).* 
different from baseline, † different from 25%FVC, ǂ different from 40%FVC, ¥ different from IL1/LBPP2. P < 0.002. 
 
 Baseline 25%FVC 40%FVC IL 1 IL1/LBPP1 IL1/LBPP2 IL 2 IL2/LBPP1 IL2/LBPP2 
RSA (ms) 170±21 268±25* 347±33* 432±44* 432±44*† 424±44* 459±41*† 479±36*†ǂ 426±36*† 
fC (beats∙min-1) 61±2 62±2 61±2 61±2 60±2 60±2 62±1 61±2 63±1 
fcI (beats∙min-1) 64±2 69±3 71±3 74±3 77±5 72±3 80±4 90±11 79±3*¥ 
fcE (beats∙min-1) 56±2 53±2 50±2 50±2 49±2 49±2 50±2 49±2 50±2 
LVSV (mL∙beat-1) 100±5 102±7 103±5 108±7 105±6 105±6 111±6 106±6 103±6 
LVSVI (mL∙beat-1) 100±5 103±6 102±6 105±7 101±5 101±6 104±5 100±5 97±5 
LVSVE (mL∙beat-1) 98±4 102±6 99±6 110±7 107±6 107±6 115±7*ǂ 113±7 110±7 
ΔSV (mL∙beat-1) 2±2 1±2 2±2 -6±2†ǂ -7±2† -6±2† -11±2†ǂ -13±3*†ǂ -12±3*†ǂ 
Q̇ (L∙min-1) 6.1±0.3 6.2±0.4 6.2±0.3 6.5±0.3 6.2±0.4 6.2±0.3 6.8±0.4*ǂ 6.5±0.4 6.4±0.4 
Q̇I (L∙min-1) 6.4±0.4 7.1±0.5 7.2±0.4 7.7±0.5 7.6±0.5 7.3±0.5 8.3±0.5 8.8±0.9 7.7±0.5 
Q̇E (L∙min-1) 5.4±0.3 5.4±0.3 5.0±0.3 5.4±0.3 5.2±0.4 5.2±0.3 5.7±0.3 5.5±0.3 5.5±0.3 
ΔQ̇ (L∙min-1) 0.9±0.3 1.7±0.2 2.3±0.2* 2.3±0.4 2.4±0.4 2.1±0.3 2.6±0.4 3.3±0.8 2.3±0.2* 
SBP (mmHg) 123±3 123±5 124±4 130±4 136±4 136±4 131±4 131±3 129±3 
DBP (mmHg) 72±2 72±2 74±1 77±2 79±2 79±2* 76±2 76±2 76±2 
MAP (mmHg) 89±2 89±3 91±2 94±2 98±3 98±2 94±2 95±2 94±2 
PP (mmHg) 51±2 51±3 50±3 54±3 57±3 57±3 56±3 55±3 53±3 
TPR (mmHg∙min∙L-1) 15±1 15±1 15±1 16±1 17±1 17±1 15±1 16±1 16±1 
BRSup (ms∙mmHg-1) 19±4 30±6 41±6* 40±10 33±5 33±7 26±4 28±5 25±3 
BRSdown (ms∙mmHg-1) 22±6 17±2 20±3 18±3 18±3 21±5 18±3 12±1 16±2 
BRSSeq(ms∙mmHg-1) 20±4 23±4 30±4 29±6 26±4 27±6 22±3 20±3 20±2 








Figure 5-3 – Difference relative to slow and deep breathing at 6 breaths·min-1 and 40% of forced vital capacity. Data are mean ± SEM for 11 participants. Differences 
for baseline (white), unloaded breathing at 25% of forced vital capacity (light blue), combined slow and deep breathing with inspiratory resistances (grey) and combined 
inspiratory resisted slow and deep breathing with lower body positive pressure (black) are presented. Two-way repeated measures ANOVA was conducted to test the 
existence of *Significant main effect for inspiratory loading, † significant main effect for lower body positive pressure. Significant main effects for the interaction between 




5-4.4 Relationship between cardiac haemodynamics and respiratory sinus 
arrhythmia 
The RSA displayed a moderate linear correlation with both LVSVE and ∆SV (R2 = 
0.19 and 0.27, respectively; P < 0.001). Stronger correlations with RSA were 
observed for Q̇I (R2 = 0.41; P < 0.001) and ∆Q̇ (R2 = 0.56; P < 0.001), while 
significant correlations were absent for LVSV, LVSVI, Q̇ and Q̇E (Figure 5-4). 
 
 
Figure 5-4 – Relationship between stroke volume (left panel), cardiac output (right panel) and 
respiratory sinus arrhythmia. Data are mean ± SEM for 11 participants. Corresponding R2 values 
are calculated using previously described multiple regression analysis. 
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Strongest influences upon respiratory sinus arrhythmia to slow and deep 
breathing inspiratory loading and lower body positive pressure  
An estimation of RSA using the previously applied three predictor model rendered 
similar results to the ones described in Chapter 4. When applying said three 
predictor model including ∆SV, fc and ∆Q̇, a significant regression equation (F (3, 
95) =55.188, P < 0.001) with an R2 = 0.635, was obtained.  
 
Predicted RSA = 241 – 12 (∆SV) – 7 (fc) + 52 (∆Q̇), where ∆SV is measured in 
mL·beat-1, fc in beats∙min-1 and ∆Q̇ in L·min-1.  
 
Participants’ RSA decreased 12 ms by each mL·beat-1 increase in within-breath 
variation in LVSV, reduced 7 ms by each beat∙min-1 and increased 52 ms by each 
L.min-1 of within-breath variation of Q̇ (∆Q̇). All three variables were significantly 
correlated with RSA. 
 
5-4.5 Heart rate and blood pressure variabilities 
All the analysed HRV and BPV indices exhibited statistically significant differences 
between some of the conditions, except in the case of the HRVHF (Figure 5-5, Table 
5-4). The HRVLF and HRVTOT indices exhibited significantly smaller values at 
baseline when compared to all SDB conditions (Figure 5-5, Table 5-4). These 
differences are especially evident in all loaded conditions, with the highest absolute 
values for both HRVLF and HRVTOT occurring with IL2, which also exhibited 
statistically higher values than those observed during the unloaded SDB conditions 
(Figure 5-5, Table 5-4). Similar trends to those found for HRVLF and HRVTOT were 
also present in the time domain variables SDNN and RMSSD and both Poincaré 
plot indices (SD1 and SD2; Table 5-4).  
 
The pattern across condition observed for most BPV variables was similar to that 
observed for HRV spectral indices, with the highest values for BPVLF, BPVHF and 
BPVTOT being observed in the IL2 sets (Figure 5-5, Table 5-4). The highest values 
for these three variables were recorded when IL2 was combined with a small 
compression at the legs (IL2/LBPP1). In this particular condition, the values were 
statistically higher than those of all of the unloaded breathing and IL1 breathing 




Importantly, BPVTOT correlated significantly with ΔSV (Figure 5-6, R2 = 0.98, P < 




Figure 5-5 – Heart rate and blood pressure variabilities total power responses to combined 
slow and deep breathing, inspiratory loading and lower body positive pressure. Data are mean 
± SEM for 11 participants. * Significantly different from baseline. † Significantly different from 
breathing at 25%FVC. ¥ Significantly different from breathing at 40%FVC, # Significantly different 





Figure 5-6 – Relationship between the within-breath variation in stroke volume and blood 
pressure variability total power. Data are mean ± SEM for 11 participants. Corresponding R2 







Table 5-4 – Heart rate and blood pressure variabilities response to slow and deep breathing with different grades of inspiratory loading and lower 
body positive pressure. 
Data represent mean ± SEM for 11 subjects. * different from baseline, † different from 25%FVC, ǂ different from 40%FVC, ¥ different from IL1, ŧ different from IL1/LBPP1, # 
different from IL1/LBPP2, P < 0.002. Note: cf. Figure 5-5 for total variability power data. 
 
 Baseline 25%FVC 40%FVC IL 1 IL1/LBPP1 IL1/LBPP2 IL 2 IL2/LBPP1 IL2/LBPP2 
SDNN (ms) 79±9 103±8* 131±11*† 157±14*† 158±13*† 158±15*† 167±14*†ǂ 167±9*†ǂ 161±12*† 
RMSSD (ms) 62±8 73±8 103±13 121±16 129±16 130±17 132±15*† 139±12*† 129±14*† 
HRVLF (ms2) 2849±1047 7863±1182* 13845±2143* 20080±3423* 20370±2999*† 19927±2927*† 22216±3218*†ǂ 20876±2278*† 20234±2910* 
HRVHF (ms2) 1572±318 1402±532 2551±750 3202±832 3754±1131 4213±1250 4405±1059 4702±1007 4050±847 
SD1 (ms) 44±6 51±6 73±9 86±11 91±12 92±12 93±11*† 99±9*† 91±10*† 
SD2 (ms) 101±12 136±10 169±14* 203±18*† 203±16*† 204±18*† 216±17*†ǂ 213±11*†ǂ 208±15*† 
SD1/SD2 0.45±0.06 0.37±0.02 0.42±0.03 0.41±0.03 0.43±0.03 0.44±0.03 0.42±0.02 0.46±0.03 0.43±0.02 
BPVLF (mmHg2) 84±33 117±17 131±23 342±43†ǂ 354±56†ǂ 390±61†ǂ 472±70*†ǂ¥ŧ 485±53*†ǂ¥ŧ 446±70*†ǂ 
BPVHF (mmHg2) 102±37 13±4 18±5 110±24†ǂ 136±23†ǂ 136±24†ǂ 250±59*†ǂ¥ŧ 338±54*†ǂ¥ ŧ# 299±65†ǂ 
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5-4.6 Cross-spectral phase angle and time shift  
There were significant differences in phase angle and time shift for all of the test 
conditions when compared to baseline for the RESP-fc, RESP-SBP and SBP-fc 
relations (Tables 5-5 and 5-6). At baseline, the decrease in SBP seemed to precede 
the inspiratory onset (cf. General Methods – Chapter 3; and Chapter 4; for a detailed 
explanation), while the opposite was observed during SDB (both loaded and 
unloaded). No significant differences between conditions were found for the RESP-
DBP and SBP-DBP relations, despite the existence of the main effect of SDB for 







Table 5-5 – Phase angle response to slow and deep breathing with different grades of inspiratory loading and lower body positive pressure for 
respiration, heart rate and blood pressure.  




Table 5-6 –Time shift responses to slow and deep breathing with different grades of inspiratory loading and lower body positive pressure for 
respiration, heart rate and blood pressure. 
Data represent mean ± SEM for 11 subjects.  
 
Relation Baseline 25%FVC 40%FVC IL 1 IL1/LBPP1 IL1/LBPP2 IL 2 IL2/LBPP1 IL2/LBPP2 
RESP – fc (deg) 20±9 74±7* 74±9* 93±6* 93±4* 91±7* 100±5* 102±7* 104±6* 
RESP – SBP (deg) -64±14 48±11* 51±9* 62±8* 64±5* 62±5* 65±9* 70±5* 67±6* 
RESP – DBP (deg) 69±20 101±15 116±20 104±16 127±14 129±14 113±13 123±10 117±11 
SBP – fc (deg) 82±8 24±8* 22±11* 30±7* 29±7* 29±7* 35±6* 32±6* 37±7* 
SBP – DBP (deg) 116±22 53±13 63±18 43±12 62±14 65±15 49±10 54±6 43±7 
Relation Baseline 25%FVC 40%FVC IL 1 IL1/LBPP1 IL1/LBPP2 IL 2 IL2/LBPP1 IL2/LBPP2 
RESP – fc (s) 0.27±0.12 2.05±0.21 2.05±0.25 2.58±0.18 2.59±0.11 2.52±0.19 2.79±0.15 2.85±0.19 2.90±0.16 
RESP – SBP (s) -0.87±0.19 1.35±0.30 1.43±0.26 1.72±0.21 1.77±0.13 1.71±0.14 1.81±0.24 1.94±0.15 1.86±0.18 
RESP – DBP (s) 0.94±0.26 2.82±0.43 3.22±0.55 2.90±0.44 3.54±0.38 3.59±0.39 3.13±0.36 3.42±0.27 3.26±0.31 
SBP – fc (s) 1.11±0.11 0.66±0.22 0.62±0.31 0.84±0.21 0.80±0.21 0.79±0.21 0.98±0.17 0.89±0.16 1.04±0.19 
SBP – DBP (s) 1.57±0.30 1.48±0.37 1.76±0.51 1.18±0.32 1.73±0.38 1.80±0.42 1.35±0.28 1.49±0.17 1.20±0.19 
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5-4.7 Relationship between cardiovascular, heart rate variability, blood 
pressure variability and cross-spectral time shift indices. 
The strongest linear correlations with the different time shift indices were observed 
for ∆SV (RESP-fc: R2 =0.98; RESP-SBP: R2 =0.93; SBP-fc: R2 =0.87; P < 0.001; 
Figure 5-7) and BPVTOT (RESP-fc: R2 =0.96; RESP-SBP: R2 =0.94; SBP-fc: R2 
=0.83; P < 0.001; Figure 5-8). In contrast, ΔQ̇ only exhibited a moderate relationship 
with RESP-SBP (R2 =0.57; P < 0.05) while no association was found with RESP-fc 
and SBP-fc (P > 0.05; Figure 5-7). 
 
The RSA and HRVTOT displayed moderate to high correlations with RESP-fc, RESP-
SBP and SBP-fc (RSA: R2 = 0.79, 0.91 and 0.54 respectively, P < 0.05; HRVTOT: R2 








Figure 5-7 – Relationship between cardiovascular and cross-spectral time shift indices. Data are mean ± SEM for 11 participants. Corresponding R2 values are 








Figure 5-8 – Relationship between heart rate variability total power, blood pressure variability total power and cross-spectral time shift indices. Data are mean ± 
SEM for 11 participants. Corresponding R2 values are calculated using group mean values.
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5-5 Discussion  
This study sought to clarify whether the addition of small inspiratory loads amplifies 
the known acute haemodynamic effects of SDB and whether mechanically-driven 
variations in systemic venous return underpin such cardiovascular responses. The 
study also attempted to shed light on whether the application of inspiratory loading 
could provide a further understanding of the acute control mechanisms relevant to 
the cardiovascular response to SDB. A major finding was that the combined 
application of SDB and IL promoted significant increases in LVSVE and ∆SV, as well 
as Q̇, Q̇I, Q̇E and RSA, when compared to unloaded SDB, while only Q̇ was affected 
by LBPP. These changes occurred without any significant alteration of MAP during 
to both IL or LBPP. The application of LBPP attenuated the response of Q̇ to IL, 
supporting the idea that IL operates via a mechanism that involves mechanical 
modulation of systemic venus return. The RSA correlated strongly with the 
amplitude of within-breath fluctuations of LVSV and Q̇, providing support for an 
important functional link between the respiratory driven fluctuations in LVSV and 
RSA. Consistent with this notion, were the significant effects of IL upon spectral 
measures of HRV and BPV. Collectively, the data support the existence of an 
important contribution of intrathoracic pressure swings to the generation of within-
breath fluctuations in LVSV, leading to fc and ABP variations, which are attributable 
to both mechanical and reflex mechanisms. The addition of small inspiratory loads 
to SDB seems to amplify the acute cardiovascular and autonomic responses to 
SDB. 
  
5-5.1 Effects of loaded breathing upon systemic haemodynamic response 
A first aim of the study was to examine the haemodynamic response to inspiratory 
resisted SDB. Significant main effects were detected for IL upon Q̇, Q̇I and Q̇E (Table 
5-2, Figure 5-3). Despite significant main effects of IL and/or LBPP being found for 
MAP, SBP, DBP and TPR, only DBP exhibited a significant difference between 
conditions after post-hoc analysis; more precisely, DBP differed between baseline 
and IL1/LBPP2 (72±2 vs 79±2 mmHg, respectively). Nonetheless, it is important to 
highlight that the magnitude of changes of SBP between baseline and SDB with IL1 
(~7 mmHg increase with IL1, and ~13 mmHg increase if the combined IL1 and LBPP 
conditions) are comparable to previous studies, which have reported significant ABP 
increases with small inspiratory resistances (Convertino, Ratliff, Ryan, Cooke, et al., 
2004, Convertino, Ratliff, Ryan, Doerr, et al., 2004, Cooke et al., 2006). Therefore, 
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the results reported herein are consistent with the known acute effects of breathing 
against small inspiratory resistances (between 6 and 12 cmH2O), which include 
increases in LVSV, Q̇ and MAP in both normovolemic supine individuals 
(Convertino, Ratliff, Ryan, Doerr, et al., 2004, Cooke et al., 2006) and in 
hypovolemic models (Convertino, Ratliff, Crissey et al., 2005, Ryan et al., 2008, 
Convertino et al., 2011). A salient finding of the present study was the difference in 
∆SV, which became increasingly negative (bigger LVSVE relative to LVSVI) with the 
increase in inspiratory load magnitude. It has been suggested that the left ventricular 
expression of respiratory related changes in systemic venous return is delayed by 
the resistance and capacitance of the pulmonary circulation in such a way that an 
inspiratory increase in right-atrial filling is expressed as an increase in LVSVE 
(Dornhorst et al., 1952b, Hamzaoui et al., 2013), which helps to explain the changes 
in LVSVE and ∆SV observed with our intervention. As discussed in the previous 
chapter (cf. 4-5.1), PulTT has a high inter-individual variability and is sensitive 
variations in Q̇ (Lund et al., 1997, Zavorsky et al., 2003). Accordingly, our results 
might be limited to individuals with similar characteristics to our sample. In healthy 
individuals, a fall in intrathoracic pressure is accompanied by increase in transmural 
pressures for the left atria, pulmonary artery, right atria and aorta, as a result of 
pleural pressure falling more than cardiac chamber pressures (Alian and Shelley, 
2012). Thus, a favourable pressure gradient is created throughout inspiration as a 
result of a progressively more negative right atrial pressure with the decrease in 
intrathoracic pressure, contributing to an inspiratory increase in systemic venous 
return (Brecher, 1952, Guyton et al., 1957). This effect and the impact it has upon 
LVSV is limited by a combination of factors that include: i) venae cava collapse 
(Guyton and Adkins, 1954, Kimura et al., 2011), ii) ventricular interdependent 
mechanisms (Brinker, Weiss, Lappe et al., 1980, Amoore and Santamore, 1989, 
Amoore, Santamore, Corin et al., 1992) and, iii) the interplay between intrathoracic 
and abdominal pressures (Miller, Pegelow, et al., 2005b). These factors impact both 
cardiac and aortic transmural pressures and therefore preload and afterload 
(Robotham and Mintzner, 1979, Scharf et al., 1979, Robotham et al., 1985, Takata 
et al., 1990, Scharf, 1995). The influence of these mechanisms helps to explain why 
human Q̇ and MAP are relatively insensitive to fluctuations in venous return 
(Triedman and Saul, 1994).  
 
Another salient finding from the current study is the significant magnification of RSA 
with IL, which was accompanied by unchanged mean fc, suggesting no changes in 
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cardiac vagal tone with the application of IL. The increase in RSA was accompanied 
by a trend for the inspiratory fc to increase (fcI: 64±2 vs. 71±3 vs. 74±3 vs. 80±4 
beats∙min-1 for baseline, unloaded SDB at 40%FVC, IL1 and IL2, respectively), 
confirming previous observations with inspiratory (St. Croix et al., 1999) and dually 
resisted breathing  (Blaber and Hughson, 1996, Calabrese, Dinh, Eberhard et al., 
1998), which demonstrated the existence of a positive association between RSA 
and the magnitude of respiratory loading. 
 
The study findings support an additive effect of IL to the within-breath responses of 
Q̇ and LVSV to SDB, via a respiratory driven increase in venous return. However, it 
is not clear exactly which mechanisms are responsible for the observed increase in 
RSA. Some possibilities include, but are not limited to, a) reflex (Bainbridge, 1915, 
Bernardi et al., 1989, Pawelczyk and Levine, 1995, Barbieri et al., 2002) or direct 
mechanical stimulation of the sinus by atrial distention (Bolter and Wilson, 1999, 
Wilson and Bolter, 2002, Cooper and Kohl, 2003, Quinn and Kohl, 2012), b) carotid 
and aortic baroreflex response  to variations in left ventricular output (Triedman and 
Saul, 1994, Karemaker, 2009a), and/or c) stimulation of lung stretch receptors 
(Anrep et al., 1936a, Gandevia et al., 1978, Taha et al., 1995). Furthermore, the fact 
that the role of fc oscillations (with emphasis on RSA) upon the amplification or 
buffering of the arterial ABP oscillations is surrounded by controversy (Buchner, 
Żebrowski and Gielerak, 2010) makes the identification of the underlying 
physiological mechanisms, particularly difficult. Fundamentally, the contradictions 
between studies seem to be due primarily to postural differences.  For example, 
Elstad and colleagues (2001) reported opposite effects of RSA upon SBP and MAP 
in supine, but not in upright humans, while drastic reductions in RSA due to vagal 
blockade (Taylor, Carr, Myers et al., 1998) and fixed rate atrial pacing (Taylor and 
Eckberg, 1996) are accompanied by reduced SBP oscillations in the supine, but not 
in the upright position.  
 
5-5.2 Potential influences upon baroreceptor stimulation 
Cardiac BRS indices were analysed based on both the sequence-method and the 
cross-spectral transfer function between SBP and fc at a frequency corresponding 
to fR. Interpretation of these data carries the same caveats as were articulated in the 
previous chapter (cf. 4-5.1 – ‘Impact on baroreflex sensitivity’). No indication of any 
significant alteration of BRS in the presence of SDB with IL or IL combined with 
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LBPP was found. The only exception was the difference observed between 
unloaded breathing at 6 breaths·min-1 at 40% FVC and baseline for BRSup (41±6 
and 19±4 ms·mmHg-1, respectively; P <0.05; Table 5-1), which is in line with the 
results from Study 1 (Chapter 4). Mean fc remained unchanged throughout the 
intervention and no statistical differences between conditions were found for mean 
MAP, SBP and TPR (despite a significant main effect of the combined application 
of IL and LBPP being detected by the repeated measures one-way ANOVA). 
Nonetheless, it is important to mention that the magnitude of the trend of SBP and 
MAP between baseline and IL1 (SBP: ~7 mmHg with IL1, and reaching ~13 mmHg 
if the combined IL1 and LBPP conditions are considered; MAP: ~5 mmHg with IL1) 
is comparable to other studies that reported significant ABP increases with small 
inspiratory resistances (Convertino, Ratliff, Ryan, Cooke, et al., 2004, Convertino, 
Ratliff, Ryan, Doerr, et al., 2004, Cooke et al., 2006). The application of small 
inspiratory impedances (~10 cmH2O) has been proposed previously to induce a 
‘resetting’ of the cardiac vagal baroreflex response, as suggested by unaltered fc 
and BRS in the presence of significant MAP increase (Convertino, Ratliff, Ryan, 
Cooke, et al., 2004). Hypothetically, this change in the operating point of the 
baroreflex provides a physiological advantage by allowing increases in fC even with 
high MAP, thus improving Q̇. While the author might be inclined to interpret the 
presented  data as a confirmation of Convertino’s (2004) construct, there are 
methodological concerns that must be emphasised. Firstly, the usefulness of both 
time- and frequency-domain mathematical based techniques for the evaluation of 
cardiac baroreflex response to respiratory challenges is questionable. Some 
limitations of these techniques have been highlighted previously in Chapter 4 (cf. 4-
5.1). Furthermore, the analysis of the cardiac baroreflex response may yield 
different outcomes depending on the ABP variable considered: SBP or MAP (Elstad 
et al., 2001, Buchner et al., 2010). Arguably, the use of MAP, and not SBP, provides 
a better representation of the stimulus being sensed by the baroreceptors, 
particularly as the respiratory-driven fluctuations in MAP are less dependent on the 
position of the body (Buchner et al., 2010). Moreover, body position seems to play 
a relevant role on the ability of the cardiac baroreflex responses to counteract 
increased BPV. In the supine position, the magnitude of ABP fluctuations seems to 
be amplified by HRV itself, as fc seems to lead SBP fluctuations, while the opposite 
occurs with upright postures at the respiratory frequency (Taylor and Eckberg, 1996, 
Cooke et al., 1999, Buchner et al., 2010), adding another confounding factor to the 
interpretation of both time-domain and spectral analysis of the cardiac baroreflex 
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control loop. These caveats make the interpretation BRS data problematic and 
highlight the confounding nature that posture might have on the evaluation of 
cardiovascular response to SDB challenges. Thus, it is not possible to discern 
whether inspiratory loaded SDB acts acutely to alter the gain of the vagal cardiac 
baroreflex response.  
 
The addition of IL magnifies the negative intrathoracic pressure at any given VT 
(Seals et al., 1993). This amplifies the known, VT-dependent, fluctuations in 
intrathoracic, transmural and intravascular pressures that occur with normal, un-
resisted breathing (Dornhorst et al., 1952b, Wise et al., 1981). Intravascular 
pressures primarily influence the carotid baroreceptors, while aortic baroreceptors 
are mostly influenced by aortic transmural pressure (Angell James, 1971, Fitzgerald, 
Robotham and Anand, 1981). This becomes particularly relevant with resisted 
inspiratory efforts as aortic transmural pressure is increased due to a more 
pronounced decrease in intrathoracic pressure than the observed reduction in 
systemic intravascular pressure (Robotham and Mintzner, 1979, Karam et al., 1984, 
Peters, Fraser, Stuart et al., 1989). The increase in aortic transmural pressure can 
alter the relative stimulation of cardiopulmonary, aortic and carotid baroreceptors 
(Wallin and Fagius, 1988) when compared to spontaneous, un-resisted, breathing. 
In other words, during inhalation, the intravascular pressure is decreased, which 
‘unloads’ the carotid baroreceptors, while aortic transmural pressure is increased, 
which ‘loads’ the aortic baroreceptors. Contrarily, during expiration, as LVSV 
increases, both aortic and carotid baroreceptors might be stimulated simultaneously 
due to increased intravascular pressure. The net baroreflex response is thus a 
composite of the signals from aortic and carotid baroreceptors. 
 
As mentioned previously in this chapter, inspiratory loaded breathing is believed to 
augment systemic venous return to the right atrium and enhance right atrial filling. 
Right atrial blood volume increases are known to elicit tachycardic responses in 
human beings (Pawelczyk and Levine, 1995, Barbieri et al., 2002); commonly 
known as Bainbridge reflex. This chronotropic effect can also be accomplished by 
direct mechanical stretch of the sinus node, without the involvement of neuronal 
pathways (Bolter and Wilson, 1999, Wilson and Bolter, 2002, Cooper and Kohl, 
2003, Quinn and Kohl, 2012), and has been previously been suggested to occur in 
healthy human beings with inspiratory loaded breathing (Cooke et al., 2006). 
Despite not assessing RVSV in the current study, the significant increase in ∆SV 
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and LVSVE (∆SV: 40% FVC = 2±2, IL1 = -6±2, IL2 = -11±2 mL·beat-1; LVSVE: 40% 
FVC = 99±6, IL1 = 110±7, IL2 = 115±7 mL·beat-1) is most likely due to respiratory 
fluctuations in systemic venous return, as demonstrated recently in resting human 
beings in the left lateral decubitus position (Elstad, 2012).  
 
Simultaneously, it is assumed that amplified LVSV oscillations result in phasic 
variations of ABP throughout the respiratory cycle; this assumption is supported by 
the observed increase in BPVTOT with increasingly negative intrathoracic pressures 
(BPVTOT: unloaded 40% FVC < IL1 < IL2; Figure 5-5, P < 0.05) and by significant 
relationship between the BPVTOT and ∆SV (Figure 5-6, R2 = 0.98, P < 0.001). Based 
on the previous reasoning, if the cardiac chronotropic response to inspiratory 
resisted SDB was determined mainly by baroreflex mechanisms, a decrease in fc 
would be expected during the expiratory phase; furthermore, the conflicting effects 
of IL upon aortic and carotid baroreceptors throughout inspiration would be expected 
to limit the net cardiac-baroreflex response. No differences were observed in either 
fcE and fcI, despite the existence of a slight, non-significant, trend for fcI to increase 
with the increments in IL (40% FVC = 71±3, IL1 = 74±3, IL2 = 80±4; Table 5-1). The 
author’s findings support a potential involvement of atrial stretch mechanisms to the 
magnification of fcI and RSA, thereby questioning the contribution of baroreflex 
mediation of respiratory-driven fc fluctuations in inspiratory resisted SDB. 
 
5-5.3 Effects of loaded breathing upon HRV and BPV 
Heart rate variability  
The response of HRV to different breathing patterns was systematically evaluated 
in chapter 4 of this thesis and has also received attention from other researchers 
(Cooke et al., 1998, Lehrer et al., 1999, Stark et al., 2000, Song and Lehrer, 2003, 
Chang et al., 2013). In contrast, the effect of breathing with an inspiratory load upon 
HRV has been largely unexplored, and to the best of the author’s knowledge, no 
studies have been conducted in human beings exploring the acute, combined 
effects of SDB and inspiratory loading.   
 
A main finding of this study is the existence of significant increments in HRV in the 
time domain (SDNN and RMSSD), frequency domain (HRVLF and HRVTOT) and 
Poincaré indices (SD1 and SD2) with increments in IL magnitude during SDB. The 
consensus is that for both time and frequency domain HRV parameters, there is a 
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positive linear correlation with VT, whilst the correlation is negative for fR (Cooke et 
al., 1998, Song and Lehrer, 2003, Larsen et al., 2010). By fixing fR, VT and PaCO2, 
my study design eliminated the confounding effect of changes in breathing pattern 
between conditions and permits the conclusion that increases in HRV with IL stem 
from the increasingly negative intrathoracic pressures. These findings contradict, in 
part, those of Calabrese and colleagues (2000), who studied the impact of 
progressive resisted breathing of both breath phases, simultaneously, upon HRV 
and RSA. In common with the present study, they observed a significant increase 
in HRV and RSA that paralleled the magnitude of the respiratory resistance. 
However, because Calabrese and colleagues’ study was conducted in 
spontaneously breathing individuals, the increments in load were accompanied by 
a systematic reduction in fR and increase in VT. When Calabrese and colleagues 
statistically controlled for the changes in breathing pattern, no significant differences 
between loaded and unloaded conditions were observed, leading the authors to 
conclude that HRV and RSA amplitude during loaded breathing was determined 
mainly by ventilatory compensatory mechanisms associated with loaded breathing 
(Calabrese et al., 2000). The presented data do not support this interpretation as 
the changes in HRV and RSA in response to IL occurred in the absence of variations 
in fR and VT (and therefore V̇E). Instead, I believe that the significant correlations 
between RSA and ∆SV, ∆Q̇ and Q̇I (Figure 5-4), as well as the very strong 
correlations between BPVTOT and ∆SV (Figure 5-6) support the influence of 
mechanical effects of breathing upon LVSV and the existence of a functional link 
with RSA.  
 
The latter interpretation is supported by an earlier study (Blaber and Hughson, 
1996), which used fixed-paced breathing at 12 breaths·min-1 with simultaneous 
inspiratory and expiratory loading, and suggested that the increases in LVSV 
associated with resisted breathing were intimately related to the increase in HRV at 
the respiratory frequency. My study has important methodological differences to 
both of these previous studies (Blaber and Hughson, 1996, Calabrese et al., 2000); 
in particular, the fact that the present study loaded only inhalation. The 
discrepancies between studies raise the question of whether different modalities of 
loaded breathing have distinct effects upon the cardiovascular response to SDB, 
and if this translates to concomitant dissimilarities in HRV. This uncertainty will be 




The potentially important role of right atrial filling in the chronotropic response 
(Bainbridge reflex) to inspiratory resisted SDB was discussed above. This 
mechanism most likely impacts HRV at the respiratory frequency, but the 
contribution of vagal feedback from lung stretch receptors also merits consideration 
as a potential contributor to HRV, as suggested by a much reduced of RSA in lung 
denervated patients breathing at a fixed fR and high VT and/or IL, when compared 
with healthy individuals (Taha et al., 1995). Furthermore, evidence from 
spontaneously breathing animal models indicates increased activation of slowly 
adapting pulmonary stretch receptors (Widdicombe, 1961a, Davenport et al., 1981, 
Barrière, Delpierre, Del Volgo et al., 1993) with resisted breathing. These data 
support the case for a contribution from respiratory vagal afferent feedback to 
increases in HRV and RSA with inspiratory loading. 
 
Blood pressure variability 
The assessment of combined SDB and IL also yielded novel findings in relation to 
BPV. A noteworthy finding was a significant main effect of IL for BPVLF, BPVHF and 
BPVTOT. Compared to unloaded SDB, BPVLF was more than doubled with IL1 and 
quadrupled with IL2. Similarly, BPVHF increased progressively with the increase in 
inspiratory load (18±5 vs. 110±24 vs. 250±59 mmHg2 for SDB alone, IL1 and IL2, 
respectively). The frequency-dependent response of BPV during paced breathing 
was established recently (Chang et al., 2013), but the present study is the first to 
describe the response during IL. The BPVLF is believed to arise from changes in 
vascular tone and peripheral resistance and to reflect the sympathetic modulation 
of vascular regulation, while BPVHF has been ascribed primarily to the respiratory 
modulation of ABP (Pagani, Lombardi, Guzzetti et al., 1986, Di Rienzo et al., 1991, 
Parati, Saul, Di Rienzo et al., 1995). Both fR and VT seem to have important 
modulatory effects upon muscle sympathetic nerve activity (MSNA). This is most 
likely associated with vagally mediated lung inflation feedback (Seals et al., 1990, 
Seals et al., 1993, St. Croix et al., 1999, Limberg et al., 2013), since increasing 
respiratory motor output with IL does not seem to affect sympathetic nerve activity 
discharge (Seals et al., 1993, St. Croix et al., 1999). In the present study, fR and VT 
were identical in all conditions (except for unloaded SDB at 25%FVC), and fR 
remained in the LF band. Therefore, in the present study, the BPVLF represents SBP 
variations due to respiratory modulation of LVSV, fc and Q̇, entrained with naturally 
occurring fluctuations in ABP at 0.1Hz. These are unlikely to be associated to the 
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respiratory modulation of MSNA, but instead to be related to: 1) resonant oscillations 
in the sympathetic component of the baroreflex loop (De Boer et al., 1987, Malpas 
et al., 2001, Julien, 2006); 2) the intrinsic regulation of vascular regulation by 
endothelial nitric oxide release following cyclic variations in ABP (Malpas, 2002), or 
3) the manifestation of the myogenic activity of the smooth muscle cells 
(Stefanovska and Bracic, 1999a). While it is impossible to quantify the contribution 
and interplay of these mechanisms to the observed changes in BPVLF, it is 
reasonable to infer that the results represent the direct impact of the respiratory 
driven variations in left ventricular output, as well as cardiac and aortic transmural 
pressures, upon SBP fluctuations.  
 
While the association between the respiratory modulation of LVSV and low-
frequency BPV seems reasonable due to the low fRs employed in this study, the 
significant increase in BPVHF as a result of the application of progressive IL is harder 
to explain, as it is unlikely any contribution from a high-frequency respiratory 
component. Earlier it has been suggested that vagally mediated changes in fc and 
Q̇ might contribute to the BPVHF (Saul et al., 1991). Saul’s study reduced the 
respiratory impact of breathing upon spectral analysis by leading participants to 
breathe at irregularly spaced intervals corresponding to fRs from 4 to 60 breaths·min-
1. Nonetheless, the existence of HF respiratory oscillations was likely sufficient to 
generate relevant HF HRV and BPV. One plausible explanation for the present 
results involves the presence of clear harmonics of the 0.1 Hz peak in both the HRV 
and BPV spectrum, for most participants (Figure 5-9). These harmonic components 
result from the RR and SBP waveforms not being true sine wave signals. 
Consequently, Fourier analysis applied to such data produces power spectra that 
consists of the fundamental frequency component (first harmonic), together with the 
second, third and even fourth order harmonics (Ramirez, 1985). It is not clear if 
harmonics in BPV reflect vagal activity, but a few [scarce] studies have reported an 
increase in HRVHF with SDB (Strauss-Blasche, Moser, Voica et al., 2000, Van Diest, 
Verstappen, Aubert et al., 2014). Interestingly, in our study the power spectrum of 
both SBP and RR interval showed similar harmonics, which has been previously 
proposed to potentially signify the contribution of cardiac baroreflex regulation (Van 
Diest et al., 2014). The same authors attributed the presence of harmonics on HRV 
data to an imperfect sine wave respiratory signal and/or to deficient tracking of the 
imposed breathing pattern by the participants. Despite not reporting the power 
spectrum of the respiratory signal (RESP) in my study, the observation of the 
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individual tachograms allows to affirm that the observed harmonics are unlikely to 
be related to any respiratory component, as no HF peaks were identified, in any of 
the participants breathing at 6 breaths·min-1. Further to the presence of the 
harmonics, the non-true sine wave characteristics of cardiovascular waveforms 
makes the application of spectral Fourier transformation result in the creation of new 
spectral peaks at a given repetitive frequency. This effect known as leakage is 
limited by the use of ‘windowing’ techniques, though its application to HRV and BPV 
data might not be sufficient to entirely eliminate its presence. The efficacy of such 
techniques in counteracting spectral leakage seems to be inherently related to the 
window size (Singh, Vinod, Saxena et al., 2004). 
 
 
Figure 5-9 – Data from one individual breathing at 6 breaths·min-1 denoting the presence of 
high-frequency harmonic components in the HRV (top) and BPV (bottom) tachograms.Note 
how the dominant low-frequency peak is replicated with decay at 0.2, 0.3Hz despite the inexistence 
of high-frequency respiratory oscillations. 
 
 
Whether the significant increases in BPVHF encountered in the present study are a 
reflection of the presence of physiological mechanisms, or the expression of the 
limitations of the application of frequency domain methods to non-sinusoidal data, 




In common with HRV, the low-frequency component of BPV contained the majority 
of the observed variability (Figure 5-5). The general assumption is that short term 
variations in ABP are dampened by the vagal cardiac-baroreflex, effectively trading 
high-frequency BPV for HRV (Karemaker and Wesseling, 2008). However, the 
significant increases in BPVLF with the application of IL seemed not to be paralleled 
by similar-sized fluctuations in HRVLF (Table 5-4). This suggests a finite ability of fc 
fluctuations to buffer increased BPV during IL. This interpretation of the present 
findings agrees with data from atrial pacing studies in healthy human beings (Taylor 
and Eckberg, 1996) showing increased BPV with the abolition of HRV. The 
unaltered BPV at the respiratory frequency with sino-atrial denervation in conscious 
cats (Mancia et al., 1999) provides further support to the argument of a limited 
buffering ability of BPV by HRV, through the action of a cardiac baroreflex 
mechanism. Additionally, Taylor and Eckberg (1996) demonstrated that the 
dampening properties of baroreflex modulation of fc act predominantly upon DBP, 
increasing diastolic runoff time (De Boer, Karemaker and Strackee, 1985a, De Boer 
et al., 1987), and that the effects upon SBP are only evident in situations of 
augmented sympathetic outflow, i.e. not observed in supine, resting individuals. 
While DBP variability was not measured in the present study, the moderate 
association between HRV and BPV total spectral powers suggests that in seated 
healthy individuals, undergoing inspiratory loaded SDB, HRV cannot be exclusively 
determined by baroreflex modulation, and/or that such a mechanism is inherently 
unable to buffer fluctuations in SBP under these conditions. Thus, other sources of 
variability, such as that resulting from sino-atrial node stretch and vagally mediated 
feedback arising from the lungs, should be considered when interpreting HRV data. 
 
5-5.4  Effects of loaded breathing upon phase angle relationships  
To the best of the author’s knowledge, the temporal relationship between breathing, 
fc and ABP during (exclusively) inspiratory resisted SDB has not been described 
previously. In this study, a significant increase was observed in RESP-fc, decrease 
in SBP-fc and inversion of RESP-SBP phase angle (from SBP fluctuations 
‘preceding’ respiratory swings to trailing them with SDB) from baseline to all SDB 
conditions. A small, non-significant trend for RESP-fc to increase from unloaded 
SDB at 6 breaths·min-1, and during 40% FVC with the addition of both IL1 and IL2 
was also observed (Table 5-5). These findings are interpreted as being indicative of 
the involvement of the same mechanisms in both light-loaded and unloaded SDB. 
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These results contrast those obtained previously in supine individuals, in which 
combined inspiratory and expiratory resistances led to reduced lag between the 
inhalation and the RR interval (RESP-fc) shortening, without affecting the SBP to 
RR interval (SBP-fc) phase relation (Blaber and Hughson, 1996). Contrarily, in a 
similar study to Blaber and Hughson’s, no phase differences were observed 
between RESP and fc in seated, healthy human beings (Calabrese et al., 2000). 
Despite using similar resistances to those employed in the present study (0-
16cmH2O), both of the aforementioned studies applied flow resisted breathing to 
both phases of the respiratory cycle, which raises the question of how exactly the 
isolated use of inspiratory resisted breathing might have a distinct cardiovascular 
impact to that of combined inspiratory and expiratory resisted breathing, or even 
breathing against expiratory resistances alone. Furthermore, the conflicting results 
between studies strengthen previously stated concerns regarding the implications 
that posture might have in the relationship between ABP and fc (Taylor and Eckberg, 
1996, Taylor et al., 1998, Cooke et al., 1999, Elstad et al., 2001, Buchner et al., 
2010). 
 
Interestingly, phase angle (and time shift) correlated strongly with other 
cardiovascular indices (Figures 5-7 and 5-8). Most importantly, the time lag between 
the onset of inhalation (RESP) and SBP correlated strongly and positively with RSA 
(R2 = 0.91), HRVTOT (R2 = 0.87) and BPVTOT (R2 = 0.94), and negatively with ∆SV 
(R2 = 0.93). Furthermore, the RESP-fc lag exhibited similar associations with the 
same variables (R2: RSA = 0.79; HRV HRVTOT = 0.79; BPVTOT = 0.96 and; ∆SV = 
0.98), while SBP-fc only correlated strongly with ∆SV (R2 = 0.87) and BPVTOT (R2 = 
0.83). These relationships are interpreted as being representative of a strong 
mechanical link between the respiratory fluctuations in intrathoracic pressure and 
subsequent LVSV swings, resulting in substantial ABP fluctuations. This is 
corroborated by the high correlation observed between ∆SV and BPVTOT (R2 = 0.98 
for group mean values and; R2 = 0.30, P < 0.001, with multiple regression analysis 
with individual fixed effects model), as well as by the moderate to low correlation of 
SBP-fc with RSA and HRVTOT (R2: RSA = 0.54; HRVTOT = 0.59; P < 0.05). The latter 
suggests that factors other than a simple mechanical effect of IL upon LVSV 
underpin changes in RSA. This is further supported by the increase in RSA 
amplitude with the increase in IL (Table 5-2) and by the different behaviours of HRV 
and BPV in response to IL and LBPP; HRVTOT was virtually unaltered by IL and 
LBPP, whereas BPVTOT was influenced by IL and LBPP (Figure 5-5). This tends to 
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support the notion that changes in RSA are due to an ensemble contribution from 
reflex, neural and mechanical factors (Anrep et al., 1936a, b, Triedman and Saul, 
1994, Blaber and Hughson, 1996, Eckberg, 2003, 2009b, Julien et al., 2009, 
Karemaker, 2009c, a). Also, it also highlights the importance of mechanical 
mechanisms in the fc response to loaded SDB. The observations also support 
previous findings indicating the inability of baroreflex modulation of fc to fully buffer 
ABP oscillations at the respiratory frequency (Mancia et al., 1999). Considering the 
likely increase in systemic venous return with IL during inspiration (Robotham et al., 
1978, Convertino, Cooke, et al., 2005, Elstad, 2012) it would be expected that the 
resulting increased blood volume entering the pulmonary circulation could 
contribute to a transient increase in Q̇. As mentioned previously in this thesis, 
increases in Q̇ result in in reduced PulTT (Zavorsky et al., 2003), with a concomitant 
alteration of the RESP-SBP and potentially RESP-fc (if considered the presence of 
a carotid baroreflex mechanism) phase relations. However, an increase in the 
capacitance of the pulmonary circulation (blood pooling) in response to increased 
inspiratory venous return can offset this effect and maintain pulmonary transit time 
(Wilkins et al., 2001, cit by Zavorsky et al., 2003); the combined effect of both 
mechanisms could contribute to the stabilisation of the time delay in the expression 
of the mechanical effects of breathing upon LVSV. This mechanism can also explain 
why LVSVE tends to increase with the increase in IL, while LVSVI is apparently 
unaltered (as inspiratory increases in RVSV will only be expressed in left ventricular 
output during the ensuing expiratory phase due to the delay interposed by the 
pulmonary circulation).  
 
Unfortunately, the ANSlab software was unable to calculate phase relationships for 
LVSV, and this is an interesting area for future study. Finally, the lack of any 
significant changes in either RESP-DBP or SBP-DBP, suggests the presence of a 
much smaller respiratory modulation of DBP, and smaller transfer of respiratory-
driven changes in LVSV into DBP, most likely because of the arterial Windkessel 
effect (TenVoorde et al., 1995).  
 
5-5.5 Haemodynamic impact of lower body positive pressure 
The level of LBPP was altered systematically in a seated position and permitted 
evaluation of the impact of light lower limb compression upon the left ventricular 
cardiac function. No alteration was observed in steady-state EDV, ESV, LVSV, Q̇ 
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and MAP for compressions ranging from 10 to 30 mmHg (Table 1). Previous studies 
have shown significant steady-state cardiovascular changes with LBPP, and the 
discrepancy with the present findings is most likely due to posture and the method 
used to deliver the LBPP. Unlike most previous studies, which applied LBPP to 
supine individuals using a LBPP box (Shi, Crandall, et al., 1993, Shi, Potts, 
Foresman et al., 1993, Shi, Foresman and Raven, 1997), participants in the present 
study were upright-reclined, and LBPP was delivered using anti-gravitational 
compressive trousers. The observed rise in MAP, in the steady-state evaluation of 
LBPP (88±3 mmHg vs 92±3 mmHg; no compression vs LBPP at 30 mmHg, 
respectively; Table 5-1), is comparable to the 3-6 mmHg increase at 20-30 mmHg 
LBPP reported for supine human beings (Bevegard, Castenfors and Lindblad, 1977, 
Shi, Crandall, et al., 1993, Shi, Potts, et al., 1993, Shi et al., 1997). The existence 
of a posture-dependent cardiovascular response to graded LBPP has been shown 
previously, indicating ABP, but not LVSV and Q̇, to be more responsive to LBPP in 
the supine position than in a seated upright position (Nishiyasu, Nagashima, Nadel 
et al., 1998). It is also reasonable to suggest that the increase in hydrostatic 
pressure associated with a more upright position in the current study, might have 
attenuated the expression of LBPP in the applied compression range. Moving from 
supine to an upright position results in an estimated 500-600 mL of blood shifting to 
the lower limbs (Sjöstrand, 1953; Gauer and Thron, 1965, cit by Nishiyasu et al, 
1998). Previous studies reported changes in central venous pressure > 1mmHg with 
the application of LBPPs in the same range those used in the present study (Shi, 
Crandall, et al., 1993, Shi, Potts, et al., 1993). Since it is well documented that small 
variations in central venous pressure of just a few millimetres of mercury can 
significantly impact venous return (Guyton, 1955, Fessler, Brower, Wise et al., 1991, 
Gelman, 2008), it is possible that the changes in central venous pressure with LBPP 
were insufficient to counteract the hydrostatic pressure. Furthermore, given that 
LBPP was only applied to the lower limbs, and not to the abdominal compartment, 
it is conceivable that an important volume of blood has been shifted from the 
extremities and pooled in the abdominal compartment, particularly in the splanchnic 
and renal vasculature. The splanchnic circulation receives ~25% of Q̇ and holds 20-
25% of total blood volume (Rowell, 1990). Splanchnic veins are much more 
compliant than the veins from extremities (Hainsworth, 1986) and are known to play 
a fundamental role in the maintenance of Q̇, even without the contribution of reflex 
mechanisms (Rothe, 1983, Rothe and Gaddis, 1990). More importantly, splanchnic 
venous return is greatly dependent on the pressure gradient between the inferior 
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vena cava and the hepatic vein (Guyton et al., 1955, Aliverti, Bovio, Fullin et al., 
2009). Under resting conditions, when the effect of the abdominal pump (by increase 
of intraabdominal pressure) upon mean splanchnic vascular resistance is minute, 
an increase in the inferior vena cava’s intraluminal pressure by compression of the 
lower limbs can limit venous flow from splanchnic circulation (Aliverti et al., 2009), 
thus not affecting venous return to the right atria (and LVSV and Q̇). Furthermore, 
the existence of a respiratory alternation between systemic venous flow and 
splanchnic flow into the inferior vena cava has been demonstrated both in dogs and 
resting humans (Moreno, Burchell, Van der Woude et al., 1967, Moreno and 
Burchell, 1982), with systemic venous flow predominating through inspiration while 
splanchnic flow is increased during expiration. Under this construct, the increased 
inferior vena cava’s intra luminal pressure with LBPP would make the oscillations in 
right atrial pressure with IL less relevant towards the creation of a favourable 
pressure gradient for venous return to the right atrium during inspiration. 
Notwithstanding, when combined with SDB and IL, a significant main effect for LBPP 
upon Q̇ was found (Figure 5-3). This suggests that the application of LBPP 
attenuated the impact of IL upon Q̇. This observation is consistent with the 
hypothesis that increasing abdominal blood volume lessens the importance of the 
‘suction’ effect created by inhalation, thereby supporting the notion that the 
haemodynamic changes induced by SDB and IL are underpinned by fluctuations in 
intra-thoracic pressure.  
 
Finally, it is pertinent to note that the magnitude of the applied LBPP was limited to 
a maximum of 20 mmHg during the main intervention, as previous reports 
suggested activation of intramuscular pressure-sensitive receptors above this level, 
which would, in theory, have counteracted the reflex response to cardiopulmonary 
baroreceptor loading (Shi, Crandall, et al., 1993). 
 
5-5.6 Translational relevance  
The amplification of the influence of intrathoracic pressure swings upon venous 
return has proven to be useful in an array of clinical conditions, particularly those 
where hypotension is involved (Convertino, Cooke, et al., 2005, Convertino, Ryan, 
Rickards et al., 2007, Rickards et al., 2007, Rickards et al., 2008, Ryan et al., 2008, 
Convertino et al., 2011, Rickards et al., 2011, Convertino, Parquette, Zeihr et al., 
2012, Metzger, Rees, Segal et al., 2013, Segal, Yannopoulos, Truchot et al., 2013). 
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Furthermore, recent studies suggest improved antihypertensive efficacy of daily 
SDB practice with the addition of a small IL, when compared to SDB alone 
(Sangthong et al., 2016). Moreover, a study of respiratory muscle resistance training 
highlighted the importance of large intrathoracic pressure swings, but not large lung 
volumes, to the antihypertensive effect of such training in healthy human beings 
(Vranish and Bailey, 2015).The data presented herein suggest that inspiratory 
loading amplifies acute cardiovascular and autonomic responses to SDB, leading to 
the hypothesis that LVSV oscillations may underpin the anti-hypertensive effects of 
both SDB and respiratory loading. Despite the suggestion that the increased acute 
cardiovascular response suggests that, on balance, inspiratory resisted SDB is 
beneficial, additional studies are necessary to identify if other modalities of resisted 
SDB might also impact the cardiovascular and autonomic nervous system. The 
isolated or combined (with IL) use expiratory resistances, and the deployment of 
alternative loading devices (e.g., pressure threshold loading) are just two examples 
of future research paths. 
 
5-6 Conclusions  
This study provides evidence that the application of small ILs enhances the within-
breath response (inhalation vs. exhalation) of LVSV, fc and Q̇ to SDB, without 
affecting mean fc or MAP. This behaviour suggests the absence of significant tonic 
parasympathetic or sympathetic alterations during loaded SDB. Furthermore, the 
significant main effect of LBPP also supports the existence of a mechanical ‘suction’ 
mechanism, since the presence of LBPP attenuated the improvements created by 
IL. 
 
Also, the responses of RSA, HRV and BPV to graded inspiratory loading during 
tightly-regulated SDB were characterised. The data suggest that IL magnifies 
inspiratory pressure-driven increases independently of changes in VT and fR. 
Furthermore, strong evidence is provided that the amplitude of within-breath 
fluctuations in both LVSV and ABP are highly correlated with small phase shifts 
between cyclic fluctuations in lung volume, SBP and fc. We interpreted these 
findings as evidence of the contribution of both mechanical and reflex factors to the 
generation and amplitude of RSA during loaded SDB. Further investigation of the 
role of these mechanisms in the acute and chronic response to SDB will help to 
improve the potential therapeutic use of SDB as an antihypertensive intervention.  
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CHAPTER 6 – THE INFLUENCE OF DIFFERENT 
MODALITIES OF AIRWAY RESISTANCE UPON THE 
ACUTE CARDIOVASCULAR RESPONSES TO 





[Note: parts of this chapter were accepted for publication in Proceedings of the 







Introduction and objective: The brief daily bouts of breathing via inspiratory and/or 
expiratory resistances has recently been shown to exert antihypertensive effects in 
both healthy and hypertensive individuals. The present study tested the hypothesis 
that adding inspiratory and/or expiratory resistances during slow and deep breathing 
(SDB) enhances acute cardiovascular and autonomic responses, compared to SDB 
alone. The study also explored whether different loading methods (flow resisted 
breathing vs. threshold loaded breathing vs. single nostril breathing) affected the 
magnitude of the cardiovascular response to resisted SDB.  
Materials and methods: Fifteen healthy males (25±4 years; 179±8 cm; 73.4±9.3 
kg) were tested in a seated upright-reclined position. Participants completed nine 5 
min bouts of SDB at a breathing frequency (fR) of 6 breaths·min-1 and tidal volume 
(VT) of 30% of forced vital capacity (FVC). One bout consisted of SDB alone, while 
six sets combined SDB with inspiratory and/or expiratory loads of approximately 10 
cmH2O delivered by a flow resistive or pressure threshold device. Two other sets 
consisted of single-nostril (right and left) SDB. All interventions were randomised. 
Results and conclusion: The cardiovascular and HRV responses to resisted SDB 
did not differ between different loading devices, with one exception; with the 
threshold loaded breathing, heart rate (fc) and total peripheral resistance (TPR) 
during inspiration were significantly higher than other conditions. The addition of an 
expiratory resistance resulted in a significant pressor response when compared to 
inspiratory resisted SDB, or SDB alone. A small inspiratory resistance in conjunction 
to SDB increased RSA and within-breath LVSV swings without acutely increasing 
MAP. Finally, the use of single nostril breathing, which generated comparable 
respiratory pressures to the ones encountered with the resisted SDB, resulted in no 
significant differences from flow resisted breathing, while there was no suggestion 
of a differentiated cardiovascular or autonomic response when comparing right vs. 
left nostril breathing. The data support the notion that magnified respiratory-related 
intrathoracic pressure swings are the dominant breathing-related alteration 
underlying cardiorespiratory interactions. While it is not clear what is the exact 
contribution of baroreflex mediated mechanisms to the amplification of RSA, HRV 
and BPV with inspiratory loaded SDB, the data are consistent with the involvement 





The previous chapter reported the acute cardiovascular response to the 
combination of fixed pace SDB with different inspiratory loads; a positive correlation 
was found between the magnitude of inspiratory resistances (more negative 
intrathoracic pressure) and changes in expiratory LVSV, inspiratory Q̇ and the 
magnitude of within-breath LVSV fluctuations (∆SV), without a concomitant increase 
in MAP. Similarly, RSA, HRV and BPV were significantly higher in the presence of 
inspiratory loading and related strongly with the resulting time shift variations 
between the changes in lung volume, SBP and fc. These results built upon 
previously reported data from healthy individuals (Convertino, Ratliff, Ryan, Cooke, 
et al., 2004, Convertino, Ratliff, Ryan, Doerr, et al., 2004, Cooke et al., 2006); 
hypovolemia/hypotension models (Convertino, Cooke, et al., 2005, Convertino et 
al., 2007, Rickards et al., 2007, Rickards et al., 2008, Ryan et al., 2008, Convertino 
et al., 2011, Rickards et al., 2011, Convertino et al., 2012), and fixed-paced resisted 
breathing (Blaber and Hughson, 1996). Collectively, these data suggest an 
important functional link between respiratory driven fluctuations in right atrial filling, 
left ventricular output and the acute cardiovascular and autonomic response to 
inspiratory resisted SDB. 
 
Recently, it has been suggested that large intrathoracic pressure swings (either 
negative or positive) result in chronic reductions in SBP, DBP and MAP in 
normotensive individuals, following a 6-week training period, while more modest 
intrathoracic pressure variations led to no improvements, independent of the lung 
volume (Vranish and Bailey, 2015). This study highlights the importance of 
understanding the acute cardiovascular and autonomic responses to both 
inspiratory and expiratory loaded slow and deep breathing, in order to better 
comprehend its potential clinical relevance. 
 
As mentioned previously in Chapters 2 and 5, breathing against an inspiratory 
resistance places significant mechanical strain upon the cardiovascular system and 
promotes important changes in systemic venous return, while contributings to 
enhanced right ventricular filling during inspiration Simultaneously, the more 
negative intrathoracic pressure also contributes to an increase in left ventricular 
afterload as a result of increased aortic transmural pressure (Robotham et al., 1978, 
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Karam et al., 1984), with the final impact upon the cardiac function being determined 
by the interaction among the changes in preload, contractility and afterload. 
 
In contrast, breathing against an expiratory resistance mimics the increase in 
intrathoracic pressure associated with the Valsalva manoeuvre albeit with 
decreasing lung volume (Laciuga et al, 2012); an initial increase in LVSV and SBP 
is observed due to the direct mechanical effect of increased pleural pressure upon 
the heart and intrathoracic vessels, assisting blood ejection and contributing to the 
increase in aortic intravascular pressure (Eckberg, 1980, Looga, 2005). Similarly, 
expiration against a moderate expiratory resistance (24 cmH2O) in healthy 
individuals results in an increase in LVSV during the first couple of heart beats 
following the start of the expiratory effort (Natarajan, Wise, Karam et al., 1987). The 
authors showed that this increment was due to an increase in left ventricular filling 
and not to an increase in left ventricular contractility or decrease in afterload. 
However, the scarcity of studies means the acute response to expiratory loading 
remains very poorly understood. 
 
A handful of studies have characterised fc and ABP responses to expiratory resisted 
efforts, but most did not involve SDB, and/or imposed much larger expiratory loads 
(relative to maximal expiratory pressure - PEmax). One particular study reported 
unchanged in fc in response to brief and repetitive exertions with swallowing 
manoeuvres in orthopaedic patients, while supraventricular tachycardia and 
premature atrial and ventricular contractions were encountered in stroke patients 
(Chaudhuri, Hildner, Brady et al., 2002). Conflicting findings have also arisen 
regarding the acute cardiovascular effects of applying large expiratory resistances 
(60-75% PEmax) in healthy individuals, with reports of both unchanged (Laciuga, 
Davenport and Sapienza, 2012) and increased fc (10-15 beats∙min-1) and SBP (~20 
mmHg) following expiratory resisted breathing sessions (Derchak, Sheel, Morgan 
et al., 2002). These studies suggest that the application of expiratory resistances 
possibly has a meaningful acute cardiovascular impact in healthy individuals, but 
might be contraindicated in patients with a history of cardiovascular disease.  
 
The application of resistance to breathing can be accomplished through two different 
methods. Firstly, flow resistive loading creates the resistance by having individuals 
breathing through an orifice, whereby, for a given flow, the resistance to breathing 
increases with the decrease in the size of the orifice. Secondly, pressure threshold 
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loading requires the production of sufficient airway pressure to overcome the 
threshold load on a valve, in order to initiate respiration (McConnell and Romer, 
2004). Importantly, threshold loading provides an inertial load that results in a rapid 
pressure build-up, which precedes the production of airflow, thereby creating a 
different pattern of intrathoracic pressure changes, compared to the flow dependent 
resistance of flow resistive loading. While both methods have the ability to deliver 
the same absolute resistance to breathing, no study has yet compared the acute 
cardiovascular impact of these two distinct types of loading during resisted SDB. 
Furthermore, studies using single nostril breathing appear to have similar effects to 
the observations from Chapter 5 of this thesis, but with claims of different effects for 
right-nostril vs. left-nostril breathing (Raghuraj and Telles, 2008). It is likely that 
these effects are simply the result of the inherent flow resistance of the nasal airway 
(in single nostril breathing), but to the author’s knowledge, this has not been tested 
experimentally, particularly under conditions in which the airflow resistance of the 
nostrils has been quantified. 
 
Accordingly, the aims of this study were to compare: 1) the influence of adding 
inspiratory and/or expiratory resistances upon the responses to SDB alone; 2) the 
effects of inspiratory and expiratory resistances upon responses to SDB; 3) the 
cardiovascular responses to flow resistive loading and pressure threshold loading, 
and 4) compare the cardiovascular response to the different routes of respiratory 
airflow, specifically mouth, right nostril and left nostril.
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6-3 Specific Methods 
6-3.1 Participants  
Fifteen healthy, recreationally-active men participated (mean ± SD; age 25±4 years; 
179±8 cm; 73.4±9.3 kg). All participants were nonsmokers with no previous record 
of cardiovascular or respiratory disease and reported not taking any medication. 
  
6-3.2 Ethical Approval  
Fully informed, written consent was obtained from the participants before the study. 
All procedures were approved by the Brunel University Research Ethics Committee 
(RE49-14) and conformed to the guidelines of the Declaration of Helsinki (World 
Medical Association, 2013). 
 
6-3.3 Protocol 
Participants visited the laboratory on a single occasion. Initially, the participants 
were introduced to the experimental set-up and familiarised with the measurement 
methods. A baseline pulmonary function assessment was performed; any 
participants showing signs of asthma or other lung disease were excluded from the 
study. In addition, a familiarisation trial using a bespoke device guided breathing 
biofeedback system was performed (Labview, National Instruments Inc.) (refer to 
Chapter 3 - General Methods, for a detailed description of pulmonary function 
assessment and familiarisation session protocols).  
 
After the initial screening, participants undertook a session of device guided SDB. 
The trial session began with 5 min of quiet baseline spontaneous breathing, followed 
by ten, randomised 5 min sets of device guided SDB. 
 
These interventions were all performed at an fR of 6 breaths∙min-1 and a VT 
corresponding to 30% each participants’ forced vital capacity (FVC) and included: 
• SDB with no added resistance (unloaded; UL); 
• SDB combined with flow resistive inspiratory (IF), expiratory (EF) and dual 
(DF) loading; 
• SDB coupled with pressure threshold inspiratory (IT), expiratory (ET) and 
dual (DT) loading,  and, 
 
180 
• SDB through the right (RN) or left nostril (LN), with contralateral nostril 
occluded. 
Five minute rest periods separated each 5 min set (Figure 6-1). All sets were 
conducted in a fully randomised order (a detailed description of the randomisation 
procedures can be found in the General Methods section).  
 
 
Figure 6-1 – Example sequence of the experimental protocol (order was randomised). 
Participants were exposed to 5 min of spontaneous baseline breathing (B) followed by randomly 
assigned device guided slow and deep breathing sets, with and without resistance. Unloaded slow 
and deep breathing (large white bar: UL), flow resistive slow and deep breathing (light grey: IF, EF 
and DF), pressure threshold slow and deep breathing (dark grey: IT, ET and DT) and single nostril 
breathing (black: RN and LN) 5 min interventions were interleaved by 5 min of spontaneous, 
unrestricted breathing (R). 
 
6-3.4 Procedures and instrumentation of participants 
Participants were asked to refrain from alcohol, caffeine and strenuous physical 
activity for at least 12 h and to avoid consuming food during the 2 h leading up to 
testing. Throughout the entirety of the trials, participants assumed an upright, 
reclined position by sitting on a reclining lounge chair, set at an approximate 60o 
angle, and breathed through a mask that allowed for normal mouth and/or nasal 
breathing (Intersurgical Quadralite Mask; Intersurgical Ltd., Wokingham Berkshire, 
UK). Room temperature remained at a comfortable 22-25oC and barometric 
pressure was recorded for each of the trial sessions. Specified respiratory flow rates 
and a respiratory duty cycle (Ti/TTOT) of 0.5 (inspiratory time = expiratory time) were 
delivered using the aforementioned bespoke guided breathing biofeedback system 
(Labview, National Instruments Inc.). Respiratory flow rates were measured using a 
heated pneumotachograph (Hans Rudolph 3700, Hans Rudolph Inc.), whilst airway 
pressure was measured using a separate, auxiliary differential pressure transducer.  








Table 6-1 – Characterisation of respiratory parameters during all loaded breathing sets. 
Data represent mean ± SEM for 15 subjects. Slow and deep breathing conditions performed at 6 breaths∙min-1 and 30% FVC. Breathing frequency (fR) in breaths·min-1, tidal 
volume (VT) in % of forced vital capacity, duty cycle (Ti/TTOT), partial pressure of end tidal carbon dioxide (PETCO2) in mmHg, inspiratory pressure (PI) in cmH2O, expiratory 
pressure (PE) in cmH2O. IF – flow dependent inspiratory load, EF – flow dependent expiratory load, DF – flow dependent dual inspiratory/expiratory load, IT – threshold 
inspiratory load, ET – threshold expiratory load, DT – threshold dual inspiratory/expiratory load, RN – right nostril breathing, LN – left nostril breathing. * unloaded slow and 




 Baseline Unloaded IF EF DF IT ET DT RN LN 
fR (breaths∙min-1) 11.5±1.0 5.9±0.2* 5.8±0.2 6.0±0.2 5.9±0.2 5.9±0.2 5.9±0.2 5.9±0.2 5.8±0.2 5.8±0.2 
VT (L∙min-1) 0.82±0.08 1.58±0.07* 1.61±0.07 1.63±0.07 1.64±0.07 1.61±0.07 1.65±0.07 1.62±0.07 1.61±0.08 1.61±0.08 
TI/TToT 0.44±0.01 0.49±0.01* 0.50±0.01 0.53±0.01 0.52±0.01 0.47±0.01 0.51±0.02 0.49±0.01 0.48±0.01 0.48±0.01 
PETCO2 (mmHg) 42.0±1.0 40.2±1.1 40.3±1.2 42.2±1.3 41.6±1.2 40.2±1.0 42.7±1.1 40.4±1.0 40.0±1.1 40.7±1.1 
PI (cmH2O) -0.5±0.1 -0.5±0.1 -10.3±0.5‡ -3.5±0.1 -10.0±0.6‡ -10.3±0.3§ -3.2±0.1 -10.0±0.1§ -8.6±1.1 -8.7±1.4 
PE (cmH2O) 0.5±0.1 0.5±0.1 2.7±0.1 9.8±0.3† 9.8±0.5† 1.8±0.1 12.3±0.3# 12.6±0.1# 8.9±1.9 9.0±2.2 
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Flow resistive loading  
A bespoke breathing circuit imposed the flow resistive loads, as previously 
described in Chapter 3 (Figure 3-6). To allow for selective inspiratory, expiratory and 
dual loading, the flow resistors were placed in the inspiratory, expiratory or both 
paths of the device. The y-shape and separate inspiratory and expiratory valves 
ensured that the load only acted upon the desired portion of the respiratory cycle.  
 
Threshold loaded breathing 
Threshold loaded resisted breathing was performed by a bespoke breathing circuit 
that included a y-shape connector and inspiratory and expiratory valves, similar to 
the ones used in the aforementioned flow-dependent resistor. Inspiratory and/or 
expiratory spring-loaded threshold devices (inspiratory: Philips Threshold IMT; 
expiratory: Philips Threshold PEP; Philips Respironics, Murrysville, PA, USA) were 
attached to inspiratory and/or expiratory arm of the breathing circuit (Figure 6-2). 
 
 
Figure 6-2 - Left panel: expiratory (Threshold PEP) and inspiratory (Threshold IMT) threshold 
loading devices. Right panel: Bespoke threshold loading circuit, including threshold loading 




Single-nostril breathing sets involved the use of a nasal probe for nostril pressure 
measurements (CareFusion UK 232 Ltd., Basingstoke, UK; Figure 6-3). Prior to the 
insertion of the nasal probe, participants performed a nasal wash with saline solution 
to remove accumulated nasal mucous. 
 
 
Figure 6-3 – Placement of nasal probe for single left nostril breathing. The nasal probe was 
attached to the pneumotachograph auxiliary pressure channel for continuous respiratory pressure 
measurement. The probe was taped tightly to avoid leaks, particularly during expiration.  
 
Cardiovascular measurements are described in detail elsewhere (General Methods 
– Chapter 3), but briefly, non-invasive beat-to-beat arterial blood pressure was 
obtained using finger photoplethysmography (Finometer® PRO, Finapres Medical 
Systems, Amsterdam, The Netherlands), while heart rate was monitored using a 3-
lead ECG (PysioControl VSM® 3, PhysioControl Inc.). Total peripheral resistance 
(TPR) was calculated by dividing cardiac output (Q̇) by the mean arterial pressure 
(MAP). Baroreflex sensitivity (BRS) was calculated by the sequence method 
(Bertinieri et al., 1985, 1988, Parati et al., 1988), as well as from the cross-spectral 
transfer function gain (Robbe et al., 1987). Phase angles and coherence between 
respiration and cardiovascular (heart rate, SBP and DBP) waveforms were obtained 
from the cross-spectra transfer function at the peak respiratory frequency. Average 
phase angles were calculated as the un-weighted circular mean (?̅?) for phase angles 
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for all relationships of interest (Mardia and Jupp, 2009).  A more detailed description 
of the BRS and cross-spectral calculations can be found in section 3-3. 
 
Statistical Analysis 
Data were analysed using IBM® SPSS version 21.0 statistical software (IBM Corp.).  
Values are expressed as means ± SEM unless stated otherwise. After normality 
was confirmed via the Shapiro-Wilk test, repeated measures ANOVA with post hoc 
planned, pairwise comparisons (determined by study aims), using Bonferroni 
correction (see below) was used to assess differences between conditions. Circular 
(cross-spectral) data were analysed using multi-sample Watson-Williams F-test 
following confirmation of the existence of a Von Mises circular distribution (Fisher, 
1995, Mardia and Jupp, 2009). Bonferroni adjusted alpha levels of 0.004 per test 
(0.05/13; Baseline vs. UL; IF vs. EF; IF vs. DF; IF vs. IT; EF vs. DF; EF vs. ET; DF 
vs. DT; IT vs. ET; IT vs. DT; ET vs. DT; DF vs. RN; DF vs. LN; RN vs. LN) were 
used in this study for both ANOVA and the Watson-Williams multiple sample 
posthoc analyses. Despite some violations of requirements for the multisample 
ANOVA and Watson-Williams F-test, involving deviations from the required 
distributions that could not be corrected using data transformation, a decision was 
made to use the parametric options rather than the nonparametric alternatives. This 
was justified because: 
1) We were working with continuous rather than ordinal data; 
2) repeated measures ANOVA is relatively robust against moderate deviations 
in normality (Glass et al., 1972); 
3) similar results encountered when we analysed the data using the 
nonparametric Friedman and Mardia-Watson-Wheeler (for circular data) 
alternatives.  
 
To assess the existence of a causal path between the use of inspiratory vs. 
expiratory resisted breathing upon the response of key cardiovascular variables, 
mechanism analysis as described by Hopkins (2003). With this method, we plotted 
the change in mean respiratory pressure between inspiratory (X-pre), and expiratory 
(X-post) loaded conditions against the corresponding change in the key dependent 
variables and visually analysed the directionality and consistency of the 
individualised responses. To complement the analysis of the relationship between 
mean respiratory pressure and the cardiovascular response, a multiple regression 
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for within-subject repeated measures was used (Bland and Altman, 1995). Finally, 
after confirmation of the homoscedasticity, multicollinearity and normality of 
residuals assumptions, stepwise multiple linear regression was employed to help 
determine how strongly selected cardiovascular variables contributed to changes in 




6-4.1 Cardiovascular response 
Effects of unloaded slow and deep breathing  
The RSA response to SDB showed significantly higher values for the unloaded SDB 
condition than for baseline (Baseline: 189±29 vs. Unloaded SDB: 306±32, P < 
0.004; Figure 6-4). Similarly, LVSVE, LVSVI/E, SBPEmax, ∆SBP-DBP, PP, PPI and 
PPE all increased with Unloaded SDB (P < 0.004; Table 6-2). In contrast, fcE 
decreased, while ∆SV became negative (LVSVI< LVSVE) with SDB (P < 0.004; 
Table 6-2). No changes in any other analysed cardiovascular variables were 
observed with unloaded SDB. 
 
Comparison of flow resistive and pressure threshold loading 
There were small, but significant differences between the two types of inspiratory 
load (IF vs. IT) for fcI (71±2 vs. 74±2 beats∙min-1, respectively) and TPRI (14±1 vs. 
13±1 mmHg∙min∙l-1, respectively; Table 6-2; P < 0.004). For the two types of 
expiratory load (EF vs. ET), there were no significant differences for any of the 
analysed variables. Similarly, dual inspiratory and expiratory loading did not differ 
between loading types (DF vs. DT), or between single nostril breathing and oral DF 
(RN and LN vs. DF).  
 
Comparison of right vs. left single nostril breathing  
No significant cardiovascular differences were observed between right vs. left single 









Figure 6-4 – Systemic haemodynamic responses to resisted slow and deep breathing. Black: B- Baseline, UL -Unloaded slow and deep breathing; Blue: IF – flow 
dependent inspiratory load, EF – flow dependent expiratory load, DF – flow dependent dual inspiratory/expiratory load; Red: IT – threshold inspiratory load, ET – threshold 
expiratory load, DT – threshold dual inspiratory/expiratory load; Green: RN – right nostril breathing, LN – left nostril breathing. Data are for 15 participants (n=14 for RN and 







Table 6-2 – Systemic haemodynamic responses. 
Data represent mean ± SEM for 15 participants. Respiratory sinus arrhythmia (RSA), heart rate (fC), heart rate during inspiration (fcI), heart rate during expiration (fcE), left ventricle stroke 
volume (LVSV), stroke volume during inspiration (LVSVI), stroke volume during expiration (LVSVE), within-breath variation in stroke volume (ΔSV), ‘peak-valley’ amplitude of LVSV (LVSVI/E), 
cardiac output (Q̇), cardiac output during inspiration (Q̇I), cardiac output during expiration (Q̇E), within-breath variation in cardiac output (ΔQ̇), systolic blood pressure (SBP), peak systolic blood 
pressure during inspiration (SBPImax), peak systolic blood pressure during expiration (SBPEmax), ‘peak-valley’ amplitude of systolic blood pressure (SBPI/E), diastolic blood pressure (DBP), ‘peak-
valley’ diastolic blood pressure (DBPI/E), mean arterial pressure during inspiration (MAPI), mean arterial pressure during expiration (MAPE), pulse pressure during inspiration (PPI), pulse pressure 
during expiration (PPE), ‘peak-valley’ pulse pressure (PPI/E), total peripheral resistance during inspiration (TPRI), total peripheral resistance during expiration (TPRE), sequence baroreflex 
sensitivity positive sequence gain (BRSup), sequence baroreflex sensitivity negative sequence gain (BRSdown), sequence baroreflex sensitivity average gain (BRSSeq); cross-spectral baroreflex 
sensitivity gain (BRSFreq). Slow and deep breathing conditions performed at 6 breaths∙min-1 and 30% FVC. UL – unloaded slow and deep breathing, IF – flow dependent inspiratory load, EF – 
flow dependent expiratory load, DF – flow dependent dual inspiratory/expiratory load, IT – threshold inspiratory load, ET – threshold expiratory load, DT – threshold dual inspiratory/expiratory 
load, RN – right nostril breathing, LN – left nostril breathing. Data for RN and LN are for 14 participants, due to issues with placement of the nasal probe in one individual. * unloaded slow and 
deep breathing different from baseline, † different from IF, ‡ different from EF, # different from IT, § different from ET. P < 0.004. 
 Baseline UL IF EF DF IT ET DT RN LN 
fcI (beats∙min-1) 65±3 67±2 71±2 67±2 71±2 74±2† 72±3 73±2 72±2 70±2 
fcE (beats∙min-1) 60±2 56±2* 55±2 61±2 58±2 55±2 62±3 57±2 59±4 54±2 
LVSVI (mL∙beat-1) 100±5 97±4 91±4 84±4 86±4 93±4 84±4 85±5 88±5 89±5 
LVSVE (mL∙beat-1) 96±4 109±4* 114±5‡ 100±5 112±5‡ 118±5§ 98±4 108±6 110±7 111±7 
LVSVI/E (mL∙beat-1) 14±1 19±1* 29±2 27±2 30±2 31±2 27±2 29±1 29±3 28±2 
Q̇I (L∙min-1) 6.4±0.3 6.4±0.2 6.3±0.2‡ 5.6±0.3 6.1±0.3‡ 6.8±0.2§ 6.0±0.3 6.1±0.3 6.2±0.3 6.1±0.3 
Q̇E (L∙min-1) 5.8±0.3 6.0±0.2 6.2±0.2 6.0±0.2 6.4±0.3 6.4±0.3 6.0±0.3 6.1±0.2 6.4±0.4 5.8±0.3 
SBP (mmHg) 120±2 126±1 125±3 132±3 129±2 121±3 129±2# 129±3# 128±2 127±2 
SBPImax (mmHg) 121±2 127±2 128±3 133±3 130±2 126±3 129±2 130±3 129±2 129±3 
SBPEmax (mmHg) 126±2 135±1* 137±3 144±3 143±2 132±2 143±3# 146±3# 141±2 141±2 
SBPI/E (mmHg) 16±1 20±1 29±1 21±2 29±2‡ 29±2 23±1 34±2§ 31±3 30±3 
DBP (mmHg) 72±1 73±1 73±2‡ 81±2 77±2 70±2 80±2# 78±2# 77±2 75±2 
DBPI/E (mmHg) 9±1 9±1 11±1 19±2† 17±1† 11±1 21±1# 18±1# 14±2 14±2 
MAPI (mmHg) 88±1 90±2 89±2‡ 95±2 90±2 85±2 93±2# 90±2 90±2 89±3 
MAPE (mmHg) 91±1 95±2 97±3‡ 107±2 104±2 92±2 107±2# 104±3# 102±2 100±2 
PPI (mmHg) 52±2 58±1* 61±2 61±2 62±2 62±2 58±2 62±3 60±2 61±3 
PPE (mmHg) 55±2 63±2* 64±2 64±2 66±2 64±2 63±2 67±2 65±3 66±2 
PPI/E (mmHg) 10±1 14±1 21±1‡ 16±2 17±1 21±2§ 15±1 20±2 19±2 19±2 
TPRI (mmHg∙min∙L-1) 14±1 14±1 14±1‡# 18±1 16±1‡ 13±1 16±1# 16±1# 15±1 15±1 
TPRE (mmHg∙min∙L-1) 16±1 16±1 16±1‡ 19±1 17±1‡ 15±1 19±2 18±1# 17±1 18±1 
BRSup (ms∙mmHg-1) 17±3 22±2 27±4 15±2 20±4 23±5 17±3 17±2 22±2 23±2 
BRSdown (ms∙mmHg-1) 15±2 15±1 14±2 11±1 11±2 12±1 13±2 10±1 12±2 16±3 
BRSSeq(ms∙mmHg-1) 16±2 18±2 20±3‡ 13±2 16±2 18±3 15±2 14±1 17±1 20±2 
BRSFreq (ms∙mmHg-1) 19±4 17±2 15±1 16±4 12±2 17±2 10±1 11±1 12±1 15±2 
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6-4.2 Inspiratory vs. expiratory resistances during slow and deep breathing  
The analysis of the pooled (combined data from flow resistive loading and pressure 
threshold loading), individualised, systemic cardiovascular response to the 
application of inspiratory and expiratory resistances (dual inspiratory and expiratory 
resisted breathing conditions not included) showed that in all individuals, except 
one, RSA was higher during inspiratory loading (Figure 6-5A). Similar patterns were 
found for LVSV (Figure 6-5C) and Q̇ (Figure 6-5E), while the opposite was observed 
for ∆SV, TPR and MAP (Figure 6-5D, G-H), indicating lower values of these 
variables with inspiratory loading, compared expiratory loading (Figure 6-5). In 
contrast, no clear pattern emerged for fc and ∆Q̇ (Figures 6-5B and 6-5F) responses 
for either directionality, or magnitude of the change, which varied widely between 
participants. 
 
A regression analysis of the individualised response of RSA to inspiratory loaded, 
expiratory loaded and unloaded SDB was consistent with the aforementioned 
response patterns, i.e., mean respiratory pressure (average pressure during the 
entire respiratory cycle) related strongly and negatively with RSA (R2 = 0.64; P < 
0.001; Figure 6-6). Similarly, moderate positive correlations were observed between 
mean respiratory pressures and ∆SV, TPR and MAP (R2 = 0.53, 0.46 and 0.47, 
respectively; P < 0.001; Figure 6-6). Weaker, but significant, relationships emerged 
between mean respiratory pressure and Q̇ (R2 = 0.32; P < 0.001), LVSV (R2 = 0.22; 



















Figure 6-5 - Individual cardiovascular responses to inspiratory and expiratory resisted breathing. The 0 (zero) values in both axes refer to individual values for the 
expiratory loaded conditions, while the remaining dots represent the difference between the inspiratory and expiratory loaded conditions. Positive y-axis values indicate an 
individual increase in the variable of interest with the application of inspiratory resisted breathing vs.similar magnitude expiratory resisted breathing. The figure depicts data 










Figure 6-6 – Relationship between mean respiratory pressures (average pressure during the entire respiratory cycle) and the cardiovascular response to 
inspiratory loading, expiratory loading and unloaded SDB. Data are mean ± SEM for 15 participants. Corresponding R2 values are calculated using previously described 




6-4.3 Strongest influences upon respiratory sinus arrhythmia during loaded 
breathing 
A four-predictor model including PPI/E, ∆Q̇, fc and ∆SV provided a significant 
regression equation (F (4, 143) = 92.473, P < 0.001), with an R2 = 0.721. 
 
Predicted RSA = 281.13 + 12.864 (PPI/E) + 83.931 (∆Q̇) – 3.794 (fc) – 3.736 (∆SV), 
where PPI/E is measured in mmHg, ∆Q̇ in L·min-1, fc in beats∙min-1 and ∆SV in 
mL·beat-1.  
 
Thus, RSA increased by around 13 ms for each mmHg increase in PPI/E amplitude, 
84 ms by each L.min-1 of within-breath variation of Q̇ (∆Q̇), reduced 3.79 ms by each 
beats∙min-1 increase and varied inversely to within-breath amplitude in LVSV by 3.74 
ms by each mL·beat-1 change. All variables were significantly correlated with RSA. 
 
This four-predictor model provided a better estimation of RSA than the previously 
applied (cf. Chapters 4 and 5). When applying said three predictor model including 
∆SV, fc and ∆Q̇, a significant regression equation (F (3, 144) =68.487, P < 0.001), 
with an R2 = 0.588.  
 
Predicted RSA(I/E)4 = 201 - 9 (∆SV) –5 (fc) +98 (∆Q̇), where ∆SV is measured in 
mL·beat-1, fc in beats∙min-1 and ∆Q̇ in L·min-1.  
 
Participants’ RSA(I/E) decreased 9 ms by each mL·beat-1 increase in within-breath 
variation in LVSV, reduced 5 ms by each beats∙min-1 and increased 98 ms by each 
L.min-1 of within-breath variation of Q̇ (∆Q̇). All three variables were significantly 
correlated with RSA(I/E). 
 
 
                                            
4 In the previous experimental chapters, RSA was calculated by the difference between the maximum RR 
interval during expiration minus the minimum RR interval during inspiration, as described by Grossman et al. 
(1990). Contrarily, in the current experimental chapter, RSA was calculated as the maximal difference between 
maximum and minimum RR interval within a breath cycle, independently of the respiratory phase in which 
they occurred (Hirsch and Bishop, 1981). 
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6-4.4 Heart rate and blood pressure variability response 
Effects of unloaded slow and deep breathing  
Unloaded SDB resulted in significant increments of SDNN (75±8 ms) and Poincaré 
plot’s SD2 (158±15 ms) when compared to baseline (SDNN: 51±7 and SD2: 104±13 
ms; Table 6-3, P < 0.004), with no impact in time domain RMSSD and spectral HRV 
indices. Similarly, BPV spectral components did not change significantly from 
baseline with the application of SDB alone (Table 6-3, P > 0.004).  
 
Comparison of flow resistive and pressure threshold loading 
The application of different methods of loading (flow resisted breathing vs. threshold 
loaded breathing) did not result in any significant differences in any of the analysed 
HRV and BPV variables. Similarly, no differences were observed for either HRV and 
BPV indices during single nostril breathing (right nostril vs. left nostril; Table 6-3, P 
> 0.004). 
 
Comparison of right vs. left single nostril breathing 
No significant differences were found between single nostril breathing and the dually 
(inspiratory and expiratory) flow resisted breathing condition (DF), for any of the 
HRV and BPV analysed indices. Similarly, the comparison between right and left 
nostril breathing revealed no dissimilarities between these two conditions (Figure 6-
7, Table 6-3, P<0.004).  
 
Inspiratory vs. expiratory resistances during slow and deep breathing 
When comparing the effects of inspiratory, expiratory and dual loaded breathing, a 
consistent pattern emerged for both time domain and Poincaré plot HRV indices. 
The SDNN, RMSSD, SD1 and SD2 all showed systematically higher values during 
the inspiratory (IF and IT) and dual (DF and DT) loading conditions than during the 
expiratory (EF and ET) resisted breathing trials (Table 6-3, P < 0.004) 
 
The HRVTOT during the IF condition was significantly larger than that observed 
during the EF condition (Figure 6-7, Table 6-3, P < 0.004), but the same pattern was 
not observed during threshold loading (IT vs. ET). BPV was highest with the 
combined use of inspiratory and expiratory loads (DF and DT). The BPVTOT for the 
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dual loading conditions was significantly greater than the expiratory resisted 
breathing conditions using the same type of loading device (DF vs. EF and DT vs. 










Figure 6-7 – Total heart rate variability and blood pressure variability power responses to resisted slow and deep breathing.  Black: B- Baseline, UL -Unloaded slow 
and deep breathing; Blue: IF – flow dependent inspiratory load, EF – flow dependent expiratory load, DF – flow dependent dual inspiratory/expiratory load; Red: IT – threshold 
inspiratory load, ET – threshold expiratory load, DT – threshold dual inspiratory/expiratory load; Green: RN – right nostril breathing, LN – left nostril breathing. Data are for 







Table 6-3 – Heart rate and blood pressure variabilities  
Data represent mean ± SEM for 15 subjects. Slow and deep breathing conditions performed at 6 breaths∙min-1 and 30% FVC. IF – flow dependent inspiratory load, EF – flow 
dependent expiratory load, DF – flow dependent dual inspiratory/expiratory load, IT – threshold inspiratory load, ET – threshold expiratory load, DT – threshold dual 
inspiratory/expiratory load, RN – right nostril breathing, LN –left nostril breathing. Data for RN and LN are for 14 participants, due to issues with placement of the nasal probe 










 Baseline Unloaded IF EF DF IT ET DT RN LN 
SDNN (ms) 51±7 75±8* 98±9 63±9† 80±9† 101±8§ 66±8 86±9§ 95±10 97±10 
RMSSD (ms) 43±8 51±7 73±9 48±11† 60±9† 75±9§ 47±10 61±8§ 74±13 75±12 
HRVLF (ms2) 49841±23801 50381±19485 78462±23811 34256±12899 55807±16262‡ 91034±26488 23928±7168 61789±19389 58914±12837 67506±21236 
HRVHF (ms2) 16560±5809 20580±5049 36782±9625 27664±11816 36150±9312 34818±9251 34127±14329 30953±8161 51211±27708 46402±17639 
SD1 (ms) 49±9 58±8 86±10 57±12† 70±10† 86±10§ 53±11 75±9§ 83±12 85±11 
SD2 (ms) 104±13 158±15* 211±18 132±17† 172±19† 213±16§ 139±15 189±13§ 203±23 205±21 
SD1/SD2 0.47±0.05 0.36±0.02 0.40±0.02 0.40±0.04 0.40±0.02 0.40±0.02 0.35±0.03 0.40±0.05 0.41±0.04 0.42±0.05 
BPVLF(mmHg2) 100±24 194±52 408±108 297±89 564±148 437±123 320±98 677±173 410±98 446±110 
BPVHF (mmHg2) 53±14 16±3 101±14 91±21 109±19 136±12 82±18 101±22 106±36 102±34 
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6-4.5 Phase angle and time shift 
There were no differences in phase and time shift for the SBP-fc transfer function 
(P > 0.004 for all selected comparisons).  
 
Effects of unloaded slow and deep breathing  
Significant differences between baseline and unloaded SDB were found for the 
RESP-fc (baseline: 0.21 ± 0.09 s vs. UL: 1.91 ± 0.23 s; P < 0.004) and RESP-SBP 
relationships (baseline: -0.93 ± 0.32 s vs. UL: 1.48 ± 0.48 s; P < 0.004; Figure 6-8, 
Table 6-4) alone.  
 
Comparison of flow resistive and pressure threshold loading 
The use of different loading devices did not result in significant differences for any 
of the analysed phase relations (P > 0.004; Figure 6-8, Table 6-4). 
 
Comparison of right vs. left single nostril breathing  
Single nostril breathing conditions (RN and LN) showed similar behaviour for all 
analysed transfer functions, while also not differing significantly from dual loaded 
flow resisted breathing (DF; P > 0.004).  
 
Inspiratory vs. expiratory resistances during slow and deep breathing  
Both RESP-DBP and SBP-DBP functions exhibited larger phase angle and time 
shift values for the inspiratory loaded conditions (IF and IT) when compared to the 
expiratory and dual loaded breathing conditions using the same loading devices (IF 




Figure 6-8 – Respiratory, heart rate and blood pressure time shift variations with resisted slow 
and deep breathing. Black: B- Baseline, UL -Unloaded slow and deep breathing; Blue: IF – flow 
dependent inspiratory load, EF – flow dependent expiratory load, DF – flow dependent dual 
inspiratory/expiratory load; Red: IT – threshold inspiratory load, ET – threshold expiratory load, DT – 
threshold dual inspiratory/expiratory load; Green: RN – right nostril breathing, LN – left nostril 
breathing. Data are mean ± SEM for 15 participants (n=14 for RN and LN due to issues with 
placement of the nasal probe in one participant). Signalled significant differences are for 
corresponding phase angles (Table 4). * UL different from B, † different from IF, # different from IT. 








Table 6-4 – Respiratory, blood pressure and heart rate phase angle response to loaded slow and deep breathing. 
Data represent mean ± SEM for 15 subjects.  Slow and deep breathing conditions performed at 6 breaths∙min-1 and 30% FVC. IF – flow dependent inspiratory load, EF – 
flow dependent expiratory load, DF – flow dependent dual inspiratory/expiratory load, IT – threshold inspiratory load, ET – threshold expiratory load, DT – threshold dual 
inspiratory/expiratory load, RN – right nostril breathing, LN –left nostril breathing. Data for RN and LN are for 14 participants, due to issues with placement of the nasal probe 




 Baseline Unloaded IF EF DF IT ET DT RN LN 
Resp-fc (deg) 14±6 66±8* 88±8 120±12 103±10 92±8 114±13 94±9 88±10 88±10 
Resp-SBP (deg) -60±21 51±10* 64±8 54±6 61±7 67±7 41±6 59±7 64±6 64±9 
Res-DBP (deg) 68±13 116±13 114±13 49±6† 66±5† 125±13 47±7# 70±6# 85±4 92±15 
SBP-fc (deg) 59±18 13±5 23±4 60±12 38±10 26±6 51±17 34±6 26±7 23±5 
SBP-DBP (deg) 112±33 64±11 49±9 -2±9† 6±8† 56±12 11±4# 11±7# 21±6 39±10 
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6-5 Discussion  
This investigation sought to elucidate the acute cardiovascular and autonomic 
response to loaded SDB in healthy human beings by establishing: 1) the influence 
of adding inspiratory and/or expiratory resistances upon the efficacy of SDB alone; 
2) the effects of inspiratory and expiratory resistances upon cardiovascular 
responses to SDB; 3) the cardiovascular responses to flow resistive loading and 
pressure threshold loading, and 4) the cardiovascular response to the different 
routes of respiratory airflow, specifically mouth, right nostril and left nostril. 
 
A major finding was that the application of resistances that resulted in more negative 
intrathoracic pressures was correlated significantly with an increase in RSA and 
HRV indices. These responses were accompanied by increases in LVSV and the 
amplitude of ∆SV (such that LVSVE > LVSVI), while MAP, similarly to the previous 
studies, remained unchanged from unloaded SDB. In contrast, the application of 
expiratory loads promoted small, but significant ‘pressor-like’ response during SDB. 
Consistent with this notion, the use of expiratory resistances affected the phase 
relationships for DBP, with both the instantaneous variations in lung volume (RESP) 
and SBP showing a shortening of the delay in their relationships with DBP. Other 
important findings included the absence of any differences between right and left 
nostril breathing, and between these and dual flow resisted breathing (DF), at a 
similar respiratory pressure. When combined with the fact that no meaningful 
differences existed between the two types of loading, these data suggest that the 
acute cardiovascular response to loaded SDB is primarily driven by variations in 
mean respiratory pressure. Overall, the addition of a small inspiratory resistance 
seems to amplify of the acute within-breath LVSV and Q̇ responses to SDB, as well 
as HRV, without a concomitant increase in blood pressures, whilst the use of 
expiratory resistances increases blood pressures without enhancing the amplitude 
of other cardiovascular and HRV responses observed with inspiratory resistances 









6-5.1 Effects of inspiratory vs. expiratory resisted breathing 
Cardiovascular effects  
Similar magnitude inspiratory and expiratory resistances were applied 
systematically using two different loading methods, as well as single nostril 
breathing. A major finding was the discovery of a tight inverse relation between 
changes in RSA magnitude and mean respiratory pressure (Figures 6-5 and 6-6). 
This pattern might be attributable mechanistically to increases in systemic venous 
return and LVSV with the application of inspiratory resistances, as previously 
suggested by others (Lurie, Mulligan, McKnite et al., 1998, Lurie, Zielinski, McKnite 
et al., 2000, Convertino, Ratliff, Ryan, Cooke, et al., 2004, Convertino, Ratliff, Ryan, 
Doerr, et al., 2004), and supported by data from Chapters 4 and 5 of this thesis. 
Several observations underpin this interpretation. 
 
Firstly, in all but one participant, RSA was higher with the use of inspiratory 
resistances than with expiratory loaded breathing. Furthermore, similar 
individualised patterns were found for the LVSV and Q̇, when comparing the 
application of inspiratory and expiratory resistances, while an opposite response 
(decrease with inspiratory resisted breathing vs. expiratory loaded breathing) was 
observed for TPR, MAP and ∆SV.  The more negative values for ∆SV with the 
application of inspiratory resistances, under conditions where LVSV tends to have 
the opposite behaviour, suggests that any increases in LVSV with the inspiratory 
loaded breathing occur mainly during the expiratory portion of the respiratory cycle 
(↑ LVSVE). This is consistent with findings from the two previous studies (Chapters 
4 and 5) and likely reflects a delay between the changes in venous return to the right 
side of the heart and its expression in left ventricular output, interposed by relatively 
large pulmonary transit time, when compared to the normal length of the respiratory 
cycle, in spontaneously breathing individuals (5 to 10 s vs. 2.5 s, respectively) 
(Blumgart and Weiss, 1927b, Dornhorst et al., 1952b).  
 
Secondly, multiple individual fixed effects regression analysis confirmed the close 
relationship between the increase (more positive) value of mean respiratory 
pressure and a decrease in RSA (R2 = -0.80; P < 0.001), with weaker relationships 
observed for the within-breath LVSV amplitude (∆SV: R2 = 0.53; P < 0.001), MAP 
(R2 = 0.47; P < 0.001), TPR (R2 = 0.46; P < 0.001), Q̇ (R2 =0.32; P < 0.001) and 
LVSV (R2 = 0.22; P < 0.001). Finally, stepwise multiple regression analysis 
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generated a four-predictor linear model that suggested RSA was most strongly 
influenced by PPI/E, ∆Q̇, fc and ∆SV (R2 = 0.721, P < 0.001). The presence of PPI/E 
(i.e. maximal amplitude in pulse pressure within the epoch), ∆Q̇ and ∆SV in this 
model, highlight the contribution of respiratory-driven fluctuations in left ventricular 
output to the generation and amplitude of RSA. However, it must be refered that, 
similarly to the previous experimental chapters, ∆Q̇ and fc are not independent from 
RSA, as RSA effectively represents the within-breath amplitude of fc and Q̇ is given 
by the product of fc by LVSV. Since, participants  breathed at 0.1 Hz, it is possible 
that the respiratory variations in Q̇ enhanced RSA by entraining with naturally 
occurring low-frequency ABP oscillations at the same frequency (Elstad, Walloe, 
Chon et al., 2011). The complexity of the contributory mechanisms makes it 
extremely difficult to understand if ∆Q̇ is in fact enhancing RSA by its effect on ABP 
and subsequent stimulation of carotid baroreceptors, or whether RSA is in fact 
contributing to (or buffering) the phasic fluctuations in Q̇ (Elstad et al., 2011). 
 
Recently, results from a 6-week trial in healthy people of different loaded breathing 
patterns (at normal or slightly raised fR) showed no difference in the magnitude of 
chronic reductions in blood pressure between expiratory and inspiratory loads, 
independent of VT (Vranish and Bailey, 2015). The authors concluded that similar 
acute mechanisms should be involved for expiratory and inspiratory loading. 
However, the present data indicate that expiratory and inspiratory loads induce very 
different cardiovascular responses, which does not support Vranish and Bailey’s 
interpretation. Two methodological differences are important to highlight before 
further consideration of the findings; firstly, the present study used much lower 
absolute respiratory loads and fR, compared with Vranich and Bailey. A consistent 
pressor-like response was observed in the current study with the application of 
expiratory resistances, which was not present in the inspiratory resisted breathing 
conditions, suggesting there may be different aortic and carotid baroreceptor loading 
patterns, depending on the phase of breathing that is loaded. The elevations in 
MAP, SBP and DBP during expiratory loading are not consistent with earlier 
observations by Laciuga et al. (2012), who found no alterations in ABP with short (5 
s) Valsalva manoeuvres and expiratory muscle training in healthy individuals. 
However, the magnitude of the expiratory load applied in Laciuga’s study was much 
higher (75% of individual maximum expiratory pressure) and the length of the 
resisted breathing tasks lower (12 consecutive breaths, followed by another 13 
breaths after measurement), compared to the present study. Nonetheless, the 
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present data also contradict previous reports of significant elevations in ABP 
following light inspiratory resisted breathing (6 to 12 cmH2O) in human beings 
(Convertino, Ratliff, Ryan, Cooke, et al., 2004, Convertino, Ratliff, Ryan, Doerr, et 
al., 2004). Since BRS was unchanged in both Convertino’s studies, the authors 
interpreted the increase ABP as evidence of ‘resetting’ of the operating point for 
SBP on the baroreflex stimulus-response continuum. In contrast, the present study 
found no changes in SBP, MAP or DBP during inspiratory loading, relative to 
baseline or unloaded SDB; furthermore, all BRS indices remained relatively 
unchanged throughout all interventions (except BRSSeq, which was significantly 
higher for IF than for EF). For Convertino and colleagues, the changes in SBP were 
considered to be due to increased venous return, LVSV and Q̇.  However, the 
present study found no evidence to support the idea that the addition of a small 
inspiratory load during SDB could significantly increase LVSV and Q̇ beyond what 
is generated by SDB alone. In contrast, when comparing the responses to 
inspiratory and expiratory loading, the present study found that a higher LVSV and 
Q̇ was present during inspiratory loaded SDB, despite reductions in MAP. These 
observations are in agreement with previous observations by Seals and colleagues 
(1993), who reported an abrupt decrease in MAP during early inspiration with the 
application of inspiratory resistances of ~20 cmH2O.  
 
Within the constraints of the present study, it is reasonable to suggest that ABP 
fluctuations were mainly determined by the differing effects of loading inspiration 
and expiration, upon TPR and systemic venous return. This is consistent with 
echocardiographic evidence from studies of Valsalva and Mueller manoeuvres (as 
mentioned previously, breathing against an expiratory resistance can be likened to 
a partial Valsalva, with a similar logic being applied to inspiratory loaded breathing 
and the Mueller manoeuvre). Under this construct, the increase in MAP with 
expiratory resisted breathing is likely due to the combined effect of the following 
factors operating during expiration: 1) decreased ABP during the preceding 
unloaded inspiratory phase (Murgo, Westerhof, Giolma et al., 1980, Looga, 1997); 
2) reflex response from arterial baroreceptors and lung vascular mechanoreceptors 
leading to a rise in fc and TPR in response to the above-mentioned decrease in ABP 
(Looga, 2005), 3) this reflex response is combined with the effects of an increase 
venous return during the preceding inspiratory phase upon LVSV, further 
contributing to an in increase in ABP (Looga, 2005), 4) the pneumatic effect of the 
enhanced expiratory effort compressing the heart and intrathoracic vessels, forcing 
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blood into periphery, despite an increased aortic intravascular pressure (Eckberg, 
1980, de Burgh Daly, 1986). In contrast, inspiratory loading would resemble the 
cardiovascular response observed in the Mueller manoeuvre, with an initial increase 
in systemic venous return to the RV, accompanied by a rise in aortic transmural 
pressure (increased afterload), but followed rapidly by a reduction in preload as the 
difference between the negative intrathoracic pressure and positive intraabdominal 
pressure causes the large extrathoracic vessels to collapse at the thoracic inlets 
(Condos et al., 1987). Due to the length of PulTT (averaging ~6.5s at rest, according 
to Blumgart and Weiss [1927b]), during SDB the inspiratory increases in venous 
return to the RV translate into an expiratory rise in LVSV (Dornhorst et al., 1952b); 
similarly, the LVSV during inspiratory loading is determined by the preceding 
expiratory phase of breathing. Simultaneously, aortic transmural pressure 
decreases, contributing to a maintenance of MAP during inspiratory loaded SDB. 
Collectively, these observations suggest that the phase of the respiratory cycle 
where loading is applied, combined with inherent system lags (e.g. PulTT) 
determines the pattern of the cardiovascular response to loaded breathing, affecting 
MAP, but also left ventricular output, and consequently the magnitude of RSA.  
 
Heart rate and blood pressure variability effects 
Results from the present study show that loading the inspiratory phase of breathing 
results in significantly higher time domain (SDNN and RMSSD) and non-parametric 
HRV indices (SD1 and SD2) when compared to expiratory loaded SDB (Table 6-3). 
Loading simultaneously both phases of the respiratory cycle resulted in values 
between those observed for inspiratory and expiratory loaded SDB. In contrast to 
the time domain indices, in the frequency domain, only HRVTOT seemed to be 
significantly increased by IF (but not IT) compared to a similar expiratory load 
delivered by the same method (IF: 115,243±29,563 vs. EF: 61,920±23,985 ms2). 
Respiration is known to represent a significant portion of spectral HRV, profoundly 
altering HRV independent of changes in autonomic cardiac activity (Angelone and 
Coulter, 1964, Melcher, 1976, Hirsch and Bishop, 1981, Brown et al., 1993) making 
the quantification of spectral variability arising from different sources particularly 
challenging. The maintenance of an identical respiratory pattern across all 
conditions guaranteed that any significant differences in spectral HRV herein 
reported were either direct or indirect consequences of the different types and 
phases of loading. It must be emphasised that HRV measurements are not 
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analogous to direct measurements of either sympathetic nerve activity or cardiac 
parasympathetic outflow, providing a merely qualitative reflection of changes in 
cardiac autonomic regulation (Billman, 2011). As described in other sections of this 
thesis (see Chapter 2) there are several concurrent mechanisms interacting in a 
complex way that contribute to the variations in HRV, in such a way that any 
evaluation of cardiac autonomic activity based on the power spectral density in any 
of the HRV spectral bands is no more than an over-simplification of a nonlinear, 
multi-faceted phenomenon. The acute elevation of SDNN, RMSSD and HRVTOT 
represents an increase in the overall cardiac short-term variability (Task Force, 
1996) and is thought to positively contribute to an improved health status (Bigger, 
Fleiss, Steinman et al., 1995, Task Force, 1996, Bigger, 1997, Billman, 2011). Thus, 
the increases HRV in the present  study likely reflect the action of mechanical factors 
contributing to changes in right atrial filling and stretch (Bainbridge, 1915, 1920, 
Bernardi et al., 1989) and respiratory regulated reflex responses involving aortic and 
carotid baroreceptor stimulation (Eckberg and Orshan, 1977, Eckberg, Rea, 
Andersson et al., 1988, Eckberg, 2003, Rothlisberger et al., 2003). These 
observations supplement those of Calabrese et al. (2000) who, using simultaneous 
inspiratory and expiratory resisted breathing, observed no changes in spectral HRV 
with an increase of load, after correcting for the differences in respiratory pattern 
across their different conditions. These authors argued that the applied load (0-12.5 
cmH2O) had either been insufficient to alter baroreceptor input to cardiac 
motoneurones or that the marked within-breath ABP fluctuations were not the 
determinant factor involved in the changes in RSA and HRV. There is some support 
for the latter interpretation in our data, as suggested by the larger BPVTOT values in 
the dual loaded conditions. Furthermore, in Calabrese’s study inspiratory and 
expiratory phases were loaded simultaneously (similar to DF and DT in our study), 
and our HRV results for dual loading sets are akin to those observed with unloaded 
SDB, and thus consistent with those of Calabrese, under similar loading conditions. 
However, during single breath phase loading, our study did show a distinct HRV 
patterns, which were directly related to the phase of breathing that was loaded. 
Collectively, these findings point to a dissociation between the amplitude of ABP 
fluctuations and HRV, strengthening the case for a significant contribution arising 





Cardiorespiratory phase angle and time shift  
The DBP transfer function phase angle and time shift with both the instantaneous 
lung variation (RESP-DBP) and SBP (SBP-DBP) decreased substantially when an 
expiratory load was applied (either isolated or combined with an inspiratory 
resistance) despite RESP-fc, RESP-SBP and SBP-fc remaining fairly unaltered 
across all conditions (Table 6-4; Figure 6-8). These findings expand on previous 
research (Blaber and Hughson, 1996) and show that loading the expiratory phase 
of breathing has an almost immediate, mechanically driven, impact upon peripheral 
resistance as DBP is determined by the TPR, the viscoelastic properties of the 
arteries, and by diastolic interval (fc). As mentioned in chapter 4 (section 4-5.2), 
increased TPR decreases systolic run-off while diastolic run-off is increased, 
resulting in an elevation of MAP (London and Guerin, 1999), which is consistent with 
the changes in TPR and MAP observed in the present study (Table 6-2). Blaber and 
Hughson (Blaber and Hughson (1996) implemented dual inspiratory and expiratory 
resisted breathing, founding no changes in the phase relationship between LVSV, 
SBP and RR interval with the increase in applied resistance, suggesting that these 
phase relationships were primarily mechanically-driven by respiration. Similarly, in 
the present study, the phase angle for SBP-fc remained relatively constant across 
conditions. Moreover, while the RESP-SBP was unaltered, irrespective of the 
breathing phase being loaded, the SBP-DBP phase angle reduced from ~50º (1.5 
s) in the unloaded or inspiratory loaded conditions to 0-10º (0-0.3 s) when expiratory 
resistances were applied. As fluctuations in SBP and DBP are occurring almost 
simultaneously, and LVSV has a much more pronounced impact upon SBP than 
DBP, the SBP-DBP relation is likely a reflection of the respiratory mechanical effects 
of expiratory loading upon TPR. Due to insurmountable methodological limitations, 
within the time constraints of this work, we were unable to calculate LVSV phase 
relationships with RESP, fc and SBP. 
 
 
6-5.2 Flow resisted breathing vs. threshold loaded breathing 
The third aim of the present study was to examine if the application of different 
respiratory loading methods, at similar respiratory pressures, would influence the 
cardiovascular and autonomic response to the loaded SDB; flow resistive loading 
was compared with pressure threshold loading. To the best of the author’s 
knowledge, this is the first such comparison. Thus, a novel finding emerging from 
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the study is the absence of any significant differences between the two loading 
methods for any cardiovascular variables, or HRV and BPV, irrespective of the 
respiratory phase in which the load was applied (inspiratory, expiratory or both). The 
only exception was a small, but significantly higher fcI (IF: 71±2 vs. IT: 74±2 
beats∙min-1) and slightly lower TPRI (IF: 14±1 vs. IT: 13±1 mmHg∙min∙L-1) with IT, 
when compared to IF. We associate these small differences to slightly different 
pressure variation and airflow profiles between the two methods, particularly when 
the respiratory loading is applied during the inspiratory phase. With inspiratory 
threshold loading, the airflow is obstructed until enough pressure is generated to 
open the inspiratory valve. In order to be able to generate airflow and follow the 
visual feedback corresponding to a sinusoidal flow profile in the IT condition, 
participants had to produce the necessary opening pressure very early in the 
inspiratory phase, leading to a very abrupt decrease in intrathoracic pressure. In 
contrast, during flow resisted breathing, the pressure changes developed more 
progressively, for most participants (Figure 6-9). 
 
 
Figure 6-9 - Comparison of airflow and respiratory pressures for one individual using a flow 
resisted breathing device (upper panel) and a threshold loading device (lower panel). Red 




One potential effect of a quicker decrease in intrathoracic pressure might be an 
earlier (and more pronounced) increase in systemic venous return to the right 
atrium, with a more potent activation of cardiac mechanical stretch receptors, 
leading to the observed small inspiratory increase in fcI with IT. Notwithstanding this 
nuance, the findings reported in this chapter show for the first time, that the loading 
method does not affect the cardiovascular and HRV responses to loaded SDB, 
provided that the respiratory pressures and respiratory pattern are similar. Small 
differences in fc between methods might be due to dissimilarities in the rate of 




6-5.3 Single-nostril breathing 
Over the last couple of decades, some evidence has arisen suggesting that 
unilateral nostril breathing can have distinct beneficial effects upon ABP (Raghuraj 
and Telles, 2008, Pal et al., 2014), HRV (Pal et al., 2014) and autonomic activity 
(Telles et al., 1994). Breathing through the right nostril alone has been shown to 
contribute to an acute increase in SBP, DBP and MAP, and heightened sympathetic 
activation, while the opposite has been observed for left nostril breathing (Telles et 
al., 1994, Raghuraj and Telles, 2008, Pal et al., 2014). An explanation offered by 
authors for these observations is that single nostril breathing differentially activates 
the brain hemispheres, impacting both cognition and emotional states (Block, Arnott, 
Quigley et al., 1989, Schiff and Rump, 1995). 
 
The existence of a cyclic engorgement of left and right nasal mucosa has been 
documented to range from 25 to 200 min, leading to an alternation of the nostril 
through which airflow resistance is greatest (Schiff and Rump, 1995). This 
phenomenon has been related to known lateralised rhythmic activation patterns of 
the cerebral hemispheres (Werntz, Bickford, Bloom et al., 1983). This relationship 
between increased airflow and  the(contralateral) hemisphere activation is also 
present with single nostril breathing, as suggested by increased EEG activity in the 
contralateral hemisphere to the open nostril (Werntz, Bickford and Shannahoff-
Khalsa, 1987). 
 
A novel finding of the present study was that, in contrast to previous research, we 
found no differences in the cardiovascular and HRV response to single nostril 
breathing. Further to this main finding, no differences in any of the analysed 
variables were observed between the single nostril breathing conditions and the 
dual flow resistive breathing condition (both inspiratory and expiratory phases 
loaded). Unlike any of the studies mentioned above, air flow rate was controlled 
closely, and respiratory pressure monitored so that respiratory flow rates were 
identical for DF, RN and LN, while both PI and PE were quantified. The latter were 
very similar, despite larger intra-individual differences between RN and LN (Table 
6-1). As an additional precaution, excess nasal mucus was removed by nasal wash 
with saline prior to any of the single nostril breathing sets, guaranteeing that any 
differences between right and left nostril breathing respiratory pressure were 
determined by individual anatomical differences. Collectively, the present data 
suggest that any differences between nostrils during single nostril breathing 
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encountered in previous studies are likely due to different airflow resistances 
resulting from anatomical differences or mucus accumulation, leading to dissimilar 
inter-nostril resistances and associated pressures. Notwithstanding, the consistency 
across previous studies suggesting a sympathoexcitatory effect of right nostril 
breathing, with somewhat opposite effects associated with left nostril breathing, may 
warrant further investigation. 
 
 
6-6 Limitations  
In this study, evidence is provided for the existence of an important functional link 
between the within-breath fluctuations in LVSV and BPV. Further to this finding, it 
was speculated that there is a contribution of systemic venous return variations, in 
phase with respiration, to the generation of RSA. However, the absence of spectral 
and cross-spectral data relating to the LVSV waveforms is a limitation that leaves a 




6-7 Conclusions  
Inspiratory loaded SDB acutely heightens RSA, HRV, LVSV and the amplitude of 
within breath LVSV fluctuations, without concomitant increases in MAP. The 
addition of inspiratory loads amplifies the cardiovascular and HRV of SDB alone. 
Expiratory loaded breathing, on the other hand, failed to elicit the same 
cardiovascular and HRV response, while generating a significant pressor response 
(likely associated with mechanically-driven increases in TPR), and might therefore 
indicate that expiratory loads should be used with caution in certain clinical 
populations, especially as they seem less ‘effective’. The data lent support to the 
previous construct (see Study 2 – Chapter 5) that RSA is a ‘composite’ index to both 
mechanical and reflex effects of SDB, with the existence of an important functional 
link between respiratory driven variation in LVSV and the amplitude of RSA. The 
application of multiple regression analysis to this study’s data indicates that PPI/E, 
∆Q̇, fc and ∆SV are the main determinants of RSA. The use of different loading 
methods (flow resistive breathing vs. pressure threshold) seems to have no impact 
on the acute response to loaded SDB. Considering that the quantification of the 
resistance with flow resisted devices involves a precise control of the respiratory 
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flow rate, which normally can only be accomplished with the assistance of expensive 
equipment, the use of an inspiratory pressure threshold loading device may 
represent a more reliable and affordable alternative. Finally, the use of single nostril 
SDB proved to generate similar responses to that of dual flow resistive breathing, 
while no differences between left and right nostril breathing was identified. The 
observation of comparable outcomes with single nostril breathing, at similar airflow 
rates and respiratory pressures warrant further investigation, particularly how its 
application in combination with other respiratory techniques may provide potential 
therapeutic benefits in certain clinical populations, particularly in hypertensive 
individuals. Furthermore, whilst an argument has been made for a potential 
therapeutic effect of combining SDB with small inspiratory loads, future studies are 
required to test its clinical efficacy, particularly as an anti-hypertensive therapy. 
Results from this study have provided evidence of positive cardiovascular and HRV 
acute responses with inspiratory resisted breathing that have been previously 
shown to be related with an improved health status. Whether the magnitude of the 
observed acute changes is sufficient to cause long term cardiovascular and 
autonomic adaptation, and whether the same benefits are observed in 
hypertensive/elderly populations, in comparison to the healthy cohort herein 
reported, remains to be scrutinised. 
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The goal of this chapter is to appraise the major findings of this thesis and to discuss 
them in the context of the existing state-of-the-art. A mechanistic perspective is 
provided by integrating findings from this thesis and previous work described in the 
extant literature. The chapter concludes by outlining potential future research paths. 
 
7-2 Overview of Objectives 
The primary aim of this thesis was to characterise the acute cardiovascular and 
autonomic responses to SDB, in healthy individuals. To meet this goal, a number of 
objectives were addressed, which included: 
 
1) determine the independent effects of fR, VT and PaCO2 to the acute 
cardiovascular and autonomic responses to SDB; 
2) ascertain the contribution of intrathoracic pressure swings to the acute 
cardiovascular and autonomic responses to SDB; 
3) compare the acute impact of different methods of creating intrathoracic 
pressure swings during SDB. 
 
7-3 Main Findings 
7-3.1 Effects of breathing frequency, tidal volume and PaCO2 
The aims of Chapter 4 were to evaluate the independent effects of fR, VT and PaCO2 
to the responses to SDB. The main findings of chapter 4 confirmed previous 
observations that heart rate variability (HRV) and RSA magnitudes tended to 
increase with the decrease in fR, with average maximal values reached at 
frequencies close to 0.1 Hz (Angelone and Coulter, 1964, Hirsch and Bishop, 1981, 
Cooke et al., 1998, Song and Lehrer, 2003). Simultaneously, increments in VT 
promoted linear increases HRV, independently of fR. Furthermore, blood pressure 
variability (BPV) was significantly reduced at the lowest fRs, likely due to the 
involvement of a baroreflex mediated responses, while VT did not impact BPV 
significantly. We speculate that RSA worked to buffer the impact of respiratory-
driven fluctuations in venous return upon left ventricular cardiac output (Q̇) and 
arterial blood pressure (ABP). A novel finding of Chapter 4 was that for fRs < 8 
breaths·min-1, SDB promoted an inversion of the normal within-breath (inhalation 
vs. exhalation) pattern of left ventricular stroke volume (LVSV) such that expiratory 
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LVSV exceeded inspiratory LVSV. We attribute this finding to the influence of a lag 
between enhanced right atrial filling and RVSV during inspiration, and its expression 
in LVSV. We believe this lag was created by the effect of the time required for blood 
to transit the pulmonary circulation. Finally, there appeared to be a limited influence 
of PaCO2 upon the cardiovascular and HRV response to SDB. 
 
7-3.2 Effects of intrathoracic pressure variation 
The data presented in Chapter 5 supported the important contribution of respiratory-
driven increases in right-atrial filling during inspiration, and suggests a relevant 
contribution of previously underappreciated reflex, and/or ‘myogenic’, cardiac 
response mechanisms, to the amplification of RSA and HRV during SDB. Inspiratory 
loading during SDB (i.e. magnified negative intrathoracic pressure) increased 
inspiratory pressure-driven fluctuations in LVSV and fc, and enhanced Q̇, 
independently of changes in VT and fR. When SDB was loaded, the within-breath 
(inhalation vs. exhalation) behaviour of LVSV, fc and Q̇, combined with the non-
existence of significant changes in MAP and TPR suggested the absence of 
meaningful, additional acute autonomic changes. Evidence was provided regarding 
a causative relationship between within-breath fluctuations of LVSV and BPV. 
Furthermore, respiratory-driven fluctuations of LVSV (SV), SBP (BPV) and fc 
(RSA) were strongly, linearly related to phase shifts between cyclic fluctuations in 
lung volume, SBP and fc. Overall, Chapter 5 provided support for a contribution of 
both mechanical and reflex factors in the generation and amplitude of RSA during 
loaded SDB. 
 
7-3.3 Effects of different methods of creating intrathoracic pressure 
variations 
The aims of chapter 6 were to examine the effects of specific methods of increasing 
the magnitude of within-breath intrathoracic pressure fluctuations upon the 
responses to SDB. The findings in chapter 6 suggested that the method of loading 
did not affect the cardiovascular response to resisted SDB. In other words, flow 
resisted breathing and threshold loaded breathing resulted in similar patterns of 
acute response at the same level of resistance. Notwithstanding, the directionality 
of the resistance (i.e. inspiratory vs. expiratory) impacted the response pattern to 
SDB; the isolated use of inspiratory SDB amplified the effects observed with un-
resisted SDB (reported in chapter 5), while the application of expiratory resistances 
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increased the ABP and total peripheral resistance (TPR) response to SDB, while 
limiting RSA, LVSV and Q̇, when compared to inspiratory resisted SDB. The 
simultaneous application of inspiratory and expiratory resistances did not result in 
increased magnitude of acute cardiovascular responses, when compared to 
inspiratory resistances alone. Finally, single nostril breathing provided similar results 
to those observed with the simultaneous application of inspiratory and expiratory 
resistances of a similar magnitude, while no differences were found between the 
right and left nostril. 
 
 
7-4 Interpretation of findings 
The following section focuses on an interpretation of the main findings previously 
described in point 7-3. Figure 7-1 is a schematic representation of a potential model 
depicting the different factors that interplay to determine the acute cardiovascular 
response to SDB and frames the discussion that follows. 
 
The primary aim of the current chapter is to interrogate the findings of the present 
thesis in the context of the extant literature. Considering the accumulated of data 
that currently exists, and to which we believed to have been able to contribute with 
this thesis, it seems reasonable to depict an integrated model to portray the 
mechanistic pathways involved in the acute cardiovascular response to SDB. 
 
The proposed model aims to provide a possible exemplar from which a clearer 
understanding of how the manipulation of breathing pattern, as performed during 
the studies that comprise this thesis, impacts key cardiovascular variables acutely. 
The extreme complexity and multiplicity of systems that interplay and contribute 
towards this phenomenon mean that, to date, most studies exploring cardio-
respiratory interactions have examined potential mechanisms in isolation. Thus, the 
vast majority of quantitative data examining the acute cardiovascular effects of SDB 
breathing have been derived from reductionist human models that have, in my view, 
failed to systematically address the potentially independent effects of fR, VT, PaCO2 
and the amplitude of intrathoracic pressure variation. 
 
In contrast, the development of complex multifactorial mathematical models has 
allowed for the advancement of the state-of-the-art in this area of physiology, and 
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for the simulation of expected cardiovascular responses to a variety of perturbing 
stimuli. However, said models are far too complex to enable the identification of the 
key features that make the largest contribution(s) to cardiovascular system 
perturbation during SDB, in an integrated human model. While the proposed model 
draws from diverse sources of research, it mostly reflects the findings and 
interpretation of the data that emerged from the current thesis, and should, 
therefore, be interpreted within the constraints of this specific experimental 
paradigm.  
 
The model is based upon a hierarchy of respiratory, cardiovascular and autonomic 
interactions, where for simplicity, many intermediary factors have been omitted. The 
model proposes that the manipulation of the respiratory pattern by SDB induces 
direct and indirect physiological responses to the key mediating inputs: intrathoracic 
pressure (ITP), tidal volume (VT) and breathing frequency (fR). These inputs also 
carry a degree of interdependence.  
 
A general mechanistic description of the effects of SDB, based on the model 
presented in Figure 7-1, is underpinned by inspiratory increases in venous return 
associated with a more negative intrathoracic pressure throughout inspiration. The 
latter amplifies the pressure gradient between the right atrium and the systemic 
venous pressure, effectively ‘sucking’ blood from the major venous vessels into the 
right atrium (Brecher, 1952, Dornhorst et al., 1952b, Brecher and Hubay, 1955, 
Robotham et al., 1978, Robotham and Mintzner, 1979, Kim et al., 1987, Peters et 
al., 1989, Innes et al., 1993). Breathing at larger VTs amplifies the inspiratory 
decrease in intrathoracic pressure, and promotes increased intra-abdominal 
pressure, as the diaphragm obtrudes upon the abdominal cavity (Willeput et al., 
1984, Boutellier and Farhi, 1986, Kimura et al., 2011, Mesquida, Kim and Pinsky, 
2012), thereby contributing to the pressure gradient between the right atria and 
systemic venous pressure. This pressure gradient can be further amplified by the 
addition of an inspiratory resistance, thus promoting a more accentuated decrease 
in intrathoracic pressure throughout inspiration. Finally, fR can also impact 
cardiovascular dynamics, not only via an effect upon ITP (as fR decreases air flow 
rate is reduced for the same VT, thus attenuating ITP swings; this effect is likely 
negligible during SDB), but more potently, by altering the duration of the periods of 
facilitated venous return and the relation between the expression of increased 
venous return to  the right atrium and the expression of such variations into 
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augmented LVSV, due to the lag interposed by the pulmonary circulation. 
Furthermore, at specific fRs, entrainment occurs between respiratory, cardiac and 
systemic oscillations, which have been attributed to the resonant properties of the 
systemic baroreflex; this phenomenon is believed to greatly contribute to the 
amplification of ABP and fc oscillations at the predominant respiratory frequency 
(Vaschillo et al., 2002, Vaschillo et al., 2006). 
 
Finally, while not included in the model, this section also includes an overview of the 
significance of the findings regarding the impact of PaCO2 changes upon the acute 








Figure 7-1 – A schematic of an integrated mechanistic model to describe the acute cardiovascular responses to slow and deep breathing
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7-4.1 Effect of breathing frequency 
Relation with pulmonary transit time 
A novel finding of the present study was the frequency-dependent interrelationship 
of the within-breath (inspiration vs. expiration) changes in LVSV (Figure 4-3B). The 
apparently paradoxical decrease in LVSV during inhalation observed at some fRs is 
due to the delay between increases in venous return to the right atrium being 
expressed in the LVSV, likely induced by the pulmonary circulation (Dornhorst et 
al., 1952b, Harrison, Goldblatt, Braunwald et al., 1963, Hamzaoui et al., 2013). 
Thus, the inversion of inspiratory LVSV relative to expiratory LVSV below 6.6 
breath∙min-1 can be explained by the influence of pulmonary transit time (PulTT). 
During spontaneous breathing, increased right ventricular filling during inspiration 
and is translated into increased left ventricular filling and LVSV during the ensuing 
expiration (Figure 7-2). 
 
 
Figure 7-2 - Effect of pulmonary transit time upon the transmission of right to left ventricular 
filling changes, during spontaneous breathing. Inspiration results in increased right ventricular 
(RV) filling and stroke volume (SV). Pulmonary transit time interposes a phase lag between the right 
ventricle and the left ventricle (LV) so that LVSV is maximal during expiration. Adapted from 






Cross-spectral analysis of the relationship between instantaneous lung volume 
changes and SBP further supports the interpretation of a significant role of PulTT in 
determining LVSV phasic changes during SDB. A variable lag was identified 
between the start of inspiration and the induced reduction in SBP. This lag was, on 
average, 0o (completely in phase) at an fR of approximately 6.7 breaths·min-1. A 
possible explanation is that, at this frequency, the expiratory LVSV (LVSVe), and 
the associated decrease in SBP, lag behind the inspiratory increase in venous return 
by half a respiratory cycle (breath); in other words, the onset of inspiration coincides 
with the arrival at the left ventricle of the [attenuated] RVSV generated by the 
preceding exhalation.  
 
Previous reports suggest PulTT ranges from 5 to 17s (Blumgart and Weiss, 1927b), 
with an average PulTT of ~6.5s-7.9s in healthy human beings at rest (Blumgart and 
Weiss, 1927b, Levinson, Pacifico and Frank, 1966). A simple mathematical exercise 
based on the zero lag between the change in lung volume and the variation in SBP, 
at an fR of 6.7 breaths·min-1, leads to an estimation of a group mean PulTT of around 
4.5s. Whilst this crude estimate is lower than the aforementioned reported PulTT, it 
worth pointing out the vast variation in methods and criteria that exist in relation to 
estimates of PulTT, perhaps the most important of which being, 1) health status of 
the participants; 2) the start and end points for the estimation, e.g. right atrium to left 
ventricle. Furthermore, if we consider that increases in Q̇ can significantly impact 
PulTT, as demonstrated by the considerable reduction of PulTT when moving from 
rest to exercise (Zavorsky et al., 2003), it is plausible that small changes in Q̇ and 
ΔQ̇ associated with SDB might have resulted in a small reduction in average PulTT 
in our healthy, young male participants, compared to a spontaneous breathing 
condition. Despite the small discrepancy, my crude calculations nonetheless 
support the potential influence of the pulmonary circulation upon determining the 
amplitude and directionality (inspiratory vs. expiratory) of the within-breath 
variations in LVSV. Future research using first pass radionuclide cardiography 
(Zavorsky et al., 2003) during SDB, might help to further clarify the role of PulTT in 
the within-breath cardiovascular patterns.  
 
Spontaneously breathing individuals (paced breathing at the spontaneous fR) 
normally demonstrate phase opposition between RVSV and LVSV (Gabe, Gault, 
Ross et al., 1969, Elstad, 2012). However, while other factors like interventricular 
dependence (Bove and Santamore, 1981, Amoore and Santamore, 1989, Peters et 
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al., 1989, Amoore et al., 1992) and the compliance of the right ventricle (Santamore 
and Amoore, 1994) can possibly play a role in determining such phase relations, 
most studies examining this phenomenon have failed to do so in the context of SDB 
and/or overlooked the potential impact of PulTT. Also, the impact of the drop in 
intrathoracic pressure during inspiration, affecting afterload and SBP, independently 
of the changes in left ventricular output, cannot be disregarded. Thus, the above 
interpretation of the data should be considered as ‘food for thought’, and as a 
stimulus for further research regarding the potential influence of PulTT upon the 
haemodynamic responses to SBD. Nonetheless, it seems extremely probable, 
given the unquestionable existence of a transit time delay interposed by the 
pulmonary circulation, that alterations in fR contribute to changes in the phase 
relationship between the outputs of the two ventricles, thereby contributing to fR–
dependent behaviours of left ventricular ∆SV (LVSVI minus LVSVe). 
 
Breathing frequency and resonant behaviour of the cardiovascular control 
system 
It is well established that HRV indices, and particularly RSA, are affected by fR and 
tend to maximise at around 6 breaths·min-1 (Angelone and Coulter, 1964, Kelman 
and Wann, 1971, Hirsch and Bishop, 1981, Berger et al., 1989a, Saul et al., 1989, 
TenVoorde et al., 1995, Cooke et al., 1998, Taylor, Myers, Halliwill et al., 2001, 
Giardino, Glenny, Borson et al., 2003, Song and Lehrer, 2003). These observations 
are consistent with the data reported in Chapter 4. Notwithstanding, important inter-
individual differences in the fR at which RSA was maximised were observed by us, 
and by others, possibly reflecting differences in stature, gender and the volume of 
individual participant’s vasculature (Lehrer, 2007), including their pulmonary 
vasculature.  
 
Some authors have speculated that the maximisation of HRV at 6 breaths·min-1   
reflects an attempt of the cardiovagal baroreflex to buffer the ABP oscillation 
occurring at 0.1 Hz and the existence of resonances in the baroreflex control loop 
at frequencies close to 0.1Hz (TenVoorde et al., 1995, Julien, 2006, Di Rienzo et 
al., 2009). However, the increased RSA and HRV does not necessarily indicate 
increased buffering ability of the cardiac baroreflex at such frequencies. In fact, it 
has been suggested that when breathing at frequencies close to 0.1 Hz, RSA and 
 
221 
HRV can further magnify respiratory-driven fluctuations in ABP (Taylor and Eckberg, 
1996, Elstad et al., 2001, Vaschillo et al., 2002, Tan and Taylor, 2010).  
 
While we found no definitive evidence of the existence of a resonant behaviour 
linking ABP and fc through the cardiac baroreflex, previous studies seem to support 
the contribution of such phenomena to the amplification of ABP variability at 
frequencies close to 0.1Hz (De Boer et al., 1987, Lehrer et al., 2000, Vaschillo et 
al., 2002, Julien, 2006, Vaschillo et al., 2006). It has been suggested that breathing 
at a specific, individualised, resonant fR, potentially contributes to an amplification of 
cardiovascular variability due to an approximate 5-second delay in the baroreflex 
control of vascular tone; likely determined by the elasticity of the vasculature 
(Vaschillo et al., 2002), which is regulated by both neural (Fagius and Wallin, 1980, 
Wallin and Nerhed, 1982, Julien, 2006, Zamir, Goswami, Liu et al., 2011) and 
myogenic processes (Stefanovska and Bracic, 1999a, b, Zamir et al., 2011). 
Supporting his theory of resonance, Vaschillo and colleagues described regular 
phase relationships between fc and ABP at very specific, individualised, frequencies 
(Vaschillo et al., 2002). Under this construct, ABP and fc fluctuations are 180º out 
of phase at the resonant frequency for fc (which occurs within the low-frequency 
range, close to 0.1Hz). This results in perfectly opposite fluctuations in fc and ABP, 
which reinforce each other. In other words, as respiration produces oscillations in fc 
through mechanical and reflex processes, these are further amplified by 
engagement of baroreflex control of ABP. The baroreflex response produces 
decreases in fc and vascular tone (MSNA) in response to increased ABP, while 
decreases in ABP result in increased MSNA and fc. Subsequently, baroreflex-
induced fluctuations in fc and MSNA produce and maintain oscillations in ABP, thus 
contributing to its modulation and amplification at said resonant breathing frequency.  
 
However, there are some caveats that need to be applied to Vaschillo’s theory. 
Firstly, Vaschillo suggests that ABP resonant frequency occurs within the very low-
frequency band and that at this frequency fc and ABP oscillate in phase with each 
other, resulting in an inhibition of fc oscillations by baroreflex influences, while BPV 
is increased (Vaschillo et al., 2002). This contradicts the prevalent belief that 
buffering of BPV occurs fundamentally within the very-low frequency spectral band, 
while it’s resonant frequency lies within the low-frequency band and is intimately 
related to the occurrence of the so called Mayer-waves (Julien, 2006), as 
demonstrated by sino-atrial denervation in animals (Di Rienzo, Castiglioni, Parati et 
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al., 1996, Mancia et al., 1999), mathematical modelling (van de Vooren et al., 2007) 
and evidence arising from paraplegic (Castiglioni, Di Rienzo, Veicsteinas et al., 
2007) and quadriplegic (TenVoorde et al., 1995) individuals.  
 
Secondly, MSNA is believed to display respiratory-dependent pattern, inverse to 
that of fc (i.e. fc increases throughout inspiration, while MSNA tends to decrease 
during inspiration), with most MSNA bursts taking place at the lowest lung volumes 
(Eckberg et al., 1985, Seals et al., 1990, Seals et al., 1993). To the best of the 
author’s knowledge, no systematic characterisation of the effect of fR upon the 
phase relation between respiration and MSNA has been produced to date. However, 
it is accepted that MSNA during spontaneous, uncontrolled breathing does not differ 
from controlled paced breathing (Eckberg et al., 1985). Nonetheless, the duration of 
the respiratory cycle, more particularly the length of the inspiratory phase, might shift 
the onset of sympathoinhibition (Seals et al., 1990). Therefore, without the 
characterisation of the impact of fR upon MSNA and a complete understanding of 
the phase relationships between, fc, ABP and MSNA, a precise description of the 
mechanisms involved in cardiovascular resonant behaviour remains merely 
hypothetical. 
 
Thirdly, most depictions of the cardiovascular resonant behaviour seem to disregard 
the direct contribution of respiratory-mediated changes in MSNA to the Traube-
Hering wave5 amplitude and consider these oscillations in ABP as the logical 
consequence of respiratory-driven changes in systemic venous return, and 
subsequent effect upon Q̇. It has been demonstrated that respiratory-mediated 
changes in MSNA are closely associated with Traube-Hering wave amplitude 
(Towie et al., 2012, Shantsila, McIntyre, et al., 2015). Furthermore, while earlier 
work has described the respiratory modulation of MSNA in terms of its effects upon 
total activity (Eckberg et al., 1985, Seals et al., 1990, Seals et al., 1993, St. Croix et 
al., 1999, Dempsey et al., 2002, Limberg et al., 2013), some studies have 
characterised the MSNA response to external stimulation in terms of the burst 
incidence, frequency and strength (Kienbaum, Karlssonn, Sverrisdottir et al., 2001, 
Shantsila, McIntyre, et al., 2015), and determined that these factors are modulated 
differently by respiration (Shantsila, McIntyre, et al., 2015) and baroreflex stimulation 
                                            
5 Traube-Hering waves are respiratory related oscillations in arterial blood pressure. A more detailed description 




(Kienbaum et al., 2001), adding yet another layer of complexity to any interpretation 
of the contribution of changes in MSNA to resonant behaviour of baroreflex control.  
 
Fourthly, Vaschillo’s theory ignores the contribution of central respiratory-
sympathetic coupling to the generation of respiratory-related oscillations in MSNA, 
and consequently of ABP oscillations. Others have recently demonstrated, in human 
beings, a significant association between Traube-Hering wave amplitude and the 
amplitude of the preceding respiratory related MSNA bursts (Towie et al., 2012, 
Shantsila, McIntyre, et al., 2015). Additionally, the inhibitory role of pulmonary 
stretch receptors upon sympathetic activity during SDB is not considered within 
Vaschillo’s theory. This is particularly relevant in the light of data that suggests a 
reduction in MSNA burst incidence with SDB (Shantsila et al., 2014b), potentially 
secondary to increased lung inflation afferent input (Seals et al., 1990, Seals et al., 
1993, St. Croix et al., 1999, Khayat, Przybylowski, Meyer et al., 2004).  
 
Fifthly, BPVLF also contains contributions from intrinsic vasomotor rhythmicity, as 
shown by the persistence of BPVLF after ganglion blockade (Zhang, Iwasaki, 
Zuckerman et al., 2002). Moreover, BPV may also be dependent on experimental 
conditions, and vary between individuals with regards to the relative weight of 
vasomotor and neural/reflex contributions to its genesis, and cannot be assumed to 
simply reflect changes in MSNA (Parati et al., 1995, Zhang et al., 2002).  
 
Finally, if the so called ‘resonant behaviour’ was simply a reflection of the 
baroreceptor control delay, the amplification of the HRV by SDB at specific fRs will 
necessarily need to almost completely obliterate BPV, which does not seem to be 
suggested by Vaschillo’s or most studies that have reported BPV under SDB 
conditions (TenVoorde et al., 1995, Cooke et al., 1998, Chang et al., 2013, Jones, 
Asadi, Valipour et al., 2014, Chang et al., 2015). However, in the case of Vaschillo’s 
findings on BPV behaviour during SDB, some methodological peculiarities need to 
be highlighted. The SDB in the studies by the Vaschillo group employ a biofeedback 
intervention that does not dictate specific breathing frequencies. Instead, 
participants are instructed to use any means (respiratory, muscular or mental 
activity) to voluntarily match their fc response to a sinusoidal signal with a period 
between 7 and 100s (Vaschillo et al., 2002). Furthermore, in their 2002 study, 
Vaschillo and colleagues used a small sample of just five cosmonauts. It is known 
that repeated exposure to high G forces, such as those encountered by pilots and 
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trainee cosmonauts, can lead to marked adjustments in the baroreflex regulation of 
blood pressure (Newman, White and Callister, 1998), which might result in altered 
cardiovascular interactions, when compared to our healthy, untrained, participants. 
 
In Chapter 4 we reported that unlike most others (TenVoorde et al., 1995, Cooke et 
al., 1998, Chang et al., 2013, Jones et al., 2014, Chang et al., 2015) we encountered 
much reduced BPV at frequencies lower than 8 breaths·min-1. To the author’s 
knowledge, only one study has reported a similar decrease in the amplitude of SBP 
oscillations accompanying a reduction in fR (Sin et al., 2010). Several explanations 
might be advanced, most involving the contribution of cardiac and vascular 
baroreflex responses. Elstad and colleagues (2011) suggested that low-frequency 
fluctuations in HRV determine Q̇, while MAP fluctuations at 0.1 Hz are determined 
by fluctuations in TPR. Importantly, Elstad reported that Q̇ and TPR fluctuations are 
180o out of phase at 0.1Hz, meaning that TPR variations potentially counteract 
within-breath variations in Q̇, when breathing at 6 breaths·min-1 or below. 
 
The impact of the HRV (and RSA) upon the modulation of respiratory driven BPV 
should also be considered, as it has been suggested that RSA contributes to 
buffering left ventricular fluctuations in Q̇ and therefore BPV (Elstad, 2012). This is 
supported by data from Chapter 4 suggesting that RSA counteracts the within-
breath fluctuations in LVSV (∆SV) and that at these low frequencies, SBP and fc 
fluctuations tend towards being in phase opposition. Taken together, all of the above 
stated factors would conspire to minimise in BPV at low fRs, which reassures that 
my observations are physiological in origin. 
 
One possible reason for the dissimilarities between my BPV results and those of 
others is the difference in the extent of control over the independent effects of VT 
and fR upon respiratory modulation of ABP. In the present study, VT and fR were 
controlled rigorously in an upright-reclined position. In contrast, most previous 
studies have evaluated the cardiorespiratory phase relationships and transfer 
functions (including BPV) under supine resting conditions (Baselli et al., 1986, Toska 
and Eriksen, 1993), in response to orthostatic challenges (Baselli et al., 1986, Saul 
et al., 1991, Taylor and Eckberg, 1996, Cooke et al., 1999, Elstad et al., 2001), 
carotid baroreflex stimulation (Keyl et al., 2000), paced breathing (Berger et al., 
1989a, Saul et al., 1989, Taylor and Eckberg, 1996, Keyl et al., 2000), or following 
the administration of drugs (Saul et al., 1991, Toska and Eriksen, 1993, Elstad et 
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al., 2001). One notable exception is Cooke and colleagues’ (1998) study, which not 
only characterised HRV and BPV through a comprehensive range of fRs, with and 
without VT control (with spectral power peaks for both HRV and BPV occurring at 
the same fR close to 0.1 Hz), but also described the phase relation between SBP 
and fc throughout said range. However, unlike us, Cooke’s study was performed in 
the supine position. Previous research has demonstrated that under these 
conditions HRV (RSA) enhances SBP fluctuations, while in our upright-reclined 
position these are expected to be buffered (Elstad et al., 2001). 
 
Collectively, the experimental data presented herein seems to suggest that 
reductions in fR result in decreased BPV, likely due to the buffering action of RSA 
upon mechanically driven fluctuation in LVSV. Nonetheless, the amplification of ABP 
oscillations by the action of a mechanism that is not exclusively dependent of 
mechanically driven increments in LVSV, remains a strong possibility, as the 
application of the concept of system resonance cannot be excluded, albeit perhaps 
not in the simplistic way is has been in the past.  
 
Other factors affecting the cardiovascular response to changes in fR – rate of 
acetylcholine hydrolysation  
One element that has been referred in the literature as contributing to the breathing 
frequency dependent response of HRV is the kinetics of acetylcholine (ACh) 
influences on the sinus node, particularly (but not limited to) the rate of ACh 
hydrolysation (Eckberg and Eckberg, 1982, Taylor et al., 2001, Song and Lehrer, 
2003). These authors have speculated that during spontaneous breathing the 
amount of ACh released during expiration is limited by its duration. Since the time 
required for the de-activation of ACh by acetylcholinesterase is a relatively slow (1.5-
2s), fixed-rate process that seems to be independent of fR (Baskerville et al., 1979, 
Eckberg and Eckberg, 1982), ‘quick’ fRs result in less ACh being released during the 
expiration and incomplete hydrolisation of the same during inspiration. This creates 
an ‘ACh floor’ that limits the effects of the waxing and waning of ACh upon the 
sinoatrial node. At slower fRs, a larger bolus of ACh is released during expiration 
(contributing to maximal inhibition of sinoatrial note firing and decreased fcE), while 
the longer inspiratory time allows for complete inactivation of the larger bolus of ACh 




Consequently, longer respiratory cycles result in more complete hydrolysation and 
inactivation of ACh even if the bolus of ACh released during each expiration is 
similar, which partially helps to explain the higher RSA at lower fRs described in this 
study, as well as others (Eckberg and Eckberg, 1982, Taylor et al., 2001, Song and 
Lehrer, 2003). 
 
Like Song and Lehrer (2003) we encountered a more pronounced decrease in fcE, 
but without a significantly larger increase in fcI, as fR decreased. These changes 
seem to have occurred in the absence of significant changes in mean fc, confirming 
previous observations that even though breathing might impact the timing of cardiac 
vagal discharge, it has little impact on the magnitude of such discharge. The 
amplitude of RSA seems to be determined by several factors, not just by the level 
of cardiac vagal activity (Brown et al., 1993). 
 
7-4.2 Effects of tidal volume 
The HRV and BPV respond inversely to changes in fR (Table 4-10), with both tending 
to increase when VT is augmented (Table 4-11). We previously highlighted the 
contribution of baroreflex mechanisms to the amplitude of HRV and RSA, in 
response to reductions in fR. However, the results from Chapter 4 also showed a 
relatively unchanged LVSV, Q̇, ∆SV, ∆Q̇ and BPV (despite a significant linear 
increase in ∆Q̇ with the progression in VT). Simultaneously, the phase relations 
between changes in lung volume, SBP and fc are seemingly unaltered by the 
increase in VT. The linear increase in RSA and other HRV indices with larger VTs 
has been repeatedly demonstrated (Freyschuss and Melcher, 1976c, Hirsch and 
Bishop, 1981, Brown et al., 1993, Taha et al., 1995, Ritz, Thons and Dahme, 2001, 
Poyhonen et al., 2004) and while it has been widely attributed to baroreflex 
mechanisms (Davies and Neilson, 1967, De Boer et al., 1987, Toska and Eriksen, 
1993, Scheffer, TenVoorde, Karemaker et al., 1994, Karemaker, 2009a, b, c), the 
lack of effect upon LVSV, SBP and BPV hints at a direct influence of respiratory-
induced changes in right atrial filling upon sinus node activity (Freyschuss and 
Melcher, 1976a, Bernardi et al., 1989, Slovut, Wenstrom, Moeckel et al., 1998, 
Taylor et al., 2001), and/or increased vagal afferent input to the sinus node arising 
from the influence of feedback to the cardiovascular control centre from lung stretch 
receptors (Freyschuss and Melcher, 1976c, Taha et al., 1995). Overall, these results 
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support the view that the systemic implications of breathing at larger lung volumes 
are minor compared to the more potent effects of altering fR.  
 
7-4.3 Effect of changes in intrathoracic pressure 
Inspiratory loaded breathing 
The addition of an inspiratory impedance (Study 2, Chapter 5) increases venous 
return throughout inspiration and amplifies within-breath variations in LVSV (∆SV) 
by significantly increasing LVSVE while enhancing Q̇. This is accompanied by 
increases in the amplitude of BPV, RSA and HRV. Interestingly, while both BPV and 
HRV are proportional to the magnitude of the inspiratory resistance being applied, 
the response of BPV is the most pronounced, and correlates strongly with ∆SV, 
supporting the mechanical origin of respiratory-driven fluctuations in SBP.   
 
The magnitude of HRV (and RSA) on the other hand, has been linked to a plethora 
of factors, which have been described previously in this thesis (cf. sections 2-4 and 
2-5 in Chapter 2 - Literature Review). Considering the absence of significant 
differences in fcE with the addition of inspiratory resisted breathing, and a ~9 
beats∙min-1 (non-significant) increase in fcI, (underpinning the higher RSA during 
inspiratory loading), a case can be made for a contribution from sinus node stretch 
to the chronotropic response to inspiratory resisted SDB (Freyschuss and Melcher, 
1976a). Interestingly, findings from this thesis contradict reports from a similar 
experiment  (Freyschuss and Melcher, 1976c), which observed decreased fcE (but 
not increased fcI) during inspiratory resisted SDB. Oddly, in a study from the same 
year and using a similar respiratory protocol (Freyschuss and Melcher, 1976a), the 
authors reported simultaneous increases in fcI and decreased fcE, leading to 
enhanced RSA. Like us, Freyschuss and Melcher also clamped fR and VT, so the 
changes in breathing pattern cannot account for the observed differences. Taken 
together these results seems to suggest that the effect of inspiratory loading upon 
RSA can be underpinned by changes in fcI, fcE or both. 
 
The slight dissimilarities between the response patterns of HRV and BPV to the 
increase in inspiratory resistance can be interpreted as evidence that the response 
of HRV, and concomitantly RSA, is influenced by more than just vagal cardiac 
baroreflex mechanisms. Other potential sources of cardiac chronotropic stimulation 
during SDB are the cardio-acceleration induced by right atrial stretch (Freyschuss 
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and Melcher, 1976a, Bernardi et al., 1989), as well as a contribution arising from 
afferent feedback from pulmonary stretch receptors (Taha et al., 1995). 
 
Effect of increased within-breath left ventricular stroke volume fluctuations 
Data arising from this thesis’ experimental chapters point to a respiratory-driven 
enhancement of the within-breath fluctuations in LVSV and to a smaller extent Q̇, 
particularly when combined with inspiratory resisted breathing. The within-breath 
pattern and amplitude of LVSV is highly related to BPV at the respiratory frequency 
(Table 4-10). Importantly, the amplification of the within-breath fluctuations in 
intrathoracic-pressure with the application of inspiratory resistances significantly 
increased HRV above those values encountered during any other breathing 
condition (SDB alone; SDB combined with expiratory resistances; simultaneous 
inspiratory and expiratory resistances). However, the simultaneous application of 
inspiratory and expiratory resistances proved to generate significantly larger BPV at 
the respiratory frequency, when compared to expiratory resisted SDB. 
 
Recent studies employing daily bouts of inspiratory resisted SDB show a more 
pronounced and sustained reduction in ABP in hypertensive individuals when 
compared to SDB alone, following eight weeks of SDB training (Jones et al., 2010, 
Sangthong et al., 2016). Other respiratory interventions, using inspiratory and 
expiratory muscle training, appear to confirm the importance of intrathoracic 
pressure variations, rather than large respiratory volumes, to sustained reductions 
in ABP after six weeks of daily respiratory training (Vranish and Bailey, 2015). While 
these studies have considered the chronic effects of systematic respiratory training 
with large intrathoracic pressure variations, they support a view that the repeated, 
daily, amplification of within-breath ABP swings is the most likely triggering factor 
for any chronic antihypertensive effects of (resisted) SDB. 
 
Our research shows that the use of inspiratory resistances (or combined inspiratory 
and expiratory resistances) in conjunction with SDB heightens the acute 
cardiovascular perturbations induced by SDB, without necessarily promoting an 
acute increase in MAP, as was observed during expiratory resisted SDB. 
Furthermore, if the objective is to maximise cardiovascular system perturbation, 
results from Chapter 4 (Study 1) suggest that fR should be set at a level that 
potentiates the influence of intrathoracic pressure changes, with inspiratory and 
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expiratory durations that are slower than, or a harmonic of PulTT. Future research 
should then focus on unravelling the link between the acute effects of resisted SDB 
and the development of long-term cardiovascular adaptations. Studies that look into 
the immediate short-term effect of SDB interventions in the period immediately after 
the cessation of the resisted SDB stimulus might shed light of potential stimuli.  
 
 
7-4.4 Effects of different methods of respiratory loading 
In contrast to inspiratory resisted SDB, expiratory resisted SDB tended to reduce 
RSA and HRV, LVSV and Q̇, while increasing TPR and MAP. The simultaneous 
application of resistances to both phases of the respiratory cycle (dual loading) led 
to similar LVSV and Q̇, lower (non-significant) RSA and HRV and higher BPV, when 
compared to inspiratory resisted SDB. Dual loading also promotes an elevation of 
MAP and TPR, similar to that observed with isolated expiratory resisted SDB. A 
similar response is observed during nasal breathing through a single nostril, 
provided that similar intrathoracic pressures are achieved. In contrast to claims by 
others (Telles et al., 1994, Raghuraj and Telles, 2008, Pal et al., 2014), there were 
no significant differences in the acute cardiovascular and autonomic response to 
SDB between right and left nostril breathing. It is likely that any differences found in 
previous studies are an artefact of individual differences in nostril anatomy leading 
to different pressures being generated between nostrils, for the same airflow rate. 
 
The use of inspiratory resisted SDB seems to provide the largest stimulus to the 
cardiovascular system without triggering a significant acute rise in MAP, which 
particularly in hypertensive populations, might be safer, and therefore would be a 
preferred strategy to improve SDB interventions. A recent study has shown anti-
hypertensive effects using large inspiratory and expiratory resistances (Vranish and 
Bailey, 2015), but it remains unclear whether similar effects could be achieved 
during SDB, with much smaller respiratory resistances. Nonetheless, it does seem 
that an intervention that combines SDB with inspiratory resistances generates 
superior and more sustained reductions in ABP, compared with SDB alone, in 




7-4.5 Effects of PaCO2 
Chapter 4 provided no evidence that failing to clamp PaCO2 has an important impact 
on the acute cardiovascular response to SDB when compared to clamped 
conditions. Breathing with unclamped PaCO2 occurred only in the semi-spontaneous 
breathing conditions used in Chapter 4. For those conditions, either fR (Protocol 1- 
SSVT) or VT (Protocol 2 - SSfR) was the only respiratory parameter being controlled, 
allowing participants to freely adjust their respiratory frequency (with SSfR) or 
volume (with SSVT) to a comfortable, spontaneous range. Participants 
spontaneously maintained minute ventilation (V̇E) at comparable levels to those 
encountered in the fully clamped conditions conducted at similar fR or VT. At the 
same time, PaCO2 levels were within the ‘normal’ physiological range, varying 
between ~35 mmHg (PETCO2) in the semi-spontaneous conditions and ~41 mmHg 
in the fully controlled conditions, in both experimental protocols (Tables 4-2 and 4-
3).  
 
Nonetheless, small but significantly higher values for SBP, DBP, MAP and pulse 
pressure (PP) were present at fRs (clamped VT) between 6 and 10 breaths·min-1 
than those observed at 4 breaths·min-1 and in the semi-spontaneous condition 
(SSfR). These differences could not be explained by a peripheral vasoconstrictor 
response to elevated PaCO2 in the fully controlled conditions as PETCO2 and TPR 
remained almost unaltered across all conditions. Furthermore, the 4 breaths·min-1 
condition was clamped at the same slightly elevated level observed for the higher 
fRs and semi-spontaneous breathing condition (SSfR). The slight increase in ABP 
(around 10 mmHg in SBP and 5-6 mmHg for MAP, PP and DBP) between 6 and 10 
breaths·min-1 was likely associated with a trend towards increased LVSV, Q̇ and 
TPR, and arguably lacks physiological relevance. Thus, the significant pressor 
response observed for fRs ≥ 6 breaths·min-1 does not seem to be related to a 
chemoreflex response. Furthermore, it has been argued that small alterations in 
PaCO2 have negligible effects upon HRV and RSA (Freyschuss and Melcher, 1976a, 
c, Cooke et al., 1998, Henry et al., 1998) and that the effect of chemoreceptor 
stimulation upon HRV is mainly indirect and mediated by changes in ABP (Henry et 
al., 1998). Simultaneously, the effects of chemoreceptor stimulation are larger when 
baseline ABP is high (Henry et al., 1998), which might help to explain the apparently 




Previous studies have argued about the need to control for PaCO2 when evaluating 
HRV in human beings, particularly in conscious individuals (Sasano et al., 2002, 
Poyhonen et al., 2004). We did not encounter any evidence to suggest a significant 
impact of PaCO2 upon HRV during SDB interventions, provided that the PaCO2 is 
maintained within normal physiological limits (35 to 40 mmHg). In all likelihood, 
differences between my findings and those of others are solely related to the fact 
that in those studies HRV was evaluated in the presence of significantly larger 
PaCO2 variations than those reported herein (Al-Ani et al., 1996, Henry et al., 1998, 
Sasano et al., 2002, Poyhonen et al., 2004, Tzeng et al., 2007).  
 
Most SDB interventions only control fR; under these conditions, alveolar ventilation 
might increase, and PaCO2 decrease, because of a lowering of dead space 
ventilation. Nonetheless, the increase in VT likely overrides any potential effect of 
hypocapnia upon RSA/HRV (Ritz et al., 2001), which is in line with the RSA data 
from Protocol 2 of Study 1 (Chapter 4), as well as the data arising from both semi-
spontaneous conditions in the same study (SSfR and SSVT – Chapter 4). A possible 
avenue to empirically test such statement involves manipulations of dead space 
ventilation at constant fR and VT with an experimental setting similar to the applied 




In the preceding sections of this chapter, I discussed the main findings of the 
experimental chapters at the light of my current understanding of the existing 
literature, having as a framework the model presented in Figure 7-1. The discussion 
was based on trying to establish a mechanistic link between ‘input variables’ that 
were manipulated during the experimental studies comprised in this thesis, and the 
‘outcome variables’ depicted in Figure 7-1. 
 
The novel findings of this thesis can be summarised as follows: 
1) The reduction in fR resulted in an inversion of the normal within-breath pattern 
in LVSV, likely due to the influence of PulTT; 
2) The alteration of the within-breath pattern of LVSV at low fRs leads to 
frequency dependent changes in the phase relationship between respiration 
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and the ensuing respiratory-driven fluctuations in SBP, which leads to 
decreased amplitude of BPV at the lowest fRs; 
3) Increasing VT has a minor cardiovascular impact compared to the effect of 
reducing fR; 
4) The generation of progressively more negative intrathoracic pressures with 
inspiratory resisted SDB amplifies the cardiovascular effects of SDB, likely 
due to increased inspiratory venous return; 
5) The combination of inspiratory and expiratory resistances does not amplify 
the within-breath effects of inspiratory resisted SDB alone, but acutely 
increases MAP; 
6) The acute cardiovascular response to single-nostril SDB is determined by the 
variation in intrathoracic pressure generated by a given airflow and not by the 
nostril being used per se. 
  
The links between these ‘input variables’ and any chronic adaptations to SDB need 




7-5.1 Sample size 
The sample size in each of the three studies was relatively small (Chapter 4, n = 14 
for Protocol 1; Chapter 4, n = 11 for Protocol 2; Chapter 5 n = 9; Chapter 6, n = 14) 
and therefore vulnerable to the occurrence of Type II statistical errors. There is a 
possibility that physiologically relevant alterations might have been described as 
statistically non-significant as a result of both the sample size and the use of 
conservative Bonferroni post-hoc procedures. This is particularly important in 
Chapters 4 and 5, where the post-hoc analysis involved multiple comparisons 
between all experimental conditions, which greatly reduced the alpha level. While 
this means that Type I errors were very unlikely in our interventions, it further 
increased the likelihood of Type II errors, i.e. increased the risk of underreporting 
significant physiological responses to the interventions. This is especially true for 
the second experimental chapter (Chapter 5), which had the smallest sample, and 
the largest number of multiple comparisons of the three studies. This effect was 
mitigated to some extent in Chapter 6, when a pre-defined number of relevant 
comparisons were made, based on my research hypothesis. Nonetheless, the 
reported magnitude of change, particularly for the haemodynamic parameters, was 
much smaller than other interventions that are known to significantly impact the 
haemodynamic response, such as exercise. The fact that most variables reached 
significance suggests that the few reported significant differences in the 
haemodynamic parameters, with SDB, represent meaningful physiological 
responses to the applied interventions and support the presence of adequate 
statistical power. Furthermore, the use of other statistical interventions like (multiple) 
regression analysis and mechanism analysis (Hopkins, 2003) allowed for the 
identification of trends and relationships that would otherwise remain obscured by 
the use of analysis of variance (ANOVA) tests. Whilst it is unarguable that larger 
samples would have been beneficial for the analysis of the various parameters 
collected throughout the experimental procedures, the complexity and length of the 
interventions meant that a) recruitment of participants was highly restrained by their 
availability to perform several lengthy visits to our laboratory, b) not all the 
participants were able to complete the procedure (particularly in study 1 – Chapter 





7-5.2 Measurement errors 
Although the Modelflow method of estimating LVSV has been shown to agree 
strongly with LVSV measured by Doppler ultrasound (van Lieshout et al., 2003), 
relevant research has indicated that Modelflow-measured LVSV demands 
calibration against a standard method, such as the Fick principle (van Lieshout, Pott, 
Madsen et al., 2001) or thermodilution (Jansen, Schreuder, Mulier et al., 2001), if 
accurate values are required. Nonetheless, LVSV measured through the Modelflow 
method does track changes in LVSV with the same precision (Jansen et al., 2001, 
Bogert and van Lieshout, 2005). Similarly, ABP derived non-invasively from infrared 
photoplethysmography (Finometer) tracks, but it is not identical to, intra-arterial 
pressure measurements (Bogert and van Lieshout, 2005). Nonetheless, the 
reconstructed brachial ABP signal that was utilised in my studies meets the 
Association for the Advancement of Medical Instrumentation (AAMI) criteria (Bos, 
van Goudoever, van Montfrans et al., 1996, Guelen, Westerhof, Van Der Sar et al., 
2003, Schutte, Huisman, van Rooyen et al., 2004, Guelen et al., 2008), which 
warrants an acceptable error when compared to intra-arterial pressure 
measurements. Importantly, the Modelflow estimates of LVSV are based on the 
premise that transmural aortic pressure remains stable in the presence of increased 
intra-abdominal pressure or extreme pulmonary hyperinflation (Bogert and van 
Lieshout, 2005), which in the context of the interventions employed within this thesis, 
might have influenced the results. Nevertheless, the use of the Finometer did allow 
for continuous, non-invasive monitoring of ABP and cardiac haemodynamics during 
SDB, without the methodological constraints of other methods, like Doppler 
ultrasound (which precludes measurements during inhalation due to signal 
interference resulting from lung inflation), or the need for an invasive intra-arterial 
pressure measurement. All other equipment used throughout the studies that 
comprise this thesis were calibrated according to the manufacturers’ specifications. 
 
7-5.3 Day to day variability 
Considering the magnitude of the change in some analysed cardiovascular 
variables, compared to other interventions (e.g. during different forms of exercise), 
and the issues with sample size addressed in section 7-5.1, an evaluation of the 
within-individual variability of the repeated cardiovascular measures would have 
been advisable. This test-retest reliability analysis could have strengthened the 
arguments made in this thesis, if established that the coefficient of variation (or 
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another measure of within-subject variation) of repeated cardiovascular measures 
on at least two different occasions is lower than the effects of the interventions 
employed in this thesis (Hopkins, 2000). 
 
Results from studies of short-term variation of RSA (over the course of days to 
weeks) have generally produced good to excellent test-retest reliability in adults 
(Kleiger, Bigger, Bosner et al., 1991, Sinnreich, Kark, Friedlander et al., 1998, Pinna, 
Maestri, Torunski et al., 2007, Bertsch, Hagemann, Naumann et al., 2012, Borges, 
Mathewson and Schmidt, 2017). Substantial variation of the magnitude and 
direction of within-subject change in resting RSA has been reported in the literature 
(Borges et al., 2017), which translates a well-known ‘intrinsic lability’ of resting RSA 
(Sandercock, Bromley and Brodie, 2005). 
 
In contrast to RSA, recent studies on the within-individual variation of fc, SBP and 
DBP in healthy young adults are scarce. One notable exception is the recent study 
by Borges and colleagues (2017) These researchers reported excellent short-term 
test-retest reliability for fc and SBP, and good test-retest reliability for DBP, 
particularly when controlled for age and difference in time of day between the test 
and retest  
 
To the best of the author’s knowledge, no study of test-reliability of within-breath 
cardiovascular variables reported in this thesis (cf. Appendix II) has been performed 
to date. Establishing the short-term test-retest reliability of cardiovascular measures 
is critical if they are to be used to clarify the acute cardiovascular and autonomic 
response to SDB interventions.  
 
7-5.4 Breathing pattern control 
The pattern of breathing (thoracic vs. diaphragmatic) and its impact on the phase 
relationship between respiration and subsequent variations in LVSV was not 
sufficiently considered and addressed in the preparation of the experimental 
chapters. Unfortunately, we only encountered supporting evidence of a 
differentiated effect of thoracic vs. diaphragmatic breathing, in the form of two 
papers by Miller and colleagues (2005b, 2005a), close to the end of the project. 
Such events implied that while we state the relevance of said studies in the 
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Literature review (Chapter 2) and this section of the thesis, we did not control for the 
possible effect upon the results herein described. 
 
In short, thoracic breathing resulted in more negative intrathoracic pressure, which 
lowered right atrial pressure creating a favourable pressure gradient that facilitates 
venous return during the inspiratory portion of the respiratory cycle. While promoting 
a similar reduction in intrathoracic pressure, diaphragmatic breathing also increased 
intra-abdominal pressure, which compromised venous return during inspiration due 
to its effect upon inferior vena cava resistance. It also amplified venous return during 
expiration, when the effect of increased intra-abdominal pressure is removed (Miller, 
Pegelow, et al., 2005b). In addition, the same authors demonstrated that 
diaphragmatic breathing could cancel the effects of larger intrathoracic pressure 
variations. Using similar-sized respiratory resistances to the ones applied in 
Chapters 5 and 6, they showed that a more negative intrathoracic pressure during 
inspiration had no impact on venous return in the presence of a diaphragmatic 
breathing pattern, while with thoracic breathing, the inspiratory venous return is 
amplified beyond what is observed during spontaneous breathing. Finally, the 
application of simultaneous inspiratory and expiratory resisted breathing in 
conjunction with diaphragmatic breathing resulted in an inversion of the within-
breath pattern of for venous return, when compared to spontaneous diaphragmatic 
breathing (Miller, Pegelow, et al., 2005a). 
 
These data (Miller, Pegelow, et al., 2005a) highlight the necessity for future studies 
to investigate the interplay between the phase response of LVSV to changes in fR 
and those resulting from changes in breathing pattern (thoracic vs. diaphragmatic). 
While I do not believe that intra-individual changes in breathing pattern were present 
in our experiments, or affected the amplitude of the within-breath cardiovascular 
patterns reported, it is questionable whether the data are generalisable, since 
breathing pattern is known to vary widely between individuals. 
 
7-5.5 Uncoupling of heart rate and HRV 
A frequently documented but largely unexplored issue in research studies involving 
HRV analysis is the inverse relation between most HRV parameters and the actual 
mean fc, such that HRV is lower when mean fc is high and vice-versa. This 
phenomenon is fundamentally due to the inverse relationship between HR and R-R 
 
237 
interval, which is normally used to calculate HRV instead of HR time series (Sacha, 
2014). When HRV parameters are calculated from fc time series this inverse relation 
tends to disappear . While other factors like the sinoatrial node action potential 
dynamics (Monfredi, Lyashkov, Johnsen et al., 2014) might contribute to the 
relationship between mean fc and HRV, the problem is most and foremost 
mathematical in origin. Thus, for the correct interpretation of HRV parameters it is 
paramount that the relationship between HR and HRV is considered, as overlooking 
it can lead to serious misinterpretation of experimental data. Unfortunately, within 
this thesis, mean fc was not taken into consideration when analysing and 
interpreting the HRV data. Notwithstanding, the absence of statistically significant 
differences to mean fc as the result of the interventions that comprised the 
experimental chapters of the thesis suggests that the reported changes in HRV were 
not impacted by mean fc fluctuations.   
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7-6 Directions for future research 
7-6.1 Effects of breathing pattern (thoracic vs. diaphragmatic) 
Results from this thesis provide evidence that reducing fR with SDB alters the within-
breath pattern (inspiratory vs. expiratory) of LVSV. As previously mentioned, future 
studies addressing the effects of the breathing pattern (thoracic vs. diaphragmatic) 
may extend these findings further by clarifying the impact of fluctuations in intra-
abdominal pressure upon the frequency-induced phase changes in left ventricular 
output.  Previous research analysing the effects of breathing pattern, with and 
without increased intrathoracic pressure variations, have reported important within-
breath phase differences in venous return when comparing thoracic with 
diaphragmatic breathing (Miller, Pegelow, et al., 2005b, a). No study to date has 
investigated the effects of breathing manner upon the within-breath cardiovascular 
modulation during (resisted) SDB. An understanding of these issues may contribute 
to the improvement of future interventions that aim to amplify the acute within-breath 
cardiovascular oscillations as a potential error signal for the cardiovascular control 
centres. 
 
7-6.2 Heart-lungs interactions – right vs. left ventricular function response to 
SDB 
Phase alterations in SBP and LVSV with the reduction of fR, likely reflect the effects 
PulTT. Notwithstanding, we are not aware of any study that has evaluated the phase 
relationship between RVSV and LVSV in the context of SDB. More particularly, it 
has been demonstrated that in spontaneously breathing individuals in the lateral 
decubital position, RVSV and LVSV are in complete opposite phases and that RSA 
contributes to minimise the effects of LVSV upon left ventricular Q̇ (Elstad, 2012).  
 
Given the alteration of the within-breath phase pattern in LVSV during low frequency 
SDB, it is unclear how RSA impacts right ventricular Q̇ and pulmonary blood flow 
and how that might influence the pulmonary artery baroreceptors, which are known 
to trigger an opposing reflex response to those of the systemic circulation 
baroreceptors (Moore et al., 2011, Hainsworth, 2014). 
 
The lack of noninvasive technologies that allow for simultaneous evaluation of the 
right and left cardiac function in the presence of large respiratory excursions is 
perhaps the main constraint to such assessment. Others have used pulsed Doppler 
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ultrasound to extrapolate RVSV from pulmonary artery flow (Elstad, 2012), but 
mentioned the impossibility of the measuring RVSV in the presence of large chest 
movements. Echocardiographic measurements of tricuspid valve flow have been 
suggested to be a valid option to evaluate right ventricular function, even during 
exercise (Argiento, Chesler, Mule et al., 2010, Claessen, La Gerche, Voigt et al., 
2016), but lack accuracy when compared to cardiac magnetic resonance (Claessen 
et al., 2016). Cardiac magnetic resonance is the most reliable, but also costly, 
alternative to evaluate cardiac dynamics in response to SDB. This technique was 
recently used to characterise the interactions between respiration, RVSV and LVSV, 
both at rest and during supine exercise (Claessen et al., 2014). Unlike the 
ultrasonographical methods, cardiac magnetic resonance imaging is not limited by 
the effects of chest excursion, as long as such excursion is maintained constant 
throughout several breaths. Thus, it may be possible to evaluate cardiac function 
even in the presence of large lung volumes associated to (resisted) SDB using 
cardiac magnetic resonance imaging.  
 
However, if Doppler ultrasound is the only available noninvasive option, brief 
collection periods with paced breathing at low fRs consistent with SDB and small 
lung volumes may be regarded as an initial approach to understand right vs. left 
cardiac function relationships during SDB,  
 
7-6.3 Sensitisation and neuroplasticity in response to SDB 
Understanding the mechanistic factors that link repeated acute physiological 
changes induced by the regular practice of SDB with long term cardiovascular 
adjustments remains a great challenge. In the human body, the stimuli that engage 
systems involved in the maintenance of homoeostasis often result in progressive 
increases in the magnitude of the response, when stimulated repeatedly (Johnson, 
Zhang, Clayton et al., 2015).  
 
It has been hypothesised that in the case of SDB, the repeated stimulation of the 
arterial baroreflex may produce a chronic increase in baroreflex efficiency (Lehrer, 
2007). Evidence of neuroplasticity, defined as persistent morphological and 
functional changes of a given neural pathway, have been reported for 
musculoskeletal reflexes (Bawa, 2002), and respiratory neural control (Mitchell and 
Johnson, 2003). In the particular case of the cardiovascular system, it is believed 
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that neural remodelling (neuroplasticity) is involved in the development of essential 
hypertension (Johnson et al., 2015) and several forms of cardiovascular disease,  in 
response to inactivity (Mischel, Subramanian, Dombrowski et al., 2015). Thus, the 
repeated stimulation of the baroreflex (or other unappreciated neural, molecular or 
cellular mechanisms) by SDB might underpin the adaptations to SDB, as well as 
their reversibility.  
 
Even though we have previously referred to the limitations of the traditional time and 
frequency domain cardiac BRS measurements, BRS has been demonstrated to 
increase both acutely and chronically following regular practice of SDB in both 
healthy individuals (Lehrer et al., 2003) and patients with heart failure (Bernardi et 
al., 2002). This can potentially be regarded as an indicator of sensitisation of the 
baroreflex control mechanism. Sensitisation phenomena have been the object of 
recent interest in the context of essential hypertension development and implicate 
molecular and cellular adjustments in elements of the neural network controlling 
ABP, resulting in sensitisation of the response to hypertensinogenic stimuli 
(Johnson et al., 2015). 
 
In the context of SDB, the identification of relevant changes in respiratory, 
cardiovascular or autonomic variables for a relatively prolonged, period that outlasts 
the duration of the acute SDB stimulus, must be understood as a first evidence for 
the existence of any neuroplastic response to SDB.  Furthermore, the identification 
of the brain structures engaged during SDB can further the understanding of both 
the acute and chronical cardiovascular response to SDB. Recently, novel insights 
arising from fMRI have shown a strong relation between rostroventral medulla 
activity, BPV and HRV, likely reflecting the impact of breathing upon baroreflex 
regulation (Critchley, Nicotra, Chiesa et al., 2015).  
 
7-6.4 Effect of slow and deep breathing upon cerebral blood flow 
Other possible lines of investigation are to more fully understand the effects of SDB, 
with and without the addition of inspiratory resistances, upon blood flow to key 
organs like the brain or the kidney.  
 
At least one study involving SDB has indicated increased inspiratory CBF (Lucas et 
al., 2013); a similar finding to that encountered with the use of small inspiratory 
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resistances in supine, spontaneously breathing, healthy individuals (Aufderheide, 
Pirrallo, Provo et al., 2005, Convertino, Cooke, et al., 2005, Cooke et al., 2006, 
Rickards et al., 2007, Rickards et al., 2008, Hayen, Herigstad, Kelly et al., 2013). 
Important respiratory modulation of cerebrospinal fluid movement has also been 
described as a response to increasingly negative intrathoracic pressures (Dreha-
Kulaczewski, Joseph, Merboldt et al., 2015).  This is particularly important in the 
light of one current theory for the generation of systemic hypertension, based on the 
existence of a  protective ‘Cushing mechanism’ (Paton, Dickinson and Mitchell, 
2009)6, termed the ‘selfish brain hypothesis’ (Rodrigues, Hart, Hassan et al., 2015, 
Warnert, Rodrigues, Burchell et al., 2016). This theory argues that brainstem 
hypoperfusion may trigger systemic hypertension as part of a defence mechanism 
aimed at increasing CBF. Brainstem hypoperfusion leads to increased cerebral 
vascular resistance, which is believed to precede changes in MSNA and the onset 
of hypertension (Warnert et al., 2016). Reduced CBF and cerebral vessel alterations 
have been previously reported in hypertensive individuals (Dai, Lopez, Carmichael 
et al., 2008, Rizzoni, De Ciuceis, Porteri et al., 2009, Waldstein, Lefkowitz, Siegel 
et al., 2010).   
 
Observations made both at rest and during exercise (50% maximal oxygen uptake) 
show that Q̇ is linearly related to CBF, independently of cerebral autoregulation 
(Ogoh, Brothers, Barnes et al., 2005). However, with whole body exercise at higher 
intensities CBF tends to decline, while Q̇ increases (Ogoh, Dalsgaard, Secher et al., 
2007). Furthermore, this notion does not apply to small muscle mass exercise such 
as the one legged kneed extensor exercise or to ATP infusion induced increases in 
leg blood flow, where Q̇ increases progressively but CBF remains unchanged. In 
those scenarios Q̇ increases but CBF does not (Ogoh, Brothers, Jeschke et al., 
2010, Bada, Svendsen, Secher et al., 2012). This supports that local brain blood 
flow is dependent upon local factors, rather than MAP and/or Q̇. It is thus unclear 
how any [within-breath] changes in LVSV and Q̇ resulting from the use of SDB can 
impact the regulation of CBF. It is therefore worthwhile investigating if SDB, 
particularly when used in conjunction with small inspiratory resistances, might bring 
about beneficial long-term changes in cerebrovascular perfusion and auto-
                                            
6 Cushing’s mechanism is a terminology used by Julian Paton, John Dickinson and Graham Mitchell, in their 
2009 review, to describe a long term ABP control mechanism that in humans consists of a sustained systemic 
ABP increase triggered by narrowing of the arteries supplying the brainstem. Such mechanism is based on 
Harvey Cushing’s (early 20th century physiologist) early studies in dogs that showing a relation between 
brainstem compression and ABP elevation. 
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regulation. In addition, understanding how CBF is affected acutely by fR, breathing 
pattern and the magnitude of intrathoracic pressure variation, can help to refine SDB 
interventions aimed at promoting large within-breath oscillations in CBF. 
 
Furthermore, the study of changes in cerebrovascular flow and architecture 
following a period of training with SDB and/or inspiratory resisted breathing might 
further the understanding of the contribution of the ‘selfish brain’ compensatory 
mechanism in triggering hypertension in otherwise healthy individuals.
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7-7 Novelty and utility of findings 
The thesis confirms and expands the known association between SDB and the 
modulation of within-breath cardiovascular oscillations, providing further insights 
into the contribution of fR, VT and ITP into the complex interplay between respiratory, 
cardiovascular and autonomic nervous systems. It shows that there is an 
individualised fR that triggers the most substantial cardiovascular perturbation and 
supports the role of ITP changes as a potent modulator of cardiovascular variability.  
 
Breathing against a small inspiratory resistance at an individual (resonant) 
frequency between 4 and 6 breaths.min-1 generates large within-breath variations 
in fc, SV and Q̇ that are thought to represent an error signal to the cardiovascular 
control centres in the brain. While the studies within this thesis only describe the 
acute cardiovascular response to a series of respiratory perturbations, they clearly 
show the potent effect that (inspiratory resisted) SDB can have in generating large 
within-breath cardiovascular fluctuations without a concomitant raise in mean ABP 
or TPR. Overall, this thesis suggests that an individualised SDB intervention, used 
in combination with a small inspiratory resistance, might result in more favourable 
outcomes than the ‘one size fits all’ approach seen in other SDB modalities that 
simply try to drive breathing to a constant frequency (normally 6 breaths.min-1). 
Strong support to this idea comes from recently published data showing larger 
reductions in ABP in older hypertensive patients after 8 weeks of daily inspiratory 
resisted SDB training vs. SDB alone (Sangthong et al., 2016). However, to optimize 
utilization, it would be reasonable to compare the effects of SDB with different levels 
of inspiratory resistance, distinct  intervention durations (e.g., 10 min vs. 20 min. vs. 
30 min) and whether the optimal breathing frequency is altered within one training 
session or  training period. 
 
The present studies accessed the acute cardiovascular effects of different 
modalities of SDB in a healthy cohort, and the study durations were designed to 
establish physiological impact and significance of the tested processes in 
accordance with the study hypotheses. Nonetheless, none of the studies that form 
this thesis was designed to determine the effects of the findings on long-term clinical 
outcomes in a hypertensive population. Thus, adequately structured, randomised 
trials are required to evaluate the clinical benefits of (inspiratory resisted) SDB, as 
applied in this thesis. Furthermore, the potential of SDB as an anti-hypertensive 
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treatment intervention must be assessed not only regarding the direct impact upon 
ABP but also on the effect upon markers of autonomic activity as HRV, BRS, MSNA 
and plasma catecholamine levels. Additionally, as a wide range of pharmacological 
agents is routinely used in the management of hypertension, it would be essential 
to know the effects of these agents when used in combination with SDB. 
 
Considering the complex interrelationships between the cardiovascular, respiratory 
and autonomic nervous systems, an integrated analysis of all systems will allow for 
a better understanding of the involved mechanisms and help tailor more effective 





The findings of the present thesis show that fR is the most potent determinant of the 
acute cardiovascular response to unloaded SDB. Changes in lung volume result in 
minor further augmentation, in the presence of a low fR. The within-breath pattern of 
LVSV is inverted for fRs close to or below 6 breaths· min-1, possibly due to a delay 
interposed by the pulmonary circulation, which also impacts the phase relations 
between respiration and SBP. During SDB, total BPV is reduced, while HRV is 
increased with progressive lowering of fR. Increasing VT has little impact upon BPV, 
but it promotes an increase in HRV, supporting a contribution of vagal afferent 
feedback from lungs stretch receptors to the amplitude of RSA.  
 
The addition of small inspiratory resistances to SDB promotes increased within-
breath fluctuations in fc (RSA), LVSV and left ventricular Q̇, in the absence of 
physiologically relevant changes in mean ABP. The within-breath cardiovascular 
pattern is associated with increased HRV and BPV, suggesting an important 
mechanical link between respiratory-driven fluctuation in venous return, within-
breath oscillations in left ventricular output, and BPV. Furthermore, increased RSA 
in the presence of more negative intrathoracic pressure swings, but identical VTs, 
highlight a potential contribution of both mechanical SA node stretch and arterial 
baroreflex-mediated factors to RSA. Finally, loading different phases of the 
respiratory cycle resulted in differentiated acute cardiovascular effects, with 
inspiratory resisted SDB resulting in significantly higher RSA, HRV, BPV, ΔSV and 
Q̇, than expiratory resisted SDB. Furthermore, expiratory resisted SDB resulted in a 
pressor response for the same variation in intrathoracic pressure, which was not 
present during inspiratory loading. A lower RSA for higher ABP, suggest a formerly 
underappreciated contribution of SA node stretch to RSA, and argue against the 
clinical benefits of expiratory resisted SDB, particularly in hypertensive populations.  
Finally, it remains to be seen how the acute perturbations characterised in the 
present thesis relate to the long-term regulation of blood pressure, and indeed, 
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Appendix I – Summary table of relevant studies for 








Authors n Method Relevance 
Dornhorst et al. (1952b) 50 records in 
individuals with 
normal circulatory 
control. Total n not 
reported.  
Several postural and respiratory 
manipulations including apnoea 
and paced breathing at different 
fRs 6-20 breaths·min-1. 
Identification of an fR-determined phase relation between RESP 
and ABP. Amplification of ABP swings with the decrease of fR. 
Angelone and Coulter (1964) 1 healthy male adult Paced breathing from 1-40 
breaths·min-1 at a fixed VT 
Description of RSA response to different fRs with maxima at 6 
breaths·min-1. Progressive reduction of RESP-fc phase angle with 
fR. 180º phase at 10 breaths·min-1 and 0º phase for ≤ 4 
breaths·min-1 (0º representing fc starting at the same time as the 
beginning of expiration). 
Freyschuss and Melcher (1976a,b,c) 5 healthy male adults 
7 healthy male adults 
? healthy male adults  
All studies. fixed fR at 6 
breaths·min-1 and fixed VT at 1, 1.5 
and 2 L. Interventions included 
paced breathing with and without 
NIP and IPPV. Study c) also 
included INPV. 
  
Increasing VT increases RSA by impacting both minimum, and 
maximal fc NIP increases fc, RVSV, ABP and ventricular filling 
pressure during inspiration while augmenting RSA. IPPV abolishes 
RSA and reduces the respiratory variations in venous return, while 
INPV does not impact RSA. Overall these studies favoured the 
theory that RSA amplitude was determined by cardiopulmonary 
reflexes, rather than central or arterial baroreflex mechanisms.  
Eckberg and Orshan (1977) 6 healthy adults (5m, 
1f). 
Fixed VT at 100% and 150% of 
spontaneous VT. Spontaneous fR. 
Two intensities of neck suction 
applied during early inspiration or 
expiration. 
Inspiration inhibits the cardiac baroreflex response to moderate 
(but not intense) baroreflex stimulation. Increasing VT reduces the 
response to inspiratory baroreflex stimuli. Evidence for a central 
respiratory baroreceptor reflex interaction dependent upon the 
level of afferent baroreceptor activity and the depth of inspiration 







    
Eckberg et al. (1980) 6 healthy adults (5m, 
1f). 
Fixed VT at 100% of spontaneous 
VT. Spontaneous fR as well as 3, 6, 
12 and 24 breaths·min-1. Brief, 
moderate neck suction applied 
during early, mid, and late 
inspiration or expiration with 
spontaneous breathing and during 
early inspiration or expiration, with 
paced breathing. 
Maximal cardiac deceleration is observed when baroreflex stimuli 
is delivered in late inspiration of early expiration. At breathing rates 
of 3, 6 and 12 breaths·min-1, baroreflex responses are significantly 
greater during expiration than during inspiration, while at 24 
breaths/min, inspiratory and expiratory baroreceptor stimuli 
resulted in similar increases in RR interval. This study identifies the 
existence of regular oscillations in human baroreflex 
responsiveness, determined by breathing, but that cannot be 
(solely) ascribed to the existence of a central oscillator. 
Hirsch and Bishop (1981) 17 healthy adults 
(10m, 7f) 
Paced breathing at a wide range of 
fRs (1-60 breaths·min-1) and VTs 
(0.5 to 3L). A condition with breath-
hold is also included. 
Established the existence of a linear relationship between VT and 
RSA. Determined the existence of individualised fR-RSA curves, 
with a plateau at low fRs bellow 6 breaths·min-1 and a linear inverse 
relation with increasing fRs. RSA observed during spontaneous 
breathing falls under the individualised curves observed with 
paced breathing. 
Eckberg (1983) 6 healthy adults  Controlled breathing: fR between 
6-24 breaths·min-1; VT between 1 
and 1.5 L. 
Cardio-acceleration (RR interval shortening) begins in inspiration 
for high fRs and expiration at slower rates. The RR interval 
lengthening always initiates in early expiration. RR interval 
shortening in phase with the start of inspiration at 10 breaths·min-
1. A Linear relation between VT and RSA and an inverse relation 
between fR and RSA. The suggestion of phasic respiration-related 
changes of vagal motoneuron activity during expiration, but that 







Eckberg et al. (1985) 20 healthy adults  Spontaneous breathing (n=20); 
Controlled breathing (n=8):  a) 12 
breaths·min-1, no VT restriction; b) 
12 breaths·min-1 while mimicking 
a). Carotid afferent activity 
reduced by neck pressure. MSNA 
was measured. 
Reported respiratory fluctuations in MSNA with maximum activity 
occurring at end-expiration and minimum activity occurring at end-
inspiration. Voluntary control of breathing does not impact MSNA. 
The RR interval and MSNA activity paralleled each other and were 
related to changes in diastolic pressure. MSNA is more responsive 
to reductions in carotid baroreceptor afferent activity during 
expiration than inspiration. This study highlights the existence of 
parallel phasic changes in spinal muscle sympathetic and 
medullary cardiac vagal efferent activity, illustrating the presence 
of spontaneous activity and greater susceptibility to excitation 
during expiration.  
Saul et al. (1989) 18 healthy adults 
(10m, 8f)  
Pseudorandom fluctuations (fR 
between 0 and 42 breaths·min-1). 
Measurements in the upright and 
supine position. 
Onset of inspiration coinciding with the increase in fc for fRs above 
9 breaths·min-1, while for lower fRs fc increases precede the start 
of inspiration. The gain of the transfer function was lower in the 
upright posture when breathing above 9 breaths·min-1 but similar 
at lower fRs.  
Seals et al. (1990) 7 healthy adults a) fR at 12 breaths.min-1 and VTs of 
30%, 50%, and 70% of inspiratory 
capacity; and b) simulated 
exercise hyperpnoea (fR at 40 
breaths.min-1; VT = 60-70% 
inspiratory capacity). MSNA was 
measured. 
Within-breath modulation of MSNA was observed during with 30% 
of inspiratory capacity with most activity occurring during the 
expiratory phase. The effect was potentiated by paced breathing 
at 12 breaths.min-1 producing strong sympathoinhibition from 
onset-mid inspiration to early-mid expiration. Duty cycle impacts 
the onset of sympathoinhibition. Sustained low or high-frequency 
deep breathing does not alter total minute MSNA compared with 
spontaneous breathing. These results demonstrate that the depth 
and pattern of breathing exert marked influences on the within-
breath modulation of MSNA in humans but not on the total 
sympathetic outflow.  







Saul et al. (1991) 14 healthy male 
adults 
Pseudorandom fluctuations fR 
between 0 and 42 breaths·min-1. 
Compared purely sympathetic 
(standing + atropine) and pure 
vagal (supine + propranolol) 
modulation of fc. 
Demonstrated reduced sympathetic control of fc for frequencies 
above 0.1Hz whereas pure vagal modulation of fc has higher 
magnitude at all frequencies. Established mechanical link between 
respiration, RSA and ABP. The RSA contribution to ABP is 
significant in the pure vagal condition but not in the pure 
sympathetic. The mechanical effects of respiration on arterial 
pressure are seemingly related to flow rather than to the actual 
lung volume. Mechanical effects of breathing are ampler during 
systole than diastole and are larger in the standing than supine 
position. 
TenVoorde et al. (1995) 21 healthy adult men 
and 9 quadriplegic (no 
sympathetic control) 
adult men of 
equivalent age. 
Fixed fR at 4, 6, 10, 15 and 20 
breaths·min-1. a) comparison 
between supine and standing in 
healthy individuals; b) comparison 
between healthy and quadriplegic 
individuals. 
a) Standing enhanced the respiratory modulation of SBP, DBP and 
RSA which maximised at 4 breaths·min-1. RSA maximises at 6 
breaths·min-1 when supine. Cardiac baroreflex gain is enhanced in 
the supine position, but such effect tends to be cancelled at the 
lowest fRs. SBP-fc phase slightly increases with the decrease in fR. 
b) The lack of sympathetic control significantly decreases 
respiratory modulation of SBP and fc, particularly at 6 breaths·min-
1. The suggestion of the existence of a resonant effect of the 
vasomotor baroreflex control loop at 0.1 Hz, directly impacting BPV 
modulation and indirectly affecting RSA. 






a) spontaneous breathing; b) 
stepwise breathing (at 3, 6, 9, 12, 
15 and 20 breaths·min-1); c) 
stepwise breathing as above, but 
with prescribed VT; d) random-
frequency breathing (3-30 
breaths·min-1), and e) fixed-
frequency breathing (15 
breaths·min-1).  
HRV and BPV increase with the decrease in fR. Simultaneous 
control of fR and VT reduce HRV during 0.1Hz breathing. Stepwise 
and random-breathing yielded comparable coherence and RESP-
fc and SBP-fc transfer functions. Indication that stringent control of 









Vaschillo et al. (2002)  5 healthy male adults HRV biofeedback. Seven fRs 
within the range of 0.6 and 8.4 
breaths·min-1. 
Describes the use of a biofeedback method for the non-invasive 
study of baroreflex mechanisms. HRV biofeedback produces large 
within-breath fluctuations in fc and ABP. The highest oscillation 
amplitudes occur in the range of 3.3-6.6 breaths·min-1 for fc and 
1.2-3.3 breaths·min-1 for ABP. Oscillation amplitudes at specific 
fRs can be explained by resonance among various oscillatory 
processes in the cardiovascular system. Resonant frequencies 
show inter-individual variability. 
Song and Lehrer (2003) 5 healthy female 
adults 
Fixed fR at 3, 4, 6, 8, 10, 12, and 
14 breaths·min-1.  
No change in mean fc, RSA increased at 4 and 6 breaths·min-1 
with the highest values at 4 breaths·min-1 and decreased at 3 
breaths·min-1. The results are interpreted as reflecting the possible 
effects of the rate of acetylcholine metabolism and negative 
resonance at 3 breaths·min-1. 
Tzeng et al. (2009) 30 healthy male 
adults 
Cardiovagal BRS evaluated by the 
Oxford pharmacological method, 
α-index BRS and sequence BRS, 
at 15 and 6 breaths·min-1. 
Breathing at 6 breaths·min-1 showed increased α-index BRS and 
sequence BRS up-sequences when compared to 15 breaths·min-
1, while no changes were seen in BRS measured by the Oxford 
method. Mathematical BRS indices may not reflect the BRS 
determined by experimentally driven baroreceptor stimulation. 
Sin et al. (2010) 16 healthy male 
adults 
Fixed fR at 6, 9 and 12 breaths·min-
1, with and without sympathetic 
blockade.  
The time interval between RRinterval maximum an expiratory 
onset is not altered by the change in fR. while RRinterval minimum 
shifted from expiratory onset to mid-inspiration with slower 
breathing. The time interval from inspiration onset to SBP minimum 
and expiratory onset to SBPmax was not impacted by fR. 
SBPmaximum and RRmaximum temporal alignment is maintained 
irrespective of fR. RR minimum increasingly lags SBPminimum with 
the decrease in fR. Adrenergic blockade does impact the 
relationship between respiration and RR interval or RSA observed 
with SDB, suggesting that temporal and phase alterations with 







    
Limberg et al. (2013) 21 adults (13m, 8f) Fixed fR at 7, 14 and 21 
breaths·min-1 
fR and VT changes did not affect mean MSNA, blood flow to the 
forearm, vascular conductance or MAP. Previously described 
within-breath MSNA pattern was observed. Collectively this study 
challenges the conception that SDB lowers ABP through inhibition 
of peripheral sympathetic tone. 
Lucas et al. (2013) 16 healthy adults 
(10m, 6f) 
Fixed fR at 6 breaths·min-1 vs. 
spontaneous breathing. 
Orthostatic stress with tilt and 
LBNP. 
SDB improves tolerance time to pre-syncope, increased low-
frequency oscillations in MAP and cerebral arterial blood velocity 
and reduced rate of decline in cerebral arterial blood velocity and 
MAP with orthostatic stress. Orthostatic tolerance is improved by 
SDB likely due to respiratory-driven fluctuation in venous return 
and ABP.  
ABP – arterial blood pressure; BPV – blood pressure variability; BRS – baroreflex sensitivity; DBP – diastolic blood pressure; fR – breathing frequency; HRV – heart rate 
variability; INPV – inspiratory negative pressure ventilation; IPPV – inspiratory positive pressure ventilation; LBNP – lower body negative pressure; MAP – mean arterial 
pressure; MSNA – muscle sympathetic nerve activity; NIP – negative inspiratory pressure; SBP – systolic blood pressure; RESP – instantaneous lung volume variation; 
SASR – slowly adapting stretch receptors; RVSV – right ventricular stroke volume; VT – tidal volume; 
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Variable Unit Description 
fcI beats∙min-1 Average fc during inspiration 
fcE beats∙min-1 Average fc during expiration 
RSA ms 
Largest RR interval minus lowest RR interval during an entire respiratory 
cycle (Chapter 6). 
RSA ms 
Largest RR interval during expiration minus lowest RR interval during 
inspiration.(Chapters 4 and 5). 
LVSVI mL∙beat-1 Average LVSV during inspiration 
LVSVE mL∙beat-1 Average LVSV during expiration 
ΔSV mL∙beat-1 Average difference between LVSVI and LVSVE 
LVSVI/E mL∙beat-1 Highest LVSV during expiration minus lowest LVSV during inspiration 
Q̇I L∙min-1 Average Q̇ during inspiration, calculated as the product of fcI and LVSVI 
Q̇E L∙min-1 Average Q̇ during expiration, calculated as the product of fcE and LVSVE 
ΔQ̇ L∙min-1 Average difference between QI and QE 
SBPImax mmHg 
Maximum SBP value recorded during each inspiration. Presented as 
average value for the epoch 
SBPEmax mmHg 
Maximum SBP value recorded during each expiration. Presented as 
average value for the epoch 
SBPI/E mmHg Highest SBP during expiration minus lowest SBP during inspiration 
DBPI/E mmHg Highest DBP during expiration minus lowest DBP during inspiration 
MAPI mmHg 
Average MAP during inspiration. Calculated as the average value of the raw 
blood pressure waveform, throughout inspiration 
MAPE mmHg 
Average MAP during expiration. Calculated as the average value of the raw 
blood pressure waveform, throughout expiration 
PPI mmHg Average pulse pressure during inspiration, calculated as SBPI minus DBPI 
PPE mmHg Average pulse pressure during expiration, calculated as SBPE minus DBPE 
PPI/E mmHg 
Average difference between maximum and minimum pulse pressure 
throughout the entire epoch 
TPRI mmHg∙min∙l-1 Average inspiratory systemic vascular resistance calculated as MAPI / Q̇I 
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[Some of the participant information sheets contain information 
regarding methods and interventions that are not reported in this 
thesis. These result from either a retrospective decision not to collect 
such data, or in some cases, a deliberate decision to not present the 
collected data as doing so would not further the understanding of the 
topics debated in this thesis. Importantly, no procedures were added 









‘Effects of different breathing patterns on cardiovascular responses to guided 
breathing’ 
This research investigation has been granted full ethical approval by the Brunel University School and 
Education Research Ethics Committee (SREC): Approval #: RE45-12 
Contact Position Phone  Email 
Mr Pedro Vargas, MSc 
 
PhD Researcher 01895 266499 pedro.vargas@brunel.ac.uk 
Professor Alison McConnell  Professor of Applied Physiology 01895 266480 alison.mcconnell@brunel.ac.uk 
Dr Richard Godfrey Chair of the SREC 01895 266473 richard.godfrey@brunel.ac.uk 
  
 
Recent evidence suggests that practicing deep, slow breathing patterns can reduce blood pressure. These 
breathing patterns have been practiced for centuries during yoga, and more recently, through devices that 
guide users to adopt deep slow breathing. The purpose of this study is to explore changes in breath volume 
(tidal volume) and breathing frequency upon the acute response of a range of cardiovascular variables, e.g., 




The purpose of this study is to explore the impact of a change in breathing volume (tidal volume) or 
breathing frequency on heart rate and blood pressure. 
 
Study design 
You have been invited to participate in this research study as one of 12 participants. The entire experiment 
will require approximately 4.5h of your time split over 3 sessions on different days (separated by at least 
24h and no more than a week). On the first session we will collect some baseline measurements you will 
learn how to control your breath at a specific rhythm and depth, using a visual feedback device. During 
session 2 you will perform 5 bouts of controlled breathing at a fixed tidal volume (constant breath depth) 
and varying breathing frequencies (10, 8, 6 and 4 breaths per minute), plus one bout at your spontaneous 
breathing frequency. Every bout will last approximately 5 minutes, with 5 minutes of rest between them. 
Session 3 will also involve 5 bouts of controlled breathing, but this time at a fixed breathing frequency, and 
with varying tidal volumes (5 minute bouts with 5 minutes rest between each). During the entire trial 
specific measures of your physiological function will be assessed (see below).  In order to determine the 
between-day variation and accuracy of the collected data, approximately half of the study participants will 
be required to repeat both session 2 and 3 in five consecutive days, totalizing 10 testing sessions. During the 





you will be inquired regarding your availability to perform the 10 testing sessions. Irrespective of your 
answer, you will always be able to enrol in the study, performing the 3 aforementioned testing sessions.  
 
Do I have to take part? Can I change my mind and withdraw from the study? 
Your participation in the study is entirely voluntary and at no time should you feel obliged to take part in, 
or continue the study. You may withdraw from the study at any time, without the need to provide any 
reason, without subsequent penalty or prejudice, and without affecting your University grades or 
professional evaluation.  
 
What will happen to me if I take part? 
As stated in the ‘Study Design’ paragraph you will be submitted to a series of bouts of controlled breathing, 
during which we will be performing a series of physiological measurements. 
 
Pre-test requirements 
You will be first required to complete a health questionnaire and sign a consent form to confirm that you’re 
healthy and able to participate in the study. To ensure that external factors do not influence your test results,  




Your height and weight and lung function will be accessed during your first visit (lung function will be also 
assessed at the start of subsequent testing sessions and height and weight measurements will not require you 
to remove any cloths except for your shoes), by performing a series of sub-maximal and maximal breathing 
manoeuvres into a mouthpiece. A face mask will be used throughout each trial to measure breathing 
patterns, and the amount of CO2 and oxygen that you expire, during testing. We will measure your blood 
pressure and estimate the amount of blood that is pumped out of your heart using two cuffs;  one placed on 
the upper arm and one on the middle finger. A small sensor in the finger cuff will also allow the measurement 
of the amount of oxygen carried in the blood. 
 






Heart rate will be measured continuously using a 3-lead ECG whose sensors will be placed on your chest (1 
sensor in the vicinity of both shoulders) and lower rib-gage (1 sensor placed about one palm bellow the 
chest). In order to guarantee proper placement and adhesiveness of the sensors throughout the entire testing 
sessions (excessive body hair and/or sweat might result in reduced electrode adherence), these might have 
to be secured with duct tape. This procedure will also eliminate the need for other, less pleasant procedures, 
like shaving the areas where the electrodes are meant to be placed. 
 
 
Figure 2 – Placement sites for the 3-lead ECG electrodes. 
 
Breathing function  
As above stated, your lung function will be accessed during all of your visits through an instrument called a 
spirometer. The instrument measures the rate of airflow in and out of your lungs during a maximal breathing 
manoeuvre. The maximal flow and volume changes that a person can produce provide an indication of how 
healthy their lungs are. The manoeuvre requires that you inhale until your lungs are full, and then exhale as 
hard and fast a possible until they are as empty as you can make them. Once empty, you will then fill your 
lungs as rapidly as possible by inhaling immediately. This manoeuvre will be repeated 3-5 times, with 30-60 
rest between each test. During the first testing session the lung function assessment will be performed in a 
whole body plethysmograph or “body-box”. This equipment will allow to quantify of your lung volumes as 
well as point out the existence of eventual respiratory conditions. A special filter is used to protect the 
equipment and each user from potential cross-infection between users. There are no risks associated with 
this test, which is a routine medical assessment. 
 






This study is aimed at male non-smokers between the ages of 18 and 35 years and with no previous medical 
history of cardiovascular or respiratory disease (e.g. asthma). Similarly, if you smoke, or if you’re currently 
taking anti-depressants or irritable bowel remedies (e.g., Buscopan®), you cannot to take part in this study. 
You will also not be able to participate in the study if you present any reaction to the conducting gel used on 
the ECG or if the “body-box” tests provide evidence of undiagnosed respiratory disease. Finally, if you fail 
to demonstrate the capacity to control your breathing following a visual cue, during an initial training session 
(further training sessions might be necessary to overcome this difficulty).  
 
 
What are the possible disadvantages and risks of taking part? 
Controlled breathing 
Since you will not be breathing at your spontaneous breathing frequency and amplitude, there is a high 
likelihood of becoming slightly hypercapnic (excess CO2 in the blood) or hypocapnic (deficit of CO2 in the 
blood). Neither of these conditions represent any known risk to your safety and you are free to interrupt the 
procedure in the unlikely event that you feel unwell. If you become hypercapnia you will feel a strong urge 
to breathe more, which can be accompanied by sensations of heat, sweating and flushing. On the other hand 
if you become hypocapnic, the symptoms may include dizziness. Both sensations will subside quickly once 
spontaneous breathing is resumed. 
 
What if something goes wrong? 
The investigator conducting the experiment is qualified in basic life support, and an individual with 
advanced life support training will be onsite at all times. In addition, an emergency name and contact 
telephone number must be provided by all participants in the health check questionnaire. In case of a 
problem or complaint, contact details for the investigator in addition to the Research Ethics Committee can 
be found at the top of this document. 
 
 
Will my taking part in this study be kept confidential? What will happen to the results of the research 
study? 
The researchers hope to publish data collected from this study in scientific journal articles, and/or present 
the research findings at relevant scientific conferences. No personal information will be used or referred to 
in the study and you will instead be issued with an identification number. All data will be stored for a 
maximum of 5 years at the Centre for Sports Medicine and Human Performance, Brunel University, and will 
not be released without written permission from yourself or unless required by law. 
 




The research is being organized by the Centre of Sports Medicine and Human Performance, Brunel 
University, and funded by the Portuguese Foundation of Science and Technology as part of Mr. Pedro 
Vargas’ PhD project. 
If you have any questions, please contact: 
 
 
Mr. Pedro Vargas, MSc 
Centre for Sports Medicine and Human Performance 
Brunel University, Uxbridge, UK UB8 3PH 















‘The cardiovascular and autonomic effects of deep and slow breathing’ 
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The information contained within this document is divided into two parts. Part A provides an overview of the 






Recent evidence suggests that practicing deep, slow breathing patterns can reduce blood pressure. These 
breathing patterns have been practiced for centuries during yoga, and more recently, through devices that 
guide users to adopt deep slow breathing. Our previous studies showed that changes in breath volume (tidal 
volume) and breathing frequency do have an immediate impact upon some cardiovascular variables, such 
as blood pressure and heart rate. In this study we intend to explore in more detail, the impact of different 
breathing patterns (breathing frequency, volume and resistance to inhalation) upon the acute responses of 
the cardiovascular system. In addition, we wish to manipulate certain conditions that we think might affect 
responses to deep slow breathing, such as the effect of gravity upon the return of blood to the heart. 
 
Study purpose 
The purpose of this study is to explore some of the factors we believe underpin the effect of deep, slow 
breathing upon heart rate and blood pressure. 
 
Do I have to take part? Can I change my mind and withdraw from the study? 
Your participation in the study is entirely voluntary and at no time should you feel obliged to take part in, or 
continue the study. You may withdraw from the study at any time, without the need to provide any reason, 
without subsequent penalty or prejudice, and without affecting your University grades or professional 
evaluation. This study will require 14 healthy, active males aged 18-35. 
 
How long will the study last?  
The study will require participants to visit the lab on two occasions. During the first testing visit we will collect 
some baseline measurements, including echocardiographic imaging (cardiac ultrasound), and you will learn 
how to control your breathing at a specific rhythm and depth, using a visual feedback device (see Figure 1). 
You will also be required to ingest a therapeutic dose of a medicine named Buscopan®, to check for any 
potential hypersensitivity (further information about this medicine can be found in the following pages). The 









Figure 1. Participant undergoing breathing pacing. 
 
Your second visit will consist of the following parts: 
1. Baseline measurements at rest, preparation and calibration procedures: 15 min 
2. Phase 1 of the intervention: 2h 
3. Comfort break: 20 min 
4. Phase 2 of the intervention (repetition of steps 1 and 2): 2h15 
 
During phase 1 you will be requested to perform 3 bouts of controlled breathing at a fixed percentage of your 
lung capacity and fixed, slow breathing frequencies. Later on, you will be asked to do 2 more bouts at a 
similar volume and breathing frequency but this time however, you will be breathing against two different 
inspiratory resistances. The resistances will make inhaling feel slightly harder, but you will still be able to 
breathe quite freely. The third part of our intervention will involve the repetition of the previous step, with the 
addition of lower body positive pressure (LBPP), which involves applying pressure to your legs by inflating 
special trousers that are worn by jet fighter pilots (see figure 4). We will impose mild levels of compression, 
which shouldn’t cause any significant discomfort, or represent any risk for your wellbeing. The next stage of 
this trial will involve repeating the combination of breathing pattern and LBPP that produced the largest 
increase in your cardiac response, and at the same time that we will stimulate a nerve branch located in your 
outer ear using a transcutaneous electrical nerve stimulation (TENS) machine (see figure 5). An overview of 
the protocol is provided with Figure 2. 
 
Figure 2- Schematic of study design. General structure of each phase – Baseline(yellow) – spontaneous 
breathing; Rest (green) – spontaneous breathing; Control (blue) – device guided breathing; Intervention 1 
(red) – device guided inspiratory loaded breathing; Intervention 2 (orange) – device guided inspiratory loaded 
breathing with lower body positive pressure (LBPP); Intervention 3 (grey) – selected breathing patterns with 
transcutaneous vagal nerve stimulation (tVNS).   
 
Each bout of controlled breathing will last approximately 5 minutes, with 5 minutes of rest between them. 
During the entire trial, specific measures of your physiological function will be assessed. You will be given a 




some fruit (e.g. – banana) and biscuits. You will be allowed to drink approximately 200 ml of water during 
each phase of the study. 
 
In the second phase of the study, we will ask you to repeat everything you did in the first half, but after having 
taken a medication that blocks feedback from nerves within the vagus nerve. This will require the ingestion 
of 20mg of hyoscine butilbromide (Buscopan®). In the UK, Buscopan® is an over the counter treatment for 
abdominal pain, irritable bowel syndrome and abdominal cramps. As well as treating these conditions, 
Buscopan® also has an important effect upon the cardiovascular system by blocking the signals that are sent 
to the brain by a series of receptors in your heart and major blood vessels. The drug is perfectly safe, which 
is why it can be purchased in any supermarket or pharmacy, without the need to consult a pharmacist. The 
Buscopan® will be administered orally and the dosage is in line with the therapeutic recommended dose. 















































What will happen to me if I take part? 
As previously stated, you will be submitted to a series of bouts of controlled breathing, during which we will 
be performing a number of physiological measurements. These measurements are described below: 
 
Pre-test requirements 
You will be first required to complete a health questionnaire and sign a consent form to confirm that you’re 
healthy and able to participate in the study. To ensure that external factors do not influence your test results, 
you will be required to refrain from eating for 2 hours, caffeine for 6 hours and alcohol for 24 hours prior to 
testing. You will also be asked to take a therapeutic dose of Buscopan® a few days prior to undertaking the 
protocol to test for any side effects (during your first visit). Side effects are rare, but might include: 
• Dry mouth; 
• tachycardia; 
• dyshidrosis (an eczema-like skin condition);  
• skin reactions such as urticaria and pruritis (itching); 
• difficulty passing urine.  
 
In very rare situations you may experience: 
• Anaphylactic reaction and shock; 
• Dyspnoea (difficult breathing); 
• Allergic reactions (hypersensitivity) such as skin rash and erythema (patchy red skin); 
 
Also, if you suffer from any of the following conditions you will not be allowed to partake in this study: 
• allergy or hypersensitivity to any of the ingredients in the medicine; 
• fever; 
• fructose intolerance; 
• glucose-galactose malabsorption problems 
• heart problems, including tachicardia; 
• myasthenia gravis (condition that provokes fatigue and weak muscles); 
• angle glaucoma (abnormally high eye pressure); 
• megacolon (dilated colon); 
• other gastrointestinal problems; 
• sucrase-isomaltase deficiency 
• thyrotoxicosis (excess amount of thyroid hormones in the bloodstream); 




Baseline measurements - Your height, weight and lung function will be assessed during your first visit 
(height and weight measurements will not require you to remove any cloths except for your shoes). Lung 
function will be assessed by performing a series of maximal breathing manoeuvres into a mouthpiece (cf. 
figure 3). Cardiac function testing using ultrasonography will also be performed during your first visit (cf. figure 
6). 
 
Lung function - As stated above, your lung function will be assessed using an instrument called a spirometer 
(figure 3). The instrument measures the rate of airflow in and out of your lungs during a maximal breathing 
manoeuvre. The maximal flow and volume changes that a person can produce provide an indication of how 
healthy their lungs are. The manoeuvre requires that you inhale until your lungs are full, and then exhale as 
hard and fast a possible until they are as empty as you can make them. Once empty, you will then fill your 
lungs as rapidly as possible by inhaling immediately. This manoeuvre will be repeated 3-5 times, with 30-60 








Figure 3 – Handheld Spirometer  
 
 
During the controlled breathing bouts, a face mask will be used throughout, to measure breathing patterns, 
and the amount of carbon dioxide and oxygen that you respire (see figure 1).  
 
Cardiovascular function - We will measure your blood pressure and estimate the amount of blood that is 
pumped out of your heart using two cuffs; one placed on the upper arm and one on the middle finger (figure 
4). 
 
Figure 4 – The finger cuff to be used for the continuous measurement of arterial blood pressure. 
 
Heart rate will be measured continuously using a 3-lead ECG. Sensors will be placed on your chest; 2 sensors 
in just below your clavicles and 1 sensor placed just above your left iliac crest, in the midaxillary line (figure 
5). In order to guarantee proper placement and security of the sensors throughout the entire testing sessions 
these might have to be secured with tape. Taping will also eliminate the need for other, less pleasant 













Figure 5 – Placement sites for the 3-lead ECG electrodes. 
 
The amount of blood pumped by the heart per minute (i.e., cardiac output) and on each heartbeat (stroke 
volume) will be calculated non-invasively from images obtained by ultrasonography of the heart (see figure 6 
below).  
 




Lower body positive pressure (LBPP) - A slight compression at the legs will be imposed via the inflation 
of Anti-G trousers, the same that modern jet fighter pilots use (figure 7).  This equipment was developed to 
avoid blood pooling in the legs and facilitate its return to the heart. The maximum inflation pressure of the 
system is around 50 mmHg, which is much lower than the required pressure necessary to fully occlude 










Ear Nerve Stimulation (Transcutaneous Vagal Nerve Stimulation (tVNS)) - Electrical stimulation of the 
auricular (ear) branch of your vagus nerve will be accomplished through a standard transcutaneous electrical 
nerve stimulation (TENS) machine. A bespoke ear-clip electrode will be placed in the external part of both 
ears, more precisely on the tragus (figure 8). Stimulation will be kept at a constant intensity and frequency 
throughout the entire procedure and sustained for approximately 15 min. This procedure is free from risk or 
pain, and has no known side-effects. You should experience little or no sensation during stimulation. If at any 









Vagal blockade - During the final half of the protocol you will be asked to take 20mg of Buscopan®. As 
previously stated this is an over the counter medication and should not pose any risk for your health. 
 
 




This study is aimed at male non-smokers between the ages of 18 and 35 years and with no previous medical 
history of cardiovascular or respiratory disease (e.g. asthma). Similarly, if you’re currently taking anti-
depressants or irritable bowel remedies (e.g., Buscopan®), you cannot take part in this study. You will also 
not be able to participate in the study if you present any reaction to the conducting gel or sticky pads/tape 
used on the ECG electrodes, to any of the constituents of Buscopan® or if you suffer from any of the 
conditions listed in the ‘pre-test requirements’ section.  In addition, if the spirometry tests provide evidence 
of undiagnosed respiratory disease, you will not be able to take part. Finally, it will also not be possible for 




What are the possible disadvantages and risks of taking part? 
Controlled breathing - Since you will not be breathing at your spontaneous breathing frequency and 
amplitude, there is a high likelihood of becoming slightly hypercapnic (high carbon dioxide in the blood) or 
hypocapnic (low of carbon dioxide in the blood). Neither of these conditions represent any known risk to your 
safety at the levels you might experience, and you are free to interrupt the procedure in the unlikely event 
that you feel uncomfortable or unwell. If you become hypercapnic you will feel a strong urge to breathe more, 
which can be accompanied by sensations of heat, sweating and flushing. On the other hand if you become 
hypocapnic, the symptoms may include dizziness. To avoid hypocapnia the breathing circuit will include a re-
breathing system that will eliminate the likelihood of becoming hypocapnic. Both sensations will subside 
quickly once spontaneous breathing is resumed. 
 
Breathing against inspiratory loads - There are no foreseeable risks associated with breathing against 
inspiratory loads, which are used in the treatment of a number of medical conditions. Inspiratory loading has 
been implemented in our laboratories for almost 15 years without any adverse events. 
 
Lower body positive pressure (LBPP) - There is no known side-effects or risks associated to the 
application of LBPP. Notwithstanding this, it is conceivable that the sudden removal of the LBPP might 
cause gravitational hypotension, i.e., blood rushing away from your head under the force of gravity. This will 
translate into dizziness and in extreme cases fainting. This is a similar phenomenon to what you might 





of a sudden drop in blood pressure you are advised to remain seated for a few minutes after the release of 
the LBPP. The maximum pressure generated by the system is just over 50 mmHg, which is much less than 
the pressure necessary to occlude of arterial circulation. Nonetheless, the system is equipped with a pressure 
release safety valve. 
 
Transcutaneous vagal nerve stimulation (tVNS) - Transcutaneous electrical nerve stimulation (TENS) is 
used widely in a range of healthcare applications. The technique is safe and there are no significant adverse 
effects known. However, skin irritation, or even burns, are fairly common if the applied electrical current is 
too intense. The currents that will be applied in the present study should be barely perceptible, therefore 
minimising the risks involved. In the particular case of tVNS, the stimulation of the ear branch of the vagus 
nerve might elicit some side effects, such as cough, gagging, watery eyes, and fainting. All of these effects 
are extremely rare and cease once stimulation has stopped. If you report discomfort or burning/electric shock 
sensation, or if any of the aforementioned responses are observed, tVNS will be ceased immediately. 
 
Vagal blockade - The side effects of Buscopan® might include dry mouth, tachycardia, dyshidrosis (an 
eczema-like skin condition) and difficulty passing urine. Symptoms like transient hypotension (low blood 
pressure) or hypertension (high blood pressure) may also occur. You will be seated, and your arterial blood 
pressure and heart rate will be monitored continuously, so in the unlikely event that a substantial change in 
blood pressure should arise, this will be apparent immediately. In the unlikely event of substantial hypotension 
you will be quickly transferred to the supine position without transferring from the reclining chair in which you 
will be seated. To avoid any discomfort arising from the intake of Buscopan® you will be allowed to drink 
water throughout the experiment. Buscopan® has reportedly very low toxicity levels, which means that the 
occurrence of any noxious reaction is highly unlikely. Any side effects or discomforts will be transient and 
cease as the drug is eliminated from your body. 
 
What if something goes wrong? 
The investigator conducting the experiment is qualified in basic life support, and an individual with advanced 
life support training will be onsite at all times. In addition, an emergency name and contact telephone number 
must be provided by all participants in the health check questionnaire. In case of a problem or complaint, 
contact details for the investigator in addition to the Research Ethics Committee can be found at the top of 
this document. 
 
Pre-participation health check questionnaire  
Health and safety within this investigation is of paramount importance. For this reason we need to be aware 
of your current health status before you begin any testing procedures. To identify whether you are eligible to 
participate in this investigation, we will ask you to fill in the pre-participation health check questionnaire 
included below.  
 
Benefit of participating in the study  
You will gain information on how your body responds to deep and slow breathing and you will have the 
opportunity to receive lung function information that might useful for your health. You also will have the 
opportunity to witness some laboratory procedures, such as cardiovascular ultrasonography.  
 
Will I be paid for my participation in the study?  
You will not be remunerated for participating in this study, but in case of harm Brunel University has an 
insurance policy (NHE-01CA29-0013) with public and products liabilities of £30m. In the case of clinical trials 
the University maintains a comprehensive policy to cover negligent and no fault harm up to a maximum of 





Will my taking part in this study be kept confidential and what will happen to the results of the 
research study? 
The researchers hope to publish data collected from this study in scientific journal articles, and/or present the 
research findings at relevant scientific conferences. No personal information will be used or referred to in the 
study and you will instead be issued with an identification number. All data will be stored for a maximum of 5 
years at the Centre for Sports Medicine and Human Performance, Brunel University, and will not be released 
without written permission from yourself or unless required by law. 
 
Who is organising and funding the research? 
The research is being organised by the Centre of Sports Medicine and Human Performance, Brunel 
University, with the financial support of the Portuguese Foundation of Science and Technology as part of Mr. 
Pedro Vargas’ PhD project. 
 
How can I get information about the study findings?  




Mr. Pedro Vargas, MSc 
Centre for Sports Medicine and Human Performance 
Brunel University, Uxbridge, UK UB8 3PH 














‘Impact of resisted breathing modality upon respiratory induced cardiovascular 
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Recent evidence suggests that practicing deep, slow breathing patterns can reduce blood pressure. These 
breathing patterns have been practiced for centuries during yoga, and more recently, through devices that 
guide users to adopt deep slow breathing. Our previous studies support this idea and showed that changes 
in breath volume (tidal volume) and breathing frequency do have an immediate impact upon some 
cardiovascular variables, such as blood pressure and heart rate. In this study we intend to further explore 
the impact that different breathing patterns (breathing frequency, volume and resistance to inhalation and/or 
exhalation) might have on the acute regulation of the cardiovascular system.  
 
Study purpose 
The purpose of this study is to explore the effect of deep, slow breathing against small respiratory 
resistances, as well as via the nose, upon heart rate and blood pressure. 
 
Study design 
You have been invited to participate in this research study as one of 15 participants. The entire experiment 
will require approximately 2 h of your time. During the testing session we will also collect some baseline 
measurements, and you will learn how to control your breathing at a specific rhythm and depth, using a 
visual feedback device (Cf. Figure 1).  
 





During the testing session you will be requested to perform 9 bouts of controlled breathing at a fixed tidal 
volume (constant breath depth of 30% of your lung capacity and at a fixed breathing frequency (approx. 5.5 
breaths per minute). Six out of those 9 bouts will include breathing against some form of resistance. This 
resistance will be applied either in the expiratory or inspiratory phases of your breathing cycle, or may be 
delivered during both phases. These inspiratory or expiratory loads will be delivered either through a flow 
dependent type of resistance (the quantity of air or air flow that passes through the circuit per unit of time 
will determine the resistance, just like breathing through a straw) or by a threshold respiratory pressure 
device (the resistance is determined by an adjustable pressure release valve, making inspiration or expiration 
only possible if a respiratory pressure above the opening threshold is generated). The final two sets will be 
single-nostril breathing, with no added respiratory resistance.  
Each bout of controlled breathing will last approximately 5 minutes, with 5 minutes of rest between them. 
During the entire trial, specific measures of your physiological function will be assessed (see below). 
 
Do I have to take part? Can I change my mind and withdraw from the study? 
Your participation in the study is entirely voluntary and at no time should you feel obliged to take part in, 
or continue the study. You may withdraw from the study at any time, without the need to provide any 
reason, without subsequent penalty or prejudice, and without affecting your University grades or 
professional evaluation.  
 
What will happen to me if I take part? 
As stated in the ‘Study Design’ section you will be submitted to a series of bouts of controlled breathing, 




You will be first required to complete a health questionnaire and sign a consent form to confirm that you’re 
healthy and able to participate in the study. To ensure that external factors do not influence your test results, 




Your height and weight and lung function will be accessed during your first visit (height and weight 
measurements will not require you to remove any clothes except for your shoes). Lung function will be 
assessed by performing a series of maximal breathing manoeuvres into a mouthpiece. During the controlled 
breathing bouts, a face mask will be used throughout, to measure breathing patterns, and the amount of 
carbon dioxide and oxygen that you respire. We will measure your blood pressure and estimate the amount 
of blood that is pumped out of your heart using two cuffs; one placed on the upper arm and one on the 
middle finger. A small sensor in the finger cuff will also allow the measurement of the amount of oxygen 






Figure 2 – The finger cuff to be used for the continuous measurement of arterial blood pressure and 
blood oxygenation. 
 
Heart rate will be measured continuously using a 3-lead ECG. Sensors will be placed on your chest; 2 sensors 
in just below your clavicles and 1 sensor placed on the lower ribs, just above your left iliac crest. In order to 
guarantee proper placement and security of the sensors throughout the entire testing sessions these might 
have to be secured with tape (figure 4). Taping will also eliminate the need for other, less pleasant procedures, 
like shaving the areas where the electrodes are to be placed. 
 
 
Figure 3 – Placement sites for the 3-lead ECG electrodes. 
 
 
Breathing function  
As stated above, your lung function will be accessed using an instrument called a spirometer (cf. Figure 4). 
The instrument measures the rate of airflow in and out of your lungs during a maximal breathing manoeuvre. 
The maximal flow and volume changes that a person can produce provide an indication of how healthy their 
lungs are. The manoeuvre requires that you inhale until your lungs are full, and then exhale as hard and fast 
a possible until they are as empty as you can make them. Once empty, you will then fill your lungs as rapidly 









Figure 4 – Handheld Spirometer  
 
Respiratory resistances 
The respiratory resistances of approximately 10 cmH2O will be delivered via two different devices attached 
to the aforementioned respiratory circuit (cf. Figure 1). The flow dependent respiratory load will be imposed 
by a bespoke breathing circuit (cf. Figure 2) containing a flow resistor that comprises a number of nylon 
washers that reduce the internal diameter of the airway, thus creating resistance to flow and generating a 
precisely calibrated respiratory load. 
 
Figure 5 – Flow-dependent respiratory breathing circuit 
 
 
The threshold respiratory pressure loads will be delivered by a commercially available device (PowerLung®; 
cf. Figure 6). The load will be adjusted by a spring mechanism that increases/decreases the pressure that the 








Figure 6 – Threshold respiratory pressure device (PowerLung®) 
 
 
Nasal pressure measurements 
The single-nostril breathing part of the protocol will involve the use of a nasal probe for nostril pressure 
measurements (cf. Figure 7). 
 
 




This study is aimed at male non-smokers between the ages of 18 and 35 years and with no previous medical 
history of cardiovascular or respiratory disease (e.g. asthma). You will also not be able to participate in the 
study if you present any reaction to the conducting gel used on the ECG or if you’re currently experiencing 
frequent episodes of nasal bleeding. In addition, if the spirometry tests provide evidence of undiagnosed 
respiratory disease, you will not be able to take part. Finally, it will also not be possible for you to take part 
if you fail to demonstrate the capacity to control your breathing following a visual cue. 
 
What are the possible disadvantages and risks of taking part? 
Controlled breathing 
Since you will not be breathing at your spontaneous breathing frequency and amplitude, there is a high 
likelihood of becoming slightly hypercapnic (high carbon dioxide in the blood) or hypocapnic (low of 
carbon dioxide in the blood). Neither of these conditions represent any known risk to your safety and you 





On the other hand if you become hypocapnic, the symptoms may include dizziness. To avoid hypocapnia 
the breathing circuit will include a re-breathing system that will eliminate the likelihood of becoming 
hypocapnic. Both sensations will subside quickly once spontaneous breathing is resumed. 
 
Breathing against respiratory loads 
There are no foreseeable risks associated to breathing against respiratory resistances, which are used in the 
treatment of a number of medical conditions. Respiratory loading has been implemented in our laboratories 
for almost 15 years without any adverse events. 
 
Single-nostril breathing 
The only potential risk of this particular part of the intervention is the forceful insertion of the nasal probe. 
To mitigate this risk the probe will be inserted by you, the participant. In addition, all the probes, as well as 
the masks to be used in this study, will always be new or sterilised. 
 
What if something goes wrong? 
The investigator conducting the experiment is qualified in basic life support, and an individual with 
advanced life support training will be onsite at all times. In addition, an emergency name and contact 
telephone number must be provided by all participants in the health check questionnaire. In case of a 
problem or complaint, contact details for the investigator in addition to the Research Ethics Committee can 
be found at the top of this document. 
 
 
Will my taking part in this study be kept confidential and what will happen to the results of the research 
study? 
The researchers hope to publish data collected from this study in scientific journal articles, and/or present 
the research findings at relevant scientific conferences. No personal information will be used or referred to 
in the study and you will instead be issued with an identification number. All data will be stored for a 
maximum of 5 years at the Centre for Sports Medicine and Human Performance, Brunel University London, 
and will not be released without written permission from yourself or unless required by law. 
 
Who is organising and funding the research? 
The research is being organised by the Centre of Sports Medicine and Human Performance, Brunel 
University London, with the financial support of the Portuguese Foundation of Science and Technology as 





If you have any questions, please contact: 
 
 
Mr. Pedro Vargas, MSc 
Centre for Sports Medicine and Human Performance 
Brunel University London, Uxbridge, UK UB8 3PH 





Please retain this information document for your records 
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This research investigation has been granted full ethical approval by the Brunel University Department of Life Sciences Research 
Ethics Committee (SREC): Approval #: 
 
The participant should complete the whole of this sheet 
                      Please tick the appropriate box 
YES  NO  
Have you read the Research Participant Information Sheet? 
Have you had an opportunity to ask questions and discuss this study?  
Have you received satisfactory answers to all your questions? 
Who have you spoken to? 
Do you understand that you will not be referred to by name in any report 
concerning the study? 
Do you understand that you are free to withdraw from the study: 
• at any time? 
• without having to give a reason for withdrawing? 
• (where relevant, adapt if necessary) without affecting your 
future care? 
Do you agree to take part in this study? 
Signature of Research Participant:  
Date: 
Name in capitals: 
 
Witness statement 
I am satisfied that the above-named has given informed consent. 
Witnessed by: 
Date: 
Name in capitals: 
 
Researcher name: Signature: 












PRE-PARTICIPATION HEALTH CHECK QUESTIONNAIRE  
 
Health and safety within this investigation is of paramount importance.  For this reason it is essential that we are aware of your 
current health status before you begin any testing procedures.  Additionally, the following questions are designed to establish 
whether you are suited to take part in this study. 
 
Participant name:    ……………………………….…………………………………………   Date of birth:    ___/___/______  
 
Emergency Contact Name:………………………………………………………………   Emergency Contact Tel:...................................... 
 
Please answer the following questions:                          YES             NO 
 
1. Has your doctor ever diagnosed a heart condition or recommend only  
medically supervised exercise? 
2. Do you suffer from chest pains, heart palpitations, arrhythmia or tightness of the chest? 
3. Do you suffer from myasthenia gravis, megacolon, narrow angle glaucoma, thyrotoxicosis,  
        Intolerance to or difficulty digesting sugars, intestinal/urinary obstruction or any other   
gastrointestinal problems?  
4. Do you have known high blood pressure? If yes, please give details (i.e. medication). 
 
5. Have you ever taken Buscopan®?  
If yes, did you experience any side effects (please give details)?    
 
6. Do you suffer from any lung/chest problem, e.g., asthma, bronchitis, emphysema? 
If yes, please give details (i.e. medication).  
7. Do you suffer from epilepsy? If yes, when was the last episode? 
8. Are you currently being medicated with anti-depressants, anti-histamines, antipsychotics, 
        antiarrhythmics, or any drugs for nausea, asthma or Parkison’s disease (please give details)? 
 
8.   Are you a smoker? If yes, please give number of cigarettes per week. 
9.   Do you have any known allergy to conductive gel? 
       (i.e. the gel that is used in ECG, Doppler, etc…)  
10. Please document your current weekly exercise routine; 
Type of exercise (cycling, running, weight training etc) Number of sessions/week Duration of session 
   
If you feel at all unwell as a result of a temporary illness (cold or fever) please inform the investigator. Please note that 
if your health status changes and in any way affects the answers you provided to the questions above, it is paramount 
that you notify the investigator immediately. 
 
 
I have read and fully understand this questionnaire. I confirm that to the best of my knowledge the answers 
provided are correct and accurate. I am aware of no reasons why I should not participate in physical activity and I 
am fit and fully able to volunteer for this investigation.  I understand I will be taking part at my own risk. 
 
Participant’s name & signature:     Date:__________                                                   








Evaluation of the independent influences of breathing frequency and tidal 
volume upon heart rate variability in healthy men 
 
P. Vargas1, J. González-Alonso1 and A. McConnell1 
 
1Centre for Sports Medicine and Human Performance, Brunel University London, 
Uxbridge, (UK) 
 
Introduction: Respiratory sinus arrhythmia (RSA), a main component of heart rate 
variability (HRV), maximises at a breathing frequency (FR) of 4-6 b.min-1 (1), and 
correlates with cardiac vagal activity (2). The independent influences of FR and 
concomitant changes in tidal volume (VT) and PCO2 upon HRV and autonomic 
nervous system (ANS) function are unknown. We tested the hypothesis that HRV 
may be maximised by controlling both FR and VT. Methods: Nine healthy, 
recreationally active men participated (27.1±2.6 yr). In part 1 the relationship 
between FR was assessed and individual FR optima identified, whilst maintaining a 
constant VT of 30% of vital capacity (VC). In part 2 the optimal FR identified in part 
1 was implemented across a range of VT. Parts 1 and 2 included a semi-
spontaneous condition in which only VT or FR were controlled, respectively. 
Conditions were randomised and made in an upright-reclined position. Mild 
hypercapnia was maintained under all conditions except semi-spontaneous 
breathing (GA-200 gas analyser, iWorx Systems Inc.). A biofeedback system 
(LabView, National Instruments Inc.) specified respiratory flow and duty cycle, which 
were measured by heated pneumotachograph (Hans Rudolph 3813, Hans Rudolph 
Inc.), whilst heart rate was measured via 3-lead ECG. Primary outcomes were the 
standard devi ation of normal R-R intervals (SDNN) and the total power (TP) of the 
power spectrum density. Repeated measures ANOVA with post hoc pairwise 
comparisons using Bonferroni correction were used to test differences between 
conditions and Pearson correlations accessed the inter-relationships. Results: In 3 
of 9 participants SDNN and TP maximised at 4 b.min-1, whilst the remaining 6 
maximised at 6 b.min-1. Significant main effects of FR and VT were found for SDNN 
[F (5, 40) = 8.195; p<0.001; F (6, 48) = 13.280; p<0.001] and TP [F (5, 40) = 11.147; 
p<0.001; F (6, 48) = 7.233; p<0.001] respecttively. Effect sizes were moderate for 
all variables and conditions (ηp2=0.475-0.624). Discussion: There were significant 
independent effects of FR and VT, upon SDNN and TP, with maxima at 6 b.min-1 for 
6/9 participants, and at the highest VT for all participants. Adopting a higher VT than 
that used spontaneously at optimal FR did not significantly increase HRV. Whether 
VT s over 40% VC yield significantly greater HRV remains to be explored. 
References 
1) Song H & Lehrer PM (2003). Applied Psychophysiol Biofeedback, 28 (1),13-
23; 2) Kollai M & Mizsei G (1990). J Physiol, 424 (1), 329-342. 
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Evaluation of the independent influences of breathing frequency and tidal 
volume upon respiratory sinus arrhythmia, blood pressure and baroreflex 
sensitivity in healthy men. 
 
Pedro Vargas1; José González-Alonso1; Alison McConnell1,2 
 
1Centre for Sports Medicine and Human Performance, Brunel University London, 
Uxbridge, (UK); 2Faculty of Health & Social Sciences, Bournemouth University, 
Christchurch Road, Bournemouth, (UK). 
 
Keywords: Respiratory sinus arrhythmia, Baroreflex Sensitivity  
Background: Slow breathing exerts a potent effect upon blood pressure regulation, 
but the independent influences of breathing frequency (fR) and tidal volume (VT) 
upon the interplay of respiratory sinus arrhythmia (RSA), mean arterial pressure 
(MAP) and the baroreflex sensitivity (BRS) are poorly understood.  We hypothesised 
that the fR and VT would exert independent effects upon RSA, MAP and BRS. 
Methods Part 1: the relationship between fR and cardiovascular outcomes was 
characterised, and the fR (between 4 and 10 b.min-1) that maximised RSA in each 
of 14 healthy men was identified. Part 2: the optimal fR identified in part 1 was 
implemented across a range of VTs (20 to 40% FVC). PaCO2 was controlled using 
added dead-spaces. A bespoke biofeedback system specified the respiratory flow 
rates. Results: RSA, MAP and BRS exhibited a bell-shaped response to changes 
in fR, with a peak at 6 b.min-1 for all variables. A significant main effect for fR upon 
RSA (p<.05) and BRS (p<.05) was detected, but MAP showed no significant 
relationship to fR (p>.05). RSA increased linearly with increments in VT, peaking at 
the highest VT tested (40%FVC; p<.05). A positive main effect for VT upon MAP 
(p<.05) was found, but post-hoc analysis found no differences between VTs (p>.05). 
VT induced changes in BRS were not significant (p>.05). Discussion: Independent 
effects of fR and VT upon RSA were found in all participants, whilst only changes in 
fR affected BRS. It is possible that VTs above 40%FVC might elicit even higher RSA 
and BRS. 
 
This work was supported by the Portuguese Foundation for Science and 
Technology - FCT 
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Acute cardiovascular responses to slow and deep breathing with different 
modalities of airway loading 
Alison Kay Mcconnell1; Pedro Miguel Fernandes Vargas1,2; José González-
Alonso2. 
1Bournemouth University, Bournemouth, (UK); 2Brunel University London, 
Uxbridge (UK). 
Introduction: Daily bouts of slow, deep breathing (SDB) with added inspiratory 
resistance have been shown to have a larger antihypertensive effect than SDB 
alone, in people with hypertension (Jones et al., 2010; Sangthong et al., 2016). We 
compared acute, with breath (inhalation vs. exhalation) cardiovascular responses to 
different modalities of respiratory loading during SDB. Methods: Fifteen healthy 
males were tested in a semi-recumbent position. Participants completed 
randomised, 5 min bouts of SDB at 6 breaths·min-1 and a tidal volume of 30% of 
forced vital capacity. One bout consisted of 5 min of unloaded SDB (UL), remaining 
bouts combined SDB with flow resistive (FR), or pressure threshold (PT) inspiratory 
(I) or expiratory (E) loads of ~10 cmH2O, interspersed by 5min of normal breathing. 
Results: Loading type (FR vs. PT) did not influence cardiovascular responses to 
SDB, data were therefore pooled for subsequent comparisons. Compared with UL 
(306±SD120 msec), the amplitude of within breath oscillations in heart rate (fc) was 
smaller during E (249±SD140 msec; P<0.001), but larger during I (435±SD145 
msec; P<0.001). Compared with UL (11.6±SD6.2 mL), the amplitude of within breath 
oscillations in stroke volume (SV) were unchanged during E (15.1±SD6.4 mL), but 
larger during I (24.0±SD7.3 mL; P<0.001). Compared to both UL (92.3±SD5.8 
mmHg) and I (90.7±SD8.8 mmHg), E elicited a significant pressor response 
(100.1±SD7.2 mmHg; P<0.001), but significantly lower cardiac output (6.2±SD0.85 
vs. 6.4±SD0.89 vs. 5.8±SD0.94 l.min-1; P<0.004). Conclusions: Inspiratory loading 
generated the largest within breath perturbation of fc (respiratory sinus arrhythmia) 
and SV, most likely due to an augmentation of venous return via a more negative 
intrathoracic pressure. This may contribute, at least in part, to the reportedly more 
potent antihypertensive effect of SDB with I loading. However, potential underlying 
mechanisms remain to be resolved.  
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